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The effects of a six-week physiotherapist-led exercise and education intervention in 
patients with osteoarthritis, awaiting an arthroplasty, in South Africa: a randomised 
controlled trial. 
Author: Melissa Michelle Saw 
 
Background: Osteoarthritis (OA) is one of the leading causes of disability worldwide. A 
major challenge facing those with severe OA is long waiting lists delaying access to joint 
replacements. Patients are known to wait more than five years for a joint replacement in 
the Western Cape of South Africa (SA). The main complaint in this population is pain and its 
consequences including activity limitations, participation restrictions and reduced quality of 
life. Hip or knee OA is not merely joint degeneration but a condition requiring holistic 
management, even while waiting for surgery. Most of the literature in this field is available 
from high income countries exploring the effects of interventions during short waiting 
periods. Thus research is warranted in a low income country such as SA, in those waiting 
for long periods to explore the effects of a six-week physiotherapist-led exercise and 
education intervention.  
Methods: A single blinded randomised controlled trial, aligned with CONSORT guidelines, 
was performed at Tygerberg Hospital in the Western Cape, SA. The experimental group 
attended a six-week group-based physiotherapist-led intervention including education, 
exercise and relaxation. The control group continued to receive usual care. The primary 
outcome measure was pain with secondary measures of disability, function, quality of life 
and self-efficacy. Measures were obtained at six weeks, 12 weeks and six months by a 
blinded physiotherapist. An open ended questionnaire was completed by the participants 
in the experimental group at month six. Analysis was by intention to treat. Two-way 
analysis of variance and post-hoc Tukey comparisons were used for parametric data, 
Pearson Chi squared calculations for categorical data. Effect sizes were established for 
significant differences between groups. 
Results: The study recruited 42 participants from the waiting list for a hip or knee 




Compared to the control group, the experimental group had significant improvements with 
large effect sizes at month six for pain interference (3.49 ± 2.63 vs. 6.09 ± 2.43; p=0.02, 
ES=1.15) and function (15m fastest speed walk) (15.09 ± 6.04s vs 20.10 ± 8.79s; p=0.03, 
ES=0.88). Furthermore, the experimental group displayed significant (p < 0.01) and 
sustained improvements at month six in pain severity, disability and function (15m normal 
speed walk, sit-stand, 6-minute walk). Subgroup analysis showed participants with knee OA 
responded better to the intervention than those with OA of the hip or combined hip and 
knee OA. Participants enjoyed the intervention reporting improved knowledge, function 
and activity, pain relief and improvement in psychosocial aspects.  
Conclusions: A six-week physiotherapist-led exercise and education intervention brought 
about significant long term improvements in pain interference and functional walking 
ability in patients with osteoarthritis, awaiting a joint replacement compared with a control 
group. Such a programme also appears to have significant and sustained improvements in 
pain severity and disability. Further research with longer follow up is recommended to 
determine if results are sustained.  
 
Keywords: Hip/knee osteoarthritis; arthroplasty/joint replacement; waiting list;  
physiotherapy; exercise; education; chronic pain.  
Ethical approval: University of Cape Town Faculty of Heath Sciences Human Resource Ethics 
Committee: Ref 378-2013. 
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Glossary of Terms 
Acetabulum/acetabular: an anatomical term that refers to the socket of the hip joint in 
which the head of the femur articulates(1).  
Acupuncture: traditionally a type of Eastern medicine that involves the insertion of thin 
needles into the skin and muscle. It is used to treat a variety of symptoms and is known as 
the physiotherapy term “dry needling” in South Africa(1). 
Allodynia:experiencing pain in response to a stimulus that does not normally provoke 
pain(2). 
Apartheid:  a historical term meaning “separateness” used to describe a political periodof 
racial discrimination in South Africa that ended in 1994. 
Arthroscopic lavage:asurgical procedure performed by thin telescopic instruments to 
examine and wash out an area or joint(1). 
Arthroplasty:a surgical procedure whereby the total joint surfaces areremodelled and 
replaced by a prosthesis(1). 
Assistive device:an artificial aid designed to assist a person to perform a task. In this study 
it refers to mobility assistive devices like walking sticks, crutches and walking frames that 
allows for transfer of weight from the legs through the arms(3). 
Chronic pain: pain that persists past the normal time of healing(4). 
Coxa valga: an anatomical term used to describe a deformity of the hip joint whereby the 
femur neck angle is abnormally large(1). 
Coxa vara: an anatomical term used to describe a deformity of the hip joint whereby the 
femur neck angle is abnormally small(1). 
Delphi technique:a term used to describe a systematic method of analysis, decision making 
and forecasting in order to eliminate subjective views or opinions. Typically it lasts at least 
two rounds of experts answering questions and giving justification for their answers, 
providing the opportunity between rounds for changes and revisions. The multiple rounds, 
which are stopped after a pre-defined criterion is reached, enable the group of experts to 
arrive at a consensus forecast on the subject being discussed(5). 
xxii 
 
Electrotherapy: amanual branch of physiotherapy that makes use of electrical equipment 
for therapeutic purposes. The passage of electric currents through the body’s tissues is 
used to stimulate the functioning of nerves and the muscles that they supply(1). 
Fear avoidance: the characteristic or belief based on the fear of pain and therefore the 
avoidance of activities that cause pain(6).   
Femur/femoral: an anatomical term that refers to the long bone of the thigh that 
superiorly articulates with the acetabulum to form the hip joint and inferiorly with the tibia 
to form the knee joint(1). 
Genu valgum: an anatomical term used to describe a malalignment of the knee joint 
whereby the knees are angulated inwards (knock kneed)(1). 
Genu varum: an anatomical term used to describe a malalignment of the knee joint 
whereby the knees are angulated outwards (bow legged)(1). 
Hyperalgesia:an abnormal state of increased sensitivity to pain whereby extreme pain is 
experienced in response to a normally painful stimulus(2). 
Innocuous: a term used to describe a stimulus which is harmless or does not usually evoke 
pain(2).  
Leptin: a protein produced by adipose tissue that plays an important role in regulating 
eating(1). 
Manipulation: a treatment term used in physiotherapy when a jointis moved in a brisk 
manner to facilitate more mobility at the joint(1). 
Morning stiffness: difficulty moving a joint through full range of movement experienced in 
the morning directly after lying for a long period with minimal movement. It usually lasts 30 
minutes or less for OA(7). 
Nociceptor:a sensoryreceptor involved in the pain processing system, which if stimulated 
can result in central nervous system processing which produces a pain reaction to warn the 
body of actual or potential tissue damage(1).  
Nociception: refers to the process whereby nociceptor receptors are stimulated(1). 
Osteophyte: an additional piece of bone, often formed in an attempt to create stability at a 
site such where cartilage degeneration or destruction near joints occur(1). 
Osteotomy:a surgical procedure whereby a portion of bone is removed(1). 
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Pain:an unpleasant sensory and emotional experience associated with actual or potential 
tissue damage or described in terms of such damage(8). 
Pain intensity: describes the severity or amount of pain felt by an individual(9). 
Pain interference: describes how much pain interferes or affects an individual(9). 
Placebo effect:a therapeutic effect from the administration of a placebo intervention, 
aimed at achieving a non-specific benefit of treatment(1). 
Plasticity:the ability of the nervous system to change and adapt as necessary(2). 
Primary level care: a term used in South Africa to describe the first level in the public 
health care system, these clinic facilities are usually situated in a small community and 
deliver health care to the population of and surrounding that community(10).  
Prosthesis: an artificial implant used to replace a biological part of the body. In terms of 
this study, a hip prosthesis comprises of an acetabular cup and a femoral head and shaft. A 
knee prosthesis comprises of a femoral and tibial articulating surface(1). 
Rehabilitation: the process whereby the aim is to maintain, improve or restore normal 
health and function to prevent disability from worsening(1). 
Reliability: a term used in research to describe the consistency of an outcome 
measurement tool.  
Self-management: wherebythe patient assumes an active part in the daily care of their 
health condition that involves three components namely; medical, behavioural and 
emotional management(11) 
Secondary level care: a term used in South Africa to describe the second level in the public 
health care system, these small hospitals deliver health care and simple surgery(10).  
Self-efficacy:the belief in one self’s perceived capability to perform a task or achieve a 
goal(12).  
Thermotherapy: a therapeutic term used in physiotherapy to describe therapy based on 
temperature; either cold named cryotherapy to reduce pain or inflammation or heat 
named thermotherapy to relieve pain, stiffness and promote circulation(1). 
Tertiary level care:a term used in South Africa to describe the third level in the public 
health care system, these big hospitals deliver specialised health care and surgery(10). 
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Tibia/tibal: an anatomical term that refers to the long bone of the shin that superiorly 
articulates with the femur to form the knee joint and inferiorly with the talus bone to form 
the ankle joint(1). 
Transcutaneous electrical nerve stimulation: an electrotherapy modality used in 
physiotherapy which causes electrical impulses to pass into tissues to activate a muscle or 
inhibit pain(1). 
Ultrasound: an electrotherapy modality used in physiotherapy which sends high frequency 
sound waves into the tissues to stimulate a pro-inflammatory response(1).  
Validity: a term used in research to describe how sound research is or to what extent a sign 
or test is a true indicator of what is being tested(1). 
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1 Introduction and scope of thesis 
1.1 Background 
Osteoarthritis (OA) is known as the most common joint disease worldwide(13). The 
prevalence of OA continues to rise exponentially in both high and low income 
countries(14,15), including South Africa (SA).The burden of OA leads to a large portion of the 
older population suffering with daily pain and disability(16-20). This burden extends far 
beyond the physical aspects of a joint pathology alone as OA is considered a complex 
condition affected by and affecting various factors related to the individual(21,22). These 
include and are not limited to personal, psychological, social and environmental factors(22).   
 
Due to the complexity of OA, effective management is necessary at all stages of the 
condition.As insight into this field of research is constantly improving, many evidence-
based guidelines have been published for OA of the hip and knee(23-30).The gold standard of 
treatment for OA begins withnon-pharmacological methods of education, exercise and 
weight control(29). Pharmacological agents are subsequently added as required, in 
combination with first-line management(29).Finally, surgery is indicated for those with late 
stage OA who do not respond to conservative treatment methods(29). 
 
A major concern identified internationally is the limited accessibility of the necessary 
management options, especially in the public health system(14). This is true for many 
individuals with OA of the hip and/or knee in the Western Cape of SA, where delays in 
surgery are experienced as a result of long waiting lists for a joint replacement(31). 
Tygerberg hospital (TBH) is one of eight health care facilities in the province that provides 
joint replacements to patients with late stage OA(32). It has been reported that waiting for 
surgery leads to negative impacts on the individual and thus adds to the burden of OA(33,34). 
 
In response to the increasing burden of OA and long waiting lists at Tygerberg hospital, 
research was warranted to establish the effects of an exercise and education intervention 
in patients with osteoarthritis on the waiting list. Once these effects are known, the results 
can be utilised to provide the appropriate evidence-based management to patients, while 
awaiting surgery. Additionally this study can lead to further valuable research in this field. 
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1.2 Aim and objectives 
1.2.1 Aim of the study 
The aim was to determine the effects of a six-week physiotherapist-led exercise and 
education intervention in patients with OA, awaiting a hip/knee joint replacement. 
 
1.2.2 Objectives of the study 
The objectives were to determine whether participating in a six-week physiotherapist-led 
exercise and education intervention, resulted in a significant change in the following 
outcomes, when compared to the control group,in patients with OA awaiting a hip or knee 
replacement:  
- Pain severity and pain interference as measured on the Brief Pain Inventory (BPI)(35) 
- Function as measured by the Physical Performance Task Battery(36) 
- Disability as measured by the Stanford Health Assessment Questionnaire (HAQ)(37) 
- Self-efficacy (SE) as measured by the Self-Efficacy for Managing Chronic Disease 6-
Item Scale(38) 
- Health-related quality of life as measured by the EQ-5D(39). 
In addition, to determine whether body mass index (BMI) value(40); orOA of the hip or knee 
or a combination of hip and knee OA, accounted for any significant differences in the above 
outcome measures. Finally, to determine the acceptability of a six-week physiotherapist-




2 Literature review 
2.1 Introduction 
According to research statistics in low- and middle income* countries, the adult burden of 
disease (BOD) is shifting from infectious diseases to an increased prevalence of chronic 
non-communicable diseases (NCD)(41,42). This prevalence rate wasreported to be close to 
45% in 2004(41). Chronic NCD include musculoskeletal conditions (MSC), which are the most 
common causes of severe long term pain and disability(43). According to studies by Murray 
and Lopez(44), MSC account for 4.68 x 106 disability adjusted life years† (DALY) lost in higher 
income countries. This figure is expected to increase to 5.6 x106 DALYs by the year 2020(45). 
Similar statistics for lower income countries are scarce. Statistics available from SA in 2004 
show that 28% of the total DALYs lost are attributed to NCD(46).  However, it is noted that 
risks for attaining NCD are higher in low to middle income countries than in higher income 
countries(41) and that the burden caused by these conditions is estimated at two to three 
times higher than in higher income countries(46). The expected increase in burden in lower 
income countries is said to be due to a greater life expectancy of the population(45,46), and 
increasing co-morbidities such as obesity, diabetes mellitus (DM) and cardiorespiratory 
conditions(47,48). Of the various musculoskeletal conditions, OA is one of the four leading 
causes of disability worldwide, together with rheumatoid arthritis(RA), osteoporosis(OP) 
and low back pain (LBP)(19,49,50,50,51).  
 
Disability is not a simple term but rather a complex phenomenon(52). Being “disabled” is not 
a category that a person falls into or not, as traditionally described(52,53). For many years 
disability was defined by biomedical terms alone, due to the presence of pathology. 
However since 1994, disability has been recognised as the disparity between an individual’s 
capability and their unique social or environmental demands(54). The term “disability” 
differs from the term “functional limitation” by explaining the individual’s functional 
inadequacyin terms of the person’s social and cultural context(53,54).  
                                                          
* The World Bank’s definition of classifying country’s economies is based on the country’s gross national income per capita; 
low income, middle income (subdivided into lower middle and upper middle), or high income. South Africa is classified as an 
upper middle income country(362). 
† Disability-adjusted life years (DALYs) represent a health gap; it measures the state of a population’s health compared to a 
normative goal. The goal is for individuals to live the standard life expectancy in full health. DALYs are the sum of two 
components: years of life lost due to premature mortality (YLLs) and years lived with disability (YLDs). YLLs = number of 
deaths at each age multiplied by a standard life expectancy at age x. YLDs - the prevalence of different disease-sequelae and 
injury-sequelae multiplied by the disability weight for that sequelae. DALYs are an absolute measure of health loss; they count 
how many years of healthy life are lost due to death and non-fatal illness or impairment. (363) 
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In order to accurately define and measure disability, assessment of the person’s physical 
condition as well as their functional ability in their personal and social environment is 
necessary(52). The information gained from an assessment such as the aforementioned, is 
then used to formulate a tailored approach to management options for the individual. This 
explains how two individualswith the same condition, such as OA, may present with the 
same physical impairment, such as decrease range of movement (ROM) in a joint, yet 
function at different levels due to variances in their personal environments or social 
settings either facilitating or hindering their functional ability.  Additionally, personal 
factors such as meaning or importance placed on the achievement of a certain task or 
participation in an activity has an influence on the way two people with the same condition 
experience a similar situation(55). In order to provide a framework to define disability and 
facilitate the development of personalised treatment plans, the WHO released the 
International Classification System of Functioning, Disability, and Health (ICF) in 2001(56). 
The ICF will be used in this thesis as a theoretical framework. 
 
2.1.1 International Classification of Functioning, Disability and 
Health – a theoretical framework 
The development of a theoretical framework for defining disability and health commenced 
in the 1960’s and over the years has been revised on a number of occasions(54,57,58). In 2001, 
the World Health Organisation (WHO) released the newest classification called the ICF(56). 
This classification has been accepted and utilised worldwide, as it reflects the best 
understanding of the complexities of disability, as mentioned above(52,59). The ICF model not 
only describes disability in medical terms of physical pathology or impairments, but also 
incorporates personal and social aspects of disability. It does so by integrating the physical 
condition and personal or psychological aspects with functional and/or environmental 
restrictions that are experienced. This is done by identifying difficulties in specific activities 
or participation in the individual’s social situation and the reasons therefore(53,56). See Table 




Table 2-1 Definitions and Concepts of the ICF components 
Component Body functions 
and structures  
Activity Participation Environmental 
Factors 
Definition: Body functions 
are the 
physiological 








of the body, such 






of a task or 





a life situation 
Environmental 
factors make up the 
physical, social and 
attitudinal 
environment in 
which people live 
and conduct their 
lives  















Figure 2-1 ICF links showing the different components of disability 
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In rehabilitation medicine, the ICF is used to bring structure and clarity to the problems 
identified during assessment by the rehabilitative professional(60). This is done by evaluating 
the many different components involved to give a clear picture of the entire impact of the 
condition(60). Rehabilitation definitions have previously focused on solely “enabling the 
individual” by addressing their physical ailment but not necessarily attendingto personal 
factors or addressing function in a social or environmental context(59). However, re-
education of function in rehabilitation according to the ICF, incorporates impairments, 
function, personal aspects and the social environment to enable the individual in their 
different contexts. 
 
As with most frameworks or models, limitations of the ICF have been noted in the 
literature by various authors. Oncology researchers(61) raise a few logistical concerns 
regarding the ICF and have put forward recommendations to improve these areas.  Firstly, 
an issue has been raised regarding the term used as “health condition”. Bornbaum and 
colleagues(61) suggest that a “health condition” is either present or absent which 
realistically is not the case in many chronic disorders; some conditions have different stages 
and progressions which are not fully described by the term above. Another point was made 
regarding the term “condition” being in the singular form; suggesting that this model does 
not account for the common occurrences of co-morbidities that result in further health, 
personal and social consequences(61). The recommendation has been made to add in a 
component dedicated to co-morbidities and to rather make use of the term “health state” 
as this better reflects the presentation of different health concerns and their related 
aspects as they affect the individual.  
 
Furthermore, it is noted that limitations exist surrounding the classification terms for 
personal factors and the subjective dimension of a patient’s experience; more specifically 
highlighting the aspect of quality of life(55,61). It is known that personal factors such as the 
perception of one’s quality of life and psychological aspects have a great influence on a 
person’s way of functioning and participating in a work or social context. The aim of the 
WHO and researchers is to improve this component of the framework by the addition of 
“personal perception” as a personal factor in order that quality of life is correctly 
accounted for when using this model(55).  
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Other authors criticise the model as being purely a useful classification system to detect 
deviations from the norm in those with a disability and is not always carried over into 
rehabilitation(62).   
 
Additionally, the layout of the ICF implies that disability is first and foremost focused on 
identifying concerns related to a condition with a physical impairment and not necessarily 
on the development of a condition or impairment due to personal or environmental 
factors. The structure infers that once the physical condition has been treated or cured, the 
components of activity restrictions and participation limitations should no longer be of 
concern. In this way it fails to account for issues prior to the development of a disorder or 
persistent problems after the impairment has been managed(61).  
 
Despite the above criticisms the ICF is a useful framework to ensure the importantaspects 
which impact an individual are assessed, treated and measured during rehabilitation. 
Essentially, the ICF provides a biopsychosocial framework for the analysis of the multiple 
factors affecting a person with OA. 
  
2.1.2 Research Setting  
As discussed, when using the ICF as a framework for the management of various conditions 
requiring rehabilitation, the patient’s environment is therefore an important factor to 
consider. One individual can function well in one environment but can be disabled in 
another. For instance; a patient with OA of both knees walks safely on the smooth hospital 
floors with a walking aid, however at home the patient is unable to walk beyond his front 
door as the surface in front of his house is a sandy terrain. Therefore, the setting in which 
assessment and on-going management of this condition takes place should be considered 
and adapted accordingly to facilitate the highest level of functioning. Additionally, if the 
person is faced with an unknown environment as a barrier to function, it may be necessary 
for the person to adapt to this new setting by being able to evaluate the situation and 
problem solve accordingly. This draws focus to a very important aspect of effective 




Self-management is defined as the patient assuming an active part in the daily care of their 
health condition that involves three components namely; medical, behavioural and 
emotional management(11).  As a prelude to further discussion on OA and related topics 
such as self-management, a brief overview is first given aboutthe population and health 
care setting under investigation.  
 
i. South African population and health care  
Data gathered from the most recently published burden of disease study in 2000(63) gives a 
clear breakdown of the South African population. Black Africans account for the majority of 
the population (79.2%), followed by whites (9.2%), coloured (9%) and Indian population 
(2.6%). Economically, 10% of the wealthy population is considered rich and possess51% of 
the country’s income, whereas the majority of the population are poor(45.5% of the 
population are classified as poor and 20.2%as living in extreme poverty(64)) with the poorest 
10% accounting for only 0.2% of the country’s income(65).  
 
The entire health system ofSA has had many struggles from the past apartheid era until the 
current day(66). Despite SA being classified economically as a middle income country, the 
health outcomes reported are still not in accordance with this income level; instead it 
reflects results expected of a lower income country(66). Differences seen in health statistics 
based on race clearly show the ever present carry over effects from apartheid times. Values 
recorded for morbidity and mortality rates in SA for the last decade are much higher in 
poorer black populations compared to middle-class white populations(66).  Since the 
emergence of the private health sector, public health care is presented with a multitude of 
challenges, as close to half of the country’s expenditure on health care goes towards the 
minority of wealthier patients in the private sector(66). Statistics emerging from the South 
African General Health Survey in 2011(67) reported mostly black and coloured households 
utilise the public health care facilities in SA (81.3% and 63.1% respectively). 
 
In 2009 the major problems affecting the health systems of the country were brought to 
the attention of the national government and major institutions with the aim to improve 
factors contributing to the ongoing issues(68).  
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The four main health concerns related to Human Immunodeficiency Virus 
(HIV)/Tuberculosis (TB), Chronic/mental health conditions, injury/violence and 
maternal/neonatal and child health(68).  As mentioned, particular issues originating from 
previous racial and gender discrimination remain a challenge and have longstanding 
influences on the health of the population today(66). High levels of unemployment, 
inadequate housing and sanitation,and malnutrition aresome of the social factors that play 
a part in determining health and well-being(66,68).  
 
Three key suggestions were made to address the ongoing challenges in the country: firstly, 
emphasis was placed on better prevention of major health conditions, followed by the 
need for integration of public and private sectors at a primary level to effectively promote 
well-being and manage conditions at entry point into the health system. Subsequently 
implementation of evidenced-based strategies and interventions to successfully manage 
these conditions is essential(68).Together with this, is the ongoing need for high quality 
research to continually produce relevant and scientifically sound material on which health 
care decisions can be based(68).   
 
ii. Increasing rise in non-communicable diseases in SA 
It has been noted that, like many other countries, South Africa has also displayed a rising 
prevalence of NCD in the last 25 years and that chronic conditions present a large burden 
on the existing health care system(68). The increase in NCD is predominantly in the large 
portion of the SA population living on low income and with low levels of education(68). The 
national department of health set a goal to reduce NCDs like hypertension (HPT), diabetes 
mellitus and asthma by encouraging lifestyle changes, weight loss, regular physical activity 
and adherence to medication(69). In order to aspire to this goal, among other prerequisites, 
is the need for further human resources within both the urban and rural areas of the public 
healthsector(66). Furthermore, human resources required at all levels of the health system 
need to be adequately trained(66). If the goal is to provide healthcare based on the ICF 
framework, all personnel (including rehabilitative personnel) require specific education in 





With the increase in burden from chronic diseasesin SA, service delivery from community 
or district level to tertiary level has beenplaced under severe pressure(46).  Ongoing 
issuessuch as limited staffing capacity and growing numbers of patients presenting with 
both infectious and chronic conditions cause lengthy waiting periods at all levels(31). At 
primarylevel care facilities the focus needs to be on prevention of illness or disability and 
promotion of health and self-management, so as to prevent a further burden on the higher 
levels of the public health system. A recent media release(31) by the Western Cape’s 
Minister of Health reported on the challenges faced in the province wherebed occupancy is 
over 100% in many of the major secondary hospitals. At tertiary level, both out-patient 
clinics and inpatient services are often delayed or re-scheduled. Elective waiting lists for 
various surgeries are extremely long as there are restricted resources in terms of surgery 
time, theatre staff, beds, nursing and rehabilitative personnel. Elective surgeries are also 
often pushed back to accommodate the unacceptably high emergency waiting lists. This 
leads to further time delays and inevitably patients are forced to wait long periods before 
receiving recommended surgical management. Concerted efforts have been made to 
reduce these waiting times but the population in the Western Cape has had a sudden 
increase in number since 2001 (28.8%) due to migration from surrounding provinces 
compounding the issues(31).  
 
Of particular interest to this study is the waiting time for surgery at one of three tertiary 
hospitals in the province; Tygerberg Hospital. The hospital,located in Parow, Cape Town, 
services in- and outpatients primarily from, but not restricted to, the Western Cape. 
Patients are usually referred from secondary hospitals or primarylevel care facilities in the 
surrounding areas to TBH for tertiary level care. The population of interest for this study 
are persons with osteoarthritis who have been referred to the orthopaedic department for 
consultation by the doctors concerned with arthroplasty surgery. Those requiring surgery 
are placed on the waiting list to electively receive a hip or knee joint replacement. The 
waiting list at TBH consists of over 3000 patients(32) and average waiting time for surgery 






Literature from higher income countries such as Canada, United Kingdom (UK) and New 
Zealand show that waiting for an arthroplasty has negative effects on a person’s function 
and quality of life(70-72) and that conservative management, led by a physiotherapist, is 
necessary while waiting for surgery(70). Literature on the effects of pre-operative treatment 
has inconsistent views; a systematic review (SR) and meta-analysis (MA)was performed in 
2011exploring pre-operative conservative and non-pharmacological interventions, mainly 
exercise with some including education, in those with OA of the knee and hip awaiting joint 
replacement(73).It showed low to moderate evidence from small randomised controlled 
trials (RCT) exist that support the use of pre-operative treatment, specifically exercise, to 
reduce pain(73). While, a more recent SR on pre-operative interventions while on a waiting 
list stated that exercise can improve pain and function in those with hip OA but not with OA 
of the knee(74). The limited literature available justifies the need for further research into 
OA management while on a waiting list as well as to ascertain whether the effects, 
particularly of exercise, are different for those awaiting a hip or knee replacement(74). 
 
Loirg and Holman advised that the most likely option for pre-operative intervention would 
be to provide management at out-patient primary level facilities in the community(11). 
Additionally group-based treatments which attend to a larger number of patients at once 
could potentially address the issue of waiting for individual time with a health professional. 
Treatment in the interimduring the waiting period has been shown to improve fitness and 
quality of life as well as having the added benefit of possible improvements in activity(73) 
and perceived disability post-operatively(70). Whether these recommendations are practical 
to implement and more importantly of benefit to the South African population with 











iii. An attempt to address the issue in SA 
In order to explore the many factors related to osteoarthritis, a literature review on the 
different aspects surrounding OA and the current management options was conducted. 
The following search engines were used: Medline, (PubMed, Ebscohost, OVID), Science 
Direct, Google scholar, Cinahl, Scopus, and Web of Science. Keywords used: ICF, 
musculoskeletal conditions, osteoarthritis, chronic disease, disability, health systems in SA, 
burden of disease, non-communicable diseases, guidelines for management of 
osteoarthritis, self-management, education, physiotherapy, exercise, weight loss, surgery, 
arthroplasty, waiting lists, effects of waiting for surgery, pain, chronic pain, pain physiology 
and pathophysiology, central sensitization in OA. The available literature of evidence-based 
research on this topic is presented below. 
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2.2 Overview of Osteoarthritis 
Osteoarthritis is defined as a degenerative joint disease, primarily affecting the articular 
cartilage and subchondral bone of the joint(75,76). In simple terms; it is the breakdown of 
previously healthy joint surfaces or the loss of cartilage, causing friction between the 
bones(77). Unlike rheumatoid arthritiswhich affects both sides of the body, OA is often 
asymmetrical(78). The course of progression differs for each person affected, but most 
commonly the condition progresses as one ages to result in extensive joint damage with 
deformities(19).  
 
Osteoarthritis is most common in the hip and knee joints(50) and the small joints of the 
hands(79). Classification between primary and secondary OA is made according to the cause, 
either known or unknown. Primary OA is of unknown origin or is idiopathic, and secondary 
OA is due to a specific cause or event(7). The development and progression of OA is very 
seldom due to one factor alone, but rather a combination of two or more factors acting 
together(79). Known causes or risk factors include but are not limited to the 
following(19,76,78,79):  
- Increasing age – which means that other co-morbidities may co-exist(80) 
- Genetic predisposition to developing OA, especially in the hands(77) 
- Gender – females have a higher incidence of OA than males 
- Obesity  
- Faulty biomechanics  
- Certain occupations, sports and/or repeated stresses on the joints  
- Previous trauma 
Diagnosis is relatively simple and is made primarily by clinical diagnosis including history 
taking and completing a physical examination of the patient and their main symptoms(78). 
Radiological imaging such as an X-ray can aid in the diagnosis, but is not necessary in order 
to diagnose OA(78). Notably, there is no correlation between osteoarthritic changes seen on 
X-ray and severity of clinical symptoms. In other words, some individuals may present 
clinically with severe arthritis however, show minimal changes on X-ray and vice versa(81). 
Changes which may be seen on X-ray include decreased or narrowed joint space, 
breakdown of joint surfaces, and osteophyte formation amongst others(82).  
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Kellgren & Lawrence‡ describe a radiological scoring system used to diagnose OA in the 
1950’s, which is still utilised today. The American College of Rheumatology (ACR) has 
further classified the diagnosis of OA of the hip to include purely clinical symptoms, or 
clinical and radiological symptoms which are present or absent (Table 2-2below)(7). Further 
radiology or laboratory tests are not often necessary or recommended in the diagnosis of 
this condition. The fact that initial diagnosis can be done without complicated tests or 
specialised doctors should make early diagnosis and management OA at primarylevel 
facilities possible in order to decrease the growing burden of OA on tertiary institutes. 
 






                                                          
‡ Kellgren & Lawrence scoring: Grade 0-4 is used to rate the severity of changes seen on X-rays; 0 = absent. 1 = doubtful. 2 = 
minimal. 3 = moderate. 4 = severe(364) 
Clinical signs and symptoms- 
pain present in combination 
with either :  
 
 hip internal rotation(IR) greater than or equal to 
15 degrees  
 pain on IR of the hip 
 morning stiffness of the hip for less than or equal 
to 60 minutes 
 older than 50 years  
OR: 
 hipIR less than 15 degrees   
 erythrocyte sedimentation rate (ESR) less than or 
equal to 45 mm/hour  
if no ESR was obtained, hip flexion less than or 
equal to 115 degrees was substituted 
Clinical and radiological - 
pain with at least two of the 
following threecriteria: 
 osteophytes (femoral or acetabular) 
 joint space narrowing (superior, axial, and/or 
medial)  
 ESR less than 20 mm/hour  
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2.2.1 Prevalence of OA 
i. Worldwide prevalence 
As mentioned, OA is the most prevalent joint disease in high, middle and low income 
countries and is reported to be a leading cause of pain and disability worldwide(16-20). 
Globally, OA has been reported to affect 18.0% of females and 9.6% of males over the age 
of 60(75,83). As previously stated, due to advances in medicine, the population’s life 
expectancy is predicted to continue to rise, contributing to a larger number of aging 
people(43). Research states that 50% of all chronic conditions in persons over 65 years, are 
as a consequenceof joint conditions; thus further research is warranted in this field(43).  
 
In higher income countries, OA has been ranked as the condition having the fourth and 
eighth greatest impact on health in women and men, respectively(41,42). Considerably more 
studies have been performed on the prevalence of OA in countries of higher income levels; 
showing that OA was third on the list for years lived with disability (YLD) in high income 
countries but wasn’t even part of the top ten contributors to YLDs in low to middle income 
countries(84). A more recent study by Brooks(51) showed thatlower income countries make 
up the majority of the burden of MSC with figures such as 21076 DALYs lost in lower 
income areas versus 8723 in high income countries, of which 11049 and 5323 respectively, 
were due to OA(51). Woolf(50)suggested that this is a consequence of limited resources and 
access to surgical techniques, such as a joint replacement for those with severe OA(50). 
However, these high figures could be due to a lack of rehabilitative personnel at a 
community and/or primary health care level in lower income areas. Early rehabilitation 
could facilitate better management of pain and dysfunction, prevent worsening of the 
condition and slow down progression to severe OA; thus lowering the number of DALYs(51).  
Further research is needed in low to middle income countries to produce much 
neededcurrent data for these regions(51). The above mentioned rising prevalence of OA, 
especially in lower income areas, contributes toincreasing health and social burden(85,86). 
 
ii. South African prevalence 
The burden of indirect health care costs related to OA in SA may be underestimated as the 
associated co-morbidities, such as cardiovascular conditions and obesity, caused by 
lowered levels of activity, are frequently present and costly to manage(76,85). 
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In a recent prevalence study of MSC in the Western Cape ofSA, the most 
frequentconditions seen were HPT, joint problems and DM; showing that MSC together 
with such co-morbidities are a common occurrence in the population examined(87). It is 
noted that many of these chronic conditions share the same risk factors of inactivity, 
unhealthy diets and abuse of substances(46). Additionally disability associated with OA has 
been seen to be worse if two or more comorbidities are present(80,88). As mentioned, due to 
insufficient current statistics, the prevalence of OA and RA was estimated to be much lower 
(150/100,000) in Sub-Saharan Africa when compared to 1,500/100,000 in Europe(84). 
However, as seen in the recent study by Parker and Jelsma(87), MSC is suggestedto be more 
prevalent than previously estimated in low to middle income countries such as SA. Their 
findings show that the prevalence rate of MSC is more likely to be closer to 362/100 000(87) 
when compared to the OA and RA combined value of only 144/100 000 in the Global BOD 
study in 1990(84). OA is further reported to be the most common joint disorder and the 
leading cause of disability in SA, with specific reference to the Cape Town Metropolitan 
area(89,90). In the 2000 South African BOD study however, MSC didnot feature in the top 20 
conditions causing YLLs and were not mentioned under the YLD section either(63). 
Nevertheless, it was reported that these statistics were incorrectly calculated and figures 
were said to be underestimated(63). The figures of YLD and DALYs for SA in this study were 
said to be initial estimates rather than definite values as data used for this study was not 
based on current data but that of 1996(63). This emphasises the need for reliable and up to 
date statistics to be made available(51). The general health survey performed in SA in 
2011(67) reported 13.9% of the population aged 65 or older to be affected with arthritis. 
Once again this supports the larger estimatesof OA asa contributor to burden of disease in 
SA(51,87). 
 
The cost of health care involved in OA, from services rendered to resources used, is an 
important factor to consider when dealing with this condition and choosing the necessary 
management options as it is seldom that OA occurs in isolation(85,86,91). It is proposed that in 
an attempt to deal with the increasing negative economic and social impact caused by OA, 
an effective chronic disease management approach be used(92). An extensive description of 
examples of these approacheswith a specific focus on OA follow in the text. Of important 
note forthe purposes of this study, is that these management options have the potential to 




2.2.2 The impact of OA 
The extent of disability caused by MSC such as OA, has not been comprehensively 
addressed prior to the year 2000(43). MSCs have been viewed as less important than other 
infections or fatal conditions as they are not primarily life threatening. Some MSC 
conditions are often regarded as a normal degenerative part of aging, but this does not 
mean the associated morbidity should go unnoticed. Health systems throughout the world 
have not properly prioritised dealing with the growing burden caused by these 
conditions(11). A possible reason for this could be due to the WHO’s focus traditionally being 
on prevention and control of infections and mortality(43,59). At last the need to draw further 
attention to the growing burden of MSC was highlighted in 1998 by the European 
Orthopaedic and Rheumatology divisions, resulting in the years 2000-2010 being declared 
the “Bone and Joint Decade”(43). The desired goals were to raise awareness of the current 
issues and to improve the health related quality of life of those suffering fromchronic 
musculoskeletal conditions(43). Once again, the association between MSC and fatal co-
morbidities was emphasised and supported by later literature showing the incidence of OA 
and co-morbidity was as high as 73% with an average of two co-morbidities being present 
in patients requiring surgery for OA of the hip or knee in Europe(88). This is an essential 
association as preventing and managing the health issues such as inactivity due to a MSC 
can begin to break the cycle of disability.  
 
The aim of the Bone and Joint Decade was to achieve a decrease in health problems by 
“empowering patients to participate in their own care; by promoting cost effective 
prevention and treatment; and by advancing understanding of musculoskeletal disorders 
through research to improve prevention and treatment”(43). As implied in this aim; better 
understanding of MSCs will enable better management thereof(43). Not only does this 
endorse the need for on-going research studies in this field, but furthermore, highlights the 
need for soundly educated health personnel to be able to deliver comprehensive education 







i. Impairments in OA  
As stated in the aim above, the need to manage OA with the purpose ofminimising its 
impact on the sufferer’s life is essential. In order to provide effective management, 
understanding of the common clinical presentation and main complaints of those affected 
by OA is necessary. The common signs and symptoms are described below; commencing 
with pain.  
 
a.  Pain in OA 
The most common reason for seeking medical attention and the main symptom of OA is 
pain; a physical impairment according to the ICF(79,94,95). The International Association for 
the Study of Pain (IASP) first presented the definition of pain in 1979(96). The terms and 
definitions related to pain have been revised since then in 1986 and 1994, and the most 
recent definition updated in 2012 defines pain as “an unpleasant sensory and emotional 
experience associated with actual or potential tissue damage or described in terms of such 
damage”(97). OA initially presents as acute pain, mainly experienced with movement or use 
of the affected joint(76). As the condition progresses, the pain becomes chronic and often 
leads to pain at rest, at night or even spontaneous pain(76,95).Additionally sufferers may 
present with acute and chronic pain at the same time; with exacerbations in pathology 
occurringtogether with chronic pain changes in the nervous system. 
 
Chronic pain(CP)is defined by the IASP as “pain which persists past the normal time of 
healing”(4),while others have broadly described CP as pain that is experienced on most days 
for at least three consecutive months(98).Essentially chronic painis described as pain that 
does not resolve as expected after the normal repair process has been completed; it has 
been said that this type of pain is no longer protective in nature(2). The time for “normal 
healing” after acute injury or pathology is complex as a result of the nervous system being 
changeable or better known as “plastic”(2,99).Plasticity of the central nervous system (CNS) 
can prolong and maintain the pain experience well after the normal time of healing.  
 
Previously, the mechanisms contributing to chronic pain in OA have not been well(95,100). 
Various suggestions of how acute pain progresses to chronic pain have recently been 
proposed based on maladaptive changes in the nervous system(95,100-103).  
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This is an area whereby knowledge of theories or mechanisms related to nociceptive 
processes are constantly changing and are expected to continue to be updated as research 
is ongoing(104). Further research is still needed to ascertain how the mechanisms ofCP 
changes influence prevention and/or effective management in various pain syndromes(8). 
Recent advances in research have led to explanations for the changes that take place in 
chronic pain disorders, including OA(2,22).  
 
Chronic pain is believed to be a multifaceted process:the role of the CNS (the spinal cord 
and brain)is key; with various neurotransmitters modulating nociceptiveinput at many 
levels(22). The major change that is said to take place in CP disorders that leads to the 
exaggeration of pain is sensitization of the nervous system. This is caused by an increase in 
the membrane excitability and synaptic efficacy in both the peripheral and central nervous 
system, that leads to neurones firing at a lower threshold(2,22). It is explained that peripheral 
sensitization and its consequences are limited to the peripheral site of nociceptive input, 
causing primary hyperalgesia at that site. This usually requires ongoing nociceptive input or 
peripheral pathology to continuously contribute to the changes that take place in the 
nociceptive system(2). Whereas, central sensitization results in both primary and secondary 
hyperalgesia by amplified nociceptive stimuli not only at the periphery, resulting in 
abnormally high levels of pain at the site of insult, but also affects other receptors such as 
mechanoreceptors which cause pain beyond the site of injury(2). 
 
Furthermore, neurones are also more sensitive to previously normalstimuli of touch or 
pressure; resulting in allodynia(2,22). This is demonstrated when a normally innocuous 
stimulus, such as movement, is a cause of pain.This has been shown in studies where 
heightened activity is seen onfunctional magnetic resonance imaging (fMRI) in the regions 
of the brain that process pain to normal stimuli that usually do not cause pain(22). Central 
sensitization changes in the nervous system are present long after the original nociceptive 
input and it is said that the body no longer generates pain due to a potential or actual 
threat, but rather as a consequence of the ongoing sensitization of the nociceptive 





Additionally, anirregularity in the modulation of the descending pain pathways also exists 
in CP. It seems as if the ascending pathways are unopposedbecause the descending 
endogenous pain pathways that inhibit pain are less active(2,22). A fairly new area of 
research in patients with chronic pain draws attention to a dysfunction in the downward 
endogenous analgesic responsefollowing exercise in some pain conditions, such as chronic 
fatigue syndrome(105-107), chronic whiplash(108) and fibromyalgia(109). This is of particular 
interest as exercise usually activates the endogenous pain pathways in healthy individuals 
and is used as an effective treatment approach to many chronic pain disorders such as 
OA(109). This is discussed in more detail in section 2.3.5 (pg. 62).  
 
A recent SR by Lluch and colleagues(110) has shown that central sensitization takes place in a 
subgroup (30%) of patients with OA. This leads researchers to believe that OA is not simply 
a peripheral joint condition; instead pain in OA can also be driven by central nervous 
system changes. Further research into this particular field is encouraged as interventions, 
such as neuroscience education, exercise and centrally acting pharmacological agents that 
have the potential to target the maladaptive changes of the CNS in this subgroup should be 
explored(110). Central sensitization can also explain why the physical impairment of OA in 
the periphery is not always synonymous to the amount or area where pain is felt or the 
overall effect on the person’s life(22,111). Statistics show that up to 50% of persons with 
moderate to severe changes on radiology display no symptoms whatsoever of OA, and 
roughly10% of individuals with moderate to severe knee pain show no arthritic changes on 
radiographs(112,113). This can be attributed in some ways to psychological factors but these 
play a limited role; however changes in the nociceptive system driven by ongoing 
pathological peripheral input and central sensitization, are more likely reasons to explain 
these occurrences(22). A study by Wideman and colleagues(114) suggest that “ many 
individuals with knee OA show a prolonged, sensitized response to routine activities of 
daily living (ADLs), such as walking”. This study attributes sensitivity to activity to 
psychological factors, such as pain catastrophizing, as well as to peripheral and central 
sensitization(114). This research presents a possible reason for low adherence rates to 






Another change seen in those with central sensitization is in the levels of neurotransmitters 
such as norepinephrine, gamma-amino-butyric acid (GABA), serotonin, glutamate, and 
substance P. Alterations in these substances account for frequently seen issues that chronic 
pain sufferers experience such as altered sleep patterns, changes in cognition, decreased 
alertness and mood disorders(22). All of which indirectly influence the individuals’ quality of 
life and daily functioning(115). Furthermore, Smith et al.(115) also state that disturbances in 
sleep are very likely related to further sensitization of the nervous system as a “direct 
contributor to both hyperalgesia and impaired endogenous pain modulation.” 
 
As mentioned earlier in the text, it is possible to have acute and chronic pain present at the 
same time, a factor which may confound the assessment and management of pain in 
OA(22,29,116). Although patients may have late stage chronic OA, pain is not necessarily 
present at all times and individuals usually experience periods of less or worse pain. 
Periods of sudden worsening of acute pain on chronic pain is named a flare up(22). 
 
The above advances in research have begun to improve understanding of the processes 
that occur with long-standing pain. These explanations are fundamental in order to address 
disorders of CP including OA. There is evidence that untreated CP can lead to further 
disability and decreased quality of lifeas well as being an important risk factor in the 
development of common co-morbidities(87,98,117). Research suggests that changes in our 
nervous system leading to widespread pain conditions, are a result of “inadequately 
treated chronic focal pain problems such as osteoarthritis or myofascial pain”(118). The 
important factor to note is that pain is a far more complex process than previously believed 
and whether acute or chronic it is clear that pain has an enormous effect on an individual’s 
life.In order to address these effects, the different aspects need to be correctly 
measured(119).Furthermore, the management of pain needs to address the full impact of 
pain by targeting all components contributing to pain; the nociceptive, the peripheral and 
the central nervous system, as well as other psychosocial aspects which influence the pain 






b. Measurement of Pain 
As important asunderstanding the definition of pain and pain-related aspects is the 
accurate measurement of pain. Research suggests that simple measures of pain often 
depict misleading information and thus a comprehensive assessment of the full pain 
experience is necessary(120). The Initiative on Methods, Measurement, and Pain Assessment 
in Clinical Trials (IMMPACT) group state that when measuring pain, the instrument used 
should not only evaluate pain on a uni-dimensional level, instead it should assess the 
efficacy of the intervention under concern in terms of pain intensity, physical functioning, 
emotional functioning, patient ratings of treatments received, symptoms and adverse 
events, and participant disposition(121,122). Many different instruments exist which are used 
to evaluate pain and its consequences. Goldenberg and colleagues(22) state that “there is no 
single best instrument to evaluate pain in the rheumatic diseases” and others state that the 
optimal tool for monitoring pain is still unknown(123). For the purpose of this study’s review, 
relevant examples of some of the frequently used instruments are discussed in the text 
below. 
 
Commonly used in current research, including rheumatological conditions, is a patient self-
administered tool called the pain visual analogue scale (VAS)(124) to vertically (VVAS) or 
horizontally (HVAS) rate pain intensity(125). The VAS is a simple single-item, subjective report 
of a 100mm long line with a pain description on either end and the patient is required to 
mark what their pain severity is on the line(126). The Numerical Rating Scale (NRS)(127) is 
based on the same structure but is less abstract as it includes numbers from 0 – 10 on the 
line and the Verbal Rating Scale (VRS) is similarly used to verbally rate pain severity. All 
three have been shown to be valid and reliable and none has been reported to be more 
sensitive to detect change than the other(128). However, NRS and VRS have been stated to 
be preferred by patients over the VAS and it is noted that errors in correctly completing the 
VAS are more common than the former scales(128). However, it has been documented that 
patients with hip or knee OA have described the NRS as too simplistic a rating scale for the 
complexities of their pain experiences(129).  
 
A tool developed in the 1970’s named the McGill Pain Questionnaire (MPQ)(130), has been 
commonly used to measure pain in more than one domain. It evaluates quantity and 
quality of pain in three domains:sensory, affective and evaluative(130).  
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Despite this measure being used in a variety of conditions, Cleeland(131) examined the 
appropriateness of this tool and yielded results that proved the instrument to be 
complicated and time-consuming to complete as it isextremely long (78 pain descriptions). 
This lead to a compact version being developed, the Short-form McGill Pain Questionnaire 
(SF-MPQ)(132), which was completed with greater ease but seemed to lack qualitative data 
in comparison to the multi-faceted original version. 
 
Specific instruments for measuring pain and its effects in OA also exist. The Western 
Ontario and McMaster Universities Osteoarthritis Index(WOMAC)(133)is the most frequently 
used instrument developed for the measuring of pain intensityand functioning in OA and 
RA patients. Whereas the Constant and Intermittent Osteoarthritis Pain measure was 
designed to evaluate the intensity, frequency and impact of pain on mood, sleep and 
quality of life(129). Similar tools were developed for both instruments for specific use in 
either hip or knee conditions, including questions on pain, stiffness, ADLs, sporting 
activities and quality of life. Issues in answering the pain severity section of these 
instruments have been noted in the WOMAC tool, as pain is not a constant, but rather an 
intermittent and variable measure(120,134). A limitation also exists in the answering of these 
tools particularly in domains of ADLs because if a person avoided certain activities, they did 
not answer the questions related to that activity completely or accurately, resulting in 
missing or incorrect data(120). Therefore a tool with more commonly executed tasks could 
be more appropriate. 
 
The Brief Pain Inventoryhas now become a regular assessment tool for measuring the 
severity of pain and the effects thereof(135). It was developed as a generic tool as far back as 
1982; the initial version called the Wisconsin Brief Pain Questionnaire(BPQ)(136). From the 
original BPQ, a long version and subsequently the more commonly used short version of 
the BPI was developed(35,137). The short form (BPI-sf) is widely used in both clinical and 
research environments(135). To correctly assess the complexity of pain, three domains were 
seen as important (sensory-discriminative, motivational-affective and cognitive-
evaluative)(138). Differences between these terms were not easy to distinguish so two 
dimensions were then used instead of three. Simply put they are the sensory and reactive 
aspects of pain(9). The sensory domain evaluates pain according to intensity and the 
reactive domain assesses the effect/interference of pain.  
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To address the limitation found with the WOMAC scale of pain being a variable factor, the 
BPI evaluates pain severity on the person’s “worst”, “least”, “average” and “now” pain over 
the last 24 hours instead of one score for intensity of pain during different tasks. Pain 
interference is scored by evaluating the effect of pain on an activity sub-dimension 
(walking, general activity and work) and four other aspects of life (relationships with 
others, enjoyment of life, mood forming the affective sub dimension and sleep)(135). These 
two dimensions (severity and functioning) are the first two dimensions, described by the 
IMMPACT panel, which should be included in all research dealing with chronic pain 
evaluation(122).  
 
Psychometric testing has been performed on the BPI’s use in cancer and non-cancer pain, 
such as acquired immuno-deficiency syndrome (AIDS), complex regional pain syndrome 
(CRPS), Fabry’s disease, LBP and OA(139,140). Literature has been published to support the use 
of this tool in the assessment of pain to distinctly depict pain intensity and itseffects on 
function(141-143). The BPI has high internal consistency in various languages and does not 
display cultural bias; instead it maintains the meaning and assessment of pain in these two 
domains(144,145). It demonstrated high levels of test re-test reliability in many 
studies(136,140,146,147),although older studies do not discuss this aspect(143,148,149). Of particular 
interest to this study, the BPI has been used in studies of OA which reported good internal 
consistencies;particularlyfor the subscale of the pain interference(148,149). This is particularly 
relevant when selecting an instrument to measure change over time and therefore the BPI 
was chosen as the primary outcome measure. 
 
Further research by Williams and colleagues(139) presented evidence for the use and 
validation of the tool in OA where the validation, consistency and reliability of the pain 
interference scale and sleep item of the BPI in OA patients was explored. Results provide 
strong support for both the responsiveness and construct validity of the BPI interference 
and sleep item scales in OA related pain(139). It also confirmed the high internal 
consistencies previously seen with optimal alpha values of 0.89 and 0.82(139). Test re-test 
reliability (intraclass correlation value = 0.81) for the interference scale is higher than the 




The intra-class correlation value for the sleep item was lower at 0.65 but is still seen as 
“good” and in this case it is seen as an accepted value considering the value is usually 
calculated for a multi-item scale and this was for a one-item scale(139).The IMMPACT panel 
has specifically singled out the pain interference scale from the BPI as a recommended 
scale to use for assessment of pain-related functional impairment(128).   
 
As seen by the above complexities of pain and the many aspects related to the impact of 
pain, measuring pain as accurately as possible in the different domains is necessary to fully 
understand the effect pain has on an individual, livingwith a chronic condition such as OA. 
 
c. Stiffness, reduced range of movement (ROM) and strength in OA 
Besides pain being the most common complaint in persons with OA, stiffness, reduced 
ROM§ and a decrease in muscle strength are also common impairments. Stiffness is 
described as the inability to move a part with ease or comfort(151). Stiffness is particularly 
felt in the affected joint following a prolonged period in one position of sitting or standing 
(called the gelling phenomenon)and is also frequently experienced in the early morning 
after waking, lasting less than 30 minutes(78). As a consequence of pain and stiffness in a 
particular area, reduced ROMat the affected joint is also a common occurrence(19). Full 
ROM is not achieved as often as needed to maintain normal ROM and thus the available 
range decreases over time. Range of motion at different joints in the body is necessary for 
functional activities of daily living(152). Following restricted ROM, the muscles and stability 
structures surrounding that joint are not as mobile as before and are unable to function as 
intended during use of the joint(152). Consequently, because muscles are seen as the force 
generators of movement, if movement is restricted, the ability of muscle to contract and 
the strength of that contraction will also be limited and decrease if not used regularly. 
Kisner and Colby(152) note that insufficient muscular strength leads to activity limitations 
and participation restrictions. These impairments surrounding a joint lead to feelings of 
instability, described as “giving way, buckling or slippage” and are reported to have a large 
impact on function(153).  
 
                                                          
§
 Range of movement is defined as the normal full motion possible at a joint and therefore anything 
less than this is considered decreased ROM
(152)
. In order to maintain a normal range of motion, a 
joint needs to move regularly through its full range, either actively by the muscles across that joint 





d. The measurement of stiffness, reduced ROM and strength  
The standard measurement of stiffness or decreased ROM is done by determining the 
available range of motion at a joint with a goniometer (measured in degrees)(154). The 
measurement can be recorded passively by an external force moving a joint through the 
available range, or by the person contracting the muscles across the joint independently, or 
with assistance, to produce movement at that joint(152). Measuring muscle strength** is a 
topic of debate in recent literature as many factors are involved during assessment(155).  
Various methods are available for muscle strength testing and can involve measuring force 
or torque and/or the rate of force or torque. It appears that a single standard measure of 
muscle strength does not exist as testing conditions and equipment can differ and 
measuring techniques vary greatly because a muscle can be tested in different positions 
and contraction states(156). Additionally, a single muscle versus a single or multiple muscle 
group also produce different measures(155). It has been proposed that a standard method of 
muscle testing be developed to minimise confounding variables and issues with 
reliability(155). It is noted that an important reason for measuring muscle strength is to 
assess functional movement performance; however other variables can confound this 
purpose of strength testing. Measures such as ROM or muscle strength can be useful when 
tracking progress over time but whether these objective measures hold meaning regarding 
functional performance is questionable. Objective functional testing is therefore indicated 
as more meaningful in relation to the effect of impairments such as stiffness, reduced ROM 
and MP in OA sufferers(157). This is described in more detail below. 
 
ii. Activity limitations and participation restrictions in OA 
As noted above, physical impairments are not the only factors to consider in such a chronic 
pain disorder, as the impairment itself is usually not the biggest issue, rather the resulting 
challenges experienced due to the impairment are the issue. A survey carried out by the 
IMMPACT group(119) revealed that besides pain; functioning, well-being and health-related 
quality of life (HRQoL) were the most important domains affected in chronic pain sufferers. 
Thus instruments that measure the effect the condition has on these three aspects as well 
as sleep, mood, and energy should also feature in research in order to grasp the full effects 
of a condition such as OA(22,119).  The first of these aspects according to the IMMPACT 
group, functioning, is discussed in the text to follow.  
                                                          
**
Muscle strength is defined as the maximumforce(in N) or torque (in Nm) developed during 





a. Function and disability 
Physical impairmentsare known to result in a decrease in function and limitations 
performing certain activities and participating in life situations(95,158). Pain, stiffness and 
decreased ROM and muscle strength limit activities of daily living such as climbing out of 
bed in the morning, walking to the bathroom for toileting and personal hygiene purposes, 
standing up from a toilet or a chair, and domestic tasksare a frequent struggle(74).  Difficulty 
completing daily tasks which require sitting or standing for extended periods is 
common(119); examples include certain occupations such as a desk job, or labour work 
respectively. Problems are commonly experienced in activities that require bending down, 
for instance bending during household tasks or cleaning, as well as activities that require 
kneeling, such as gardening, playing with small children or praying(119).Furthermore, social 
activities such as sitting in a movie or attending church and daily tasks like standing in a 
queue at the bank, post office or shops are not easily carried out(119). Joint locking or 
feelings of instability are reasons for issues experienced during walking and climbing stairs 
and persons often experience difficultyin standing up from a chair without arm rests due to 
lack of strength(78,159). It has also been reported that in those with lower limb joint 
issues,the ability to work is largely affected(160,161). It has been predicted that by the year 
2030, 25 million people living in the United States of America (USA) will have various 
activity limitations due to arthritis. This has been said to be quite a conservative prediction 
not taking into account the very possible increases in obesity and other risk factorswith co-
morbiditiesalso likely to rise(160). 
 
b. Measurement of Function and Disability 
According to the ICF model, assessment of function is imperative for determining health 
and disability status(162). Scarce documentation exists on the use of quantitative assessment 
tools to evaluate change in function in chronic pain studies(36). Many studies evaluate 
function in terms of self-reported questionnaires. However, recent literature shows that 
results obtained from an objective performance test provide additional and valuable 
information(163). The reason forlack of use of objective quantitative measures is possibly 
due to the need for extra space and specific training of personnel administering the tests to 




To the researcher’s knowledge, only one SR has been published which aimed to assess 
different objective measures of physical performance in terms of their content and 
psychometric properties(164). This review focused on studies in older persons (over 60 years) 
living in a single community area. The sample could have caused a floor effect†† as it 
excluded those in old age homes or frail care facilities (who very possibly have higher 
disability scores)(164). Importantly, the review was also limited to those with general chronic 
condition/s. In total 12 instruments were reviewed and only three (the Short Physical 
Performance Battery, Physical Performance Test and the Continuous Scale-Physical 
Function Performance) had published evidence on properties of validity (concurrent and/or 
predictive), reliability (intra-class correlation coefficient values ranged from 0.70 – 0.99) 
and responsiveness (effect sizes ranged from 0.48 – 1.25), which can explain why many 
tests are not yet widely accepted(164).  
 
An objective measure of function, as mentioned above, that has been extensively studied 
and modified into different versions is the SPPB(163). A possible reason why the SPPB 
achieved such positive psychometric ratings could be as a consequence of having fewer 
domains as it only assessed lower limb function. Other measures, namely the PPT(165) and 
theCS-PFP(166) evaluate function of upper and lower extremities during day to day tasks of 
varying difficulty. Both have been tested for psychometric properties and displayed good 
values for the different domains but these studies were only completed in older persons 
and were not specific to OA. Additionally, the CS-PFP consists of 15 tasks compared to five 
and seven out of nine tasks in SPPB and PPT respectively and is described as multifaceted 
and thus does not prove as quick and simple to administer as the others(164).  
 
Another simple and commonly used objective measure of mobility, usually used in 
cardiopulmonary conditions, is the six-minute walk test(167) (6MWT). The distance covered 
by walking on a flat hard floor for six minutes is recorded. This measure has been shown to 
be valid and reliable as a tool for measuring mobility in older adults in general, yet not 
specifically for those with OA. In 2011 it was suggested that further research be performed 
in order to validate the 6MWT in chronic pain patients and in 2014 a pilot study was 
performed to begin the validation of this tool in this population(168).  
                                                          
†† Floor effect: occurs when a measure possesses a distinct lower limit for potential responses and a large concentration of 
participants score at or near this lower limit. In the case above, disability scores were low as the sample excluded those with 
more disability who possibly would have produced higher scores(366). 
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Other work, specific to those with OA awaiting a joint replacement, suggested that a self-
paced walk test(169) (walking two lengths of 20meters (m) without exertion), the well-known 
reliable and valid timed “up and go” test(170) (rising from a standard arm chair, walking at a 
safe and comfortable pace to a line 3m away, crossing the line, turning, and returning to a 
sitting position in the chair) and a 6MWT (as above) would provide useful information 
alongside self-reported pain and function measures(171). Furthermore, an aggregate 
functional performance time (AFPT) is obtained from a series of tasks used to objectively 
measure function(172). This consists of a fifty feet timed walk, a ‘Get up and Go’ test and a 
stairs ascent and descent test. It was stated that a single test of function provides minimal 
information about overall functional ability and therefore the four scores are aggregated to 
produce a score of general functional ability(172). At the time of this write up, no studies had 
reported on the reliability and validity of the AFPT. 
 
Following on from the above is a well-documented standard measure of function consisting 
of more than the four functional tasks of the AFPT; called the Physical Performance Task 
Battery(36). The physical performance task battery is readily available for clinical and 
research-related use. It was initially used in patients with lower back pain(173), cancer(36) and 
HIV/AIDS(174) The physical performance task battery has been shown to be responsive to 
change, valid (discriminative, concurrent, construct and predictive) and reliable(test-retest, 
intra- and inter-rater; with intra-rater correlation coefficients ranging from 0.7 – 
0.9)(157,173,175). It involves a series of nine short tasks which are easily administered using 
minimal equipment, with underlying constructs of speed, co-ordination and endurance(36). 
The tasks are namely: picking up coins, tying a belt, reaching upwards, reaching forwards, 
putting on a sock, standing up from sitting on a chair with armrests, a 50-foot walk at 
normal speed and at fastest speed and a 6MWT. It provides objective measures for 
individual tasks that are performed on a daily basis and valuable insight into how the task is 
performed instead of merely reporting that it is difficult to perform(36). When used in 
clinical practice, the clinician can establish ways to adjust the task or correct the manner in 
which the patient is performing the task so as to improve function as well as monitor 
progress(174). Important to note is that these quantitative measure of function do not aim to 





Similar to measures of function is the less commonly used concept of assessing disability. 
As described earlier in the text, despite physical impairment and even functional abilities, 
persons can present with various disabilities depending on their individual environments. 
The Stanford Health Assessment Questionnaire(HAQ) was published in 1980 as a self-
reported questionnaire of health status(37,176). The HAQ is a generic 22-item scale which 
includes a disability index assessing disability observed during common daily activities and 
a VAS pain index assessing severity of pain if present(37,176).The disability scale comprises of 
eight categories of tasks namely; dressing, rising,eating, walking, hygiene, reach, grip, and 
usual activities made up of aseries of 20 questions related to these tasks involving both fine 
and gross motor skills of the commonly used joints(37). Later, a shorter version was 
developedcalled theHAQ 8-Item Disability Scale. Psychometric testing has been reported to 
show excellent responsiveness to change as well as minimal values ranging from 0.1 – 0.22 
needed for meaningful clinical difference(37). A high internal consistency reliability of 0.85 
was previously reported(177) and validity in terms of construct, convergent and predictive 
has also been established(37). The HAQ has been used in different languages and in a wide 
range of population groups in terms of income levels, age, health status and conditions 
including OA and was therefore chosen as an outcome measure in the current study. A 
shortcoming of this scale, not of direct importance to this study but worth noting, is that it 
does not depict disability relatedto sensory organ defects such as eyesight, hearing, touch 
etc. or disability associated with psychiatric dysfunction(37). 
  
iii. Personal factors in OA 
a. Psychosocial effects 
As seen above, each measure has a limit as to what it evaluates. This shows the importance 
of utilising various instruments to fullyunderstand the effects of the condition being 
investigated. Important factors have been acknowledgedin earlier text such as cognitive 
and emotive effects of chronic pain conditions which influence well-being and quality of 
life(50,119).Hurley and colleagues(178)have described the extent to which CP influences a 
person and highlighted the interactions between biological, psychological, socioeconomic 
and environmental factors (as depicted by the ICF model). Interestingly, these authors 
report that the emotive and cognitive changes appear to beunrelated to the physical 
aspects of OA and that changes in these dimensions could more reasonably explain activity 
limitations and participation restrictions in people with OA(178). 
31 
 
Appealingqualitative research in persons with MSC, was performed in Europe to foster 
better understanding of persistent pain on the entire existence of an individual(179). Three 
major themes wererevealed regarding responses to chronic pain: “failed adaption, identity 
restoration and finding a way out”(179). The first theme is described by the individual who 
has failed to successfully adapt to changes experienced while living with persistent pain; 
this seemed to cause frustration, depression, passive reliance on medication and avoidance 
of movement or exercise. The other two themes explain how a person can react to 
persistent pain in a more positive manner by re-evaluating their thoughts and attitudes 
towards pain to form a new identity within the condition despite radical changes that have 
occurred. This attitude encourages active coping mechanisms such as physical activity, 
helpful awareness of one’s body, ongoing social interaction and personal growth(179). 
Studies such as this underline the need to include psychosocial variables such as quality of 
life and SE for example, as a part of assessing the impact of OA on a person’s life. 
 
It has been noted that the inability to take part in normal daily tasks or being able to 
participate in usual happenings or recreational activities, has immenseeffects on a person’s 
psychosocial health and overall quality of life(174,180). Commonly frustration, anger and 
depression are experienced due to the inability to perform normal activities related to 
home and work life(179,181). This causes a cascade of fear of movement, avoidance of 
activities, anxiety, dependence on others, shameand low SE; all of which are extremely 
demotivating for the individual(179).Pain and disability impacts negatively on social 
interaction between friends, dynamics at home, putting strain on relationships between 
spouses and/or children, especially if these persons also assume the carer role(119). As a 
consequence, individuals isolate themselves which then leaves them with lower self-
esteem andminimal support structures to deal with the changes in their lives(179). Therefore 
the combination of physical and psychosocial factors impacting on participation and 
function as one factor affects another which affects yet another, leading to a downward 







b. Psychosocial Measures 
Two emotional assessment tools that have been accepted and recommended by IMMPACT 
in chronic pain conditions are: the Beck Depression Inventory (BDI)(182) and the Profile of 
Mood States(POMS)(183). These tools evaluate emotional distress and have been shown to 
be reliable and valid during psychometric testing in chronic pain trials(184). The BDI 
isdesigned to measure the severity of depression and has been used in previous studies on 
chronic pain and HIV(185). The POMS scale has specific scales for the three most commonly 
experienced emotional dysfunctions mentioned above; depression, anxiety and anger as 
well as other emotional distress associated with CP(128). An interesting point has been raised 
regarding the commonly displayed symptoms of depression in this population; “decreased 
libido, appetite or weight changes, fatigue, and memory and concentration deficits”(186). 
Confusion concerning the direct cause of these symptoms exists, as the same symptoms 
can often present as a result of changes taking place in CNS from longstanding pain or as 
side-effects of medication commonly used(186). Thus monitoring symptoms of depression as 
a result of a specific intervention in clinical trials can possibly provide insight into what may 
be contributing to these symptoms depending on the manipulated variables (either 
physical impairments, mood disturbances or a combination of these)(187).However for the 
purpose of this study, depression or anxiety was not the primary outcome measure and 
therefore monitoring of these emotional aspects were performed to a small degree as a 
part of the HRQoL (EuroQol 5 Dimension) outcome measure discussed below.   
 
Well known generic measures of quality of life are: The Medical Outcomes Study 12-Item 
Short Form Health Survey (SF-12)(188) derived from the commonly used Medical Outcomes 
Study 36-Item Short-Form Health Survey (SF-36)(189) and the EuroQol 5 Dimension (EQ-
5D)(190). The SF-12 and the EQ-5D comprise of 12 and five questions respectively. Questions 
are related to different physical and mental components, including pain and depression, to 
create a health status index(188). Both of these measures are accepted in terms of reliability, 
validity and response to change in chronic conditions. They are easily administered and 
thus widely used in research and clinical practice to determine quality of life. It has been 
noted in a comparison study of the two instruments that the EQ-5D is more applicable and 
sensitive to population groups with higher morbidity and the SF-12 is better used in 
persons with less severe morbidity(191). Furthermore, Brazier and colleagues found the EQ-
5D to be more appropriate for the use in persons with OA of the knee awaiting surgery 
than the SF-36(192). For this reason the EQ-5D was utilised in the present study. 
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The belief in one’s self perceived capability to perform a task or achieve a goal has been 
defined as self-efficacy; the higher one’s confidence is in the ability to carry out a task to 
completion, the higher one’s SE(12). This aspect has become increasingly more important in 
self-management strategies as people with chronic diseases have been shown to have 
lower SE than others, and therefore SE should be included as an outcome in clinical trials 
and practice(193,194). Self-efficacy has a greater impact on behaviour than previously 
thought; it affects a person’s physical activities as a person more confident in their ability to 
carry out a task, is more likely to attempt it and re-attempt it (compared to those who do 
not believe they can achieve the task at all)(195).  
 
Additionally, encompassed in SE are the skills to evaluate a situation, set desired goals and 
form expectations linked to goals made. Self-efficacy influences the amount of effort put 
into achieving a goal, reaction to challenges experienced, emotional well-being and beliefs 
held regarding individual’s impairments and how this affects their activities in daily tasks 
and participation in social situations(196). Studies have shown that probable correlations 
exist between SE and many different domains in arthritis patients such as: pain, coping 
strategies, stiffness, function, mood and mental well-being(197-199).  All of the above factors 
impact the behaviour of the patient and thus functioning. Recognition of the role of SE and 
the importance of enhancing SE during the management of OA is fundamental to bring 
about change in all arms of the ICF model(200). 
 
Various SE scales exist, most of which are specific for certain conditions or domains such as 
the exercise- or pain self-efficacy scales(201-204). Different arthritis SE scales have been 
developed; beginning in 1989 with the Arthritis Self-Efficacy Scale (ASES)(205) followed by a 
shorter version, the ASES-8(206). The 8-item version includes two items on pain, four items 
on other symptoms, and two items that relate to preventing pain and fatigue from 
interfering with daily activities. Importantly, the English version of ASES-8 has not been 
supported by psychometric evidence in literature and therefore it cannot be assumed that 
this scale is appropriate for use in English populations yet(204).  
 
From previously used scales, six items were selected to develop a short generic scale called 
the Stanford Self-Efficacy for Managing Chronic Disease 6-Item Scale(177).  
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This scale is seen as an improvement from previous scales as it covers appropriate aspects 
involved in determining SE in chronic diseases (setting and achieving goals, managing 
conditions in general and symptoms), as well as being easy to use(177,204). It was noted that 
not all questions may be appropriate for various chronic diseases; however with the rising 
trend in multiple chronic diseases of lifestyle or co-morbidities present in the global 
population, this factor does not seem to hold much weight as a negative for this scale and it 
is still recommended for use above disease- or task specific instruments(194). Furthermore, 
this scale’s limited psychometric results have yet to be formally published however some 
results have been made available online. Despite this, the 6-item scale has been and is 
currently widely used for research purposes and was therefore chosen as a secondary 
outcome measure in this study(204). 
 
2.2.3 Summary 
As discussed in the above section, effective assessment of the full impact caused by OA and 
the progression thereof, not only deals with the physical ailments or impairments, but 
evaluatesall areas of the ICF model; namely activity limitations, participation restrictions 
and personal and environment factors (psychosocial) as well. After including all domains 
affected by such a chronic pain condition in the assessment, it is even more essential to 
target each area during the management of OA. Having said this, the literature on best 




2.3 The Management of OA 
2.3.1 Evidence-based and expert consensus guidelines  
There is no known cure for OA, nor one definitive solution to manage the many aspects of 
this condition(207). Addressing the disease related factors and management thereof needs 
to be carefully balanced in order that the benefits of treating each factor outweighs the 
risks of others(76,207).Since OA is not a simple condition to treat, various evidence-based and 
expert consensus recommendations for management of the condition(207) have been put 
forward over the last 20 years(23-25,27,208).Guidelines were first published as far back as 1993 
by the Royal College of Physicians(209) and later by the ACR in 2000 on treatment of OA of 
the hip and knee(210). The European League Against Rheumatism (EULAR), Osteoarthritis 
Research Society International (OARSI),  National Institute for Health and Clinical Excellence 
(NICE), American Academy of Orthopaedic Surgeons (AAOS) and the newly revised ACR 
guidelines have been developed since then and are discussed below. 
 
i. EULAR guidelines 
The first of the guidelines is based on a review of evidence-based literature on treatment of 
OA in the knee that was conducted in 2000(211). This research was subsequently updated in 
2003(23), along with a new publication on recommendations for management of OA of the 
hip in 2005(24). These studies utilised research available from 1966 until 2004 and assessed 
the quality of literature reviewed using the evidence hierarchy‡‡. This means of literature 
appraisal distinguishes studies by ranking themaccording to methodological or design 
differences. Grading for how strongly a proposed treatment is recommended was also 
done by means of the letters A-D§§. Conclusions drawn from their development process 
presented 10 recommendations for the management of OA of the knee and hip(see Table 
2-3below–note the table shows both columns if the recommendation differedfor the knee 
and hip, otherwise the recommendation applies to both joints).  
 
 
                                                          
‡‡ Hierarchy of evidence:Ia Meta-analysis of randomised controlled trials (RCTs), Ib RCT, IIa Controlled study without 
randomisation, IIb Quasi-experimental study, III Non-experimental descriptive studies, such as, comparative, correlation, and 
case-control studies, IV Expert committee reports or opinion or clinical experience of respected authorities, or both.(354) 
§§ Strength of recommendation: A: Category I evidence. B: Category II evidence or extrapolated recommendation from 
category I evidence. C: Category III evidence or extrapolated recommendation from category I or II evidence. D: Category IV 
evidence or extrapolated recommendation from category II or III evidence(23) 
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In summary, the foremost recommendation stated that both pharmacological and non-
pharmacological methodsare to be combined for effective management of OA(23). One of 
the most widely agreed upon guideline indicated that non pharmacological methods,with 
emphasis on education and exercise,are well supported by evidence ratings of 1A and 1B 
respectively(23).Furthermore, weight loss and the use of supportive appliances, although 
only supported by weak evidence, are still strongly encouraged by expert opinion. This is 
due to the shortcomings noted in the evidence rating system used in these 
recommendations as discussed below(23). 
 
Concern has been raised over the suitability of using the evidence hierarchy when critically 
reviewing literature and providing recommendations for or against future use of different 
methods(24). In some cases, especially studies on surgical procedures, ethical issues prevent 
high rated studies, such as a RCT, from being executedand thus research in such areas is 
rated as a lower category level III(24). Suggestions have been made for the development of a 
similar rating system that would be more appropriate than the evidence hierarchy to be 
used in such cases so as to not exclude studies due to these ethical issues(24). The strength 
of recommendation in the EULAR review was mainly based on the level of evidence for that 
specific treatment option, but was said to consider other aspects such as effect size (ES), 
side effect profile, applicability to population in question and practical and economic 
concerns(23). How much these other aspects were taken into account is debatable. 
Therefore, since the strength of these recommendations is based mainly on the evidence 
hierarchy and unknown weightings of other aspects, more recent guidelines with different 
methods of rating of evidence should be consulted in conjunction with the EULAR 
recommendations. 
 
Despite the above, these guidelines were robust in their development through expert 
opinion using a 5-stage Delphi technique. An additionalstrength of the EULAR guidelines is 
that evidence-based literature included was not limited to English, but included European 
languages as 13-14 experts on the panel were from various European countries. A 
weakness however, was that the experts were solely European and this should be kept in 
mind when using this data internationally, especially in low to middle income countries 
such as SA. 
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This shortcoming is acknowledged in the guideline with a statement that each country 
should utilise the recommendations to form their own country-specific guidelines, as so far 
only a limited representation of countries were involved in the development and the 
results should be applied to each different population and environment as appropriate(23). 
Whether the same recommendations can be applied in lower income areas with limited 
resources and lower education levels is to be considered.  It is also worthy to note that the 
research by EULAR examined the treatment effects of modalities on pain and/or function 
alone, and did not include effects on other aspects, such as psychosocial components,  
affected by OA. A further point raised is that data relating specifically to the hip is scarce 
and that further research is needed into this condition to provide more insight into OA 
affecting this joint.  
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Table 2-3EULAR recommendations for the management of OA of the kneeand hip 
 Knee(23) Hip(24) 
1 The optimal management of OA requires a combination of non-pharmacological and 
pharmacological treatment modalities 
2 The treatment of knee and hip OA should be tailored according to:  
(a) Knee and hip risk factors (obesity, adverse mechanical factors, physical activity and 
dysplasia for hip)  
(b) General risk factors (age, sex, comorbidity, polypharmacy). 
(c) Level of pain intensity and disability/handicap.  
(d) Sign of inflammation—for example, effusion.  
(e) Location and degree of structural damage.  
(f) Wishes or expectations of the patient 
3 Non-pharmacological treatment: regular education, exercise, appliances (sticks, insoles, knee 
bracing), and weight reduction 
4 Paracetamol is the oral analgesic to try first and, if successful, the preferred long term oral 
analgesic 
5 Topical applications (Non-steroidal anti-
inflammatory drug (NSAIDs)and capsaicin) 
have clinical efficacy and are safe in knee OA 
No mention of the topical applications for the 
hip 
6 NSAIDs should be considered in patients unresponsive to paracetamol. In patients with an 
increased gastrointestinal risk, non-selective NSAIDs and effective gastro-protective agents, or 
selective COX-2 inhibitors should be used 
7 Opioid analgesics, with or without paracetamol, are useful alternatives in patients in whom 
NSAIDs, including COX-2 selective inhibitors, are contraindicated, ineffective, and/or poorly 
tolerated 
8 Symptomatic slow acting drugs for OA 
(SYSADOA  -glucosamine sulphate, 
chondroitin sulphate, diacerein, hyaluronic 
acid) have symptomatic effects and may 
modify structure 
SYSADOA have a symptomatic effect and low 
toxicity, but effect sizes are small, suitable 
patients are not well defined, and clinically 
relevant structure modification and pharmaco-
economic aspects are not well established 
9 Intra-articular injection of long acting corticosteroid is indicated for flare ups of pain, especially 
if accompanied by effusion in the knee and those unresponsive to analgesics and NSAIDs. 
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10 Joint replacement has to be considered in patients with radiographic evidence of OA who have 
refractory pain/disability. Osteotomy and joint preserving surgical procedures should be 
considered in young adults with symptomatic hip OA, especially in the presence of dysplasia or 
varus/valgus changes.  
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ii. The OARSI guidelines  
Since the EULAR recommendations are now over 10 years old, more recent guidelines are 
discussed. The OARSI group(25) published guidelines in 2008 which were anticipated to be 
more adaptable for countries worldwide. Firstly, a thorough appraisal of existing literature 
and new evidence was done, including literature as old as 1945 until more recently, 2006. A 
notable difference in the development of these guidelines compared to the EULAR 
guidelines was evident in the use of an assessment tool to review the quality of the 
guidelines developed. The appraisal of guidelines research and evaluation (AGREE)(212) 
instrument was utilised. This tool was accepted by the WHO to appraise the guidelines 
which they regularly develop(212). This tool was the first of its kind to be developed and 
tested internationally to assist with the increasing number of new guidelines being 
produced in clinical practice(212). This tool is exclusively focused on the quality of the 
process of development and reporting of guidelines and does not evaluate the quality of 
subject matter or data being discussed(212). See Table 2-4below for the AGREE criteria that 




Table 2-4 AGREE criteria for high quality guidelines 
1. Scope and 
purpose 
Contain a specific statement about the overall objective(s), clinical 




Provide information about the composition, discipline, and relevant 
expertise of the guideline development group and involve patients in 
their development. They also clearly define the target users and have 
been piloted prior to publication. 





Provide detailed information on the search strategy, the inclusion and 
exclusion criteria for selecting the evidence, and the methods used to 
formulate the recommendations. The recommendations are explicitly 
linked to the supporting evidence and there is a discussion of the health 
benefits, side effects, and risks. They have been externally reviewed 
before publication and provide detailed information about the 
procedure for updating the guideline. 
4. Clarity and 
presentation 
 
Contain specific recommendations on appropriate patient care and 
consider different possible options. The key recommendationsare easily 
found. A summary document and patients’ leaflets are provided. 
5. Applicability 
 
Discuss the organisational changes and cost implications of applying the 
recommendations and present review criteria for monitoring the use of 




Include an explicit statement that the views or interests of the funding 
body have not influenced the final recommendations. 




The same Delphi approach as used in the development of the EULAR guidelines was used to 
produce the OARSI recommendations. In this case a 6-rounded Delphi technique was 
executed which generated 25 recommendations; many of which were similar for the hip 
and knee joint. OARSI’s recommendations have been expanded from the mere 10 
pointsmade by EULAR.  
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The main recommendation confirms earlier proposals of optimal management by including 
both pharmacological and non-pharmacological treatment methods(25). Besides agreeing 
with the other recommendations made by EULAR, a few additional recommendations are 
discussed. Strong emphasis is again put on the importance of education and self-
management by the patient becoming actively involved in the management of their 
condition. Additionally, not only is commencement of self-management stressed but 
importance is put on the need for adherence to these strategies(25). Telephonic 
communication with patients is also encouraged. Emphasis is placed on sessions with a 
physiotherapist for education and instruction in different types of exercise as well as short-
term relief from symptoms using various physiotherapy modalities if necessary(25). Surgical 
options reiterate the role of arthroplasty and smaller joint preserving techniques, but add 
further suggestions of surgical options such as a uni-compartmental replacement orfusion 
of the joint if knee arthroplasty has failed.   
 
A strength of the OARSI recommendations by Zhang and colleagues was the rigorous 
critical appraisal of existing guidelines and a review of current research. This was done prior 
to the updated guidelines being developed, and published as a full report(213). The authors 
raised concerns as to the quality of the evidence-based literature upon which previous 
reviewers were basing their decisions. The need for internationally accepted guidelines was 
also made clear after the first part of this work was completed. To address this, a 
multinational team, not only from the European regions but also from USA and Canada 
were included on the expert panel. Detailed accounts of all methodological processes were 
clearly presented(25).  
 
A key difference was noted between the EULAR and OARSI’s order of development; the 
EULAR method firstly performed the expert opinion consensus and then proceeded to 
research the literature available on those 10 treatment options, whereas the OARSI 
technique initially performed the evidence-based research review and subsequently 
undertook the Delphi consensus. This minor difference attributes the OARSI process as 
more “evidence-driven and clinically supported” instead of vice versa; making the OARSI 
process less biased(213). Additionally, another two processes were carried out which were 
not done by the EULAR group during development.  
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A small pilot survey was undertaken to assess the perceived usefulness of the existing 
guidelines, although it was limited this assisted in confirmation of the core treatment 
modalities used. Secondly, besides the expert panel, members of the public were able to 
review and comment on the proposed OARSI recommendations during the six rounded 
Delphi process. These two supplementary consultation steps make these recommendations 
more robust(25).  
 
Another strength to be brought to attention is the approach used to rate the level of 
evidence; a VAS is recorded instead of the evidence hierarchy method(214). As indicated in 
earlier text, the issue of rating evidence is troublesome as appropriate evidence may not be 
strongly ranked due to ethical and practical issues preventing the gold standard of studies, 
a RCT, from being performed(24). The VAS allows an RCT to be rated appropriately by 
creating a rating which includes both evidence and expert opinion from clinical practice(214). 
This upgrades the strength of recommendation as it is based on overall effectiveness and 
not solely on study design(25).  
 
Despite the many strengths discussed above, a number of flaws exist within the OARSI 
guidelines(25). Firstly, the representation of multidisciplinary professionals was small with 11 
of the 16 experts being rheumatologists. An attempt to minimize this limitation was made 
by including the perception of usefulness survey (available to other members of the health 
team) as well as allowing the OARSI members to share their opinions on the proposed 
guidelines during the Delphi process(25). It was also mentioned that new evidence had 
become available after the closing date for review of literature in early 2006; whether this 
literature would have had any effect on the end guidelines is unknown. But this is the case 
with all research; new studies are constantly being performed, thus highlighting the need 
for updated guidelines and constant evidence based literature reviews. 
 
iii. NICE guidelines 
The National Institute for Health and Clinical Excellence(80)is another group who drew up 
recommendations in 2008. Similar core standards of treatment, as those discussed above, 
are recommended together with minor changes. The use of electro-acupuncture and 
glucosamine and chondroitin as a SYSADOA was excluded from this guideline.  
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The recommendation against the use of the above supplements has been questioned by 
Dalbeth and Arrol(215) as high quality studies do exist to support the use of glucosamine and 
chondroitin in knee OA. Thus this remains unclear and is thought to be safer to rather 
exclude use until consensus is reached on this point.Further emphasis is needed on the use 
of topical NSAIDs in affected hands and/or knees, as this method of management was said 
to be underused despite evidence for clinical effectiveness and high safety(215).Another 
difference was that surgical arthroscopic lavage and debridement is not recommended for 
all patients. Rather, this procedure should be recommended for specific patients who may 
benefit from this procedure(27).  
 
Other criticism of the NICE guidelines was laid out by Dalbeth and Arrol(215): interestingly 
the small effect size of most of the treatments recommended was mentioned. Only 
exercise and oral NSAIDs had a moderate effect size, the other recommendations were 
based on low efficacy or small effect sizes. The suggestion for patients to be questioned 
qualitatively to obtain their subjective opinions on the efficacy of such treatment options 
was also made(215).  
 
On a more positive note, these guidelines highlighted gaps in the effective implementation 
of previously recommended treatments. The authors identified the need for adequate 
funding, allied health professionals and surgeons who can deliver such treatment 
modalities to bridge those gaps(215). Furthermore, physiotherapists, occupational therapists, 
dieticians and/or other appropriate personnel were noted as a prerequisite to provide 
education and exercise to successfully implement the suggested treatment options(215).  
 
iv. The AAOS guidelines 
After the guideline by NICE was published, further work was done by the American 
Academy of Orthopaedic Surgeons(216)in the same field. This academy published their 
guidelines for treatment of knee OA in 2010 which consisted of 22 recommendations with 
the focus steering more in the specific direction of self-management programmesprior to 
recommending similar modalities as the previous guidelines such as exercise, weight loss 
etc. According to Richmond et al.(216) this guideline was “developed using systematic 




Differences between the AAOS and previous guidelineswere notedby a number of 
inconclusive recommendations reported.The use of a few modalities were neither 
supported nor discouraged namely; the use of bracing for either lateral or medial uni-
compartmental OA of the knee, acupuncture for pain relief, intra articular hyaluronic acid 
injection and an osteotomy in patella-femoral OA. This discrepancy leads one to question 
the quality of the original data that supported the use of these options, or the necessity to 
gain further information on the new data available. Until thorough evidence-based 
decisions have again been made on such modalities, recommendations for the use of these 
modalities remain inconclusive(216). Also, as in the OARSI guideline, evidence has shifted 
since the EULAR recommendations were developed and some modalities that were earlier 
supported, are no longer recommended. Once again, SYSADOA such as glucosamine, 
chondroitin sulphate or hydrochloride, the use of lateral heel wedges or joint washouts are 
not recommended(216). This further strengthens the use of the options that are supported 
by evidence-based literature such as education and exercise. Once again, these evidence-
based modalities were reported to have the potential to be delivered by health 
professionals such as physiotherapists(93). Bryant and colleagues(217) state that 
physiotherapists “are well placed to deliver treatments that integrate physical and 
psychosocial elements.”  
 
v. The ACR guidelines 
Even more recently revised evidence based treatment guidelines were published in 2012, 
by the ACR(208).The guidelines once again concur with previous guidelines; recommending a 
holistic approach for the management of OA(208). This work waspublished as an update of 
their first recommendations made for the management of OA of the hip and knee in 
2000(218). The need for this revision was expressed due to improvements in the methods of 
drawing up such guidelines. More importantly, new literature had become available on the 
current management for knee and hip OA. The revision also aimed to develop guidelines 
for OA of the hand which had not previously been conductedin such a manner. A strength 
of this work is once more noted by the rigorous method of development of these updated 
guidelines. This was also completed by a more balanced and diverse range of health 
experts (academic and practicing rheumatologists, primary care physicians, physiatrists, 
geriatricians, orthopaedic surgeons, and one occupational and two physical 
therapists)reaching consensus on the available evidence based research. 
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This is seen as an improvement from the expert panel in 2000 (a mere four rheumatologists 
from the USA) and when comparing to the EULAR and OASRI guidelines which had limited 
interdisciplinary input.However, a weakness is noted in that it also only included 
stakeholders from the USA and Canadainstead of extending the panel to other countries. 
This should be taken into consideration when applying these guidelines internationally, 
especially to developing countries, such as SA. 
 
In ACR this update, consensus was made by means of a formal process called the Grading 
of Recommendations Assessment, Development and Evaluation (GRADE) approach to 
ensure that the results were as evidence based as possible(207,219). This approach has also 
been adopted by the WHO, as well as other organisations such as the Cochrane 
collaboration and American College of Physicians(208). This process is based on rating 
treatments by best supported evidence available. Support of a modality by published 
evidence in the literature far outweighed professional opinion from clinical practice(208). 
Theoretically, research favours evidence-based work, so this method is hypothetically very 
strong,but some could see it as undermining professional opinion gained from clinical 
practice(208). Another limitation is that the guidelines only discuss non-surgical options that 
are used in the USA and Canada and very importantly, the committee was unable to 
explore surgical opportunities as this was beyond their scope of charge(208). We see that 
even though the ACR guidelines are one of the most recent and robust in their 
development process; this work also has a number of limitations to be taken into 
consideration. 
 
Beyond management of those who already have OA, further suggestions for strategies 
which encompass health promotion and preventative measures to reduce the development 
of OA have also been put forward(19).Mody and Woolf(19) state there is a large demand for 
improved prevention of OA by implementing strategies aimed at decreasing the risk factors 
associated with OA. Addressing the issues of obesity, reducing injuries which cause 
secondary OA, avoidance of long-term participation in certain occupations and sports that 
cause excessive or repetitive loading on certain joints and regular participation in exercises 
to improve control around joints, is proposed to assist in lowering the burden caused by 




2.3.2 Summary of guidelines - The gold standard of management 
Roos and Juhl(29) produced the most recent SR at the time of this literature reviewin 
2012,on existing and new literature available on the treatment of OA of the hip and knee. 
Additionally, a task force from theEuropeanSocietyfor ClinicalandEconomicAspects of 
OsteoporosisandOsteoarthritis(ESCEO) published a report in 2014, which reviewed the 
above existing guidelines and expressed the need for a management algorithm, similar to 
Roos and Juhl’s pyramid sequence, to prioritise the recommended practice guidelines(30). 
The SR and algorithm report are used as a summary of the above OA management 
guidelines(23-25,208). 
 
In summary, the previous guidelines’ core recommendations are reinforced by again 
describing the best supported management options for osteoarthritis of the hip and knee 
as education/information access, exercise and weight control(29,30). ESCEO specifically 
mention the important role of physiotherapy in the first steps of OA management, as well 
as the involvement of physiotherapy at later stages too(30). In addition to this first-line of 
treatment, pharmacological modalities, passive treatments, and surgical interventions are 
then indicated where appropriate(29,30). A helpful pyramid is presentedbelow (Figure 2-2) to 
depict the suggested timing of gold standards of treatment, starting with all patients 
receiving the first-line of treatment and then moving up the pyramid for those patients 
who require other modalities(25,29,207). ESCEO reports finer details of which pharmacological 
agents should be used at different stages. The task force recognised the general limitation 
that exists regarding a lack of clinical trials for various treatment options, however firmly 
states that recommendations at each stage are based on sufficient evidence(30). The full 





Figure 2-2 The first, second and third line treatment options 
 
The extensive work in this field has produced various guidelines which all reinforce the core 
modalities of education, exercise and weight control or loss as the most effective 
management of OA of the hip and knee. This shows that this gold standard of core 
treatment is evidence-based and should be utilised in the management of the condition. An 
additional management approach that has shown benefits in persons with OA is relaxation 
therapy; consisting of guided imagery (GI) and progressive muscle relaxation (PMR)(220-222). 
Although this management option does not form part of the gold standard of treatment for 
OA according to the evidence-based guidelines, the advantage of relaxation therapy is its 
ability to enhance treatment responses from the above-mentioned first-line modalities of 
education and exercise(222). These physiotherapy specific management approaches, 
focussing mainly on variations of education and exercise, as well as relaxation therapy as an 
adjunctare discussed below.  
 
2.3.3 Education 
It is evident from all the guidelines discussed that education is imperative and usually one 
of the first recommendations to be made(22).Noteworthy from the previously mentioned 
aim of the Bone and Joint Decade is the emphasis on empowerment of patients through 
education to promote more efficient self-management of their health(43). 
• First, second and third line treatments 
for few patients
Surgery
• First- and second-line 
treatment for some patients
Pharmacological pain relief, 









Patient education is a well-known term in medicine. It has been described as an 
intervention that is aimed at increasing the patient’s knowledge on a certain topic. The 
patient is usually a passivereceiver of information in order that they may better understand 
their condition, the treatment options and prognosis thereof(223). The aim is then to use this 
information to make the necessary changes to manage their condition better than 
before(224,225). However, this passive mode of educating patients has been criticised as it has 
not been shown to produce the desired change in behaviours(38). Patients with OA who 
have chronic pain need to be educated in order to change their unhelpful thoughts, fears 
and beliefs regarding pain in order that they participate in exercise and correctly 
implement helpful coping skills i.e. change their behaviours(226,227). 
 
It has also been reported that patient education is often underutilised(225). Reasons for this 
are not necessarily that education interventions are not available, but even in areas where 
they are readily available; the same underuse is still noted. An explanation is put forward 
reasoning that physicians do not see the value of such an intervention(225) as merely 
educating the patient is not sufficient to cause the necessary changes needed to manage a 
chronic condition(223,228). This supports the need for sufficient training of health 
professionals in effective patient education to bring about mind set and behaviour change 
rather than onlyproviding information(66,217). Research has stated that due to the degree of 
involvement that a physiotherapist has in patient management, physiotherapists “have the 
potential to play a key role in applying a biopsychosocial model of health care” to patients 
with OA(217). It goes on to describe how physiotherapists are trained to incorporate 
psychosocial components into treatment and with specific further training in a particular 
area, physiotherapists can provide specific interventions targeted at cognitive-behavioural 
changes(217). 
 
A fairly new and advancing area of research regarding education as a management 
approach for those with chronic pain is that of neuroscience education(229).This entails 
education onneurobiology and neurophysiology of pain and the changes that occur with 
central sensitization(229).This approach is explained as a potential method to desensitise the 
CNS, by targeting the cognitive-emotional link to central sensitization. Further research is 
being undertaken in the field of OA but it is reported that one can theoretically treat the 
changes in the CNS by reconceptualising the meaning and reason behind chronic pain. 
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The cognition that pain originates primarily from a local joint pathology(229) and that pain is 
always directly related to the amount of tissue damage at that site is incorrect(230). In fact 
unhealthy beliefs, fears related to pain and movement, catastrophizing and hypervigilance 
can lead to further central sensitization(229). However, the correct pain cognition, in those 
with central sensitization, is that the pain experience is largely influenced by maladaptive 
changes in the nociceptive processes in the body as well as psychosocial aspects within 
each individual(230). Thus if cognition surrounding pain and the associated behaviour is 
altered, processes leading to sensitization can too be altered(231). Research has been 
performed on the effects of neuroscience education on LBP(232-234)and limited MSC such as 
chronic fatigue syndrome, widespread pain and whiplash associated disorders(230). Evidence 
shows that neuroscience education can have a positive effect on pain, disability, 
catastrophization, and physical performance(230). How this should be incorporated into 
management of OA is discussed later in the text (pg. 69). 
 
2.3.4 Self-management interventions 
To address the challenges of traditional education showing limited benefits, an expansion 
on education has been well researched in the past decade. Self-management interventions 
(SMI) focus on enabling the patient to be an active member in managing their day to day 
health by improving their perception of their ability to do so(11,235). This is achieved through 
education about their condition, together with discussions on related aspects, goal setting 
and active monitoring of behaviour change progress. A key factor in physical behaviour 
change is encouraging activity and applying healthy psychosocial skills to certain life 
situations(11,236). Sadly self-management is not a simple act to master(228). For many patients 
with chronic illnesses, adherence to any sort of treatment plan is poor. This is a 
problemseen with adherence to self-management, patients often start off well making 
necessary changes but after a period of time, previous habits and behaviours are 
readopted(228). Barlow et al.(237) states in order for self-management to be effective, it 
should provide the patient with the “ability to monitor one’s condition and to affect the 
cognitive, behavioural and emotional responses necessary to maintain a satisfactory quality 
of life.” The importantcomponents in this statement are “monitor” and “maintain.” Self-




As discussed earlier, unhealthy beliefs held by patients about pain and activity, can often 
lead to further disability(178). To correct these beliefs, educating the person on an 
alternative to the unhealthy belief is the first step to adjust these thought patterns. This is 
based on the principles of cognitive behavioural therapy(238) that with knowledge comes 
understanding and once both are gained, self-confidence can then improve and changes 
can be put in place to take on healthier behaviours; allowing patients to manage their 
condition better than before(178,239,240). A key aspect to making the necessary changes is to 
improve the person’s self-belief to achieve a goal or perform a task(158,239). This term, as 
discussed earlier, is called self-efficacy(12) and an important part of this management 
approach is aimed at improving SE. Better SE means being able to make informed decisions 
and therefore having more control of their condition(158,239). Furthermore, belief in one’s 
ability to performa task is increased by the person actually exercising or practising the task 
as this helps to align the knowledge gained and converts the false beliefs that movement 
causes pain and disability(179).  
 
In order to become a successful self-manager of health, certain helpful skills are taught 
during SMIto assist the person with living with their chronic condition(92). These skills 
pertain to day to day medical management, changing behaviours and activities and 
managing the emotional aspects of the condition(11,92). Topics such as problem solving, 
decision making, correct use of resources, forming healthy partnerships within the health 
services and action planning are discussed and applied to the individual’s situation. Besides 
these core skills, content also deals with healthy lifestyle choices, incorporating exercise 
into daily life, pain and stress management techniques and general advice about their 
condition. This type of approach requires careful assessment of the problems in each 
person’s or group’s situation; explaining the necessity for discussing topics such as 
problem-based thinking and solving(92). It has been noted that a successful SMI should 
attempt to educate the patient on all the above components in order to focus on the 
aspects that the patients perceive as their main problems (impairments, activity limitations 







i. Effectiveness of SMI 
Research states that SMI have been recognised as a basic component of health care for 
chronic disease management(241).  However, studies on the effectiveness and benefits of 
self-management programmes show varied results(92,242). Although accepted 
guidelines(23,24,26,208) recommend the use of self-management strategies, a recent SR(92) and 
MA(243) have indicated that this method has not had the expected significant effects in 
reducing pain, disability(effect sizes ranged from negative to negligible to small) and 
function (negligible to small effect sizes)(92,243). Rather, improvements have been seen in 
other areas such as psychological well-being and SE (medium effect sizes were more 
common). One explanation for these results may be due to the types of outcomes used 
when assessing these programmes’ effectiveness. Nolte shares that at the timethere were 
“no objective biological measures of disease severity in musculoskeletal conditions,” and 
that the outcome measures used in these studies are reliant on a subjective measure of 
patient self-report and therefore may not indicate the actual effect of the SMI(92).  
 
a. Outcome measures in SMI 
The four most commonly reported outcomes to have been used during SMI studies in 
Nolte’s SR are pain, disability, depression and SE(92). Additionally, in the same SR, outcomes 
such as visits to physician, general health, fatigue, communication with physician, 
knowledge, anxiety, and physical functioning are also discussed(92). The 18 studies included 
in the review had to pass strict inclusion criteria as all studies were either based on or 
similar to the Stanford principles of management(244).  The homogenous intervention 
structure is a strength of this review, however many different outcomes were used across 
the 18 studies and thus makes it difficult to compare studies side by side(92). The results are 
unfavourable with regards to pain, disability, function and impairment and raises the 
questions of whether the outcome measures are being correctly administered to accurately 
detect changes in the above mentioned outcomes, or whether different primary outcome 
measures should be used instead(228). 
 
Newman and colleagues(228) rightly state that it is vital to consider what the primary aim of 
a SMI is, together with the intention of the specific outcome measures used. He states that 
self-management programmes, alone, cannot achieve a reduction in the level of pain itself.  
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However, the programme is designed to educate the person to improve their coping 
mechanisms in order to perceive the pain in a better manner, manage it appropriately and 
change the debilitating effect people equate with pain(228). Thus, outcome measures used 
should measure these expected changes andevaluation of pain interference seems to have 
more importance than pain severity. Crotty and colleagues also advise in those waiting a 
joint replacement “that changes seen in exercise and activity are the primary self-
management improvements that would be desired from the self-management 
interventions”(242). 
 
It is stated that improvements in the above areas are beneficial for those patients on a 
waiting list as this will help to prevent further stiffness and disability during the waiting 
period(242). A possible explanation has been put forward for those persons awaiting surgery 
that do not show significant improvements in pain or function after an SMI.This could be as 
a consequence of being put on a waiting list. The expectation of surgery as the following 
step in the management of their condition has been established and therefore it is possible 
that patients regard lifestyle changes and self-management as unnecessary(242). Research 
by Moffet et al.(245) supports the above rationale by attributing lower response rates to 
conservative treatment to beliefs in, or the need for surgery. Despite this negative aspect, 
lengthy waiting lists for joint replacement surgery remain a burden in both high and lower 
income countries(242) and the patient’s quality of life, while awaiting surgery, is poor and 
decreases over time with many frustrations due to their health concerns not being 
addressed(33,246,247). The detrimental effects of being on a waiting list is discussed later in the 
text, but what seems to be the essential factor pertains to the uncertainty of choice of 
outcome measures and the use of patient self-report in establishing the effectiveness of 
SMI.  
 
b. The Chronic Disease Self-management Programme 
Despite the above disparities in literature, a need for management of OA is evident both 
before surgery is required and while awaiting surgery. Therefore, individual studies that 
support the use of self-management programmes for improvements in a variety of 
outcomes, including pain and disability, should not be disregarded.Self-management 
programmes which follow prescribed outlines, have been widely used in high income 
countries, showing a range of positive results(241,248).  
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Two commonly utilised and well researched programmes from Stanford University in the 
USA are; the Chronic Diseases Self-Management Programme (CDSMP)(239), which assumes 
that patients with any one or more chronic disease/s face similar issues and can take part in 
a general programme for a variety of chronic diseases. More specifically the Arthritis Self-
Management Programme(ASMP)(249) targets people suffering specifically with arthritis.The 
two approaches are reviewedbelow. 
 
The CDSMP was originally researched in two studies including persons with a variety of 
chronic conditions(177,239).The self-management intervention initially consisted of seven 
weekly sessions and participants were followed up at month six, compared to a wait listed 
control group in the first RCT, and one and two years post intervention in the second 
longitudinal study (with no control group). The CDSMP showed after six months and one 
year respectively, significant improvements in health behaviours, status and SE as well as 
decreased health care usage. Significant improvements in health distress and SE were 
sustained at two years (p < 0.05)(240). This was evident by participants’ improved self-
confidence, exercise habits (number of minutes per week of stretching or strengthening 
and aerobic exercise), energy, less fatigue, better coping mechanisms, cognitive symptom 
management, communication and reduced hospitalisation(239,240). The studies however, did 
not show any differences in pain or physical discomfort, shortness of breath or 
psychological well-being(239). It is suggested however that this programme can reverse the 
trends seen in the control group towards a decline in health variables(239).  
 
At two years follow up, thecontrol group was included in the sample (N = 533) as the 
programme was offered to them. Despite the expected average increase in disability per 
year (0.02 - 0.03 on the HAQ)(250,251) different aspects of health status remained constant or 
improved with a decrease in the use of outpatient services(240). The primary outcomes of 
these studies were change in health behaviours, health status, and health service 
utilization. Interestingly, the measures of these primary outcomes correspond with the 
suggestion by Newman et al.(228) to focus on outcomes which possibly measure the 





The original RCT was based on a large sample size of 952 participants and displayedhighly 
significance values for the improvement in outcomes for the treatment group were noted: 
p<0.01 for health behaviours, p<0.02 for health status improvements at month six(239), p < 
0.01 for improvements in health distress and SE at one and two year visits(240). However 
effect size was not calculated or reported at the time of the studies. The CDSMP was shown 
to be cost effective in terms of considerable savings per participant when compared to a 
control group(177,240). These results support the use of the CDSMP as a management option 
for chronic diseases with the specific objective of increasing SE and reducing health service 
utilization. 
 
However, even though level of education was not seen as a covariant when analysing 
results, in this particular sample, it is noteworthy that the mean level of education for these 
subjects was high (14-15 years)(239).Results may differ in groups of lower educational levels 
such as those in SA where the majority of the older non-whitegeneration today received no 
or poor quality education in previous years(66). In SA, adult literacy rates only increased by 
4% between 1995 and 2006 and in 2007 it was reported that persons who received 
secondary to tertiary education are still presenting with issues of basic numeracy, literacy 
and problem solving skills(66).  
 
Another factor that should be considered when generalising this study to other populations 
of patients with chronic conditions is that there is a recruitment bias. Patients volunteered 
to take part in this programme. This means that the results are based on a samplewho 
were highly motivated to improve and not on patients who did not volunteer and who may 
not be as determined to show improvements. Lastly, due to the variety of different chronic 
diseases and stages of each condition in the patients attending the CDSPM, the individual 
problems and needs differed. This showswhat is known as a ceiling effect*** by only having 
a small variability in improvements in the primary outcomes, as some patients did not have 
very low health status or behaviours initially. This meant their scores were near the upper 
limit to begin with, thus did not show large improvements but rather were maintained(239).  
 
 
                                                          
*** Ceiling effect: occurs when a number of scores are seen towards the highest available limit(367) 
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Further research by means of a MA on the effectiveness of CDSMP was conducted in 
2005(252). However, this review was limited by the presence of possible publication bias 
andthe studies used in the MA were noted to be of variable quality(252). A total of 14 studies 
of OA, among other conditions, were reviewed from 1985 until 2004.  Simply put, the 
MAresults concurred with Lorig’s original work that showed CDSMPdid not cause a relevant 
clinical change in those with OA, based on ES in pain and function (ES = -0.06)(252).  
 
More recently, a RCT was performed in the UK to establish the effects of a modified version 
of the CDSMP on a variety of chronic conditions, including arthritis(253). This trial was 
designed as a pragmatic RCT; comparing a six week SMI to a wait listed control group. A 
realistic sample of 629 patients who commonly diagnose themselves with a chronic 
condition was used together with practical treatments delivered in a similar fashion to 
usual care(253). This programme had small yet significant effects on SE (ES = 0.44, p < 0.01) 
and energy (ES = 0.18, p < 0.01) in this group of patients at month six(253).There were also 
improvements in exercise habits, relaxation, psychological and social well-being and health 
distress(253). This result however is not specific to OA as it was performed on a range of 
chronic conditions. Other restrictions were also noted such as the approach to recruiting 
participants; participation was voluntary which means information on the population who 
did not volunteer is unknown. Additionally, the sample used in this study differed to a large 
extent when compared to the broader population’s data gained in the national health 
survey in England(253,254). Nonetheless, it provides valuable data on the effects of such a 
pragmatic RCT and leaves room for further research in this field. 
 
c. The Arthritis Self-management Programme 
Due to the above concerns of a heterogeneous group of chronic conditions, it is important 
to discuss the research available on similar programmes aimed at specific conditions, such 
as the ASMP(249). The initial RCT on the effectiveness of the ASMP was performed over a 
period of four months and yielded significant benefits of improved knowledge and 
behaviours (p < 0.01) and a decrease in pain according to VAS (p < 0.04)(249). It should be 
noted that despite randomisation, less pain (p = 0.03) was observed in the control group at 
baseline. These benefits were observed in a longitudinal study over 20 months, as well as 
decreased health care utilisationand improvements in depression (p < 0.01)(16,158,249,255,255). 
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Lorig continued follow up measures at four years showing further decreases in health care 
utilisation (40%) and sustained benefits in pain(158). Effect sizes were not attainable for the 
above mentioned studies and the long term studies were lacking a control group. Likewise, 
as with the CDSMP, these benefits occurred despite an increase in disability (9%) over a 
longer period(158). A 12 year review confirmed the initial results by concluding that the 
ASMP was effective, in the short- and long-term, at improving health behaviours, various 
aspects of health status and self-efficacy(256). It was also reported that the duration of such 
a programme is important as a six week programme is better than only three weeks of 
ASMP(257).  
 
In spite of the above results, this original research was performed more than 20 years ago 
and mostly in high incomecountries; henceit is relevant to discuss more recent literature 
available on such an intervention. In 2000, a randomised pragmatic controlled trial was 
performed in the UK whereby the ASMP similarly supported positive findings at four and 12 
months(235). Significant improvements compared to the control group were reported in SE, 
self-management techniques and health status (p < 0.01, ES was not calculated between 
groups)(235). This RCT similarly showed no improvementin pain or disability at four months 
but showed a significant decrease in pain (p < 0.01) in the intervention group at 12 months 
compared to their baseline measures. However, it cannot be said that this is an accurate 
reflection of the intervention’s effect as there was no control group with which to compare 
at 12 months(235). 
 
Another RCT was performed in the UK in 2006 on patients with OA who attended the 
“expert patient programme” (developed from the ASMP)(258). This study was conducted in a 
primary care setting with follow up measures at four and 12 months. Similar results were 
evident whencompared to a control group;with psychological aspects such as improved 
SEanddecreased anxiety observed (p values or ES were not obtainable). As with previously 
mentioned studies, this RCT did not showany significant differences on pain or function. 
This study excluded patients who were requiring surgery and who had poor mobility; the 
reason for this was not stated. A possible reason could be attributed to the patients 
awaiting surgery not seeing the need for self-management techniques, as surgery is 
thought to be the solution to their condition.  
58 
 
The study had a few methodological flaws and miscalculations in the required sample size 
and the relevance of the reported significant improvements is unknown due to a lack of p- 
and ES values(258). Thereforedespite similar results on improved psychological factors,the 
results from this particular trialdo not seem of sufficient quality to substantially add to the 
literature available. 
 
d. Summary of the CDSMP and the ASMP 
These two variants of SMI are widely used in high income countries such as USA, UK, 
Australia, New Zealand, Canada, Japan, Singapore, Holland, Norway, Denmark, Sweden, 
Austria, Switzerland as well as middle income countries such as Mexico and China. When 
the ASMP and the CDSMP were compared to determine which is more effective than the 
other, it was seen that both programmes are beneficial in terms of decreasing activity 
limitation, health distress and fatigue at four months and additionally improving global 
health at one year (p<0.05, ES were only reported on within group changes)(241). The 
authors suggest for patients presentingwith arthritis, the more specific course be 
administered due to the slightly better results seen for the ASMP group at four monthsand 
one year post intervention (significant improvements in pain were noted in the ASMP 
group ES = 0.26, p < 0.01 at four months, ES = 0.27, p < 0.01 at one year; with differences 
between ASMP and CDSMP approaching significance at one year, p = 0.08). However, it was 
documented that the number of patients with arthritis in the CDSMP sample was less than 
half of those in the ASMP group and therefore significant values are not completely 
accurate due to the notably smaller sample in the CDSMP group(241).  
 
Furthermore, the study of comparison between ASMP and CDSMP(241) included 
predominantly females of once again, a high educational level(15 years), which should be 
taken into account when generalising its use to the broader arthritis population. This is 
particularly important in lower income countries such as SA, where according to the 2001 
South African census, 14% of the population had no schooling and less than 1% had 
obtained a grade 12 certificate(259). Educational statistics in South Africa have improved in 
the last decade and figures in 2011 show that 27.4% of the population older than 20 years 




It has been stated that interventions based on a cognitive behavioural approach, such as 
the above ASMP and CDSMP, have the potential to be reliably delivered by 
physiotherapists in urban and rural settings(93).  It is recommended that because 
physiotherapists recognise the need for a holistic approach, this profession is a rational 
choice for delivering such a psychosocially based treatment(261). A qualitative study by 
Nielsen and colleagues(262) explored the experiences of physiotherapists who were 
educated specifically to adopt a cognitive behavioural approach during treatment of 
patients with pain. It was reported that some of the components were already familiar to 
physiotherapy training, yet applying the theory into the clinical environment was reported 
to differ somewhat to traditional physiotherapy(262). It was seen that physiotherapists, 
when trained in this field, experienced greater knowledge and ability to integrate such a 
psychological approach into management and were recognised as a profession who can 
confidently deliver such programmes(262).  
 
i. Barriers to SMI implementation 
Individualstudies(228,243,263)find that there are several benefits to participating in SMIs. These 
benefits are captured well in the quote “SMIs help people to understand and cope with 
their problems more effectively, improve adherence to management advice and reduce 
healthcare utilisation”(264).  Despite research in favour of the use of SMI in management of 
chronic diseases such as OA, this method of management is not often used and has been 
said to be not easily implemented(223).  
 
As the Bone and Joint Decade correctly emphasises; instead of being seen as an optional 
addition to regular care, this manner of management needs to be prioritised(11,43). Health 
systems require the necessary resources to support such programmes, such as sufficient 
space and numbers of adequately trained staff to be able to deliver them(228) as well as 
structures in place to sustain such interventions(11). Bodenheimer and colleagues(193) states 
that self-management is unavoidable. If one looks at how much time a clinician spends 
dealing with the patient’s condition versus how much greater the time is that the patient is 




Barriers have been identified which hinder the success of SMI which necessitate different 
suggestions to assist in successfully implementing SMIs(11,223). Firstly, as mentioned, 
according to Lorig(11)  the health system needs to prioritise SMIs and integrate theminto all 
aspects of health care. Initially instead of managing all patients with this strategy, specific 
groups of patients who would possibly benefit most from this management style should be 
distinguished(228) and the type of SMIs which are to be delivered should be chosen for these 
groups(11). In order that patients accept this approach to chronic disease management, the 
expectation of passively receiving health care needs to change to individuals adopting an 
attitude of actively being involved in the management of their condition(11).  Adequate 
financial support is clearly also required in order to disseminate such management 
methods into health systems. 
 
Glasgow and colleagues(223) describe a strategy called “self-management support” which is 
used in primary health care settings throughout the USA. It consists of five main focus areas 
to aid in implementing SMIs in health care practices. The five areas are briefly described as 
assessment of whether or not SMIs are being used at all, as well as to determine if there 
are any support systems in place to allow for changes. This includes: advice regarding what 
changes need to be made and how to make them; agreement on the key focus of SMIs and 
working together to bring about successful implementation; assistance with identifying and 
addressing barriers that may arise and lastly arrangements to review the changes and 
progress of the new system need to be done(223). These recommendations were initially 
implemented in the USA, a higher income country, and whether this strategy can be 
translated and implemented as successfully into the South African context is again 
questionable.  
 
Examples to foster implementation of SMIs into primary care facilities in higher income 
areas are presented, followed by possible barriers experienced in the SA context(223). Firstly, 
it is advised that communication should be made prior to the patient’s visit to remind them 
of previous goals and to reflect on progress. In poorer areas in SA, communication 
pathways are often unreliable as many patients do not have fixed or constant telephonic 




Additional human resources would also be necessary if extra telephone calls were to be 
made on a daily basis in preparation for those patients expected to arrive the next day. 
Limited physical resources of space, equipment and money is also an issue in health 
environments and should be considered.  
 
Secondly, while in the waiting area patients should complete forms which assess their self-
management skills since the last visit, advice on further self-management tips and 
information on community support should be readily available for reading(223). Illiteracy and 
low educational levels are a common problem in the patients serviced by the public 
community health clinics in SA(259).  Ongoing education and discussion on self-management 
progress should be commenced during interaction with nursing personnel(223). Feedback on 
any changes in the patient’s physical condition should be shared with the patient to keep 
the patient well informed and knowledgeable on their current condition. With low 
numbers of personnel available and the excessive number of patients attending any health 
setting daily in the SA environment, this interaction or in depth feedback is limited. As 
mentioned earlier, further human resources, either health professionals or lay persons, 
would be needed to facilitate such educational interactions or feedback sessions as more 
time would be needed on each patient, causing further delays and backlogs.  
 
Specific areas of concern for the patient are to be addressed in the consultation period and 
alterations to goals or plans are advised(223). Continued support by the consulting clinician 
to advocate for ongoing communication, problem-solving and behaviour change is needed 
to ensure self-management skills are sustained and improved. Once again, this advice 
requires specific attention to individual patients and ongoing support impliesongoing 
expenses, which are not readily available in lower to middle income countries(223). 
 
Glasgow et al.(223)stated that implementation of self-management support principles should 
be trialled and tested to suit the different health care environments as changing health 
care principles to a patient centred self-management model is not a simple task or an 
immediate transformation but requires time and effort at any level of health care, in both 
high and low income countries.  
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It is stressed that high quality research studies continue to be performed to confirm the 
effectiveness of self-management programmes in different groups of patients, so as to 
justify implementation of this health strategy(11).  
 
Due to previously mentioned discrepancies in the available literature on the effectiveness 
of SMIs in OA, a Cochrane review was released in 2014 concluding that low to moderate 
quality evidence exists showing no or small benefits in those with OA(265). Thus authors 
suggested no further trials such as those previously reviewed on SMI in isolation are 
needed, as good quality evidence supporting the use of SMI alone is unlikely to arise(265). 
However the use of SMI techniques in OA individuals is unlikely to cause any harm and 
therefore the recommendation for further research has been made to evaluate the effects 
of other models of SMI and/or interventions combining SMI and other approaches.  
 
2.3.5 Exercise 
i. Effectiveness of Exercise 
Literature refers to exercise as a key strategy in reducing disability in patients with OAand is 
one of the fundamental management options for those who have OA(29). Exercise for OA 
ranges from general body conditioning (cardiovascular exercise), to specific joint ROM 
exercise, to strengthening and flexibility exercises to stretch muscles. The manner in which 
exercise is delivered can either be supervised by a physiotherapist (during individual or 
group-based sessions), or by self-directed means of a home programme(23). It has been 
documented that exercise has various benefits for people living with this condition; 
although it is noted that many more studies exist on OA of the knee than of the hip. Having 
said this, the literature available on the importance of exercise in OA of the hip and knee is 
discussed below.  
 
As discussed in the evidence-based guidelines for OA, exercise is strongly recommended as 
the primary management for all persons with OA(207). In several SRs exercise has been 
shown to be effective in providing pain relief and functional improvement in patients with 
mild to moderate OA of the hip and knee(23,24,26,73,76,91,214,266-268). Accepted guidelines show 
no favour in terms of benefits or safety for either land- or water-based exercise, but rather 
that this should be decided according to the patient’s needs, abilities and preferences(208). 
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The same principle applies to choice of activity performed during strengthening and 
flexibility exercises. Promotion of exercise in general is gaining more support from recent 
literature, rather than specific exercises that target one muscle group. 
 
However, due to the broad nature of the term “exercise”, some authors do advocate for 
specific exercise programmes detailing type, intensity and duration. Fransen et al.(76) 
explains why this is thought of as necessary: in order to applyevidence-based results into 
clinical practice, one needs particular details to correctly replicate the intervention used in 
that study(76,178). Yet evidence for specified programmes is lacking in the available 
literature(23,269) and specific programmes are even seen as a limitation to implementing this 
management. Specific protocols often result in problems due to population’s needs and 
environments being so vastly different(178). This rationale supports the use of exercise in 
general, rather than specific and detailed exercises as treatment.  
 
The SR by Roos and Juhl, discussed earlier, summarised the literature made available 
during the period July 2011 to April 2012. The conclusion was made that high levels of 
evidence support the use of exercise and the benefits thereof, in cases of mild to moderate 
OA of the knee and hip(29). It is recommended in all existing guidelines that symptomatic 
patients are to be seen by a physiotherapist and prescribed an appropriate exercise 
regime(213). This highlights the important role the physiotherapist plays in the management 
of this condition. The benefits of exercise in this population according to available literature 
are discussed below. 
 
At the time of Zhang’s review in 2008, the use of exercise in persons with OA of the knee 
showed improvements in pain, function as well as health-related quality of life and clinical 
outcome(25). High evidence (level Ia) supports aerobic walking and strengthening exercise in 
knee OA to reduce pain and self-reported disability. Whereas lower level IV evidence 




An overview of systematic reviews from 2000 – 2007 (presenting high quality evidence 
according to the GRADE approach of rating studies†††) supported exercise in OA of the knee 
to bring about decreases in pain and improved function. In 2012, Brakke and colleagues(267) 
reviewed literature on physical therapy in those with OA and agreed with the above 
statement. They added that, as expected, strength training demonstrated improvements in 
muscle power in knee OA(267). These reviews further confirm that general exercise is 
supported by literature as no difference was seen when using high or low resistance 
strengthening or dynamic versus static exercises(266,267). It is stated that one concept behind 
the effectiveness of exercise lies in the “ability to reverse muscle sensorimotor dysfunction 
(weakness, fatigue, poor control) preventing abnormal movement and restore normal 
biomechanics, effecting better gait, relieving pain and improving function”(178). 
 
Most of the literature on exercise in OA thus far has focused on those patients with mild to 
moderate OA. This might explain the small effects sizes seen for the benefits of pain and 
function. Due to many studies being performed in early or mild OA only, it is speculated 
that a ceiling effect may occur because pain and function are not as affected as those with 
late stage OA(76). This means that the known effects of exercise in patients specifically with 
severe OA, is exceptionally limited(29). This area has shown to be in need of further research 
as only a small number of studies addressing this topic exist.In response to the limited 
evidence, Wallis and Taylorpublished a SR and MA in 2011(73). In summary, after reviewing 
23 small RCT’s of which only 12 were considered higher quality trials of above 6/10, the 
results showed low to moderate evidence to support exercise in those with severe OA of 
the hip or knee awaiting surgery, by reducing pain pre-operatively, and that exercise, 





                                                          
†††High-quality evidence: based on more updated, high-quality systematic reviews that are based on at least 2 high-quality 
primary studies with consistent results 
Moderate-quality evidence: based on One or more updated systematic reviews of high or moderate quality -based on at 
least 1 high-quality primary study or at least 2 primary studies of moderate quality with consistent results 
Low-quality evidence: based on One or more systematic reviews of variable quality - based on primary studies of moderate 




Another scarce area of research exists in the effects of exercise in those with OA and 
central sensitization changes due to chronic pain. The work by Nijs et al.(231) recommends 
the use of exercise in management of these individuals as exercise can “deactivate brain-
orchestrated top-down pain facilitatory pathways” and can activate the body’s endogenous 
opioid system, thus reducing hypersensitivity in the CNS(231). Exercise by means of a “time-
contingent approach” is preferred over a “symptom-led approach”(231). By participating in 
exercise for a predetermined time despite pain, instead of exercising until the symptom of 
pain prompts the person to stop, facilitates the reconceptualization of pain’s meaning 
during exercise and can reinforce the notion that pain is not only as a result of peripheral 
damage(231). Other research by Nijs and colleagues(109) examined the effects of central 
sensitization in the endogenous opioid system during exercise in chronic pain subjects. 
They found that not all chronic pain patients respond positively towards exercise as seen by 
a deactivation of their endogenous analgesia(109). Further research is suggested, by means 
of RCT, whereby longer durations of therapeutic exercise and the effects thereof on the 
central nervous system are explored. This is necessary to determine whether patients, 
particularly with OA, also display centralised endogenous analgesic dysfunction(109). This 
work has important implications for the use of exercise as a treatment option in chronic 
pain disorders with central sensitization. To allow for this dysfunction, it is recommended 
that for those with CS, aerobic and low intensity exercises suited to individual patients are 
used and progressed slowly according to each person’s capability(109).  
 
a. Outcome measures in exercise 
In the majority of the studies reviewed reporting on the effects of exercise in people with 
OA, the primary outcome measures used were self-reported pain and function.However it 
was noted that these are not recommended to be used alone but that objective measures 
should also be used to strengthen the results obtained by self-report instruments(228). 
Another point is that most of the studies reviewed may fail to reflect the full benefits of 
exercise as outcome measures should not be limited to merely pain and function but 
should include psychosocial and behavioural measures such as those identified by Newman 





Further studies have been published which havebroadened the scope of the benefits of 
exercise by not only investigating the physiological effects but furthermore the important 
psychosocial effects from exercise(21). Hurley et al.(21) speak of the “psychosocial sequelae” 
that arise from the ongoing experience of pain and disability. Again this is incorporated in 
the ICF model of how pain is not limited to a physical impairment but has many other 
complex effects. Figure 2-3belowwas obtained by permission ofCopyright Clearance 
CenterRightsLink and Wolters Kluwer Healthwhich depicts the complex association 














Figure 2-3 Complex relationship between pain, disability and psychosocial aspects 
 
The complex relationships between the physical impairments or behaviour change and 
psychosocial traits that exist in persons with OA can either impact on the management of 
OA negatively or positively(21). If the psychosocial sequelae are ignored, these factors will 
become more of an issue and further impact disability negatively. However, due to the 
associations illustrated in Figure 2-3above, exercise can be used as one of the means to 











Normal mechanical joint (ab)use; obesity; ageing; 
process of muscles and joint; disease; injury 
 
Social support 
Marital and relationship stress; size of social 
network; number of contacts; satisfaction 
with support 
 Impairment 




Inappropriate health beliefs; coping strategies and behaviours 
helplessness; depression; anxiety; low self-efficacy; 
catastrophizing 
 
Pain and disability 
 
Address biopsychosocial changes, minimise symptoms, maximise adjustment to 
physical and psychological health and social welfare 
67 
 
It has been proposed that the immediate benefits, of a reduction in pain and disability, 
seen after participating in exercise cannot solely be as a result of physiological changes 
taking place, as variables such as strength, stiffness, and endurance usually take time to 
change substantially. Thus, psychological variables are thought to have a distinct 
influence(21).  
 
Exercise has been shown to affect many different psychosocial aspects such as: incorrect 
pain beliefs, fearavoidance, catastrophizing, depression, anxiety, helplessness, social 
isolation, dependency, coping strategies, interpersonal relationships and self-efficacy(21). 
The areas that are especially important in chronic pain patients with OA are unhealthy pain 
beliefs, fear-avoidance and SE. By actively participating in exercise, patients experience for 
themselves that their pain does not dramatically increase or cause more joint damage at 
the site of OA(21). Once the belief that movement causes more pain and destruction to the 
joint is challenged and the opposite results are felt, the person begins performing 
previously avoided activity as that fear has been overcome. By achieving healthier beliefs 
about movement and activity and an improvement in their physical symptoms, patients 
feel like they have more control over their disability and have acquired helpful coping 
mechanisms. This improves SE which has a knock on effect on helplessness, dependency 
and depression(21). Physiotherapists have a key role in this field of chronic pain 
management, including patients with osteoarthritis, as physiotherapy encompasses 
strategies to alter incorrect thought patterns by actually performing the movement the 
person has been avoiding in order to overcome their fears. Physiotherapy has a major 
emphasis on “achieving health through movement”(179). 
 
b. Summary of exercise in OA 
In conclusion, literature advocates for the use of general exercise/s in the management of 
OA to reduce pain and disability as well as having substantial effects on a number of 
psychosocial aspects associated with OA. This highlights the principles discussed in the ICF 
and leads to a suggestion for further research on the importance of exercise in patients 
with severe OA to ensure exercise does not only improve body structures but translates 
into improved psychological and social traits thereby improving coping skills, ADLs and 




i. Cost effectiveness of exercise 
The cost effectiveness of exercise as a treatment option of choice is still to be established in 
the literature(270). A systematic review, which explored the cost effectiveness of first-line 
treatment options for OA, showed that studies on exercise programmes were cost saving. 
However, there were possibilities of bias in predicting costs and cost effectiveness(270). It 
was reported that such an intervention had a higher probability (81-100%) of being more 
cost effective than other treatment options(85,271).Even though,in a long-term follow up 
study, this research showsthat an exercise-based rehabilitation programme is more cost 
effective than usual primary care, flaws exist in this and other studies by Hurley and 
colleagues(85,271,272). The studies were performed in the health system of the UK and one 
cannot say if these results can be equally transferrable to other countries with different 
health systems, for example public versus private health systems in SA. Additionally, 
calculations to estimate health costs in cases that were lost to follow up may not be an 
accurate reflection of actual costs that patients would have incurred.Of interest to the 
current study is that the significant difference seen in community-based and medication 
costs alone may lower the health care costs as these are two resources often used by 
individuals with chronic pain(271). This may be true in the public health setting of SA as 
community health services are the first entry point such patients are encouraged to use 
and may be more conducive to such management than at a tertiary level.  
 
On a separate point, it could also be argued that the class-based exercise method provides 
a potentially more cost-effective alternative to individual sessions with a physiotherapist. 
This is especially true in lower income countries where waiting lists also exist for one on 
one treatment with physiotherapists. These group sessions, when introduced into 
community centres or clinics, could be more regularly accessed by older people or those 
who rely on public transport(264). The social contact with others of a similar age, particularly 
those experiencing similar disease-related symptoms, is also proposed to encourage 
treatment adherence(76). 
 
In summary, the above section has discussed the cost effectiveness of exercise in persons 
with OA. This treatment approach is believed to more costeffective in group based 
management than individual sessions or usual care.  
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In addition, the importance of on-going exercise has been recognised; as positive effects 
gained from exercise have been seen to decrease over time if exercise is not performed on 
a regular basis(76,273).  Peer support could further improve adherence to programmes but 
long-term adherence has been said to usually require stimulus of regular supervision or 
monitoring(274). 
 
2.3.6 Combined Intervention: self-management intervention and 
exercise 
i. Effectiveness of a combined approach 
The regular “stimulus” that Woodard and Berry(274) speak of is not limited to outside 
supervision or monitoring by a health professional.Rather, keeping in line with a patient 
centred approach, motivation should be driven by an internal change of mind set and self-
monitoring of changes made, progression and accomplishments achieved. This is what 
should encourage chronic pain patients to continue with new beliefs and behaviours. It has 
now been clearly laid out that firstly; education through SMIs is effective in improving 
knowledge andSE, correcting fear-avoidance beliefs and encouraging goal setting and 
activity. Additionallydue to the CNS changes that have been reported in 30% of OA 
patients, neuroscience education targeting cognitive-emotional sensitization is 
recommended as a part of initial education on pain and can be continually reinforced 
throughout intervention(2,22,231). Secondly, it is seen that exercise has benefits in reducing 
pain, improving function(275) andinfluences psychosocial factors(21), as well as affecting the 
sensitized CNS by reducing hypersensitivity and activating the endogenous opioid 
system(231).  
 
Taking these separate points into consideration, as the management guidelines suggest, 
instead of merely educating on the importance of exercise, interventionsshould include 
both educationalandactive participatory exercise components(264,276). It is proposed that by 
incorporating both aspects, the optimal benefits of these two management options 
combined could be achieved(178,264,276).Education methods of providing information and 
instruction for change alone has been said to be of little value(38). Therefore, a proposed 
more effective approach is to allow the person to incorporate new knowledge, problem 
solve and implement the advised changes in beliefs and behaviours, such as exercise, in 
order to experience the benefits first hand(21).  
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Hughes and colleagues(277)performed one of the first RCTs to establish the effects of a 
combined exercise and education intervention in persons with mild to moderate lower limb 
OA in the USA. The intervention comprised of an eight-week programme combining 
progressive exercise (aerobic and strength) with educational content to improve self-
management(277). Preliminary results from the first 150 participants were extremely 
encouraging reporting significant improvements from baseline to month six in exercise SE 
(p < 0.01), exercise participation (p < 0.01), function as per the 6MWT (p = 0.02), WOMAC 
stiffness (p = 0.03) and WOMAC pain (p = 0.02)(ES were not noted in the first study)(277). A 
second study with a larger sample size (N = 215) was carried out which supported the 
above results of improved exercise SE (ES = 0.78, p < 0.01), exercise participation (ES = 0.86, 
p < 0.01) and stiffness (ES = -0.33, p = 0.02) seen at two months. These improvements were 
sustained at month six, with added benefits of reduced pain (ES = -0.47, p = 0.04)(278). Long 
term follow up was also reported where exercise SE and exercise adherence improvements 
were maintained with large effect sizes at month 12 (ES = 0.905 and 0.669 respectively, p 
<0.01)(278).Yet improvements in stiffness and pain declined somewhat at month 12(p > 
0.05)(278). Further studies were recommended by the authors in this field of research, which 
was subsequently performed elsewhere and reviewed by a SR in 2006. Ten studies were 
included in this 2006 review to establish the effects of an integrated programme of exercise 
and education on pain and function in hip and knee OA(276). The review concluded that 
despite methodological flaws, such an approach was effective in bringing about significant 
improvements in pain and function. Again, further research was called for with fewer 
methodological flaws to establish these effects(276).  
 
Following on from the above studies, Lamb et al.(279)assessed the effects of a six week 
programme, combining exercise and education via a cognitive behavioural approach, in 
individuals with severe knee OA. Outcome measures were taken at baseline, week six and 
12. The intervention showed moderate significant improvements in pain, function and SE at 
week six which declined slightly at week 12. Interestingly, the effect sizes were larger (ES = 
0.7 and 0.8 for pain at week six and 12 respectively) in those individuals who were not yet 
on a waiting list for arthroplasty compared to those who were (ES = 0.3 and 0.1)(279). 
Evident improvements for pain, function and self-efficacy in those with severe OA are 
encouraging but a limitation to this study was noted as there was no control group to 




Hurley and colleagues(85,271,272)performed the more robust“Enabling Self-management and 
Coping with Arthritic Knee Pain through Exercise” (ESCAPE) study and yielded positive 
results. This combination of approaches (SMI and exercise) is the basis on which the 
present study has been developed and is described in the text that follows.  
 
a. The ESCAPE programme 
ESCAPE is described as comprising of two components, namely; education and exercise. 
The intervention aims to actively involve participants in their condition as a self-manager of 
their own health and is achieved by providing knowledge of the condition and related 
aspects. The participants learn to engage in regular exercise to address pain and other 
common symptoms. As mentioned, actually performing the exercises instead of just 
discussing it boosts self-confidence in the ability to do it. The intervention is usually run in 
small groups (up to 12 people) with discussions regarding different topics such as what it 
means to be an effective self-manager, goal setting, planning and problem solving and 
coping strategies amongst others. Again, this group based treatment has been shown to be 
more beneficial than individual sessions. By teaching chronic pain sufferers the appropriate 
reasons for their symptoms, unhelpful thoughts and beliefs about pain are changed and by 
seeing a change in themselves and the other participants in the group further 
enhancestheir belief in their own ability to achieve their goals(264). Importantly, the exercise 
component is supervised by a physiotherapist and can consist of a circuit of up to 10 
exercises. These exercises are commenced at low intensity and repetitions and are 
adjusted and progressed according to the individual’s abilities. This ensures safety in 
exercise and appropriate progression despite being in a group, one of the reasons to 
restrict group size. 
 
Research to support this programme was performed by means of a six month RCT in 
patients with arthritis of the knee, which compared participation in this integrated 
intervention (ESCAPE-knee pain) with usual pragmatic care. The results showed that such a 
self-management intervention, which integrates self-management and exercise, led by a 
physiotherapist, was effective in improving function as well as having a higher probability 
of being more cost effective than usual care(85,272) as well as being less costly than regular 
individual out-patient physiotherapy(264). 
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A second study was later conducted by the same group to establish the long-term 
outcomes of the intervention (up to 30 months). It was noted that initial improvements 
after the intervention had decreased somewhat. However, measures of function were still 
improved, and health care costs continued to be less when compared to the usual care 
group(271). Additional benefits of improved health beliefs and self-efficacy were also seen as 
a result of this combined approach. These two studies show that both short and long term 
benefits arise from combined intervention of exercise and education in knee OA for 
function and health costs.  
 
A strength of the study by Hurley et al.(271) was that a large sample size was used (N = 418) 
from various locations and socio-economic groups in the UK, which provided results that 
are likely to be generalizable to other areas in similar status countries. Research is 
warranted to establish if the same benefits are seen in lower income countries such as SA. 
Additionally, these results are very likely not due to chance as the required sample size of 
200 in each group was achieved andthe trial was powered at 90% CI, with 5% significance 
level and calculated to allow for attrition (only 18% withdrawal). The intervention’s content 
and delivery is well explained to allow accurate replication and necessary adjustmentsfor 
implementation in the clinical setting. What makes this intervention attractive is that it is 
realistic: requiring minimal training of health personnel such as physiotherapists and simple 
equipment for the exercise component.Simple exercises and equipment have also been 
shown to further boost compliance and self-confidence in the ability to replicate the 
exercises at home. Thus it could be introduced into other clinical environments without 
these aspects being a major barrier. Additionally, despite the model of intervention being 
performed in knee pain patients (most labelled with OA)the sample could have included 
conditions other than OA of the knee. It is hoped that the principles behind such an 
intervention can be applied to other joints such as the hip and to those suffering from 
chronic pain and therefore it has been proposed that the programme could be used with 
people with general OA and chronic joint pain(271). 
 
As supported by previous evidence,the exercises used in the program focus on becoming 




The advantage of the exercises being led by a physiotherapist and modified according to 
participant’s abilities, means that persons with either hip or knee OA could participate in 
such an exercise programme as it is not specific or fixed. Exercises can be adapted not only 
to the abilities but also the needs of the participants by exercising in a certain way to 
address issues faced during activities of daily living. This allows for a clinically relevant 
programme which targets those arms of the ICF such as activity limitations and 
participation restrictions.  
 
After the initial ESCAPE findings were published, Patel et al.(280) delivered a similar 
intervention in persons primarily with knee OA awaiting a joint replacement. The authors 
took note of previous recommendations to extend such a combined intervention to other 
conditions(226,271) and did not exclude other joint pathologies or musculoskeletal conditions 
of the lower limbs from partaking in their study(280). Likewise the intervention consisted of 
integrated education, self-management and exercise. Significant improvements were 
reported at 12 months in the Oxford Knee Score (ES = 0.27, p < 0.01 for severe OA) and 
WOMAC scale (total WOMAC score ES = 0.42, p < 0.01 for severe OA)(280). A limitation noted 
for this study was the lack of a control group to compare improvements to. Therefore, 
although the findings are encouraging, the long term improvements reported in OA 
symptoms in a sample awaiting surgery should be considered with caution. 
 
A few years later Jensen et al.(281)proposed a trial in Denmark evaluating the effects of a 
combined exercise and education interventionin those with hip OA awaiting surgery. The 
study is currently being delivered and is due to end in 2015. In this study, the intervention 
is compared to a control group of education alone which makes the study more robust than 
the trial by Patel et al.(280). The results of the study by Jensen and colleagues(281) are eagerly 
awaited as it is hoped that the results will strengthen the above findings of an integrated 








b. Summary of combined intervention 
It has been recommended that this approach be used inOA and other conditions as it could 
result in lower health care usage and costs thus decreasing the burden on the health 
system. Interestingly a study on LBP pain managementin a group based format, had higher 
attrition than individual sessions with a physiotherapist(226). The possible reason for thisis 
inflexibility of fixed group time session or difficulties travelling to sessions in disadvantaged 
persons.Also, such an intervention challenges the old ways of thinking and responding to 
pain. One of these challenges includes changing patient’s thoughts about the meaning of 
pain i.e. that in chronic pain hurt does not always mean there is harm occurring; and this 
concept could be difficult for some patients to grasp(226). Resistance to change further 
reinforces the need for this combined approach to correct this old mind set.  
 
ii. Barriers to application of combined management 
Despite strong evidence of the benefit and safety of exercise and self-management 
programs, only a minority of people are referred to these interventions because they 
continue to be erroneously considered ineffectual, expensive, and impractical. 
Consequently, few people benefit because of their poor provision and restricted access(271). 
Review of the ESCAPE-knee pain programme shows otherwise. It was effective in improving 
long-term functional outcomes as well as improving secondary outcomes such as exercise 
health beliefs and SE. It was less costly and more cost effective than usual care as well as 
being practical in terms of implementation in a flexible clinical environment.  
 
A possible barrier to the application of combined interventions is the lack of clear 
recommendations regarding precise indicationfor and timing of different treatment 
options. This explanation issupported by the low percentage (28%) of patients who are first 
managed conservativelywith education, exercise and weight loss, as recommended by 
guidelines, prior to beingscheduled for a total joint replacement in developed countries 
such as the Netherlands(282). To address this issue of unclear optimal timing of treatment 
alternatives and to improve decision making capacity, Smink and colleagues have 
developed the “stepped care strategy” in Europe whereby structure and timing of different 




A RCT is currently being undertaken in Denmark to assess whether a total joint 
replacement of the knee together with a 12 week multimodal intervention is more 
effective than a non-surgical 12 week intervention(284). These results will assist in guiding 
evidence based practice regarding arthroplasty in patients suffering from OA of the knee 
(284). 
 
It has been discussed how compliance to any intervention can and does become a barrier 
to treatment(285). Different reasons have been put forward as to why adherence becomes 
an issue, most of which are psychosocial and not due to physical factors. Three suggestions 
have been reported by patients as to why behaviours revert and unhealthy thought 
patterns return(285). The first mentions how patients experience difficulties in encompassing 
the educational advice and exercise into their normal day. The second speaks of patients 
requiring positive feedback when performing exercise as reassurance is required to 
continue taking part in it. Thirdly, patients feel helpless when faced with a challenge 
instead of being empowered. It is thus suggested that a multi-dimensional approach to 
changing beliefs and behaviours is used by the physiotherapist to build trust and 
confidence in what is being recommended so that patients can implement changes in their 
home lives(285). Instead of passively teaching a patient the importance of movement, the 
physiotherapist should guide the patient through movements so that they can experience it 
themselves, ensuring they perform it correctly. Additionally by providing the patient with 
exercises in functional positions and alternatives or variations of exercise, they are able to 
implement activity more easily into their daily lives and feel confident in repeating it in 
their own environment(285). These suggestions emphasise the combination of learnt self-
management skills and action through exercise as an approach which can be more 
beneficial when used together with SMI than when each is utilised separately(264).  
 
iii. Summary of combined intervention 
By extensively reviewing the different aspects relating to education and exercise in persons 
with OA, it is clear that these two methods are continuously recommended as first-line 
management for sound reason. As seen by evidence-based literature, combining the two 
approaches is proposed to be more beneficial than either option used in isolation. Further 
research is being performed to provide evidence that physiotherapists are capable of 
delivering such a combined programme of education and exercise.  
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Another RCT is currently underway in Australia whereby physiotherapy-led pain coping 
skills training and exercise in knee OA is being compared to education on pain coping skills 
or exercise alone(261). Since the protocol for this RCT was approved, a pilot study has been 
reported on by Hunt and colleagues(286) whereby a combined intervention delivered by a 
physiotherapist is seen as feasible and can potentially benefit patients with knee OA 
physically and psychologically. This emphasises the need for concrete evidence in this area 
of research.  
 
2.3.7 Relaxation therapy – guided imagery and progressive 
muscle relaxation 
As mentioned, the OA management guidelines have notdiscussed or included relaxation 
therapy as a recommended treatment option; this could be due to research relating to this 
approach in OA being scarce in the past. However, Baird and colleagues recognised the 
need for evidence-based studies in this field and produced encouraging findings from a 
number of studies performed on the effects of guided imagery (GI) and progressive muscle 
relaxation (PMR) in women with OA(220-222). GI is a technique using verbal suggestions to 
create a flow of relaxing thoughts based on an imagined scene, incorporating sight, sounds, 
smells and tastes. The process is aimed at refocusing attention on these imagined 
sensations instead of the pain and/or difficulties the person usually experiences(287). During 
the GI session, muscle relaxation is encouraged throughout the body, with emphasis on the 
affected sites. GI and PMR or guided imagery with relaxation (GIR) result in various 
psychological and physiological responses(287). It is understood that these complex 
responses cause changes in pain, mobility and personal factors(221).  
 
Initially, Baird et al.(220)pilotedthe effect of GI and PMR in OA in a small sample over 12 
weeks. This was followed by a longitudinal study lasting four months(222). The intervention 
consisted of listening to a 12-minute audio tape twice a day which guided the participant 
through visualisation scenes and progressive muscle relaxation.  Results showed this 
management approach to significantly reducepainand improve mobility (p < 0.01) after 12 
weeks(220,222). Improvements in mobility were seen to last for two months (p = 0.02) and 
reductions in pain were maintained at four months (p = 0.03)(222). Additionally,GI and 
PMRbrought about significant benefits in health related quality of life (p = 0.02)(221). 
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Although small female samples were used, the benefits demonstrate such a management 
approach holds the potential to bring about positive changes in this population. Further 
research, making use of standard outcomes for measuring mobility, was suggested in order 
to strengthen the results.Baird et al. suggested that such a self-management option, when 
used in isolation, is less complex than cognitive behavioural approaches, as it only requires 
one session to explain how and when relaxation should be performed(220). Additionally GI 
and PMRwas stated to be less costly than cognitive behavioural interventions as 
attendance at multiple weekly classes is minimised.  
 
Therefore the GI and PMR approach is described as simple to learn and use in the home 
environment. This makes it a very practical self-management technique for the population 
under investigation. Given that this management option is not part of the recommended 
first-line treatment for OA, it was anticipated that a short relaxation component could be 
used as an adjunct to the previously discussed combined exercise and education 
intervention. The hope is that benefits from all three components would bring about 
desired changes in pain, disability, function and personal factors in a sample with OA 
awaiting definitive surgery.   
 
Furthermore, as suggested by previously discussed guidelines, other management options 
such as weight loss and manual therapy should also be encouraged and used in addition to 
education and exercise to further benefit the person living with this chronic condition(29,207). 
These two treatment approaches are briefly discussed below.     
 
2.3.8 Weight loss 
The third aspect which forms a part of first-line treatment approach along with education 
and exercise is the need to address weight issues in those who are overweight or 
obese(29).Rationale behind this recommendation lies in the fact that higher body weight is a 
known risk factor for the development and early progression of OA(19,288). Excess or 
abnormal mechanical loading of a joint appears to be one of the main factors leading to the 
development and progression of osteoarthritis, especially in the knee(19).  This risk factor 
applies to both primary and secondary osteoarthritis, where excess loading may be related 
to obesity or abnormal loading due to mal-alignment of the hip (coxa- vara or valga) and/or 
knee (genu- varum or valgum)(80).  
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The estimated risk for developing knee OA increases from about 40% to 60% in persons 
who are considered obese(289) and a 40% and 80% increase in the odds of developing 
unilateral and bilateral hip OA respectively(290). In the normal single leg standing phase of 
walking, the knee bears three to six times a person’s body weight. Thus those that are 
overweight are exerting excessively more force through the knee joint which is proposed to 
cause damage to the joint surface(290).  
 
This association of obesity with the development and progression of OA, particularly at the 
knee and less so of the hip(291), provides justification for weight reduction as part of the 
prevention and management of OA(80). Weight loss can be accomplished by dietary changes 
together with increases in usual physical activity, as research has shown that if weight loss 
is targeted only by dietary changes without exercise, a decrease in leg muscle tissue and 
strength occurs whereas one would prefer to maintain or improve muscle mass and 
strength with a reduction in adipose tissue(292). Other studies confirm the benefits of 
combined diet changes and exercise in improving self-reported function, pain as well as 
objective measures of function or mobility in patients with OA of the knee(293-295). A MA on 
the effects of weight reduction in obese persons with knee OA showed that weight 
reduction of 5% body weight was associated with a significant decrease in self-reported 
disability(296). 
 
In addition to excess weight causing OA, studies have shown the negative effects of obesity 
on post-arthroplasty outcomes. Higher rates of post-operative complications and the need 
for revision were seen in knee replacement patients(297). Additionally, longer hospital stay 
and systemic complications were reported in overweight and obese hip replacement 
patients(298). Besides the effect of excess or abnormal loading on the structure of the 
affected joint, developingresearchhas identified that a chemical substance, called leptin, is 
produced in bodies with excess body fat. This substance circulates through the systemic 
system and it has been suggested that leptin can lead to joint damage(77). If so, this would 
provide clear physiological support for the need for weight loss, not merely to decrease 





2.3.9 Manual Therapy and assistive devices  
More and more literature is advocating for the first-line approaches such as education, self-
management, home exercises and weight loss programmesto address chronic diseases 
such as OA(29,226,271). This shows a clear shift in focus away from passive treatment delivered 
by a health care professional towards a more patient-centred management approach(299). 
This has implications on manual modalities commonly used during physiotherapy such as 
electrotherapy, acupuncture and manipulations. Despite the lack of evidence supporting 
clinical efficacy for these techniques, they are clinically usedfortheir powerful placebo 
effects(178,267,300,301). Techniques such as ultrasound (US) or transcutaneous electrical nerve 
stimulation (TENS) and manual therapy like massage and joint mobilisation are seen as 
passive modalities which could result in the patient continually relying on the therapist, 
thus leaving the patient helpless if therapy is withdrawn(178,299). It has however been 
recommended that manual techniques can be used as a second-line treatment option in 
conjunction with first-line techniques to further benefit the patient(207,208). Literature on 
these modalities is controversial which leaves physiotherapists to decide on clinical 
expertise which manual therapy techniques are to be used in this group of patients. 
Instead, education on simple modalities such as thermotherapy, that can be used at home 
are helpful; as this requires self-evaluation and use of techniques such as heat or ice 
therapy to control their symptoms of pain and/or stiffness as they deem necessary are less 
controversial(273).  
 
Completely different from manual therapy is the recommendation for the use of assistive 
aids to supply the patient with additional support from a walking stick or crutches in their 
own environment(78,208). The manner in which this works is to assist with load reduction 
through the hip or knee by bearing weight through the upper limbs as well. An assistive 
device needs to be measured properly and the person should be taught how to correctly 
make use of the device by a health professional. However, once this initial step with the 
physiotherapist is completed, the patient is able to continue with self-management skills 
learnt such as daily use or modification of the device; encouraging the patient-centred 
approach(282). The benefits obtained from other orthotic devices (knee braces or wedged 
soles) or strapping techniques used to alter the position and biomechanics of the affected 




2.3.10 Surgical Management 
Besides the first- and second-line treatment options previously discussed and the 
pharmacological treatment methods which have not been covered in this review; patients 
who do not respond appropriately to the recommended conservative management options 
are advised to undergo surgical management(23,24,26,207,273,302). Various joint preserving 
surgical methods are available for those suffering from OA of the hip or knee. An 
osteotomy involves excision of a part of bone and is usually done to influence the forces 
through the joint. Arthroscopic lavage or debridement (key-hole surgery to clean out the 
joint space of the affected joint)is performed to potentially change the course of the 
degenerative process(24,26). The effectiveness of these procedures has not yet been 
established as the literature available is limited and based on poor quality studies(24,26,78). 
 
i. Arthroplasty 
The surgical method prescribed for the population of interest in this study, which has been 
shown to clinically improve OA sufferers’ pain and disability is an arthroplasty or joint 
replacement(19,24,269,302-305). This method of management is reserved for those patients who, 
despite been treated with the above mentioned conservative and pharmacological 
methods, have persistent pain and dysfunction(78).A hip replacement involves open surgery, 
usually via the outer side of the upper leg, where the head and neck of the hip joint is 
removed and a prosthetic head and stem is inserted into the femur. The hip socket is 
enlarged and a prosthetic cup is placed in the acetabulum to create a new hip joint(306). A 
knee replacement involves open surgery via the front of the affected knee joint, both joint 
surfaces of the knee, superiorly from the femur and inferiorly from the tibia are removed 
and a metal joint surface is placed at the end of each bone to form a new knee joint(306). 
The prostheses used in these operations are said to last between 15-20 years, yet studies 
comparing different brands of prosthetics is not yet available in order to say which is 
preferred(78). Goodman(305) writes that arthroplasty surgery gives “excellent patient 
outcomes” and Hawker et al.(307) report that improvements in function and pain post 
operatively can last as long 10 years. Universal guidelines support the surgical technique of 






a. A barrier to surgery: waiting lists  
Various barriers to implementation of suggested conservative management options have 
already been discussed in the text; however a major barrier to surgical management has 
been identified in both high and low income countries due to the rapidly increasing 
prevalence of older people living with OA requiring a joint replacement(33). Waiting lists 
have been described as a growing issue causing delays in surgery as a consequence of high 
demand for this procedure(14). Statistics from 2009 predict the demand for a joint 
replacement in Canada to increase by 30 – 40% in the following ten years(14). 
 
As mentioned, surgery such as a joint replacement is necessary for those patients who do 
not respond well to best practice management recommendations for OA(78). It is almost 
seen as a last resort to effectively relieve the burden caused by pain and disability as per 
the ICF definition(308). Therefore once a patient reaches the point of requiring an 
arthroplasty they should not have to wait years or even months to receive this treatment 
option(14). From a surgeon’s perspective; the current waiting time in a high income country 
such as Canada is unacceptable at 38 weeks. Mascarenhas and colleagues(14) report that 
most patients are not satisfied with the period that they are required to wait before 
receiving surgical management. In addition to patients being unhappy about waiting, it has 
been said that delays in surgery can affect pre-operative health related quality of life, 
health status(15,34,309,310) and can cause further disability, reduced function and prolonged 
pain(33,71,246,311). Yet, the literature surrounding this topic is controversial as a few studies 
report no or minimal effect on outcomes such as pain and function while being on a waiting 
list(312,313);this is possibly due to variations in research methodology. Various studies are 
discussed below. 
 
Effects of waiting lists on pre-operative health related quality of life have been documented 
with HRQoL deteriorating while on a waiting list(14). Elsewherea decline in HRQoL and 
function has been reported in those waiting for a hip replacement forlonger than six 
months(15,309,311) and in those waiting for a hip replacement an average of eight months(310). 
The association between OA and co-morbidities is also highlighted, as research has shown 
that those on a waiting list with co-morbidities are likely to have lower HRQoL life scores 
than those without co-morbidities(88).  
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Kili et al.(314) reported in a sample waiting an average of 11 months, that pain increased and 
function deteriorated in those awaiting a hip replacement and worse pain and disability 
was correlated to the time spent on the waiting list.However, Kelly et al.(312) report minimal 
correlation between pain severity and function and time awaiting surgery, although this 
was based on a waiting list of only one month. It has also been suggested that the number 
of persons who experience a decline in different factors such as function and HRQoL due to 
waiting lists has been underestimated(313). 
 
Furthermore, there may also be adverse effects, based on health related quality of life 
measures, to post-operative outcomes if waiting periods are longer than 12 months. Kili et 
al.(314) also showed that significantly reduced post-operative quality of life was correlated 
with longer periods on a waiting list. Mahon and colleagues(311) showed lower post-
operative health related quality of life and mobility to be correlated to longer periods of 
waiting for an arthroplasty, yet this correlation was not proven to be significant in Mahon’s 
study. It is suggested that these negative effects on HRQoL are compounded in those 
waiting for periods longer than six months(311) 
 
Finally, a SR was performed in persons with OA requiring a joint replacement of the hip or 
knee, to establish what effect being placed on a waiting list has on pain and function(313). 
Results yielded no effects of being on a waiting list on pain or function pre-operatively, but 
this was also limited to a waiting period of less than six months(313). As mentioned, the 
normal waiting list at the hospital of concern in this study is at least one year and may be 
up to eight or more years (31).A small number of studies of varied quality have been 
undertaken that investigated the effects of waiting for longer than six months and 
concluded that there was some evidence to show that functional state decreased in this 
group(315). The lack of evidence in this field indicates the need for further high quality 








b. A potential solution to waiting lists 
As the burden of waiting lists rises, governments in high income countries, such as Canada, 
are developing and slowly implementing strategies to help reduce the waiting periods for a 
joint replacement(14). Various changes have been made and results documented from a 
province in Canada, whose waiting list consisted of over 2500 patients in 2006. It seems as 
though a coordinator, with the purpose of overseeing the list and its processes is helpful. In 
this developed country, upgrades to operating rooms were completed, new equipment was 
purchased and employment of more personnel was possible to help reduce the amount of 
people on the list by increasing the number of surgeries performed each week. However, 
these ideals are not easily implemented in low income countries, such as SA.  
 
Another strategy that could hold the potential to reduce the burden caused by long waiting 
lists supports the rationale behind this present study: implementing pre-operative 
preventative and maintenance programmes including advice, exercise, nutritional 
adjustments and physiotherapy to modify known risk factors associated with OA(14). 
Additionally, supporting the use of psychosocial instruments used in this study; it has been 
recommended that interventions should also target psychosocial aspects and aim to 
improve self-efficacy in those awaiting surgery(246). A programme including self-
management, education, exercise and peer support was run as an RCT in Australian 
patients with OA awaiting surgery, which showed benefits of improvements in health 
related behaviours, skill acquisition and stiffness.However, these results were limited to a 
period of six months while on a list, supporting the need for further research on benefits 





In conclusion, after reviewing the available literature on the many factors related to 
osteoarthritis and its management, it is clear that due to the steady increase in the 
incidence of OA, along with associated co-morbidities, this burden on the health system 
and more importantly, on the patient involved needs further attention. As discussed, the 
ICF framework for disability is of utmost importance when addressing a chronic pain 
condition such as OA. Not only does this common joint pathology cause several direct and 
indirect physical impairments but due to the pathophysiology of chronic pain contributing 
towards changes in the nociceptive pathways and the nervous system in a subgroup of this 
population; OA is not a simple condition to address. The condition also has a huge impact 
on psychosocial factors such as self-efficacy and quality of life among others, and as 
reported, the cumulative effects lead to severe disability in terms of daily function and 
hinder social participation for these individuals. In order to implement and provide 
effective management for those affected by this condition, further research is required in 
the South African public health setting to establish the effects of the recommended 
evidence-based guidelines from higher income countries. Of particular interest is the effect 
of first-line treatment guidelines of education and exercise in those patients with OA who 
have been placed on an extremely long waiting list for an arthroplasty, at Tygerberg 






3.1 Research design 
A single-blind randomised controlled trial was conducted. 
 
3.2 Sample 
The population of interest consisted of patients diagnosed with OA in SA. The sampling 
frame was made up of those patients who had been placed on a waiting list to receive a 
hip/knee joint arthroplasty, specifically those in the public health system in the Western 
Cape, SA. The principle investigator was allowed access to the waiting list at TBH: the 
waiting list is prioritised by the consultant in charge into three lists. The first list consists of 
those patients with extensive OA, whereas the second and third lists include those patients 
with less and the least severe symptoms/progression of the condition respectively. As 
research suggests that early non-surgical intervention is beneficial(208), this study randomly 
utilised patients who had been assigned to the third priority waiting list and were on the 
list for at least three months. This three month period was to allow for necessary 
stabilisation to any new medications that may have been prescribed or adjustments to 
their treatment when the patient was first put onto the list. By using this method of 
selection, the aim was to target the population who may achieve the most possible 
benefits from the intervention, as they had the least severe form of OA.  
 
The use of an assistive device was not a cause for exclusion from the study, but was rather 
documented and any change in assistive device usage was recorded. The study was not 
limited to participants of a certain BMI, as people with a wide range of different BMIs are 
seen as a better representation of the broaderpopulation and it was felt that the possible 
benefits from the study should not be withheld from patients with a particular BMI.  
 
A random sample (n = 281) was drawn from the patients on the third priority list by means 
of random number selection in Microsoft Excel. The sample was contacted telephonically 
to inform them of the nature of the study and to invite them to participate at 
TBH(Appendix C; pg. 213).  
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A large number of participants were unreachable (n = 147), the remainder who indicated 
that they werewilling to participate were asked to provide verbal consent for initial 
telephonic screening (n = 134). Initial telephonic screening involved questioning to ensure 
eligibility to participate in the study (Appendix D; pg. 219).  Full inclusion and exclusion 
criteria are described in Table 3-1below. All inclusion criteria were met in order to 
participate (n = 52), however the presence of any one or more of the exclusion criteria 
immediately excluded the participant from the study (n = 82). See Figure 3-1. 
 
Table 3-1 Inclusion and exclusion criteria 
  Inclusion Criteria Exclusion Criteria 
Willingness to commit to the study  Previous trauma/surgery to the unaffected 
leg 
Aged 50 – 70 years Cognitive impairment  
Diagnosed with OA of the hip/knee Do not meet the American College of Sports 
Medicine (ACSM) guidelines for exercise 
prescription (Appendix D; pg. 219) 
On the waiting list for a minimum of three 
months 
Those who have taken part in a six-week 
programme aimed at improving self-efficacy 
and management previously 
Can comprehend and are literate in English 






3.3 Sample size and power analysis  
As pain was the primary outcome measure, data was used from a previous study on pain in 
people with OA, in which the modified Brief Pain Inventory (m-BPI-sf) was validated, to 
ensure that the sample size would provide sufficient statistical power(140). Change in pain 
was selected to determine the required sample size. Required sample size for change in 
pain was calculated using a smallest meaningful difference of 3 (on a scale of 0 to 10), and a 
standard deviation of 2.49(140). Statistical significance was accepted as p < 0.05. A medium 
to large ES(ES > 0.5) is accepted as meaningful. It was calculated that samples of 26, 36, and 
45 participants would provide 80%, 90% and 95% statistical power for change in pain 
respectively.  To allow for attrition, the target sample was a total of 48 participants (24 
participants in each group). After recruiting a total of 52 participants, 10 did not arrive for 
baseline measures, which left 42 remaining as the sample.  
  
3.4 Instrumentation 
The primary outcome measure was pain as this is described as the main complaint in 
persons with OA(20).Pain was measured by Brief Pain Inventory(35), as described in Chapter 
Two (pg.22).See Appendix E for the BPI (pg. 223). In addition, secondary outcome measures 
included disability, function, self-efficacy and health related quality of life, as described 
below (Appendix E).  
 
3.4.1 Pain 
As discussed, recommendations from theIMMPACT group state that when measuring pain, 
the instrument used should not only evaluate pain on a uni-dimensional level(119).Instead it 
should assess pain in terms of pain intensity, physical functioning, emotional functioning 
and patient ratings of treatments received(121). The BPI is a measure that evaluates the first 
two of these four domains by measuring pain severity, as well as the impact/interference 
of pain on function(135). As previously stated, it was initially validated for use in patients 
with cancer(137) after which it has been validated and is widely used in non-cancer 
conditions in which pain is experienced, such as osteoarthritis(140,148). It is a short self-
administered questionnaire designed for use in research(135).The pain severity scale consists 
of four answers related to the severity of pain experienced on a scale of 0 – 10; “worst 
pain”, “least pain”, “average pain” and “current pain”. A mean pain severity score (PSS) is 
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calculated from the four answers out of 10 (0 “no pain” and 10 “pain as bad as you can 
imagine”).  
 
The pain interference scale consists of seven questions related to the impact of pain on a 
scale of 0 – 10; activity (4), emotional functioning (3) and sleep (1). A mean pain 
interference score (PIS) is calculated from the seven answers out of 10 (0 “no interference” 
and 10 “complete interference”)(135).The inventory also asked two questions regarding the 
percentage pain relief achieved from analgesics used. The BPI-sf has previously been 
translated into Afrikaans(316) as well as isiXhosa; which has been shown to be valid for use in 
amaXhosa women living with HIV in SA(317). 
 
3.4.2 Physical function 
The Physical Performance Task Battery is widely used in research studies to assess simple 
daily tasks, in order to characterize and quantify the effect of a condition on the patient’s 
function(175). This battery of tests has been validated and shown to be reliable in patients 
with back pain, cancer and HIV/AIDS(36,157,173,174).While no literature has been found to 
validate its use in lower limb OA, the individual tests which make up the battery have been 
separately validated for use in patients with OA and are appropriate for use in this sample. 
The content validity of the physical battery was explored in this study. 
 
The original battery consisted of nine tasks of which only seven were used as described 
below:  
- 50 foot (15m) walk at preferred speed. Participants were timed as they 
walked 25 feet (12.5m), turned around and walked back to the starting 
point at their normal walking pace. 
- 50 foot (15m) walk at fastest speed. Participants were timed as they 
walked 25 feet (12.5m), turned around and walked back to the starting 
point as fast as they could. 
- Forward reach test. Participants stood adjacent to a wall on which a tape 
measure was positioned horizontally at shoulder height. Participants 
reached as forward as far as they could and the distance reached was 
measured in cm. 
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- Timed, repeated sit-to-stand. Participants sat in a standard chair with arm 
rests and were timed as they stood up and then sat back down, twice.  
- The test was repeated after a brief rest and the average time of the two 
trials was used. 
- Sock test. Participants sat in a standard chair and were timed as they put 
on one loose-fitting sock on each foot. The time taken to complete each 
foot was recorded in seconds as well as the ability to don a sock or not. 
- Timed, repeated reach-up. Participants stood facing a wall and reached up 
as high as they could with both hands. A mark was placed on the wall at 
the reach distance. Participants then reached up to the mark and returned 
their hands to their sides three times, as fast as they could.  
- Six minute walk test. Participants walked as far and as fast as they could for 
six minutes. The distance walked was measured at six minutes (Participants 
were allowed to rest if and as necessary during the six minute period). 
- Timed belt tie.  Participants are to be seated. Using an elastic wrap 
bandage approximately four feet long, they are timed as they wrapped the 
bandage around their waists and tied it in front of them. This task was not 
included as a part of the current study as it does not relate to lower limb 
balance or function. 
- Coin test. Participants sit at a table. They are timed as they picked up four 
coins (a quarter, a dime, a nickel, and a penny) and placed them in a cup. 
They were required to pick up each coin individually. Again this task was 
not included as a part of the current study as it does not relate to lower 
limb balance or function. 
 
3.4.3 Disability 
The widely used Health Assessment Questionnaire (37,37,176) has been established in 
rheumatology as a comprehensive, valid and patient orientated outcome measure of 
health status in arthritis patients(318). Since the HAQ has previously been used in this group 
of patients, it will allow for comparisons to be made with other studies in this field of 
research. The HAQ assesses the functional ability of a patient and comprises of two parts. 
Firstly, 20 questions are grouped into eight categories; dressing and grooming, arising, 
eating, walking, hygiene, reach, grip and common activities.  
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The four possible responses to each question (no difficulty, some difficulty, much difficulty, 
unable to do) are scaled such that the average across functional categories produces a 
variable that ranges from 0 (no disability) to 3 (severe disability). The second part 
comprises of a pain VAS from 0 (no pain) to 100 (severe pain) which the participant 
completes as a self-report of their pain severity in the past week (Appendix E; pg. 223). 
Translation of this questionnaire has previously been done into South African English and 
Afrikaans by the Mapi Research Institute (HAQ © Stanford University 1980, All rights 
reserved).An isiXhosa translation was not available for the HAQ; therefore a translator was 
used during administration of this outcome measure. 
  
3.4.4 Self-efficacy 
Assessment of self-efficacy has been reported as increasingly more important when 
evaluating the effectiveness of any self-management programme(194). The Self-Efficacy for 
Managing Chronic Disease 6-Item Scale(177) has been modified from the Chronic Disease 
Self-Efficacy Scale and has been previouslyusedin patients with arthritis(204). This short scale 
was developed and tested for the use in chronic disease management studies(38) and a 
study by German researchers have shown this 6-item scale to be valid and reliable for use 
in measuring self-efficacy in the management of chronic conditions such as OA(194).The 
scale consists ofsix questions including several domains common to many chronic diseases: 
symptom control, role function, emotional functioning and communicating with physicians. 
The response to each question is scored on a scale of 0 (not confident at all) to 10 (totally 
confident) from which a mean SE score is calculated out of 10 (a higher score indicating a 
higher self-efficacy)(Appendix E; pg. 223). The instrument is available in isiXhosa and was 
translated via forward/back translation into Afrikaans for use in this study. 
 
3.4.5 Health related quality of life  
The EuroQol Instrument is one of the most commonly used generic measures of health 
status by summarising the patient’s HRQoL into a single index from -0.59 to 1(1 indicating a 
better health status)(39,190).Participants report on their health status in five dimensions; 
mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Responses to 
the domains are presented in three levels of severity from no problems to some/moderate 
problems, or extreme problems. Each response is scored to calculate the disability index.  
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The second part of the EQ-5D comprises of a self-reported state of health value from 0 – 
100 (100 being the best health) on a vertical VAS. Participants were asked to rate their 
health for today on the thermometer type VAS (Appendix E; pg. 223).This outcome 
measure is currently widely used in a variety of research areas in different countries(190) and 
has been deemed valid and reliable after translations into several indigenous South African 
languages, including South African English, Afrikaans(190) and isiXhosa(319). 
 
3.4.6 Body mass index 
Body mass index‡‡‡ is a measure of body fat in adults(40).It is calculated as 




Additionally, at month six the experimental group were asked to complete an open ended 
questionnaire which included seven questions about the six-week intervention and 
workbook used. This was conducted via a questionnaire with the research assistant reading 
the questions aloud and the participants were asked to write down their responses in their 
preferred language. This was to gain insight into the participant’s thoughts or feelings 
around the intervention (Appendix E; pg. 223).   
 
3.5 Intervention 
The intervention comprised of a six week physiotherapist-led education and exercise 
programme. This programme was developed from previously used programmes such as the 
ESCAPE-knee pain programme(178,226,271), the Arthritis Self-Management Programme(158,256) 
and the Positive Living Self-Management programme(317), developed for South African 
patients experiencing pain due to HIV/AIDS(317). As mentioned previously, the intervention 
is based on the ICF framework and is a multi-faceted approach to addressing the 
participant holistically by means of education (including neuroscience education), self-
management strategies and an active exercise component. Theintervention approach and 
content allows the same intervention to accommodate participants with OA ofboth hip and 
knee. 
 
                                                          
‡‡‡





The interventiontook place in an out-patient setting at Tygerberg Hospital and was led by 
the principle investigator, a qualified physiotherapist who had been trained in the 
respected field and who could deliver the programme in both English and Afrikaans. An 
isiXhosa translator was present for all intervention sessions. The same physiotherapist led 
all six sessions to ensure content and delivery of the intervention remained constant. The 
intervention session took place for a maximum of two hours, on a weekly basis for six 
successive weeks, in groups of no more than 12 participants. Each two hour session 
included an educational component of an hour, an exercise component of 20 to 30 minutes 
and a relaxation session of 10 minutes.  
 
The education and discussion topics covered are outlined in Table 3-2below. The topics and 
model of delivery of the educational and exercise content is based on evidence supported 
by literature(11,178,228,320). The educational content was evidence based using relevant 
medical textbooks and peer-reviewed articles on OA and related topics(7,30,207,230,241,321)and 
was aimed at increasing knowledge and understanding on the condition of concern, pain 
processes, exercise and related topics affected by their condition. Important topics such as 
self-management strategies, goal setting, coping mechanisms, stress management, pacing, 
nutrition, medication were also discussed. Each participant received a “Living with 
Osteoarthritis” booklet (in their preferred language) which comprised of the outline and 
content of each educational session as well as sections for the participants to complete 
during the week that followed each session (Appendix F; pg.237). Participants were 
requested to record weekly goals and if these were achieved, as well as any changes in 
abilities and/or pain scores during the week following each session.  
 
The exercise component comprised of various stretching, light aerobic exercise and 
different lower limb muscle group strengthening exercises(272,317). Each participant was 
monitored throughout the session by the investigator and exercise was adapted to each 
participant’s capability. Participants were required to set exercise and activity goals on a 
weekly basis and to record these in their workbooks. The exercise component was 
progressed weekly in duration by two minutes and intensity progressed as appropriate, 
depending on each participant’s individual ability. If a patient reported an increase in pain 
of >3/10 during testing or during the intervention, the activity was stopped, the participant 
assessed and the exercise adjusted appropriately or stopped completely.  
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The detailed exercise programme is described in Appendix G (pg. 329) The relaxation 
session consisted of the physiotherapist facilitating a relaxation visualisation while 
participants sat or lay comfortably with their eyes closed (Appendix G; pg. 329).  
 
Attendance for the intervention was recorded and monitored weekly (Appendix H; pg. 
333). When a participant was absent for a session of the intervention, the participant was 
contacted telephonically and asked the reason for absenteeism and were encouraged to 




Table 3-2 Educational content covered on a weekly basis during the intervention 
Topic for the week Content covered 
Week 1:  
Osteoarthritis, Self-management and Exercise 
Pathology of OA 
What is meant by “self-management” 
Self-management steps 
Action plans, goal setting 
Exercise dos and don’ts 
Types of exercise 
Steps to success with exercise 
An exercise routine 
Week 2: 
Managing common symptoms 
Physiology of acute and chronic pain 
Pain and flare ups of pain 
Swelling 
Joint protection, assistive devices 






What is stress? 
Managing stress 
Sleep management 
Communication with your health carer 
Relaxation skills 
Week 4:  
Eating well 
Balanced nutrition 
Dealing with barriers to eating well 
Food safety 
Weight loss benefits 
Week 5:  
Medication and disease related problem solving 
Making informed treatment decisions 
Appropriate use of medications 
Link between a healthy lifestyle, good 
nutrition and exercise 
Communicating effectively with family, 
friends, and health professionals with 




Continuing as a successful self-manager 
Recap of key components of successful 
self-managing 
Action planning for the future 







Firstly, 10% of the sample size (five participants) was requested to attend the initial 
meeting to pilot the baseline procedures with the principle investigator and the RA. This 
was to establish the feasibility of the data collection process, including the information 
sheet, informed consent document and outcome measures. This pilot process went 
smoothly and brought to the attention of the investigator two practical considerations 
regarding one of the outcome measures; namely the physical performance task battery. 
For the sock test, it was not established which foot should be included in the test, so the 
decision was made to complete the test on both feet. Additionally, it was decided that due 
to the practical environment of the research setting and to avoid possible distractions, the 
six minute walk test was measured out as a 48 meter stretch in a corridor that would be 
walked back and forth for the six minute duration. The five participants who formed the 
pilot study were included in the main study. 
 
Thereafter, eligible participants were requested to meet in person with the principle 
investigator and the RA during week 0. Ten participants did not arrive for this meeting 
(Figure 3-1). Written informed consent was obtained and full screening for ACSM exercise 
criteria was completed for the remaining sample (N=42) (Appendix C; pg. 213 and Appendix 
D; pg. 219). Demographic information was recorded with the help of the RA on the 
demographic information sheet (Appendix E; pg. 223). The participants completed the five 
outcome measures at baseline (the BPI, HAQ, SE for Managing Chronic Disease 6-Item 
Scale, EQ-5D and the Physical Performance Task Battery). The RA was blinded throughout 
the study. At baseline the RA was unaware of allocation as participants had not been 
allocated to groups yet. Additionally, at follow up measures participants were requested 
not to disclose which group they had been a part of and measurements of those in the 
experimental and control group were done concurrently. Self-report instruments were led 
by the RA and the battery was administered by the RA in the participants preferred 
language, using a translator for isiXhosa if necessary. The participants completed the tasks 
as they usually function, if they usually use an assistive device they completed the battery 
with the device and this was noted. If there was any change in the use of their device this 
was also recorded. If a participant was unable to complete a task for any reason this was 




The RA measured each participant’s weight on a digital scale and their height by a wall tape 
measure without shoes. BMI was then calculated and recorded. This measure wasrecorded 
at baseline, week 12 and month six to assess any change over the course of the study. 
 
The process of randomisation to the intervention and control groups was explained by the 
principle investigator after outcome measures were completed, as well as the need to 
maintain the blinding of the RA to either group for follow up measures. The participants 
were stratified by the primary researcher, according to whether they have OA of the hip or 
knee. Following stratification participants’ codes were randomly assigned into either the 
experimental or control group, by means of random number allocation generated by Excel 
by the principle investigator to ensure concealed allocation. Those selected for the control 
group (n = 22) were contacted telephonically in the week that followed and were 
instructed to continue receiving their usual care, determined by their primary doctor, while 
awaiting surgery. The decision to continue usual care was made as it was comparable to 
pragmatic control groups which received routine care in previous studies on similar 
integrated management interventions(226,242,271). The experimental group (n = 20) were 
contacted telephonically and were requested to begin the six week education and exercise 







Invited to participate: not 
interested (n = 28) 
 
Unreachable (n = 147) 
Met all inclusion criteria and did not have 
any exclusion criteria present (n = 52) 
Contacted (n = 134)  
Initial verbal consent obtained telephonically (n = 106). 
Inclusion and exclusion criteria asked  
Attended week 0 at TBH. Information sheets given. Written informed 
consent obtained. Full pre-participation screening for exercise 
questionnaire completed. Baseline testing completed (n = 42) 
Stratified according to hip/ knee OA. Randomised by random 
number allocation by MS Excel 
Control group (n = 22) 
 
Intervention group (n = 20) 
 
Week 1 - 6 continued with   
usual management 
 
Week 1 - 6 intervention 
occured 
 
Did not meet all inclusion criteria/ had 
one or more of exclusion criteria present 
(n = 54) 
Did not arrive 
for week 0      
(n = 10) 
 
Random sample of third priority waiting list patients 
contacted telephonically and informed of the study   












The intervention took place as described above for six weeks. All outcome measures were 
taken at week 0, week six, week 12 and month six by the same blinded RA. The RA was a 
qualified physiotherapist who was bilingual in English and Afrikaans. The instruments were 
available in the participant’s first language, either English or Afrikaans or isiXhosa to foster 
better understanding of what was being asked, as well as to allow for differences in 
cultures. Additionally, an isiXhosa translator was at all data collection meetings to translate 
in person for isiXhosa first language speakers. Participants were provided with R30.00 to 
cover travel expenses for each visit to the hospital for the intervention and outcome 
measures, as these visits are in addition to their normal care.  
 
3.7 Ethical considerations 
Ethical approval was obtained from the University of Cape Town’s Faculty of Health 
Sciences, Human Research Ethics Committee (HREC Ref no 378/2013) and from head of 
research projects at Tygerberg Hospital (Appendix B; pg. 209). An amendment was 
requested before the sixth month of follow up measures, to include an additional open 
ended questionnaire which the experimental group were to answer. This amendment was 
approved by the UCT HREC (Appendix B; pg. 209). 
 
This study adhered to the principles outlined in the Declaration of Helsinki(322). Autonomy 
was maintained throughout the study by providing the patients who were contacted and 
involved, with all the details pertaining to the study. Verbal consent was obtained 
telephonically prior to initial screening and written informed consent, in the participant’s 
preferred language, was obtained prior to agreement of participation in the study.  
 
Hypothesised advantages and any possible risks of the study were explained to the 
participants and it was made clear that, any participant had the right to withdraw from the 
study at any time for whatever reason, without prejudice or penalty. The principles of 
beneficence and non-maleficence were upheld throughout the study as previous studies 
have shown benefits of such an intervention and suggest further research on this topic. The 
intention was to replicate these positive results and bring about helpful, not harmful, 
changes to the participant’s symptoms and lives. If the participant reported worsening 
symptoms due to the testing or intervention, the participants were assessed appropriately, 
the intervention adjusted accordingly or withheld if necessary.  
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Referral to the required health professional to manage the matter further or if any other 
need arose for referral during the duration of the study was done as appropriate (one was 
referred to OT for a wheelchair assessment, two were referred to physiotherapy 
management for assessment and treatment of other conditions, one was referred to 
ophthalmologist for eye testing and two were referred to an orthotic centre for 
appropriate devices).  
 
The study did not impact regular care. All other appointments the participants had prior to 
the study, continued as normal. There were no consequences to usual care if the 
participant was not interested in participating or chose to withdraw from the study at any 
time. Participation in the study did not change the participants place on the waiting list or 
chance of receiving surgery earlier or any other future medical care available to the 
participant. Allocation to the intervention or control group was performed by random 
number generation and identities were concealed for this process to avoid unfair 
allocation. The control group continued to receive their regular management while being 
on the waiting list; no aspect was removed/added to their usual care. However, the 
intervention produced significant positive effects in the experimental group; therefore the 
intervention was offered to the control group after the duration of the study, so as to 
maintain the principle of justice.  
 
Confidentiality was maintained throughout the study by the allocation of a code for each 
participant. Personal information that was collected from the participants was not shared 
with others; instead the overall results of the group would be shared as the results of the 
study. Information gathered and data collected was stored on an external hard drive, 
protected and locked away. Coercion or undue influence was avoided as participants were 
not paid to participate in the study and the only possible cost to the participants was that 
of transport, which was covered by the researcher. Proposed benefits from the study was 
explained to participants before involvement; including decreased pain and disability, 
improved function, quality of life as well as self-efficacy and self-management of their 
chronic condition. Possible risks were also explained; including those risks associated with 





3.8 Statistical analysis  
The primary outcome measure of pain severity according to the BPI at baseline showed 
that data were normally distributed [Week 0 BPI severity (N = 42) K-S p value >0.20 (K-S p > 
0.05)]. Therefore parametric statistics were used in the numerical analysis and Pearson Chi-
squared (χ2) calculations were used for categorical data. Data was analysed using Statistica 
software (StatSoft, Inc. 2004. STATISTICA, Data Analysis Software System, Version 10. 
www.statsoft.com). Statistical significance for the two main effects of group and time, and 
the interaction (group x time) for the BPI, the HAQ index and HAQ pain VAS, the physical 
performance task battery physical time and distance tests, the self-efficacy questionnaire 
and for HRQoL EQ-5D index was assessed using a two-way analysis of variance (ANOVA) 
with repeated measures. Tukey’s post hoc comparisons were performed where necessary 
to determine significance within or between groups at different time periods.  
 
Analysis was by intention to treat. Missing data was managed by carrying forward the last 
observed measurement.  All numerical data was presented as the mean (M) ± standard 
deviation (SD). Statistical significance was accepted as p < 0.05. Effect sizes were calculated 
when there were significant differences between groups.Effect size§§§  was calculated as 




                                                          
§§§
Cohen’s d estimates the magnitude of the effect. 0.2 is considered a 'small' effect size. 0.5 






4 Results  
4.1 Sample 
The following Consolidated Standards for Reporting Trials(CONSORT) flow diagram(324) 
reflects the processes from initial contact with the sample to those participants who were 

























Assessed for eligibility and contacted telephonically (n = 281) 
Unreachable (n = 147)  
Telephonic pre-screening and invited to participate (n = 134) 
Excluded (n = 92) 
- Did not meet inclusion criteria (n = 54) 
- Declined to participate (n = 28) 
- Did not arrive at baseline (n = 10) formatting 
 
Allocated to intervention (n = 20) 
- Received allocated intervention (n = 19) 
- Did not receive full allocated intervention (n 
= 1withdrew from intervention at week 3)(See 
Appendix H for attendance records)  
Allocated to control (n = 22) 




(N = 42) 
Enrolment 
Analysed (n=20)  
- Results of the above mentioned 4 
participants were carried forward as 
appropriate 
Lost to follow-up (n=3)             - 1 
received surgery after 6 week follow up      - 1 
received surgery after 12 week follow up     - 
1 sustained a femur fracture between week 
12 and month six 
Lost to follow-up (n=3)                    - 1 
willingly withdrew from study due to family 
responsibilities                     - 2 lost 
to follow up at 6 months due to transport issues 
Analysed (n=22)  
- Results of the above 3 participants were 
carried forward as appropriate 
Analysis 
Figure 4-1CONSORT flow diagram of initial contact to analysis 
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4.2 Socio-demographic information 
Results are presented throughout for the sample (N = 42); the experimental group (n = 20) 
and the control group (n = 22). 
  
4.2.1 Age, weight, height, BMI 
Data was gathered by the demographic questionnaire and weight and height measures 
were taken at baseline to calculate BMI values for each participant.The mean age for the 
sample was59.52, SD = 4.75 years. The sample had a very high mean BMI value of 35.79, SD 
= 8.81 which is classified as class IIobesity(325). There were no significant differences 
between groups (p>0.05) for age, weight, height and BMI values (Table 4-1below).  
 
Table 4-1 Age, weight, height, BMI of the participants (N = 42) 
 Participants 
N = 42 
Experimental  
Group 
n = 20 
ControlGroup 
n = 22 
 
 Mean ± SD 
(Range) 






Age    t = 0.55; p = 0.74 
Years 59.52± 4.75 
(51.0 - 70.0) 
59.95 ± 4.98 
(51.0 - 68.0) 
59.14 ± 4.62 
(53.0 -70.0) 
 
Weight    t = -1.47; p = 0.87 
Kilograms (Kg) 
 
91.33 ± 23.23 
(40.4 -150.0) 
85.88 ± 22.44 
(40.40 - 142.6) 
96.28 ± 23.32 
(46.30 - 150.0) 
 
Height    t = 0.09; p = 0.34 
Meters (m) 
 
1.60 ± 0.10 
(1.41 - 1.8) 
1.60 ± 0.11 
(1.41 - 1.8) 
1.60 ± 0.09 
(1.49 - 1.8) 
 





35.79 ± 8.81 
(17.96 - 59.4) 
33.69 ± 9.22 
(17.96 - 59.4) 
37.69 ± 8.16 
(18.11 - 50.0) 
 





4.2.2 Gender, language, education level, employment status  
For categorical variables, Pearson-Chi squared (χ2) was calculated to determine any 
significant differences between groups.No significant differences were seen between 
groups forgender, first language spoken, educational level and employment status (p > 
0.05). The majority of the sample was female (n = 32), Afrikaans speaking (n = 27), of low 
educational levels (grade 8-9: n = 16) and unemployed (n = 36) (Appendix H; pg. 333). 
 
Table 4-2 Gender, language, educational level, employment status (N = 42) 
 Participants 
N = 42 
Experimental 
Group 
n = 20 
Control 
Group 
n = 22 
 
 
Number(%) Number(%) Number(%) 
Significance 
test 
Gender   χ
2 










First language spoken   χ
2 



















Educational level   χ
2
 = 17.06;p = 0.15 
No schooling 
Grade 1 – 7 
Grade 8 – 9  






















Employment status   χ
2
















9 (45.0)  
 





4.2.3 Clinical information: time spent on the waiting list,co-
morbidities, joint/s affected, assistive device used, medication 
used 
There were no significant differences between groups for number of months on the waiting 
list, co-morbidities present, joint/s affected, subgroup stratification and assistive device 
usage at baseline (Table 4-3below).  
  
The mean time on the waiting list was 3.61, SD= 2.44 years for the entire sample, with no 
significant difference between groups (t = 0.08, p = 0.93).The mean number of co-
morbidities per participant in the sample was calculated to be 1.29. Awide variety of co-
morbidities existed in the sample group, of which most were chronic diseases of lifestyle. 
The most common being HPT (n = 32) and HPT and DM co-existed in many of the 
participants (n = 11) (Table 4-3below).Refer to Appendix H (pg. 335)for full details regarding 
co-morbidities. 
 
When the sample was stratified by OA of hip, knee or combined hip and knee OA, it was 
seen that there were slightly more OA knee participants (n = 19) than OA hip (n = 11) and 
combined hip and knee OA (n = 12) in the sampleyet there was no significant difference 
between groups after stratification.  
 
With regards to the use of an assistive device: more than 70% of the sample used an 
assistive device, with more than half of those that used a device making use of a single 
crutch or walking stick and the rest used two crutches (Table 4-3below).  
   
There was a significant difference between the groups’ medication usage for controlling 
symptoms such as pain and inflammation as a result of OA (χ2 = 6.25, p = 0.04). The 
majority (n = 13) of the experimental group usedanalgesia alone, whereas the majority (n = 





Table 4-3 Co-morbidities, joint/s affected, assistive device and medication usage (N = 42) 
 Participants 
N = 42 
Experimental  
Group 
n = 20 
Control 
Group 











Co-morbidities   χ
2




Diabetes Mellitus (DM) 
Hypertension (HPT) 
Asthma & HPT 
DM & HPT 
Asthma & HPT & cardiac 
DM & HPT & cardiac 
Total number of co-morbidities 
(across the sample) 









































OA Subgroup stratification   χ
2
 = 0.05;p = 0.98 
Hip 
Knee 











Assistive device used   χ
2














Medication used to 


























4.3.1 Pain Severity Score (PSS) and Pain Interference Score (PIS)  
The primary outcome measure wasdetermined using the BPI and measures were obtained 
at baseline,week six, week 12 and month six. Full results of the PSS and PIS over time are 
presented in Table 4-4below. 
 
Table 4-4 PSS and PIS (N = 42) 
 Participants 
N = 42 
Experimental Group 
n = 20 
Control Group 
n = 22 
 Mean  ± SD Mean± SD Mean  ±SD 




6.70 ± 2.34 
7.23 ± 2.19 
6.75 ± 2.50 
5.85 ± 2.22 
6.65 ± 2.23 
Week 6    
PSS 
PIS 
5.10 ± 2.47 
4.57 ± 2.46 
4.43 ± 2.67* 
3.40 ± 2.27* 
5.72 ± 2.15 
5.63 ± 2.16 
Week  12    
PSS 
PIS 
5.17 ± 3.08 
5.34 ± 2.79 
4.50 ± 3.38* 
4.72 ± 3.04* 
5.77 ± 2.73 
5.91 ± 2.49 
Month 6    
PSS 
PIS 
5.32 ± 2.92 
4.85 ± 2.82 
4.40 ± 2.99* 
3.49 ± 2.63** 
6.16 ±2.65 
6.09 ± 2.43** 
**indicates a significant difference in PIS between the experimental and control group 































i. Pain Severity score 
There was no significant difference in the PSS between groups for the sample (Figure 4-2 
below).There was a significant improvement in the PSS of theexperimental groupfrom 
baseline to week six(F(3, 120)=6.06, p <0.01). The significant improvement was sustained at 



















Indicates significant improvement in PSS in the experimental group at week 6, 12 and month 6 (p < 0.01)  




When the subgroups of OA hip, OA knee and combined hip and knee OA were analysed it 
was found that for participants with OA knee there was a significant differencebetween 
groups at month six (F(3, 51) = 6.27, p < 0.01) with a large ES (ES = 2.64; p < 0.01). The 
experimental OA knee group’s PSS improved by 3.67 points on a scale of 0 to 10, which is 
considered a clinically meaningful improvement in pain severity(121)(M = 6.86, SD =2.13 to 
M = 3.19, SD= 2.65) whereas the control group experienced worsening pain over the same 




























Indicates a significant difference between groups for PSS at month 6 (ES = 2.64, p < 0.01) 
Figure 4-3 Change in PSS of OA knee subgroup (n = 19) 
 
Those in the experimental group with combined hip and knee OA had the worst PSS at 
baseline (M = 8.50, SD = 1.27) and showed a significant improvement in PSS from their 
baseline measures to week six(F(3, 30)=4.20, p = 0.02) by a reduction of 4.83 points on a scale 
of 0 to 10. Yet there was no significant difference between groups.  
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Participants in the experimental OA hip group had the lowest PSS (M = 6.35, SD = 2.84) at 
baseline and did not show a significant improvement in PSS when compared to the control 
group (F(3, 27)=1.12, p= 0.36) (Appendix I; pg. 337). 
 
a. Worst,  least, average and current pain score  
There were no significant differences for least, worst, average or current pain scores 
between groups or in the control group. There was a significant improvement in the BPI 
least pain score in the experimental group from baseline toweek six, week 12 andmonth six 
(F(3, 114)=8.48, p < 0.01). There was a significant improvement in the current pain score in 
the experimental group from baseline toweek six, week 12 (F(3, 117)=6.13, p < 0.01) 
andmonth six (p = 0.02). There were no significant changes for worst (F(3, 120)=2.08, p > 0.05) 
or average (F(3, 117)=2.30, p > 0.05)pain scores in the experimental group.  Additional results 
gathered from the subsections of least pain, worst pain, average pain and current pain are 






ii. Pain Interference Score   
There was a significant difference in pain interference scores between the experimental 
and control group (F(3, 120)=4.67, p= 0.04)(Figure 4-4 below). This significant improvement 
was seen at month six with the experimental group having significantly less pain 
interference than the control group (M = 3.49, SD= 2.63 vs. M = 6.09, SD= 2.43; p = 0.02) 
(Table 4-4above). ES calculations for BPI PIS showed a large ES for improvements in pain 
interference score between week 0 and month six (ES = 1.15, p = 0.02). Additionally there 
was a significant improvement in the PIS within the experimental group from baseline to 
week six(p < 0.01). The significant reduction in PIS was sustained over time, at week 12 (p = 
0.01)and increased at month six (p < 0.01)(Figure 4-4below). There was no significant 

































 Indicates a significant difference in PIS between experimental and control group at month 6 (ES = 1.15, p = 0.02) 
 Indicates a significant improvement in PIS in the experimental group at week 6 (p < 0.01), 12 (p = 0.01) and month 6 (p < 
0.01) 




Subgroup analysis was performedrevealing a significantdifferencebetween groups for the 
OA knee subgroup at month six(F(3, 51)=2.29, p < 0.01). Those in the OA knee group 
improved significantly when compared to the control group with a large ES from baseline 
to month six (ES = 1.21; p < 0.01) (Figure 4-5 below). There was a significant improvement 
in those with combined hip and knee OA in the experimental group from baseline to week 
six (F(3, 30)=5.06, p < 0.01), week 12 and month six (p = 0.02), yet there were no differences 
when compared to the control group. There were no significant improvements in PIS for 






























Indicates a significant difference between groups in PIS of OA knee subgroup at month 6 (ES = 1.21, p < 0.01) 
 




Table 4-5displays the detailed mean ± SD scores for each itemof the Pain Interference scale 
namely; general activity, mood, walking ability, normal work, relationships, sleep and 
enjoyment of life. There was a significant improvement in thepain interference subsection 
of mood in the experimental group from baseline toweek six, 12 andmonth six(F(3, 117)=4.13, 
p < 0.01). There was a significant improvement in the experimental group in the subsection 
of walking ability from baseline toweek six (F(3, 120)=2.89, p < 0.01), week 12 (p = 0.01) and 
month six (p <0.01), in the subsection of normal work from baseline to week six(F(3, 
114)=3.35, p < 0.01) and month six (p < 0.01) and in the subsection ofsleep from baseline to 
week six (F(3, 120)=2.75, p < 0.01), week 12 (p = 0.04) and month six(p < 0.01). There was no 
difference in the experimental group for the items of general activity, relationships with 
others or enjoyment of life (p > 0.05). There wereno significant differences for any item 
between experimental group and control group or any significant changes for any item in 






Table 4-5 Detailed PIS subsection scores (N = 42) 
  Participants 
N = 42 
Experimental 
Group 
n = 20 
Control 
Group 
n = 22 
 
 Mean ± SD Mean ± SD Mean ± SD Significance test 
PIS general activity   F(3, 117) = 2.26;p = 0.09 
Week 0 
Week 6 
Week 12  
Month 6 















PIS mood   F(3, 117) = 4.13;p = 0.01* 
Week 0 
Week 6 
Week 12  
Month 6 
6.62 ± 3.24 
4.95 ± 3.36 
4.98 ± 3.35 
4.48 ± 3.43 
7.08 ± 2.66 
3.40± 3.33* 
3.95 ± 3.33* 
3.10± 3.21* 
6.19 ± 3.72 
6.36 ± 2.75 
5.91 ± 3.16 
5.73 ± 3.19 
 
. 
PIS walking ability   F(3, 120) = 2.89; p = 0.04* 
Week 0 
Week 6 
Week 12  
Month 6 
8.36 ± 1.85 
5.81 ± 3.34 
6.43 ± 3.25 
5.88 ± 3.30 
8.45 ± 1.70 
4.70± 3.39* 
6.05 ± 3.58* 
4.80± 3.66* 
8.27 ± 2.00 
6.82 ± 3.02 
6.77 ± 2.96 
6.86 ± 2.64 
 
PIS normal work    F(3, 114) = 3.35; p = 0.02* 
Week 0 
Week 6 
Week 12  
Month 6 
7.83 ± 2.38 
4.79 ± 2.95 
5.83 ± 3.06 
5.81 ± 5.26 
8.00± 2.27 
3.50± 3.03* 
5.65 ± 3.45 
4.10± 3.06* 
7.65 ± 2.54 
5.95 ± 2.38 
6.00 ± 2.73 
7.36 ± 6.35 
 
PIS relationships   F(3, 117) = 2.39; p = 0.07 
Week 0 
Week 6 
Week 12  
Month 6 
4.83 ± 3.75 
3.00± 2.92 
4.15 ± 3.64 
3.34 ± 3.19 
4.80± 3.93 
1.60± 2.11 
3.65 ± 3.70 
2.10± 2.94 
4.86 ± 3.68  
4.33 ± 2.99 
4.62 ± 3.60 
4.52 ± 3.03 
 
PISsleep   F(3, 120) = 2.75; p <0.05* 
Week 0 
Week 6 
Week 12  
Month 6 
6.88 ± 3.63 
4.76 ± 3.32 
5.00± 3.79 




3.85 ± 3.95* 
6.86 ± 3.67 
5.45 ± 3.11 
5.27 ± 3.73 
6.45 ± 3.32 
 
* Indicates a significant improvement in PIS mood, walking ability, normal work and sleep of the 





  Participants 
N = 42 
Experimental Group 
n = 20 
Control Group 
n = 22 
 
 Mean ± SD Mean ± SD Mean ± SD Significance test 
PIS enjoyment of life    f(3, 117) = 2.31; p = 0.08 
Week 0 
Week 6 
Week 12  
Month 6 
5.83 ± 3.81 
4.60 ± 2.92 
5.40 ± 3.49 
4.95 ± 3.25 
6.00 ± 3.97  
3.55 ± 2.94 
4.50 ± 3.65 
3.60 ± 3.23 
5.67 ± 3.75  
5.55 ± 2.60 
6.23 ± 3.21 
6.18 ± 2.81 
 
     
 
 
4.3.2 Change in percentagepain relief from medicationover time 
There was no significant difference forpercentagepain relief from medication (F(3, 81) = 0.90, 
p = 0.45) within or between groups. There was a general improvement in percentage pain 
relief from baseline to month six in both groups but this was not significant(See AppendixI 
for full results; pg. 352). 
  
Additionally, according to the BPI, participants recorded what type of medication they 
made use of each week. The responses were grouped as none, analgesia, anti-
inflammatories or analgesia and anti-inflammatories. The dosage was not recorded. There 
was no significant difference between groups at baseline (χ2= 3.71, p = 0.45), week six (χ2= 











































4.4 Physical Performance Task Battery 
4.4.1 15 meter walk tests: fastest and normal speed  
There was a significant difference between groups in the time taken to walk 15 meters at 
fastest speed (F(3, 117) = 3.82, p < 0.01). This significant improvement was seen at month six 
with the experimental group walking significantly faster than the control group (M =15.09, 
SD= 6.04s vs M = 20.10, SD= 8.79s;p = 0.03)(Figure 4-6below). A large ES was evident (ES = 
0.88, p = 0.03). 
 
There was a significant improvement in the time taken to walk 15 meters at fastest speed 
in the experimental group from baseline to week 12and month six(p < 0.01). There was no 



















Indicates a significant difference between groups for the time taken to walk 15m fastest speed at month 6 (ES = 0.88, 
p = 0.03) 
Indicates a significant improvement in time taken to walk 15m fastest speed in experimental group at week 12 and month 
6 (p < 0.01) 








































When subgroup analysis was performed, there was a significant improvement in the 
experimental combined hip and knee OA subgroup from baseline to week 12 (F(3, 30)=3.35,p 
= 0.04). There were no significant improvements for the OA hip or OA knee subgroup in the 
experimental group. There was no significant difference for any of the subgroups when 
compared to the control group (Appendix J; pg. 356).  
 
There was a significant improvement in the time taken to walk 15 meters at normal speed 
in the experimental group from baseline to week 12 and month six (F(3, 117)=7.06,p < 0.01) 
(Figure 4-7below). There was no significant difference between groups or within the 
control group. Subgroup analysis showed there were no significant changes within or 



















Indicates a significant improvement in time taken to walk 15m normal speed in the experimental group at week 12 and 
month 6 (p < 0.01) 






4.4.2 Six minute walk test 
There were no significant differences between groups or change in the control group for 
the distance walked in a six minute walk test (Appendix J; pg. 368).There was a significant 
improvement in the distance in the experimental group from baseline to week 12and 































Indicates a significant improvement in distance walked in six minute walk test in the experimental group at week 12 and 
month 6 (p < 0.01) 
Figure 4-8 Change in distance walked in six minute walk test (N = 42) 
 
Subgroup analysis showed there was a significant improvement in the experimental OA 
knee group from baseline to month six (p = 0.01). There was a significant improvement in 
the experimental combined hip and knee OA group from baseline to week six (p = 0.02), 
week 12 and month six (p < 0.01). There were no differences in the OA hip subgroup (F(3, 27) 
= 0.22, p = 0.88). There were no significant differences for either subgroup when compared 




4.4.3 Repeated sit-stand test 
There were no significant differences between groups in the time taken for the repeated sit 
to stand test. There was a significant improvement in the experimental group, from 
baseline to week six, week 12 and month six (F(3, 120)=4.20, p < 0.01) (Figure 4-9below). 
There was also a smaller but significant improvement in the control group from baseline to 
week 12 (p = 0.02) and month six (p < 0.01)(Appendix J; pg. 375). 
 
Indicates a significant improvement in the time taken for repeated sit – stand test in the control group at week 12 (p = 
0.02) and month 6 (p < 0.01) 
Indicates a significant improvement in the time taken for repeated sit – stand test in the experimental group at week 6, 12 
and month 6 (p < 0.01) 
Figure 4-9 Change in time taken for repeated sit - stand test (N = 42) 
  


























Subgroup analysis showed a significant improvement in the experimental OA hip subgroup 
from baseline to week six, 12and month six (F(3, 27)=3.61, p < 0.01). There was no significant 
difference in the experimental subgroup ofcombined hip and knee OA (F(3, 30) = 2.25, p = 
0.10) and OA knee (F(3, 51) = 0.84, p = 0.48) or for either subgroup when compared to the 
control group (Appendix J; pg. 375). 
 
4.4.4 Reach tests: forwards and upwards  
There were no significant differences in the forward reach test (F(3, 120) = 1.45, p=0.23) or 
upward reach test (F(3, 111) = 1.30, p= 0.28) within or between groups (Appendix J; pg. 382). 
 
4.4.5 Sock test 
There was no significant difference in the ability to don a sock (p > 0.05) within or between 
groups. There was a significant improvement in the time taken to don the left sock in the 
experimental group between baseline and week six (F(3, 78) =3.60, p = 0.04) and month six (p 
<0.01). There was no significant difference in time taken to don a sock on the right foot 
within the experimental group. There was no significant change within the control group 
for either foot and no significant difference between groups for either foot (Appendix J;pg. 





4.5.1 Health Assessment Questionnaire score  
There was no significant change seen in the control group and no significant differences 
seen between groups in HAQ disability scores. Therewas a significant improvement in the 
experimental groupwhich was sustained over time from baseline to week six, week12and 




































Indicates a significant improvement in the HAQ sores in the experimental group at week 6, 12 and month 6(p < 0.01) 
Figure 4-10 Change in Health Assessment Questionnaire score (N = 42) 
 
Subgroup analysis showed a significant improvement in the experimental OA knee 
subgroup from baseline to week six (F(3, 51)=4.19, p < 0.01), week 12 (p = 0.03) and month 
six (p < 0.01). There was a significant improvement in experimental combined hip and knee 
OA subgroup from baseline to week six (F(3, 30)=4.34,p < 0.01) as well as a significant 
improvement in the control combined hip and knee OA subgroup from baseline to week 12 







































There was no significant improvement for the OA hip subgroup (F(3, 27) = 2.29, p = 0.10). 
There were no significant differences in either subgroup when compared to the control 
group (Appendix K; pg. 385). 
 
4.5.2 HAQ Pain VAS score 
There was a significant improvement in the HAQ pain VASin the experimental groupwhich 
wassustained over time, from baseline to week six (F(3, 120)=5.97, p < 0.01), week 12 (p = 
0.03) and month six (p < 0.01) (Figure 4-11below). HAQ pain VAS decreased from M = 
73.35, SD = 25.45 to M = 48.30, SD = 33.95in the experimental group. The reduction in pain 
on the VAS of 25.05 is considered a clinically meaningful difference in pain severity(128). No 
significant change was seen in the control group and no significantdifferences were seen 
between groups for the sample(Appendix K; pg. 385).Additionally, there was a strong 
positive correlation between the baseline values for pain severity according to the HAQ 


















Indicates a significant improvement in HAQ VAS in the experimental group at week 6 (p < 0.01), 12 (p = 0.03) and month 6 
(p < 0.01)  
Figure 4-11 Change in HAQ pain VAS (N = 42) 
124 
 
Subgroup analysis showed a significant difference between groups in the OA knee 
subgroup (F(3, 51) = 6.26, p < 0.01).There was a significant improvement in HAQ VAS with 
asubstantial effect size from baseline to week six (ES = 2.36, p = 0.02) and month six (ES = 
3.4, p < 0.01) (Figure 4-12). A slightly weaker yet positive correlation is present between 
the HAQ pain VAS and BPI PSS for the subgroup of knee OA (r = 0.53, p = 0.02).There were 
no significant improvements in the subgroup ofOA hip and combined hip and knee 
























Indicates a significant difference between groups in the HAQ VAS of OA knee subgroup at week 6 (ES = 2.36, p = 0.02) 
and month 6 (ES = 3.4, p < 0.01) 






There were no significant differencesfor self-efficacy scoreswithin or between groups. 
While there appeared to be an improvementin the SE for the experimental group, it was 
not significant. A general worsening of SE scores was noted in the control group from 
baseline to week 12; however this was also not significant(Appendix L; pg. 399). 
 
4.7 Healthrelated quality of life 
4.7.1 EQ-5D health index 
There was nosignificant change in health related quality of life as measured by the EQ-5D 
index (F(3, 120) = 0.83, p = 0.48)within or between groups(AppendixM; pg. 401). 
 
i.  EQ-5D category domains 
There were no significant changesin the five different category domains that make up the 
EQ-5D index score; namely mobility, self-care, activity, pain/discomfort and 
anxiety/depression (Appendix M; pg. 404). 
 
4.7.2 EQ-5D current state of health 
There were no significant changesin the current state of health as measured by the EQ-5D 
(F(3, 120) = 0.06, p = 0.98),within or between groups. It appears there was a general 
improvement in current health statefor both groupsover time;however this was not a 




4.8 BMI change over time 
There was no significant change in BMI (F(2, 80) = 0.59, p= 0.56)within groups or between 
groups. BMI remained stable over the six months in both groups (Figure 4-13below) 


























4.9 Assistive device usage 
Use of assistive devices was reported by participants on the demographic questionnaire at 
baseline. However, the RA also recorded what devices participants used in person 
atbaseline and at follow up visits. There was a lack of agreement between patient reported 
and RA recorded device use at baseline (χ2 = 50.13; p < 0.01) (Table 4-6below). 
 
Table 4-6 Patient reported versus RA recorded assistive device usage at baseline (N = 42) 
 Patient reported assistive 
device used 




(n = 20) 
Control 
(n = 22) 
Experimental 
(n = 20) 
Control 
(n = 22) 
Significance 
test 
Baseline:     χ
2
 = 50.13;  





























*Indicates a significant difference between patient reported and RA recorded assistive device usage 
 
There were no significant changes in AD usage within the experimental group from baseline 
to week six (χ2= 3.81, p = 0.05). There was a significant reduction in AD usage within the 
experimental group from baseline to week 12 (χ2= 7.01, p < 0.01) as five participants had 
stopped using an assistive device. This significant reduction was maintained at month six 
(χ2= 10.48, p < 0.01) as three participants were still not making use of an assistive device 
after receiving the intervention. 
 
There was a significant increase in AD usage within the control group from baseline to 
week six (χ2= 18.28, p < 0.01) as one more participant began using an AD. A further increase 
in AD usage was seen in the control group at week 12 and maintained at month six (χ2= 
15.23, p < 0.01) as a total of two participants who previously did not make use of an AD 




4.10 Open ended questionnaire 
Four themes emerged from the seven open ended questions asked at month six to the 
experimental group (n = 17, due to three lost to follow up at month six). These themes 
were: increased knowledge; improvement in function and activity; pain relief and personal 
benefits (social support,fostering a positive attitude towards life andhaving fun). Table 4-7 
presents these four themes by showing some examples of how the participants answered 
questions one, two and five. 
 
In response to question three: “What didn’t you like about the course?” most participants 
responded that there was nothing they did not like. Twoparticipants answered that they 
would like the course to be longer than six weeks. In response to question four: “Is there 
anything more you would like to learn that wasn’t in the course?” most participants 
answered “no”, while two requested to learn about falling and getting up after a fall and 
one requested to be taught additional exercises and helpful hints. In response to question 
six: “What didn’t you like about the workbook?” all participants responded that there was 
nothing they didn’t like. Lastly, in response to question seven: “What more would you add 
in the workbook that wasn’t covered?” the majority answered there was nothing more to 
add, whereas one participant requested information on falling and one participant 
requested helpful information for underweight people.See the AppendixQ for all quoted 




Table 4-7 Themes that emerged from participant’s answers to open ended questionnaire 
(n = 17) 
 Examples of the experimental group’s answers to open ended 
questions 
 
Theme: Question 1: Did you find the 6 week course helpful to you in any 
way?  



















Participant K: “Yes the information about healthy eating and 
that I don’t have to drink pills all the time.” 
Participant DD: “learnt more exercises, especially with 
equipment.” 
 
Participant A: “yes, I began with two crutches, now I walk 
most of the time with just one crutch and short distance with 
none.” 
Participant P: “This course helping me very much because I 
moving myself everyday” 
 
Participant V: “All the pain was gone” 
Participant AA: “it gave memotivation again because my life 
was all about pain before. Now I use my workbook and it helps 
a lot” 
 
Participant L: “It gave me the opportunity to get out and meet 
people with the same sort of problem” 
Participant WW: “it made me very positive… very motivating 
to exercise in a group instead of alone.” 
 






 Examples of the experimental group’s answers to open ended 
questions 















Participant P: “I like this course because I learnt a lot and I’m so 
happy for that.” 
Participant R: “Learnt a lot about stress management and diet.” 
 
Participant C: “everything, I can walk better and I feel better.” 
Participant K: “I enjoyed it a lot. The exercise was very nice, at 
the hospital and at home.” 
 
Participant S: “I learnt how to put ice on my knee to relieve the 
pain.” 
Participant WW: “how to be more positive and to control pain.” 
 
Participant N: “Fun of it all.” 
Participant AA: “a lot. I am now part of an exercise group. I have 





 Examples of the experimental group’s answers to open ended 
questions 













Participant WW: “it was very interesting. Learnt a lot of 
knowledge from the experience.” 
Participant P: “I’m just teaching others from the book.” 
 
Participant A: “Exercise.” 
 
 
Participant R: “…also the section about pain management and 
not having to rely on pills” 
 
Participant B: “Everything, I learnt a lot, especially about self-
confidence.” 
Participant R: “It was helpful when it spoke about 




4.11 Summary of results  
In summary, the results showed the following effects of a six-week physiotherapist-led 
exercise and education intervention in patients with OA, awaiting a hip/knee joint 
replacement:  
 
4.11.1 Primary outcome measure: pain as measured by the BPI 
There was a significant difference in pain interference scores between groups from 
baseline to month six (p = 0.02), with the experimental group experiencing less pain 
interference than the control group (3.49 ± 2.63 vs. 6.09 ± 2.43; p = 0.02). There was a large 
effect size for improvements in pain interference score (ES = 1.15). Although  there was no 
significant difference between groups for PSS, there was a significant sustained reduction in 
pain severity score in the experimental group from baseline to week six, week 12 and 
month six (p < 0.01). Both the PIS and PSS showed significantly improved pain scores 
particularly for those in the subgroup of knee OA (ES = 1.21, p < 0.01 and ES = 2.64,p < 0.01 
respectively). No significant differences were seen for pain severity or interferencebetween 
groups for the subgroups of hip OA or combined hip and knee OA. 
 
4.11.2 Secondary outcome measures  
There was a significant difference in function, as measured by the 15 meter fastest speed 
walk test, between groups from baseline to month six (p = 0.03). The experimental group 
walked significantly quicker than the control group (15.09 ± 6.04s vs 20.10 ± 8.79s; p = 
0.03). There was a large effect size for improvement in time taken to walk 15 meters at 
fastest speed (ES = 0.88). Similarly, those with knee OA in the experimental group improved 
their walking ability compared to baseline (p = 0.01) whereas participants with hip OA did 
not. Individuals with combined hip and knee OA in the experimental group showed an 
improvement in walking ability (p < 0.01) yet this was not significant when compared to the 
control group. 
 
Significant improvements were observed for the HAQ disability indexand pain VAS,for the 
experimental group from baseline to week six (p < 0.01), week 12 (p = 0.03 for VAS) and 
month six (p < 0.01). HAQ pain VAS showed a strong positive correlation with the BPI PSS at 
baseline (r = 0.74, p < 0.01).  
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Subgroup analysis showed a significant difference for HAQ pain VAS in participants with 
knee OA compared to the control group, from baseline to week six (ES = 2.36, p = 0.02) and 
month six (ES = 3.4, p < 0.01). No significant differences were seen in disability between 
experimental and control group for the subgroups of hip OA and combined hip and knee 
OA.  
 
No significant differences were observed between or within groups for self-efficacy.  There 
were no significant differences in the current state of health within or between groups for 
the EQ-5D VAS. There were no significant differenceswithin or between groups for health 
related quality of life, as measured by the EQ-5D index.  
 
There was no significant difference between groups at baseline for BMI, or any significant 
change in BMI over time. BMI did not account for any differences in the above mentioned 
effects. 
 
The addition of an open ended questionnaire for the experimental group at month six 
highlighted the benefits with four themes emerging. Namely: increased knowledge, an 
improvement in function and greater levels of activity, an improvement in pain relief as 









The results of this study support the use of a six-week physiotherapist-led exercise and 
education programme in patients with osteoarthritis of the hip or knee, on a long waiting 
list for a joint replacement. Clinically relevant findings were observed in the experimental 
group with significant long-term improvements in pain and function when compared to the 
control group.  
 
In this discussion the current results will be discussed in relation to the existing literature 
covered in Chapter Two (pg. 3). Firstly, the focus will be on the results of the primary 
outcome measure of pain, as measured by the BPI, with specific reference to the pain 
interference scale followed by the pain severity scale. Thereafter the results of the 
secondary outcomes function, disability and personal factors will be discussed. 
 
5.2 Primary outcome measure: pain (BPI) 
5.2.1 Pain interference scale  
As discussed in the literature review, pain is reported as the main complaint of persons 
with OA(79). It is known that one of the recommended domains of pain measurement is pain 
interference(119,122). For a chronic pain condition such as OA, it is not only how much pain 
one has but the debilitating effect that pain has on the person’s daily life and interactions 
that requires evaluation(228). Despite an average waiting period of 3.61 years (SD = 2.44), 
with the longest waiting period of 11 years, the intervention was effective at significantly 
reducing pain interference in the experimental group compared to the control group (F(3, 
120) = 4.67, p < 0.01). This statement emphasises the importance of first understanding to 
what extent the sample was affected at baseline by OA and by having to wait for such a 
length of time, before receiving surgery. Once this has been presented, full comprehension 




i. Baseline presentation for the sample according to the BPI: 
Previous research has shown debilitating effects of being on relatively short waiting lists 
(less than 12 months); with worse pain and function being correlated to longer periods of 
waiting(71,314). As a result of this sample’s long waiting period, it was anticipated that this 
group would present at baseline with severe pain; defined on a scale of 0 - 10 as above 6 
for knee OA and above 7 for hip OA awaiting surgery(326). This was indeed the case with the 
present sample’s baseline measures according to the BPI severity scale for worst pain 
beingM = 8.17, SD = 2.24. This is higher than worst pain scores reported by Mendoza and 
colleagues in their samples not on waiting lists, for hip OA (M = 7.53, SD = 1.84) and knee 
OA (M = 7.40, SD = 1.84) (Mendoza, personal communication,15 November 2014).  
 
It was also expected that this sample would present with severe interference in physical 
and emotional functioning; defined on the BPI interference scale as above M = 5.85, SD = 
2.04 for OA of the knee and above M = 6.33, SD = 1.88 for OA of the hip(327). As expected, 
the present sample’s baseline measures according to the BPI interference scale wereM = 
6.70, SD = 2.34. The PIS in the current sample is slightly higher than those reported by 
Williams et al.(139)in previous studies involving persons not on a waiting list with OA (M = 
6.60, SD = 1.9 and M = 6.33, SD = 1.7, for those with high levels of pain in studies one and 
two respectively(139)). Additionally, the PIS of the participants in the present study is higher 
than baseline PIS scores in Mendoza and colleagues’ sample with hip OA (M = 5.58, SD = 
2.69) and knee OA (M = 5.23, SD = 2.7) (Mendoza, personal communication, 15 November 
2014). Furthermore, the current sample presented with a similar baseline VAS pain score 
on the HAQ (M = 6.90, SD = 2.34 when converted to a score out of 10) to that of a closer 
matched sample on a waiting list, who had been living with OA for an average of four to 11 
years (M = 7.0, SD = 2.2)(71).  
 
The current sample had the most severe pain interference with “walking ability” (M = 8.36, 
SD = 1.85) followed by “normal work” (M = 7.83, SD = 2.38). This finding is consistent with 
common difficulties experienced during walking, leading to various activity limitations 




Although, this finding is in contrast to that of Williams et al.s’ studies(139) in persons with OA 
with moderate to severe pain, in which “normal work” was recorded as the most affected 
(M = 6.74, SD = 2.5 and M = 6.71, SD = 2.2), “walking ability” followed closely behind as the 
second and third most affected in studies one and two respectively (M = 6.54, SD = 2.7; M = 
6.58, SD = 2.4). The difference in the present study could be attributed to the wording of 
the instrument. According to the BPI, “normal work” is described as work outside of the 
house or housework. It could be that those participants who still work reported 
interference during work. However, if one considers the mean age of the sample involved 
in the present study was 59.52 years (SD = 4.75) and that most were unemployed (on a 
disability grant or on pension), participants probably reported on this subsection as 
interference with housework. It can also be assumed that in many circumstances “normal 
work”, be it formal work or housework, consists of walking and therefore either way it 
reflects that pain has a large impact on both components of daily activity.  
 
The third most affected subsection at baseline, following “walking ability” and “normal 
work” interference, was “general activity” (M = 7.34, SD = 2.77). It is seen in this sample 
that all three aspects forming the activity sub dimension of the PIS(135) were the most 
affected by pain. This was in agreement with Williamset al.s’ sample in their second study 
where work, general activity and walking were the three most affected aspects(139). This 
confirms that pain and pain interference with physical function are the most commonly 
experienced issues in the population with OA awaiting surgery(74).     
 
The next most affected subsection on the pain interference scale was that of sleep (M = 
6.88, SD = 3.63). According to the literature, it has been stated that sleep disturbances are 
common in persons with OA(22,115,328) and should be included as part of outcome measures 
in those with pain conditions(139). Sleep has an important impact on daily life as disturbed 
sleep has a considerable influence on pain(115,329), physical functioning(139) and mood(328). As 
discussed in the literature review, emerging research states that disturbances in sleep have 
been associated with central sensitization, causing further pain and functional 
limitations(115). The current study’s results which report the functional activity dimension 
and sleep as the most affected subsections of the PIS, supports an association between 
sleep, pain and functioning(21,329,330).  
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Additionally, the common occurrence of sleep interference, in those on a waiting list is 
reinforced by a longitudinal study on persons with severe pain due to OA.  It was found that 
in persons awaiting surgery for up to six months, 40% of the sample reported disturbances 
in sleep every night as a result of pain(71). 
 
Following on from the above, it was observed that the affective/emotive functioning sub-
dimension of the PIS was similarly grouped together as seen by interference scores for 
“mood” (M = 6.62, SD = 3.24), “enjoyment of life” (M = 5.83, SD = 3.81) and “relationships 
with others” (M = 4.83, SD = 3.75). This could be explained by the length of time on the 
waiting list causing not only physiological effects, but also negative psychological 
effects(246). Interestingly, despite the present sample having higher pain related functional 
and sleep interference when compared to the two samples used by Williams et al.(139); 
enjoyment of life was less affected in the current sample (Williams et al. sample 1: M = 6.2, 
SD = 2.9, sample 2: M = 6.43, SD = 2.6). The subsection of “relationships with others” was 
the least affected by pain at baseline and throughout the current study. This finding is 
consistent with research by Williams et al.(139), yet this subsection interference score was 
higher in the current sample when compared to these two studies (M = 4.1, SD = 2.9 and M 
= 4.02, SD = 2.7 in studies one and two respectively). The current sample also showed 
higher pain related mood interference when compared to both samples in the studies by 
Williams and colleagues not on a waiting list (M = 5.29, SD = 2.8 and M = 5.81, SD = 2.5 in 
studies one and two respectively(139)). The current finding of moderate pain interference on 
“mood” also reinforces the negative effect of disturbed sleep on psychological factors(139), 
with specific mention to the association between sleep disturbances and depressed or 
anxious mood states(115,328). 
 
Therefore at baseline the sample was greatly affected in terms of all aspects of pain related 
functional interference as measured by the PIS on the BPI. The current sample’s 
presentation confirmed that pain and function worsens when on a waiting list as seen by 
higher levels of pain related interference when compared to previous studies reporting on 





ii. Change in PIS over time 
Remarkably, the significant improvement between groups for overall pain interference in 
the present study, showed a large effect size at month six (ES = 1.15, p = 0.02) (pg. 112). 
This is notably better than the ES of NSAIDS [ES = 0.32, (0.24, 0.39)]and acetaminophens 
[ES =0.21 (0.02, 0.41)]for pain in people with OA as reported by OARSI(213). Both NSAIDs and 
analgesics are prescribed to most, if not all, patients on a waiting list as part of the first-line 
management of OA despite small ES(25).  
 
Further, the ES of the combined treatment of exercise and education used in this study on 
pain interference was much larger than the ES on pain in hip and knee OA for aerobic 
exercise [ES = 0.52 (0.34, 0.70)], strength exercise [ES = 0.32 (0.23, 0.42)], water-based 
exercise [ES = 0.25 (0.02, 0.47) or education or self-management interventions alone (ES = 
0.06 (0.02, 0.10)](213). The large effect of the combined intervention seen in this study 
suggests that this may be a more effective treatment strategy for these patients than 
individual treatment approaches.  
 
Furthermore, benefits observed in pain in the present study support the use of a combined 
intervention over a self-management intervention alone such as the CDSMP; which has not 
shown significant improvements in pain(239,240,252,253). This could be due to a confounding 
factor such as a larger number of co-existing chronic conditions (M = 2.2-2.3 per 
participant) in previous samples(239,240) as opposed to the current study’s average of M = 
1.29 co-morbidities per participant. The rationale behind a generic intervention is based on 
the commonly shared problems in the rapidly increasing number of people with chronic 
diseases and that approaches to manage these are similar(252). As discussed in the literature 
review, it seems that a generic intervention targeting a variety of chronic conditions is not 
as effective at reducing pain but rather leads to limited psychosocial benefits(92,243).  
 
There is a need for more than merely improved knowledge and psychological outcomes in 
those with chronic pain and disability. The current study aimed to meet this by 
incorporating active exercise into a self-management intervention to reduce pain and 
improve function.  
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It appears a combined programme of exercise and education can and does impact pain 
related functional interference in the current sample. The results of the present study 
concur with the earlier SR by Walsh et al.(276) where it was reported that a combined 
intervention has significant effects on reducing pain in patients with hip and knee OA (as 
seen in eight of ten trials reviewed with p values ranging from 0.001 - 0.05). However, ES 
for the treatments were not documented in the SR and it was not stated whether the 
participants involved in these trials were on a waiting list. Therefore caution should be 
taken when comparing the results of the SR to the present study.  
 
iii. Change in PIS subsections over time 
Interestingly, the present findings report the most improved subsection of the interference 
scale in the experimental group to be on pain interference with “mood” (F(3, 117) = 4.13; p = 
0.01). The open ended questionnaire confirmed improvements in psychological aspects 
after the intervention by participants reporting the intervention had a positive impact on 
attitude, improved motivation and outlook on life. These self-reported psychological 
benefits appear to be reflected by the immediate and sustained significant improvement in 
mood interference in the experimental group at week six (p < 0.01). The finding may be 
directly related to the significant reductions observed in pain severity in the experimental 
group discussed in the following section. This link supports the previously documented 
bidirectional association between pain and mood disorders, such as depression and anxiety 
in OA(22,328,330). The current association seen between pain and mood further supports the 
previously identified relationship between joint pain and depression in a study performed 
in a South African population(87). 
 
Another explanation of the current findings for improved mood interference can be as a 
result of the positive psychological effects of active participation in exercise(21). This 
corroborates with Hurley et al.s’ work on the psychosocial benefits of exercise; including 
improved mood, reduced stress, depression, anxiety and increased self-worth and 
esteem(21). If this explanation is the reason for change in mood seen throughout the 
duration of the study, it suggests that participants in the experimental group adhered to 
the exercises taught during the intervention, even at month six(331). 
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This is in contrast to studies which report low adherence to exercise in those with OA, 
especially when the physiotherapist is no longer involved and able to reinforce exercise 
habits(276,331). Adherence was not however recorded in this study therefore this is a 
speculation. A possible explanation as to why the current sample may have adhered to 
exercise in this study lies in the combined management approach of exercise and 
education; as discussed later in the text. 
 
Leading on from the above, it is known that exercise can improve function in those with 
OA(29). Improvements in function have been said to lead to improved mood states(21). 
Therefore the current findings support the known relationship between dysfunction and 
mood disorder in OA(328,330).  
 
This is evident by significant improvements in functional interference [walking (F(3, 120) = 
2.89; p = 0.04) and normal work (F(3, 114) = 3.35; p = 0.02)], coupled with significantly 
improved mood interference (pg. 115). Thistoo is confirmed by participants in the 
experimental group reporting improvements in their ability to function in the open-ended 
questionnaire (see Appendix Q, pg. 413).    
 
An unlikely possibility for improvements in mood may be attributed to the Hawthorne 
effect(332). This effect is described as an improvement in outcomes as a result of attention 
received by participating in clinical research(333,334). Mood improvement could have been 
said to be due to the participants eventually receiving attention by some form of 
treatment, after being on the waiting list for years. Yet, if this was so, it would be expected 
that the control group would also show significant improvements in mood, which was not 
so, as they too received attention for the duration of the study by follow up measures. This 
further strengthens the above probability of mood benefits as a result of improvements in 





As mentioned above, there appeared to be an association at baseline between poor sleep 
and mood in persons with OA(328). As the results were analysed, this association remained 
with mood interference improvingtogether with improvements in sleep interference (F(3, 
120) = 2.75; p < 0.05)
(328). Additionally, the findings of reduced sleep disturbances and the 
improvements in overall pain scores seen in the sample of the current study corroborates 
with the previously discussed association between pain and sleep. Not only do those with 
severe pain report common sleep disturbances, but when improvements in pain are 
experienced, so are improvements in sleep and vice versa(335).  
 
The significant improvement in overall pain interference in the current sample is 
encouraging. The four subsections that improved after the intervention support the known 
relationships between pain, physical function, sleep and mood. In order to further 
understand the improvements observed in the present sample, a previous research 
recommendation was applied to the current findings to establish whether differences 
existed in treatment responses between participants with hip or knee OA(73). Subgroup 
analysis for the effects seen in those with OA of the hip, knee or both hip and knee are 
discussed in the text that follows. It is acknowledged that the sample was limited for 
subgroup analysis and as such the subgroup results need to be viewed with caution. 
However, the distinct differences in results between the subgroups were felt to be worthy 
of mention. 
 
iv. Subgroup analysis for PIS 
The subgroup analysis showed that those with OA of the hip presented at baseline with the 
lowest pain interference score (M = 5.50, SD = 2.71) compared to those with OA of the 
knee (M = 6.68, SD = 2.29) or both hip and knee OA (M = 7.82, SD = 1.49). The results show 
that the participants with OA of the hip only participating in the intervention showed no 
significant improvements from baseline or compared to the control group (F(3, 27) = 1.44, p = 
0.25). To the researchers’ knowledge, comparison studies performed using the BPI PIS in a 
sample of patients with hip OA awaiting surgery does not exist. Most studies report the 
effects of treatments on pain severity instead of pain interference, which limits 
comparisons in the discussion on changes in PSS.  
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Since the subgroup with hip OA had no overall significant improvements in pain 
interference, it implies the improvement must have occurred in one of the other two 
subgroups, those with OA of the knee only or OA of both the hip and knee.  
 
Interestingly, those with OA in both the hip and the knee in the present study’s 
experimental group showed a significant improvement in PIS, contributing towards the 
overall significant difference between groups.  It was observed that this subgroup showed 
significant within group improvements from baseline to week six (p < 0.01), week 12 and 
month six (p = 0.02). As far as the researchers are aware, no literature is available on 
persons with OA of both the hip and the knee, therefore comparisons could not be made 
either regarding previous work utilising the BPI pain interference scale.  
 
The largest difference was observed in the subgroup of participants with OA of the knee. 
This subgroup presented at baseline with severe pain interference (M = 6.68, SD = 2.29) 
and showed a significant difference between groups from baseline to month six with a 
considerable effect size (ES = 1.21, p < 0.01). This suggests that such an intervention was 
more effective in the participants with OA of the knee only rather than in those with OA of 
the hip or those with OA of the hip and the knee. This result should be taken into 
consideration for future research in those with lower limb OA and when applying such an 
intervention into clinical practice. Likewise for prior studies in OA of the hip, comparisons 
of effect sizes between the current study and previous work showing benefits for PIS in 
persons with knee OA could not be drawn due to different outcome measures used for 
pain. Suitable comparisons were able to be drawn for pain severity and will be discussed in 








5.2.2 Pain severity scale 
i. Change in PSS over time 
In addition to benefits of reduced pain interference, the intervention appears to have 
resulted in a sustained significant reduction in pain severity scores seen within the 
experimental group over time (p < 0.01). It is noted that this change is not between groups 
for the sample and could be as a result of the choice of measurement instrument. 
According to Newman et al.(228), an intervention including self-management strategies 
should focus more on the effect of pain (as seen by the previously discussed significant 
between group improvements in PIS) rather than the amount of pain. Yet, most studies 
that are performed in OA assess pain severity as an outcome by a variety of measures. 
Therefore, a more likely reason as to why improvements in PSS were not noted between 
groups could be explained by subgroup analysis, as done for PIS results, to establish the 
effects according to OA of the hip, knee or both hip and knee joint.  
 
ii. Subgroup analysis for PSS  
According to a systematic review in 2011, studies support the use of various pre-operative 
interventions to moderately reduce pain severity in those with knee OA, yet, only low 
evidence exists for the use of these interventions in those with hip OA(73). Wallis and 
colleagues’ finding of conflictingresults in pain severity for those with hip OA versus those 
with knee OA suggests exercise may produce different benefits in each group based on 
differences in biomechanics, progression and risk factors for OA of the knee or hip(73,336). 
The current findings support the above statement as seen by the differences observed 
between the subgroups below. 
 
The subgroup analysis for PSS yielded the same finding as that of the PIS for the subgroup 
of those with OA of the hip. Similarly, participants with OA of the hip presented with the 
lowest pain severity scores at baseline (M = 5.27, SD = 2.89) and those in the experimental 
group showed no significant improvement compared to baseline measures or against the 
control group (F(3, 27) = 1.1200, p = 0.36)(pg. 337). This result is in contrast to those from a 
prior study(331), on the effects of exercise and education in those with hip OA, who reported 
significant reductions in pain severity (p < 0.05), although ES were not reported(331).  
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It was noted however that the intervention in de Jong at al.’s study(331) differed somewhat 
from the integrated exercise and education programme used in the current study as the 
educational component was limited to one session and the exercise component mainly 
consisted of strength training with fitness equipment. Likewise, the participants with OA of 
both the hip and the knee in the present study showed no significant difference in PSS 
between groups. As reported in the PIS subgroup analysis, it was observed that participants 
with OA of both the hip and the knee showed significant within group improvements in PSS 
from baseline to week six (p < 0.01) and week 12 (p = 0.03). Once again, to the researchers’ 
knowledge, no literature is available reporting on those with both hip and knee OA using 
the BPI PSS, thus limiting comparisons to previous work.  
 
As in the PIS, the most significant results were observed in the participants with OA of the 
knee. This subgroup presented at baseline with severe pain (M = 6.82, SD = 1.77) and 
showed a significant difference between groups atmonth six (F(3, 51) = 6.27, p < 0.01) with a 
considerable ES of 2.64. The current ES for pain severity is substantially larger than those 
reported in a prior study on a similar integrated intervention in knee OA (p < 0.01 and p = 
0.03 with small ES = 0.2 and ES = 0.27, for two pain severity measures used)(331). The 
current finding disputes previous small minimally powered studies(276) which showed no 
significant changes in pain after exercise and education interventions in participants with 
OA of the knee. Rather, the present results support a recent systematic review on the 
effects of a variety of combined exercise and education interventions in those with knee 
OA, whereby improvements in pain, ranging from short (two months) to long term 
sustained benefits (two years), were reported in all eight studies included(178). Although the 
SR did not state whether these samples included patients on waiting lists, nor were 
statistical p-values and effect sizes noted, the positive results in people with knee OA are 
considered encouraging.  
 
The contrasting findings in the present study between improvements in pain severity seen 
in those with knee OA compared to those with hip OA, supports a study design in which 
participants with knee or hip OA are separated. This would avoid different treatment 
responses within one sample confounding the results(178,272,276,279).  
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In the present study, the lack of change in the PSS in the hip OA subgroup likely resulted in 
modulating the results for the entire sample. 
 
As mentioned previously, most of the literature regarding waiting periods included short 
waiting lists of less than a year. A comparison study of integrated exercise and education by 
Lamb et al.(279) was more in line with the longer waiting period of the current study. The 
sample used by Lamb et al.(320) had symptoms of knee OA for an average of 10 years and 
were on the waiting list for over a year. The significant improvements in pain severity with 
a large ES for the knee subgroup in the present study supports Lamb et al.s’ findings that 
moderate effect sizes for pain improvement are attainable in those with knee OA(279). The 
lack of a control group was a major limitation of Lamb and colleagues’ work as the 
significant benefits seen were not compared to those not receiving the programme. This 
points to a strength of the methodological design of the current study which allows 
significant improvements to be compared to a control group. 
 
The present findings further support a more robust study in a large sample with symptoms 
of knee pain for an average of six to nine years(272). The current study design was very 
similar to that of the RCT by Hurley and colleagues(272), where a combined exercise, 
education and active coping strategies intervention was compared to a control group of 
usual care. Pain was used as a secondary outcome and showed sustained significant 
improvements in pain severity over the long term (six months) (ES = 0.27, p = 0.02)(272). The 
ES of Hurley and colleagues’ results were small, although similar to those of previous 
studies reporting the effects of exercise on pain in persons with OA (ES 0.39 – 0.52) 
(91,275,337). In a study by Fransen et al.(338), a larger ES reported on pain after an exercise 
intervention in persons with knee OA (ES = 0.94, p < 0.01), is better matched to the ES 
noted in the current study for reduction in pain severity in knee OA (ES = 2.64, p < 0.01). 
However, comparison to Fransen et al.s’ study(338) on exercise should be made with caution 





Along with the small ES it was also noted that the sample used by Hurley et al.(272) was not 
specified to be on a waiting list for arthroplasty. Therefore Hurley and colleagues’ 
sample(272) could be considered less affected by OA as they were not yet assessed as having 
sufficient joint damage to require an arthroplasty and be placed on a waiting list. However, 
WOMAC pain scores at baseline in Hurley et al.s’ sample(272) showed high levels of pain 
severity (M = 7.6, SD = 0.4) which can be compared to the current study’s high baseline 
pain severity scores on the BPI. Despite comparative pain severity scores, caution should be 
taken when drawing contrasting these two studies as different outcome measures for pain 
were utilised. Further, the sample used by Hurley et al.(272) had lower baseline WOMAC 
function scores (M = 27.2, SD = 1.45) when compared to the normal WOMAC scores 
reported elsewhere for people with OA of the knee (M = 41.3, SD = 14.8)(133). Additionally 
Hurley and colleagues’ sample of participants with knee OA had lower scores when 
compared to baseline scores of persons with OA on a waiting list (M = 40.3, SD =12.1(71), M 
= 28.3(280)). This could suggest that despite high levels of pain, Hurley and colleagues’ 
sample was more physically able than the sample in the current study and therefore the 
findings of a large effect for improvements in pain severity in those with knee OA in the 
present study are highly encouraging. Despite the worse levels of disability in the present 
sample with OA of the knee specifically, the combined intervention was effective in 
bringing about meaningful benefits in pain severity.  
 
The benefits seen in PIS and PSS, particularly in those with knee OA rather than hip OA, 
were both long term improvements with the largest significant differences noted at six 
months. It has been suggested that an effective integrated exercise and educational 
programme should be considered as an alternative to joint replacement surgery if the 
significant benefits are sustained over the long term of more than 12 months(279). It was 
never the intention of the current study to provide an intervention to substitute the need 
for an arthroplasty. However, since the wait for surgery is so lengthy, the long term 
benefits seen after the intervention are extremely positive and support the previously 
identified need to improve pain and related function in those whose waiting period is 
longer than a year(73). The current intervention appears to have met this need by reducing 
pain interference and severity for the sample awaiting surgery. However, a previous study 
by Lamb and colleagues(279)contradicts our findings by reporting that a combined 
intervention does not in fact cause the desired advantages for those on a waiting list.  
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Interestingly, those on Lamb et al.s’(279) waiting list had significant short term improvements  
in pain with low ES at week six and 12 (ES = 0.3 and 0.1) compared to those not on the 
waiting list who showed moderate to high ES which were sustained at 12 weeks (ES = 0.7 – 
0.8). As mentioned, the current results contradict Lamb et al.s’(279) findings as the significant 
reductions in pain severity with a large ES (ES = 1.15) was most significant for the current 
sample on a waiting list, in the long term at month six. This is remarkable for a sample on 
such a long waiting list and has not yet been documented elsewhere in literature. Similar 
long term improvements in pain were seen in Barlow et al.s’(235) RCT assessing the effects of 
the ASMP in a sample with arthritis symptoms for an average of 10 – 11 years, whereby no 
improvements in pain severity were seen at four months, yet improvements were seen at 
12 months. 
 
Similar findings were also reported by Lorig et al.(241) whereby the ASMP was compared 
with the CDSMP. In their sample it was only at 12 months post intervention that differences 
in pain severity between groups approached significance (p = 0.08). Furthermore, 
consistent slow improvements in pain severity are seen in a sample treated with a similar 
intervention to the one used in the current study, whereby exercise and education in 
participants with lower limb OA showed no significant changes in pain at two months but 
displayed significant improvements in pain at month six (p = 0.02 on the WOMAC pain 
scale)(277). The delay in improvements in pain is speculated to be related to the length of 
time that it takes to adopt newly learnt beliefs and self-management strategies prior to 
obtaining marked improvements in pain(235). This is supported by the recommendation that 
studies investigating the effects on pain in a chronic pain condition such as OA, should 
include long term follow ups of more than 12 months(276). Despite the current study 
following participants for shorter than the recommended duration, the results are 
encouraging as improvements in pain were observed after only six months.   
 
Due to the discrepancy in pain improvements between Lamb et al.s’(279) participants who 
were on a waiting list and those who weren’t, Lamb and colleagues recommended that a 
six-week combined intervention only be utilised before being placed on a waiting list. The 
reason behind this suggestion lies in the low probability of symptoms improving from 
conservative management, once the need for surgery has been determined.  
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Elsewhere it is explained that long term adherence to self-management and exercise is low 
and may be related to psychosocial aspects rather than physiological factors(276,285). It could 
be that those who are not yet on a waiting list hold beliefs that conservative management 
options can result in benefits and therefore pain reductions are observed.  
 
Yet for those who have been told they have severe arthritis for which only a joint 
replacement will help their symptoms, are less likely to have confidence that less invasive 
options can cause changes and therefore are not responsive to conservative 
management(242,245). Contrary to Lamb et al.s’(279) recommendation; the current significant 
long term improvements in pain interference and severity from a conservative 
management option is effective in individuals with severe OA on a waiting list in a South 
African context.  
 
To conclude the discussion on the primary outcome measure, the significant benefits 
reported in pain severity and pain interference in the current study support the statement 
by Williams and colleagues(139) that the primary outcome measure used in the present 
study is sensitive enough to establish treatment advantages for pain. This was clearly 
demonstrated by the relationships observed between pain severity, pain interference in 
physical function, sleep disturbances, effect on mood and physical functioning.  These links 
were not only evident at baseline but as different variables changed throughout the 
current study each of the variables followed a similar pattern of change over time. As 
discussed in the literature review, it is not sufficient to simply measure pain and changes in 
pain during trials related to OA. Therefore secondary outcome measures were used to 







5.3 Secondary outcome measures: function (Physical performance task 
battery) 
5.3.1. Walking 
Walking ability in the growing population affected with OA is a critical aspect on which to 
focus management(277). Even though the condition continues to progress and disability has 
been said to increase each year(250,251), the present findings show a short term intervention, 
without reinforcements, has lasting effects on daily function, particularly in terms of 
walking ability. 
 
The second important finding of this study was observed in the significant functional 
improvements of the experimental group when compared to the control group at month 
six in their ability to walk at a fast speed (ES = 0.88, p = 0.03). The ability to walk faster than 
before is a sound objective measure of improved functional ability or mobility(339). This 
finding further reinforces the significant improvements in walking ability on the PIS of the 
BPI. As discussed in the section above on pain, it is observed in research evaluating the 
consequences of waiting for surgery, that deterioration in function has been reported in 
those on a waiting list(33,71,310,314). The current findings indicate that even in a sample that 
has severe pain and functional limitations while waiting a long time for surgery, an exercise 
and education intervention is effective in bringing about long term improvements in 
walking ability with a large ES.  
 
The encouraging finding of improved functional ability is supported by previous work to 
establish the effects of integrated interventions on function in individuals with OA of the 
hip and knee. The SR by Walsh et al.(276) discussed in the previous section on pain, reported 
that exercise and educational interventions brought about significant improvements in 
function in persons with hip and knee OA (p <  0.05 in seven of the 10 studies reviewed yet 
no effect sizes documented). Again, the sample in the SR was not on a waiting list and 
baseline measures of functional ability were unavailable to draw comparisons against the 
current study. Additionally, methodological flaws existed across the studies included in the 
review and therefore caution should be taken when drawing conclusions from the results in 




The results of the current study lead the researchers to speculate that the ability to walk 
could possibly continue to improve after month six, as the time taken to walk 15 meters at 
the fastest speed shows a clear steady decrease (improvement) from baseline to month six 
(M = 18.65, SD = 6.27 to M = 15.09, SD = 6.04). Further follow up after a combined 
intervention would be needed to confirm this possibility. 
 
In addition to walking faster, those in the experimental group could walk further than 
documented at baseline. It appears that the intervention could also lead to the 
improvement seen in distance walked as measured by the 6MWT. Distance walked in the 
experimental group was significantly further than baseline scores at week 12 (27.3% 
improvement) and continued to increase at month six(30%, p < 0.01). This finding is 
supported by previous work(277) using the 6MWT as an outcome measure in persons with 
OA who completed a combined exercise and education intervention. In a RCT by Hughes et 
al.(277) the participants in the experimental group were able to walk 13.8% further at month 
six than they were able to at baseline (p = 0.02). It is noted that their sample was not on a 
waiting list, and comparisons of baseline distance walked during the 6MWT showed the 
sample in the current study to be more severely affected by OA than the sample in Hughes 
et al.s’ study(277). Hughes and colleagues’ sample(277) were able to walk considerably further 
than the current study’s sample at baseline (395.8m in the experimental group of Hughes 
et al. compared to 267.8m for the current study). This is a very encouraging comparison as 
even in a sample such as in the present study who had worse functional ability than 
previously reported(277), the current sample showed significant improvements with a higher 
percentage of change in distance walked in six minutes. Therefore the likelihood of the 
intervention resulting in improvements in walking distance should be assessed against a 
larger sample size to confirm whether the intervention produces significant improvements 
when compared to the control group.  
 
Once again, based on the findings of the present study it may be hypothesised that walking 
distance shows the potential to improve further as participants displayed a steady increase 
in walking distance over time. The proposal put forward by Barlow et al.(235) to explain the 
changes in pain occurring slowly in chronic conditions raises attention to whether the same 
applies for changes in function.  
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Therefore, evaluation of walking ability at month 12 would provide useful information as to 
whether function in chronic pain conditions such as OA also takes longer to become 
significantly evident between groups. To establish whether differences existed in walking 
ability between those with OA of the hip or knee only or those with both hip and knee OA, 
analysis of subgroups is discussed below. 
 
i. Subgroup analysis for walking  
The results of changes in walking ability in the sub groups agrees with the sub analysis 
findings performed for the primary outcome measure of pain. Those in the experimental 
group affected with hip OA, showed no significant improvement in walking ability over 
time. Unfortunately, as previously mentioned, most studies reporting on the effects of a 
combined approach in managing OA are performed in persons suffering from knee OA. 
Therefore no studies were found that evaluated the effects of a combined intervention on 
function in individuals with hip OA only, which would allow comparisons to be made. 
However, it must be kept in mind that the current finding is based on a small sample (n = 
11) and it cannot be concluded that persons with hip OA in other settings would not benefit 
from an integrated intervention. Further research should be performed to ascertain the 
effects in this population which was only analysed as a sub-group of the current study. This 
recommendation is supported by a SR reporting other interventions, such as exercise-
based interventions, can result in benefits for pain and function in participants with hip OA 
awaiting a joint replacement(74).   
 
Analysis of walking ability for the subgroup of those with knee OA was also consistent with 
the benefits seen in this subgroup for pain. The participants with knee OA had significant 
improvements in walking ability (6MWT) from baseline to month six (70m increase in 
distance, 27.5% improvement, p = 0.01). This finding was slightly less evident than that of 
pain as a significant difference was not observed between groups, as was seen for the PIS 
and PSS. Yet, improvements in function for those in the current sample with knee OA 
agrees with a previous integrated walking and education programme whereby distance 
walked on the 6MWT was improved at month two by 70m (18.4%) in those with OA of the 
knee when compared to their baseline distance walked(340).  
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Similarly, both the current control group and the one involved in Kovar et al.s’ study 
displayed a worsening in function by a decline in walking distance of 39m and 17m 
respectively (13.3% and 4.5%). Furthermore, the current results also support the findings 
from a previous SR(178) performed to establish the effects of a combined intervention on 
function in knee OA. All eight studies included in the review indicated improved functional 
abilities in those with OA of the knee, although details regarding what, when and how 
functional abilities were assessed and the magnitude of improvements were not specified 
in the review. The present findings can be better compared to a more recent study by 
Hurley et al. where the long term effect on function after participating in an integrated 
programme was established(271). The results of the current study confirm Hurley and 
colleagues’(271) significant improvements in function at month six (p < 0.01). Additionally, 
the benefits were maintained in the long term (month 30, p < 0.01) which supports the 
recommendation made by the researchers of the present study; to include longer follow up 
measures in future trials.  
 
Unexpectedly, participants in the present study with both hip and knee OA showed the 
greatest improvements in walking ability during the 6MWT. The experimental group had 
significant improvements at week six (37.4%, p = 0.02), week 12 (50.7%, p < 0.01) and 
month six (46.9%, p < 0.01)and significant improvements in the 15m fastest speed walk test 
at week 12 (23.7%, p = 0.04). This was initially thought to be attributed to this subgroup 
presenting with severe restrictions in walking ability at baselineand therefore having 
greater opportunity to improve than participants with only hip or knee OA. Yet, baseline 
measures for walking ability are contradictory to this proposed idea. Those with OA of both 
the hip and knee presented as the better of the three subgroups at baseline by being able 
to walk the fastest and furthest (Appendix J; pg. 355). This leads the researchers to believe 
that because this subgroup was slightly less affected in walking ability at baseline they were 
able to benefit more from the intervention in respect to walking ability. Although this 
finding was not anticipated, the significant improvement was seen within the experimental 
group only and no difference between groups was found. Similar to the changes recorded 
in this subgroup for PIS and PSS, these findings suggest that a combined intervention such 
as the one used in the present study is able to bring about improvements in walking in 
those with multiple lower limb joint OA.  
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Once again, previous studies assessing the functional benefits in persons with both hip and 
knee OA are unavailable to draw comparisons and therefore a larger sample may provide 
valuable results to confirm the speculations around this subgroup. 
 
5.3.2 Sit to stand 
Another commonly reported difficulty in those with OA of the lower limbs besides walking, 
is the functional ability to stand up from a seated position(74). Hughes et al.(277) emphasise 
the importance of the ability to perform this task for functional independence in daily life. 
Significant improvements in the ability to stand up from a chair were reported in the 
experimental group with participants demonstrating large and steady improvements in 
time taken to perform the repeated sit – stand test.  Time was significantly faster in the 
experimental group, compared to baseline, at week six and continued to improve until 
month six (p < 0.01). However, it cannot be said that the intervention was the only variable 
leading to these changes as there was no significant difference between groups and the 
control group also completed the task in significantly faster times at week 12 (p = 0.02) and 
month six (p < 0.01).  
 
A possible explanation as to why both groups showed a significant improvement in time 
scores could be due to familiarisation with the task. Task familiarisation is defined as an 
improvement in a performance from one administration of the outcome measure to the 
next as a result of performing the test again and becoming more familiar with how to 
perform it each time(341). Rather than this being a conscious process, it is a process of neural 
adaptation. It could be explained that the familiarisation effect was evident in this task test 
and not in the others as a consequence of the sit-stand test being the only task to be 
repeated twice at each follow up measure in order to get an average time for the 
functional task. This finding was in contrast to the study by Hughes et al.(277) in persons with 
lower limb OA, where no significant improvements or difference between groups was 





Hughes and colleagues(277) also tested by means of a repeated sit – stand test and despite 
repeating the function five times at each reassessment, familiarisation did not impact the 
results.  Instead the authors reasoned that no differences were reported due to the range 
for timed scores in both the experimental and control group being very large(277). Hughes et 
al.(277) suggested a larger sample be used to detect changes in this specific functional test. 
 
i. Subgroup analysis for sit - stand  
The functional measure of sit - stand was the only outcome measure which showed 
conflicting results when sub analysis was done to compare hip and knee OA participants. 
Those with hip OA in the experimental group showed significant improvements from their 
baseline scores to week six, 12 and month six (p < 0.01), although this was not significant 
when compared to the control group. This could be due to the participants with hip OA in 
the experimental group presenting at baseline with the longest time taken to complete the 
task (M = 11.31, SD = 2.91) and therefore it could be said that they had more chance for 
improvement. Whereas those participants with OA of the knee or both hip and knee 
showed no significant improvements.  
 
The above finding is in agreement with the recent SR(73) that stated moderate evidence 
exists for improvements in activity in those with hip OA on a waiting list and not in those 
with knee OA. However comparison between the SR and the results of the present study 
are difficult as the type of intervention reported on in Wallis and colleagues’ review was 
exercise alone and not an integrated programme. Further compounding the comparison is 
the studies included in the review had large variations in the content of the exercise 
used(73). Additionally, the changes recorded in activity levels were not maintained in the 
long term and therefore assumptions regarding sustained functional improvements in hip 
or knee OA cannot be drawn from Wallis et al.s’ systematic review(73). Similarly, the findings 
from this functional test in the present study do not present clear effects in relation to the 
intervention as results from the test could be confounded by all subgroups, including those 
in the control group, showing a steady improvement in time taken to complete the task 




A more relevant comparison can be made against the results obtained from previous 
integrated exercise and education studies(178,271,279) reporting benefits on function.  
Contradictory to the present study’s subgroup analysis results, are the positive findings of 
significant benefits achieved in function for those with knee OA only. Documented effect 
sizes for functional benefits were small (ES = 0.3 – 0.4) and moderate for functional SE (ES = 
0.5)(279). These benefits were observed from week six follow up until one year in a variety of 
studies (178). Again the findings of the present study do not concur with the results from 
Lamb et al.(279) regarding those who were on a waiting list. In the current study the large ES 
for functional improvements (ES = 0.88) compared to a smaller ES (ES = 0.2) for those on a 
waiting list in Lamb and colleagues study and those not on a waiting list (ES = 0.4 – 0.5)(279) 
and (ES = 0.29)(271) is notable. Furthermore, the ES from the current exercise and education 
intervention far exceeds the effect sizes reported for changesin function in persons with OA 
not on a waiting list receiving exercise only (ES = 0.34)(91,275,337). As discussed in the previous 
section on pain, the differences in treatment response may be attributed to psychological 
factors causing limited improvements once patients have been put on a waiting list(242,245). 
The positive findings in the present study demonstrate once again, that a conservative 
intervention combining exercise and education is an effective treatment strategy to 
improve function in those awaiting a joint replacement in a South African context.  
 
In summary, despite the average age of the sample being 59.52 years (SD = 4.75), the 
participants who took part in the combined exercise and education intervention displayed 
the ability to reduce their functional interference relating to pain and increased their 
functional activity levels. These positive results support the use of a combined intervention 
such as the one used in the current study. Firstly, including education, specifically 
education on pain and the neurophysiological changes that occur in chronic pain, into the 
intervention has shown that unhealthy beliefs regarding pain and fear avoidance 
behaviours may be changed in persons with OA on a waiting list in a South African context. 
Secondly, by incorporating an active participatory exercise component into the 
intervention allows new concepts that have been taught during the educational sessions to 




New knowledge regarding the meaning behind pain and the importance of remaining 
active in spite of pain, can be tested by participants on a first hand basis by applying new 
beliefs and learning the benefits of exercise for themselves. Once individuals experience 
improvements in pain, function and psychological aspects in their daily lives, it is more 
likely that beliefs can be changed and new behaviours adopted(271).  
 
The above is further supported by Crotty and colleagues’(242) statement that the desired 
primary changes caused by approaches involving self-management strategies is not simply 
improved knowledge on management of OA but applying the knowledge to bring about 
increases in activity and exercise. Participants’ responses to the open ended questionnaire 
confirmed these behavioural changes by nine of 17 (53%) participants reporting an increase 
in activity, exercise and specifically an improved walking ability at month six. A possible 
reason as to why much smaller effect sizes were reported in previous studies which 
assessed the effects of combined interventions on pain and function, could be due to the 
larger variation in the age of participants  in the previous studies and consequently their 
probable clinical presentation (51 – 91(271)) and (38 – 81(73)).  
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5.4 Secondary outcome: disability (HAQ)  
5.4.1 Baseline disability presentation of the sample  
As discussed in Chapter Two (pg. 3), pain and functional difficulties in persons with OA 
cause substantial disability, contributing to the growing burden on the health care system 
in South Africa(50,89,90). It was therefore expected that together with the severe pain and 
functional interference and limitations, the current sample would present at baseline with 
high disability scores (M = 1.56, SD = 0.55).  The baseline disability index for the sample was 
much larger than a population-based norm in Finland (M = 0.25, SD = 0.03) for persons with 
a similar mean age of 55.4 years (SD = 14.9(342)). A more appropriate comparison was made 
between the current sample and a South African sample used in a previous study on 
prevalence and functional impact of musculoskeletal conditions in a sample in the Western 
Cape(87). The present sample’s disability index was almost twice as large when compared to 
the SA sample (M = 0.8) of Parker and Jelsma. They considered a mean HAQ disability index 
of 0.8 as a mild to moderate disability; suggesting the HAQ disability index at baseline for 
the current sample was at least moderate to severe. Similarly low baseline measures were 
also documented in a sample of varied chronic diseases taking part in a SMI in the USA(M = 
0.81)(240) confirming the present sample was far worse off in terms of disability when 
compared to populations with chronic conditions. Furthermore, Parker and Jelsma’s(87) 
findings supported the known association between age and disability index (r = 0.31; p < 
0.001); as age increased, so did disability(342). Therefore the older age (M = 59.52 compared 
to M = 51.7 years(87)) of the participants in the current study with higher disability scores 
further supports this relationship.  
 
As mentioned throughout the literature review, adding to the burden of disability is the 
rising prevalence of co-existing conditions such as obesity, hypertension, diabetes mellitus 
and cardiac conditions(47,48). The study by Parker and Jelsma(87) highlights the prevalence of 
common co-morbidities in the South African population suffering from musculoskeletal 
conditions. In their sample high percentages were documented for hypertension (59.1%), 
diabetes (24.8%) and heart problems (18.9%) in persons with musculoskeletal disorders(87). 
These percentages are similar to a study in the USA in a sample of persons with OA who 
took part in a combined exercise and education intervention (hypertension 60.4%, diabetes 
23.4% and cardiovascular 15.3%)(343).  
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The prevalence of co-existing conditions in the participants in the current study agrees with 
those reported previously. Besides suffering with OA, 76.2% of the participants presented 
with hypertension, 33.3% with diabetes and 7.1% with cardiac conditions. Additionally, 15 
of the 42 participants (35.7%) were no longer able to work and were on a disability grant; 
this too suggests the current sample has been greatly affected in terms of disability. 
Furthermore, the current sample presented with an average of 1.29 co-morbidities per 
participant. This is slightly less than theaverage number of co-morbidities reported  in two 
studies using a combined exercise and education intervention in knee OA (M = 2.2) and hip 
OA (M = 2.6)(279). However Lamb et al.s’ two samples(279)were considerably older (M = 65 
and M = 67 years respectively) than the current sample and therefore would be expected 
to have a higher number of co-morbidities(87). 
 
The findings from a separate pain VAS that forms part of the HAQ disability outcome 
showed strong positive correlation at baseline with the BPI PSS (r = 0.74 , p < 0.01 ). 
According to Pearson’s correlation a value between r = 0.6 and r = 0.79 is considered a 
strong positive agreement(344). This finding confirms the validity of the pain severity 
measures used in this sample. The extent to which the baseline disability and pain VAS 
scores, according to the HAQ, changed throughout the study is discussed below. 
 
i. Change in disability over time 
Even though the current sample were markedly disabled at baseline, it appears that the 
exercise and education intervention resulted in significant and sustained reductions in 
disability in the experimental group at weeks six, 12 and month six (p < 0.01) when 
compared to baseline. The investigators are aware that disability was not the primary 
outcome for this study and power analysis was not calculated in terms of disability, yet the 
differences seen in disability supports those seen in the primary outcome. This probability 
is further strengthened by the participants in the experimental group’s responses to the 
open ended questionnaire. Participants described improvements in the ability to perform 
various activities that were previously too difficult to execute. Examples of this include 




Similarly, participants expressed being able to participate in social aspects of life that were 
not possible before the intervention; such as being able to leave the house and be part of 
an exercise group in the community, as well as the ability to socialize and make friends with 
others (Appendix Q; pg. 413). Therefore the significant improvement seen within the 
experimental group, although not significant when compared to the control group, is an 
encouraging finding in relation to the significant improvements already discussed in pain 
and function. The finding that disability and function displayed variations in improvement 
in this sample, supports the description made in Chapter Two on how disability differs from 
limited function(53).Even though disability is a complex phenomenon, the positive findings 
of this study suggest disability can be altered(52,53).  
 
The strong positive correlation (r = 0.74, p < 0.01) between the BPI PSS and the HAQ pain 
VAS was present throughout the study as similar response curves were seen for both pain 
severity scores on the BPI and the HAQ VAS (pg. 386). Significant and sustained 
improvements in pain severity recorded on the HAQ mirroring those from the BPI in the 
experimental group from baseline to week six (p < 0.01), 12 (p = 0.03) and month six (p < 
0.01). The pain HAQ scores in the current study showed a clinically meaningful reduction in 
pain severity (25.05 out of 100)(128)(128). This correlates with the previously discussed results 
observed in the current sample for reduction in pain severity according to the BPI (2.83 out 
of 10). 
 
The present results of decreased disability together with improvements in pain and 
function in the experimental group are contradictory to prior work on the effects of anSMI 
by Lorig and colleagues(158,240). One study(240) showed improvements in health status and 
self-efficacy while disability followed the usual trend of increasing with each year (M = 
0.025 in older persons with and without chronic conditions and M = 0.03 in older persons 
with chronic conditions)(250,251). In another study(158), despite a 9% increase in disability over 
a four year period, pain was still improved by 40% and activity and role function were 
maintained. Additionally, less health care utilisation was evident in both studies, despite 
increased disability in the participants(240). This suggests that the participants in Lorig et al.s’ 
studies implemented self-management strategies, taught in the SMI interventions, into 
their lives as they were less reliant on health professionals.  
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Yet sadly, the disability continued to worsen(M = 0.035 in the first year, M = 0.02 after the 
second year). It appears that the combined intervention used in the present study is more 
beneficial than a SMI, as the current intervention shows the potential to reverse the 
anticipated increase in disability described elsewhere.  It is noted that the decrease in 
disability in the current South African sample (M = 0.6) was only monitored until month six 
in the current study and not over a longer period as in previous work. Therefore it would be 
advantageous to extend the follow up period to 12 months in order to draw more likely 
comparisons with regards to the change in disability index. As previously discussed, the 
differences in treatment responses between subgroups are also of interest for the HAQ 
scale in order to support or contradict earlier findings. These results are discussed in the 
section that follows.    
 
ii. Subgroup analysis of disability index and pain VAS 
In accordance with the previously discussed subgroup analysis for pain, it was observed 
that participants with OA of the hip only in the experimental group did not show any 
significant improvements for disability as measured by the HAQ (F(3, 27) = 2.29, p = 0.10). 
Comparison studies of an integrated intervention on disability in individuals with hip OA 
alone are scarce as most studies have been performed in persons with knee OA, or if 
studies have been completed in those with hip or knee OA, separate data for the hip group 
is not documented. To the researchers’ knowledge, a RCT is presently underway in 
response to this limited area of research. A combined education and exercise intervention 
is being compared to an educational control group in order to establish the ability of the 
intervention to delay the need for surgery in a sample, with OA in need of a total hip 
replacement(281) . Disability, according to the Hip disability and Osteoarthritis Outcome 
Score (HOOS)(345), will be assessed as a secondary outcome measure in Jensen and 
colleagues trial(281) and once results are made available could prove a well suited 
comparison for the data in the present study.  
 
Due to the lack of literature available using the HAQ to measure changes in disability in 
persons with OA of the hip following a combined intervention programme, a comparison 
was made with a study exploring the effects of an exercise intervention in those with lower 
limb OA, of which 35.5% of the sample had hip OA(346).  
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Significant improvements in disability with small ES were reported in the study by van Baar 
et al.(346)(ES = 0.26, p = 0.07). The improvements however, are not specified according to 
joint affected and therefore it could be said those participants with knee OA, which 
consisted of the majority of the sample (59.5%), may have accounted for the improvements 
in disability noted, as seen in the results of the current study. This reinforces the need for 
further research in the specific field of hip OA. 
 
The findings of improved disability in participants with knee OA in the experimental group, 
agree with the improvements seen for this subgroup in respect to pain and function. Once 
again, significant improvements were observed in those with OA of the knee only at week 
six (p < 0.01), 12 (p = 0.03) and month six (p < 0.01), when compared to baseline values. 
Furthermore, the results pertaining to this subgroup for the HAQ pain VAS strongly mirrors 
the significant between group differences in pain severity on the BPI for those with knee 
OA. Significant and sustained improvements in the HAQ pain VAS with a large ES for 
participants with OA of the knee, was observed between the experimental group and the 
control group at week six (ES = 2.36, p = 0.02) and more so at month six (ES = 3.4, p < 0.01). 
Again it is seen that even the subgroup analysis results for PSS and the pain VAS were 
positively correlated (r = 0.53, p = 0.02), validating the use of the BPI in those with knee OA 
(pg. 387). 
 
Interestingly, response to change in the subgroup of knee OA were reiterated by 
participants in the control group reporting worsening disability over the first 12 weeks (an 
increase of 0.05 on the HAQ)(pg. 385). Their disability index was maintained at this worse 
score at month six. This deterioration was not significant, however it is notable when 
compared to the previously discussed annual rate of worsening disability reported on the 
HAQ(250,251). The subgroup analysis finding further supports the previously discussed 
significant changes in those with knee OA for pain and function; suggesting this subgroup 





The disability findings relating to knee OA in the current study are consistent with previous 
studies making use of the HAQ as an outcome measure of disability. In a study comparing 
an integrated intervention of exercise and education to a control group of education alone 
in persons with knee OA, significant reductions in disability scores were reported at three 
(p = 0.02) and six months (p < 0.01). ES were not available(347). Dias et al.s’ results(347) for the 
disability index were observed between groups, whereas the disability index for the current 
study was seen within the experimental group compared to baseline. A possible reason for 
a lack of difference between groups in the present study could be that despite an older 
sample (65-89 year) in the study by Dias and colleagues(347), who also presented with very 
severe pain at baseline (similar to the sample used in the present study); they were not yet 
specified to be on a waiting list for surgery and had better baseline disability scores 
(Median = 1.0) compared to the current sample (M = 1.56).  
 
As previously mentioned, being placed on waiting list for surgery has potentially negative 
consequences for non-surgical interventions which could also explain why significant 
differences were not observed between groups in the present study but were observed in 
Dias et al.s’ sample(242,245) not on a waiting list. Once again, it is important to note that this 
study’s power analysis was not calculated for disability and therefore may not be 
sufficiently powered to show improvements in this outcome measure. 
 
A further comparison is made with caution against a study which found an exercise 
intervention in persons with OA of the knee gave positive results for disability measured 
with the HAQ(338). Significant improvements in disability were reported with large effect 
sizes at two months (ES = 1.22, p < 0.01) and further maintained at four months. Once 
again, the sample of participants with knee OA used in the study by Fransen et al., was not 
on a waiting list and presented with better baseline disability scores (M = 0.67) than the 
sample in the current study. Another comparison is made against a prior study on the 
effect of a self-care educational intervention in persons with moderate knee pain due to 
OA (M = 5.93, SD = 2.97 on the HAQ pain VAS)(348). Significant improvements were seen 
between groups for disability at four (p < 0.01) and eight months (p = 0.4) but these 
improvements were lost at month 12.  
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Once again these results were for a sample who were not on a waiting list and presented 
with better disability scores at baseline (M = 1.21, SD = 0.61 for the experimental group, M 
= 1.13, SD = 0.66 for the control group)(348) when compared to the current study.  
Nevertheless, in the present sample, with severe pain and disability and on a waiting list for 
a knee replacement, the conservative combined intervention used in the current study 
favoured the experimental group withimprovements in disability sustained until month six. 
A larger sample size of people with knee OA only, could confirm the positive treatment 
responses observed in disability score. A longer follow up evaluation would also provide 
data to substantiate whether these improvements were maintained or lost in the longer 
term. 
 
Strangely, the participants with both OA of the hip and knee showed conflicting results with 
those in the experimental and control group improving at weeks six and 12 respectively (p 
< 0.01). Following which both groups’ scores began worsening again, with the control group 
reverting back towards baseline disability scores more distinctly than the experimental 
group.  As seen in the results on function, this subgroup of people with OA of both the hip 
and the knee presented at baseline with the worst scores on the disability index of the 
three subgroups (M = 1.89, SD = 0.42). These findings corroborate the statement that 
combined joint involvement leads to higher disability than a single affected joint(87).The 
reason for the improvements in both the experimental and control groups is unknown and 
leads one to believe there may be different treatment responses in those with more than 
one joint affected. Thus comparisons to those with either isolated hip or knee OA should be 
made with caution. Further research targeting the effects of such an intervention in this 
population is necessary to further understand varied responses.  
 
In summaryregarding the outcome of disability, a conservative intervention such as the one 
used in this study, holds the potential to impact an individual beyond improving 
impairment, i.e. a painful joint. Moreover, it appears to have the ability to influence daily 
life in terms of decreasing activity limitations and participation restrictions, which is 




5.5 Secondary outcome: personal factors  (SE and HRQoL) 
According to the ICF model, besides the interactions between and the effect of impairment, 
activity limitation and participation restriction on the overall health of an individual, 
personal factors are included as having a bidirectional effect on the former components(53). 
As alluded to in the above section on disability, intervention strategies need not only focus 
on physiological improvements such as pain and function, but should aim to impact the 
person’s entire being, involving personal and psychological aspects too. Previous literature 
has emphasised the consequences of pain, function and disability on cognitive and 
emotional well-being(50,119) as well as the impact that psychological factors and beliefs have 
on function(272). Therefore understanding to what extent the current sample was affected in 
terms of these aspects and how this changed throughout the study was of interest and is 
discussed below.   
 
5.5.1 Baseline presentation of the sample in terms of personal 
aspects 
Besides the usual consequences on psychological factors due to OA, it is assumed that the 
current sample had further negative influences on emotional well-being and quality of life 
as a result of being on a waiting list for so long(15,33,246,309,310). The baseline presentation of 
the participants’ emotive functional interference was previously covered in the 
discussionof PIS results, showing pain largely affected the aspects of mood and sleep. As 
expected, it was illustrated by the result from the EQ-5D that the current sample presented 
with a low health related quality of life at baseline (M = 0.33, SD = 0.33). This agrees with 
previous work reporting high psychological stress and low HRQoL while being on a waiting 
list for anything from one month to three years(246). The mean HRQoL scores for two 
samples on a waiting list in Ackerman and colleagues’ studies were measured by the 
assessment of quality of life tool (M = 0.39, SD = 0.24 and M = 0.37, SD = 0.26, compared to 
those with OA not on a waiting list, M = 0.52, SD = 0.22(15,246)). This was also far lower than 
the norm without OA, in an Australian population of M = 0.83, SD = 0.20 (scale ranges from 
–0.04 to 1, with 1 representing the best quality of life)(15,246). Aside from the work by 
Ackerman et al.(15),limited studies have reported on HRQoL in those awaiting surgery for 
more than one year. One study showed HRQoL to significantly deteriorate when waiting 
longer than a year, yet this was reported on changes in only three of the SF-36 domains of 
HRQoL and therefore generalizability and comparison is limited(34).  
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More suited for comparison to the current sample are studies that have made use of the 
EQ-5D to measure HRQoL(33,310,319,349). The present sample showed a far worse EQ-5D index 
(M = 0.33, SD = 0.33) when compared to the norm of the general population in the 
Khayelitsha district in the Western Cape, South African (M = 0.80, SD = 0.22)(319,349). The 
current sample also presented with a worse HRQoL index when compared to a sample of 
people living with HIV in the Khayelitsha district (M = 0.70, SD 0.28)(Jelsma, personal 
communication, 20 October 2014). It is noted that these two community samples has a 
much lower age (M = 37.7, SD = 13.6 and M = 33.6, SD = 7.6 years respectively) than the 
current sample and therefore it maybe postulated that the younger population may be 
expected to have a better health related quality of life.  
 
It would therefore be more applicable to compare the HRQoL of the current sample to that 
of an older South African community. A study was performed in a widely diverse 
community in Woodstock in the Western Cape to establish the determinants of HRQoL 
using the EQ-5D in this older population (M = 50, SD = 17.8 years)(319). However, this sample 
with a closer age match still had a better HRQoL index (M = 0.79, SD = 0.27)(Jelsma, 
personal communication, 20 October 2014). Further analysis of the Woodstock sample 
according to those with a disability or ill health and those without, showed that even those 
with a disability or ill health reported higher EQ-5D scores than the current sample with OA 
(M = 0.51, SD = 0.39 and M = 0.68, SD = 0.32 respectively)(Jelsma, personal communication, 
20 October 2014). Another comparison was made against an older European population 
norm (age 70 – 74 years) who similarly had a much higher EQ=5D index than the current 
sample (M = 0.76) (33). This leads one to assume that age is not the main factor contributing 
to the lower HRQoL scores seen in the current sample but more likely as a consequence of 
the combined effects of having OA and being on a waiting list for such a long period. 
 
In order to strengthen the above assumption, the current sample was also compared to an 
older (M = 69.4, SD = 9.7 years) European sample awaiting a hip replacement for an 





The current sample presented with slightly worse HRQoL when compared to Ostendorf and 
colleagues’ sample(33) (M = 0.39, SD = 0.31) and showed an even worse HRQoL when 
compared to another elderly European sample, awaiting a hip replacement for eight 
months (men: M = 0.47, SD = 0.028, and women: M = 0.48, SD = 0.025(310)). The finding that 
the current sample has worse HRQoL scores while waiting a considerably longer time on a 
waiting list (M = 3.61, SD = 2.44 years), supports prior work reporting quality of life 
deteriorates with time while being on a waiting list and that this is the most likely reason 
for the lower HRQoL seen in the current sample(15,33,246,309,310).  
 
Similarly, the baseline EQ-5D VAS in the current sample (M = 58.26, SD = 20.46) showed 
their self-rated state of health was far worse than both the younger and older South 
African community population norm values [M = 77.8, SD 22.7(319,349) and M = 74.7, SD = 
14.9 (Jelsma, personal communication, 20 October 2014) respectively]. Similarly, the state 
of health was still worse than those in the older SA sample with disability and ill health (M = 
62.9, SD = 19.9 and M = 70.5, SD = 17.5 respectively)(Jelsma, personal communication, 20 
October 2014).  Furthermore, the present sample’s baseline EQ-5D also revealed a slightly 
worse state of health when compared to the sample awaiting surgery in Ostendorf and 
colleagues’ study(33) (M = 60.7, SD = 20.5). The EQ-5D VAS score was not reported on for the 
similar study awaiting eight months for surgery(310).  
 
The baseline EQ-5D scores show the participants in the current study on a long waiting list 
report their state of health to be much poorer than the younger and older South African 
population norms with and without health issues and as slightly worse than those on a 
short waiting list in Europe.  
 
These findings emphasise just how remarkable the positive results of reduced pain and 
functional improvements in this study are; that in spite of a poor state of health and low 
HRQoL ratings in the current sample, improvements in pain and function are evident. 
Whether the study was also able to bring about benefits in the personal aspects of HRQoL, 





Another important factor previously discussed included under personal aspects relating to 
overall health and disability is self-efficacy. As mentioned in the literature review, self-
efficacy is often lower in those with chronic conditions and has a role to play in cognition, 
behaviour and self-management(193-195). The link previously spoken of between pain, 
dysfunction and low self-efficacy(197-199) was not as evident in the present sample as 
anticipated. The baseline presentation for SE score, according to the chronic disease 6 item 
SE scale, was in fact not very low (M = 6.30 ± 2.38). This is surprisingly higher than the 
normal value for those with chronic diseases in the USA (M = 5.17, SD = 2.22(177)). It is noted 
that the use of the SE scale is intended for a measurement of SE in a variety of chronic 
conditions, therefore the lower SE score in the US sample could be justified as the score 
was obtained from a sample not specific to OA. Furthermore, the previously documented 
correlation (r = 0.49, p < 0.01) between low SE and low quality of life in persons with OA 
awaiting surgery(246) was not supported by the findings of the present study; as seen by 
poor HRQoL scores of the current sample despite high SE scores. However these 
unexpected findings related to SE may be appropriate for the current sample used and not 
necessarily generalisable to the entire population with OA in SA. The low level of education 
in the current sample could have resulted in the discrepancy in SE scores. Correct 
understanding of the SE scale may have contributed to the values not following the 
normative scores. This is supported by a previous study stating patient reports of health 
differed according to educational levels(350). 
  
ii. Change in personal factors over time 
Although benefits seen in personal aspects as a result of participating in the intervention 
are less than those for pain, function and disability, it seems that the intervention can 
affect personal factors to some extent. Long term benefits in personal factors favoured the 
experimental group as seen by less interference in mood and sleep according to the BPI PIS. 
As discussed in the section on pain, these psychological benefits were also confirmed by 
participants’ responses to the open ended questionnaire. The intervention helped 
participants to form new positive attitudes, build self-confidence and enhanced their mood 




Health related quality of life measured on the EQ-5D disability index showed no significant 
improvement throughout the study. It appeared that at week six both groups had improved 
somewhat but began deteriorating from then onwards. None of these changes were large 
enough to be called significant. The apparent improvement at week six could be said to be 
due to the Hawthorne effect(332) as both the intervention and control groups could have 
responded to the attention received in the first six weeks of the study, after being on a 
waiting list for a long period. Subsequently less attention was given to groups as the study 
continued with participants only seen at the next two follow up points at week 12 and 
month six.   
 
The finding of no significant change in the EQ-5D index is in agreement with the study by 
Hurley et al. assessing the effects of the ESCAPE-knee integrated programme in a UK 
sample with a higher baseline mean EQ-5D score to that of the current sample (M =  0.60, 
range 0.57 - 0.63). Their sample showed no significant changes in EQ-5D index, in either of 
the arms of the trial at month six (ES = -0.01, P = 0.07)(272). Similar findings are reported in 
Barlow et al.s’ study whereby another UK sample, with a closer matched baseline mean to 
the participants in the present study (M = 0.43, range 0.35 – 0.54), reported no significant 
improvements in EQ-5D index after an arthritis self-management intervention(235). The 
current EQ-5D findings, together with prior results showing no significant improvements in 
HRQoL, supports the recent conclusion drawn on the responsiveness of the EQ-5D(351). It 
has been suggested that the three level responses can cause floor and ceiling affects and 
this instrument is not sensitive enough to changes that may take place(351). The EQ-5D index 
was described as a poor reflection of health status in a study published after the outcome 
measure was chosen for use in the current study(351). 
 
Similarly, no significant change was reported for the EQ-5D VAS in the current sample. This 
is also in agreement with Barlow et al.s’ previous study(235) evaluating the effects of the 
ASMP(235), whereby a sample was utilised with a similar mean baseline EQ-5D VAS (M = 
56.78, range = 51.8 - 62.9) when compared to the current study (M = 58.26, SD = 20.46). 




However, an interesting finding was reported in the same sample; a significant 
improvement in EQ-5D VAS was evident at month 12 (ES = 0.28, p < 0.01)(235). This finding 
could suggest that self-reported state of health may too take a longer time to demonstrate 
a significant change in chronic pain conditions. Therefore a longer follow up of the current 
sample may have revealed similar changes. 
 
In line with the current HRQoL findings, no significant improvements were reported for SE 
scores. The present SE finding contradicts Barlow and colleagues’(235) positive findings of 
improved SE after a SMI in individuals with arthritis(235). Results showed significant 
improvements in SE as measured by the ASE scale for pain and other symptoms at four 
months (p < 0.01, ES = 0.41 and 0.43 respectively) as well as sustained long term benefits in 
the intervention group for pain and other symptom SE at month 12 (p < 0.01, ES = 0.35 and 
0.39 respectively). The findings of the current study also disagree with long term significant 
improvements in SE reported by Hurley et al.(271) after a combined exercise and education 
intervention in knee conditions, where significant improvements  in SE were still evident at 
18 months post intervention (p = 0.01). Once again, Hurley and colleagues(271) explain that 
by incorporating active exercise into the intervention participants were able to experience 
on a first hand basis exercise without pain aggravation. By integrating their positive 
experiences during exercise with advice and coping strategies, self-confidence can be 
restored in the ability to perform daily tasks(271). However, even though the present 
intervention was based on these principles, SE was not significantly improved in the 
intervention group of the current study. This could be as a result of the SE scores being 
higher than expected at baseline, yet there was still room for improvement as scores were 
still lower than seven out of 10. As mentioned above, a more likely explanation for the lack 
of change could be due misunderstanding of the instrument used to measure SE, as a result 
of low educational levels in the current sample(350). The RA also noted participants reported 
difficulties comprehending and completing this instrument at follow up meetings, despite 
translators being present. This leads the researchers to believe the outcome was not as 






5.6 Body mass index 
5.6.1 Baseline presentation of BMI 
As mentioned in Chapter Four (pg. 104) the average BMI in the current study at baseline 
was extremely high indicating the sample to be obese (M = 35.79, SD = 8.81). Such a high 
BMI is a true representation of the growing obesity issue in South Africa(352). The known 
association between obesity and OA(290) is clearly illustrated by high BMI values in the 
present sample of persons with lower limb OA.   
 
Furthermore BMI coupled with severe pain and disability at baseline, supports previous 
literature illustrating the detrimental cycle of obesity on the development of OA and the 
progression of pain and disability. OA is known to cause a less active lifestyle due to the 
associated impairments and lack of independence(50). Sedentary behaviours can contribute 
towards further weight increases which in turn cause greater forces through the joints of 
the lower limbs and therefore more pain and disability and so the cycle continues(290).  
 
i. Change in BMI 
It was no surprise that the present sample’s BMI did not significantly improve over the six 
months as this was not the target of the intervention. Instead, an objective of the study 
was to observe whether any change in BMI affected changes seen in primary and 
secondary outcome measures.  Previous research on weight loss in individuals with OA, 
particularly of the knee, was evaluated by means of a systematic review and meta-
analysis(296). Across five studies average age ranged from 63 – 69 years and the maximum 
average weight loss was 6.7 kg over a period of six months. If weight loss was an aim of the 
present study, a much higher weight loss than 6.7kg would be needed in order to change 
the mean BMI status of the sample from obese class II (> 30) to overweight (25 – 29.9). 
 
However it has been previously stated that physical inactivity, not obesity, is the fourth 
leading cause of mortality globally(353). Therefore it is not too concerning that BMI did not 
show a significant change over the six months, as more important changes that have 
previously been discussed, were evident in functional interference, physical function and 
activity levels in the current sample.  
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This is extremely encouraging that in spite of high, unchanging BMI values in the present 
study, significant changes in pain and function, as well as improved disability and limited 
personal benefits, were reported in the study.  
 
5.7 Open-ended questionnaire responses  
As mentioned throughout the discussion, the open ended questionnaire provided valuable 
information regarding the participants’ thoughts towards the intervention. All responses 
were positive reports of how participants thoroughly enjoyed the intervention and 
elaborated on the various benefits according to the four themes that emerged namely: 
knowledge, function/activity, pain relief and personal benefits. These findings strengthened 
the findings on the primary and secondary outcome measures used: the BPI, the walking 
tests of the physical performance task battery and the HAQ.  
 
The theme of increased knowledge has not yet been discussed in relation to the significant 
findings in the present sample. Regardless of the fairly low educational levels, with the 
majority (28 of 42) of participants not completing schooling further than grade nine, the 
responses to the open ended questionnaire indicate that participants retained the 
knowledge that they learnt from the intervention over the six months. This is also 
supported by the long term significant improvements in pain and function observed in the 
intervention group when compared to the control group, as, if participants had not 
retained the knowledge they had learnt one would not expect the improvements that were 
most evident at month six. Additionally, it was reported by more than one participant that 
the intervention and booklet supplied during the study made it possible for the participants 
to share their newly attained knowledge with others in their daily lives (Appendix Q, pg. 
413). Lastly, despite being on such a long waiting list with no indication of when surgery 
would be taking place in the future, a sample that was greatly affected by OA still 






5.8 Strengths and limitations of the study  
In all research, one is required to highlight the strengths and limitations of the study in 
order to fully understand the findings and how they may relate to the broader population 
and clinical practice. The CONSORT group have developed guidelines which specify what 
should be reported in a RCT(324). These guidelines were used as part of the analysis of the 
strengths and weaknesses of the study (Appendix R, pg.417). First the strengths of the 
study are discussed in the text that follows below; this is followed by the analysis of 
limitations and their implications of interpreting the data. 
 
5.8.1 Strengths 
Firstly, the intervention design of exercise and education compared against a control group 
of usual care in the present study is viewed as a strength. According to Hurley and 
colleagues a safe, effective, accessible and affordable intervention that can be delivered to 
a large number of individuals is required(178). The benefits of integrating exercise with 
education and self-management skills has previously been discussed in depth and appears 
to be more advantageous than isolated interventions in persons with OA.  
 
The intervention utilised in the current study comprises two of the most commonly 
recommended treatment approaches to the management of OA by internationally 
accepted evidence-based guidelines; education and exercise(23-25,28,30,207,213,299). The goal of 
the present study was to provide a patient centred approach to the ongoing management 
of individuals withOA on a long waiting list. This was achieved by basing the intervention on 
the ICF’s understanding of health; targeting physiological impairments (pain, muscle 
weakness, joint stiffness, low fitness levels), personal factors (knowledge, health beliefs, 
self-efficacy, stress management) and behaviours during daily activities (avoidance of 
movement or exercise, eating and sleeping habits, goal setting)(21,271). This intervention has 
the potential to meet all the aspects required to attempt managing this chronic non-






Secondly, although the intervention’s exercise component in the current study was general 
(aerobic, range of movement and strengthening exercises), specific exercise components 
were tailored to address individuals’ needs throughout the study. This distinction in 
exercises varied depending on each participant’s ability and progressed accordingly over 
time. Tailoring treatment reflects usual clinical practice and justifies the size of the group 
being small, thus allowing for individual attention. Such aspects improve the likelihood that 
such an intervention and its effects can be replicated in an outpatient setting(272). 
 
Besides the intervention design, the research setting where the intervention was delivered 
is also seen as a strength of the study. The suggestion has previously been made that 
research trials should be delivered in an outpatient setting as this allows for better 
implementation into clinical practice(276). As mentioned in Chapter Two and Three, the 
current study was performed in a typical outpatient setting in a tertiary hospital; although 
if delivered in a primary health care setting it may be more accessible and affordable to 
those living in the surrounding communities. Some participants had to travel far distances 
to attend the study and if such an intervention is implemented for clinical use, transport 
costs would not be covered. This might result in lower adherence than was recorded for 
the present study as transport fees were subsidised. 
 
The use of a group based intervention is supported by Hurley and colleagues’ study which 
showed no differences between an individual or group based combined intervention for 
function or pain(272). Due to the high numbers awaiting surgery in the Western Cape, an 
intervention that is delivered in a group rather than multiple one-on-one sessions with a 
physiotherapist is more practical to reach a large population. Furthermore, added benefits 
of utilising a group based intervention were noted in participants’ response to the open 
ended questionnaire in terms of improved support and social benefits. 
 
To ensure intra-rater reliability during the study, one research assistant measured 
outcomes at follow up meetings for participants, with the presence of the sametranslator 
throughout the study. To ensure the content and delivery of the intervention was the same 
for both small groups who received the intervention, one physiotherapist provided the 
intervention with the same translator at all sessions.  
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Additionally delivery of such an intervention does not require lengthy training and the 
exercise and relaxation component does not involve expensive equipment or specific 
facilities, therefore replication of the intervention will be possible by other physiotherapists 
in the resource constrained SA health care system.  
 
The use of the primary outcome measure to assess pain severity was shown to be valid in 
this South African sample, as it showed a strong positive correlation (r = 0.74, p < 0.01) with 
the secondary outcome measure of pain severity as measured by the HAQ. This finding 
strengthens the results of the primary outcome measure used in the current study. Validity 
of the BPI in a South African population with OA on a long waiting list for a joint 
replacement has not been documented prior to this study.  
 
Furthermore, the use of both a self-reported and objective measures of function is seen as 
another strength of the present study. It has been stated in literature that although the BPI 
gives valid information about the interference of pain on physical function, the scale 
provides no specific insight into where, when and how the difficulty in function is 
experienced(174). Hence, the BPI was the primary outcome measure of pain and pain related 
functional interference and secondary scales were used to assess function and disability. 
The self-reported HAQ was used to gain the participant’s view of their functional abilities or 
disabilities, and the objective physical performance task battery was used to quantify 
functional ability. Multiple outcome measures were able to complement each other and 
strengthen findings as it is known that “performance tests do not duplicate self-reports of 
function”(174). 
 
Despite the sample size appearing quite small (N = 42), the necessary calculations for a 
sufficiently powered sample were performed prior to the study commencing. As mentioned 
in Chapter Three (pg. 87) a sample of 36 participants was required to provide 90% 
statistical power for change in BPI scores between groups and 45 participants was required 
for 95% power. Therefore 42 participants providedbetween 90 and 95% power for the 
current study.  
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The adequate sample size used to produce the significant differences in pain and function 
in the present sample disagrees with the majority of small underpowered samples 
reviewed in the SR by Walsh et al. on the effectiveness of combined interventions in hip 
and knee OA(276). Therefore the present study allows for generalizability of the sample’s 
findings to the broader population of OA sufferers awaiting a joint replacement, in the 
Western Cape public health system. Concurrently, the same study was performed in the 
province of Gauteng in SA which can be used to further strengthen results if samples are 
combined to produce a larger sample size for SA. Additionally, findings of both provinces 
can be compared to establish whether the intervention brought about the same effects in 
two different regions in SA. 
 
5.8.2 Limitations 
Following on from the current study’s strengths, several limitations of the study are also 
discussed. A double- blinded randomised controlled trial is considered the most valuable 
type of trial in human research(354). However, according to Hughes at al.(277) it is impossible 
to undertake a double blinded RCT in a study involving an active participatory intervention 
versus a control group, as participants are aware they are part of the intervention arm of 
the trial instead of the control arm. This is applicable to the present study which allowed a 
single-blinded RCT to be performed. Since the participants were aware they were receiving 
the intervention self-reported outcome measures might reflect respondent bias for those 
in the intervention group. However, objective distance and timed tests were also used to 
evaluate responses to the intervention and a large effect size was recorded in the objective 
measure of walking ability during the 15m fastest speed test. Researchers do not believe 
this limitation greatly affects the validity of self-reported results. 
 
Importantly, this sample represented a low educational group attending a public facility in 
the Western Cape of SA. This is representative of the large portion of the previously 
disadvantaged SA population, who consequently also have low income levels and therefore 
attend public health facilities(68). Caution should be applied as these findings might not be 
transferable to the private population, waiting shorter periods for surgery, with higher 




It was observed that despite efforts to recruit participants with less severe OA from the 
third priority waiting list, the participants who were selected displayed signs and symptoms 
of severe OA at the time of the study. This is thought to be a consequence of the waiting 
list being so long. Additionally, it was presumed that the third priority list would present 
with a low number of co-morbidities, as research states that with increasing age and 
progression of the condition, the risk for development of co-morbidities also increases(87). 
However this was not so as each participant had an average of 1.29 co-morbidities. 
Therefore, it is thought that the positive findings of the present study could be even more 
evident in a sample truly representative of earlier OA changes with less co-morbidity. 
 
The response findings from the subgroup analysis should be interpreted with caution due 
to the samples in each subgroup being small. Despite encouraging results as seen by the 
significant differences in those with knee OA, the power is not necessarily strong enough to 
draw clear inferences from these findings.  
 
It is important to note that a few patients were lost to follow up and data was carried 
forward in these cases (n = 6 at different follow up times). Hurley et al.(271) explains this is a 
common problem during research. This may have led to blunting of results and therefore 
could possibly explain why secondary measures of disability, functional abilities other than 
walking, HRQoL and SE were not significantly different when compared to the control 
group(355). A suggestion has previously been made to rather use “multilevel modeling and 
multiple imputation to generate robust predictions of the effect of missing data”(355). This 
approach will be explored when the data are pooled with the data from the trial being 
conducted in Gauteng.  
 
A minor limitation is illustrated by the discrepancy between patient reported assistive 
device usage and RA observed or recorded assistive device usage at baseline (p < 0.01). It 
appeared that use of an assistive device was recorded by the RA as significantly lower than 
what participants initially reported on the demographic questionnaire. It is possible that 
this could be true for each follow up session after baseline measures yet this is unknown as 
participants did not report on their use of assistive devices after the initial session. The 
information recorded at weeks six, 12 and month six by the RA may not be a true reflection 
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of normal daily assistive device usage in the participants’ home environment. It is likely that 
participants portrayed themselves as less or more reliant on an assistive device during 
follow up sessions, depending on what message was being relayed to the RA. Similar 
discrepancies in patient reports have been previously documented whereby pain responses 
and associated disability is influenced by social and environmental context(356). Therefore 
whether true assistive device usage during the six months was accurately reflected is 
questionable.  
 
After results of the present study showed no significant changes in HRQoL and SE scores for 
either group at any time, the researchers questioned whether the instruments used to 
evaluate these outcomes were in fact sensitive enough to detect change in the current 
sample. Despite both being widely used in research, the EQ-5D and the Self-Efficacy for 
Managing Chronic Disease 6-Item Scale are generic outcome measures used in a variety of 
conditions. As mentioned in Chapter Two (pg. 32), the psychometric properties of SE scale 
used in the present study have previously been questioned around its appropriateness for 
condition specific use; yet these doubts were not deemed worthy enough to only utilise the 
instrument as a generic outcome(194). The current findings seem to support the previous 
uncertainties regarding use of the instrument in condition or task specific cases(194). Since 
the present study commenced, a study providing psychometric properties for the condition 
specific English SE scale (ASES-8) has been published(357). Validity and reliability of the ASES-
8 is now available and therefore a recommendation for use of this instrument is made, as it 
could be more sensitive to detecting treatment responses in a sample so greatly affected 
by OA.  
 
As mentioned earlier in the discussion, critique has previously been put forward on the 
three level version of the EQ-5D used in the current study; whereby authors argue that 
levels of response (e.g., no problems, some problems, severe problems) are not sufficient 
to detect more subtle changes in health related quality of life(351). Use of the five level EQ-
5D (no problems, slight problems, moderate problems, severe problems, and extreme 
problems) may have provided a more accurate reflection of the HRQoL for the sample 
used. South African studies of the EQ-5D have also found that the instrument “does not 
capture all those elements of HRQoL that are important to the population under 
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study…”(319). Furthermore, despite rigorous translation processes for different SA 
languages, it was stated that further validation studies are needed for the isiXhosa version. 
Criticism regarding the appropriateness of the category domains used was raised as 
meanings behind concepts of “anxiety/depression” differ in the isiXhosa culture(349).  
 
Important to note is that the EQ-5D was not validated specifically for apopulation with OA 
either. However, the EQ-5D was not the primary outcome measure therefore use of this 
instrument was chosen as it has been described as quick and easy to administer in chronic 
conditions. Perhaps an OA-specific instrument for HRQoL, such as the full WOMAC, even 
though it is more time consuming to complete, may be more appropriate to detect change 
in a SA sample, including isiXhosa individuals with OA. Additional recommendations for 
future research in this field are noted below and draw the discussion section of this study 
to a close. 
 
5.9 Further recommendations 
While various self-report functional outcomes have been used to assess function following 
an integrated programme, the most commonly used is the WOMAC scale of 
function(73,264,271,272,279,358). Dworkin et al.(121) suggest that the BPI interference scale can be 
used for function assessment unless a validated disease specific tool is available. Since the 
WOMAC functional scale is specific to OA and frequently used in research, it may be a 
useful addition to provide data to strengthen the results of improved functional 
interference. Additionally, Brazier et al. found the WOMAC functional scale to be more 
valid and responsive to change when compared to the patient reported HAQ(192). Therefore, 
even though the HAQ was developed for the use in arthritis conditions, future research 
could consider replacing the HAQ with the OA specific WOMAC functional scale. However, 
the reliability and validity of the WOMAC in a South African context and OA population 
would need to be established. 
 
It is observed that in previous studies, objective measures of daily functional activities have 
not been utilised as much as self-reported instruments.  
180 
 
Some studies have made use of walking tests and repeated sit – stand tasks(264,276,277,359), as 
well as stair climbing(264) and a series of tasks making up a battery of tasks(281). It was stated 
in Chapter Three (pg. 87) that the content validity of the physical performance task battery 
would be explored as a part of the present study. Notably, the walking tests were 
important determinants of treatment response in this sample, yet sit-stand and the sock 
test were not helpful in ascertaining the effects of such an intervention on physical 
functioning. Despite the forward and upwards reach tests predominantly involved upper 
limb functioning, it was presumed that lower limb components during balance may be 
affected by the intervention and therefore was included as a part of the physical battery. 
However, no treatment response was observed throughout the study in either group for 
either reach test and therefore these two tests were deemed unnecessary in a sample 
affected by lower limb OA. 
 
As mentioned in Chapter Two (pg. 27), the aggregate functional performance time (AFPT) 
obtained from a series of four daily tasks(172) is similar to the physical performance task 
battery. However it combines times for the four functions to produce an aggregated score 
of function. This outcome could be used in future research to possibly give a broader result 
of functional performance for those with lower limb OA, during daily tasks of walking, rising 
from a chair and stair climbing. Hurley et al. states that performance in a single task test 
does not provide accurate information about functional ability in another task and 
therefore a general functional score could be useful(172). This measure has been used 
previously in the integrated ESCAPE trials by Hurley et al.(264,271,272) showing significant 
improvements in function after six months (p = 0.02, ES = 0.17)(272). Validation of the AFPT 
in OA against another objective functional measure such as the physical performance task 
battery and self-reported measures of function and functional interference used in the 
present study is recommended.   
 
Another recommendation regarding instrumentation is made for further research into this 
field. Although the relaxation component of the present study may have contributed 
towards the benefits reported in the current sample, no specific outcome measure was 
utilised to establish whether this adjunct to the exercise and education components was 
useful or necessary.  
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An additional open-ended question concerning the relaxation component could be a simple 
way of gaining insight into this aspect of the intervention. Future studies should consider 
whether an instrument evaluating the effects of the relaxation component is worthwhile.   
 
Continuing on from the above concerning instrumentation; this study’s aim was not to 
remove the patient from the waiting list and therefore did not assess whether the 
intervention could result in participants choosing to remove their name from the waiting 
list. While avoidance of surgery was not used in the current study, it could be a valuable 
outcome to monitor in future studies. This could substantially add to the evidence-based 
research in this field if such an intervention has the potential to improve a patient’s 
symptoms efficiently enough as to no longer require surgery.  
 
Furthermore, monitoring of adherence and compliance to the principles learnt in the 
intervention was not included in this initial study.  However, recording whether or not 
participants incorporated principles such as goal setting, pain management, coping skills, 
daily exercises and relaxation techniques etc. into their lifestyles may be of benefit. It is 
recommended that monitoring of adherence could be done during the six week 
intervention as well as during follow up periods. This could provide valuable insight into 
whether the sustained improvements seen in the study were due to the participants 
adhering to cognitive behavioural changes, as a result of the intervention.  
 
As mentioned earlier in the discussion, once results were analysed for the six month period 
and compared with previous research, the current researchers propose that future trials 
extend the follow up period to at least 12 months. Walsh et al. states that long lasting 
benefits are especially needed in persons on a long surgical waiting list(276). This will provide 
valuable comparative data whereby the current findings can further support or contradict 
prior long term research concerning persons with OA awaiting surgery.  
 
Previous research has shown that pre-operative personal and psychological aspects have 
effects on post-operative outcomes in persons with OA(15). Despite no significant change in 
HRQoL and SE in the current sample, the significant improvements in mood and sleep 
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interference, as well as the positive responses towards the intervention as seen by the 
open ended questionnaire are not to be overlooked. If a short term intervention such as 
the one used in the present study, can bring about certain personal or psychological 
benefits, then it is thought that a combined exercise and education intervention could 
possibly have carry over effects post-operatively too. Therefore recommendation is made 
for research whereby participants are also followed up after they have received a joint 
replacement to confirm this assumption. According to de Jong et al. “Implementation 
studies are recommended to assess the feasibility and effectiveness in real-life of 
programmes which have been tested in randomized controlled trials”(331). Following this 
statement, it was reasoned that more than a single RCT is necessary to implement an 
effective intervention into any health care system(360). Therefore it is recommend that 
further RCTs be performed replicating the present intervention, together with the 
suggestions discussed above in order to confirm the effectiveness of such an integrated 




The rationale behind undertaking the present study was primarily due to the rising burden 
of osteoarthritis(14,15)and delays in receiving surgery as a result of long waiting lists(14,31). As 
mentioned in Chapter One, OA is one of the leading causes of pain and disability 
worldwide(19,20). As a consequence of the expected increase in aging of the population and 
thus an increase in prevalence of the condition, effective management is essential at all 
stages of OA to minimise burden on an already stressed health care system(21,22).  
 
It is widely accepted that late stage OA requires surgical management by means of a joint 
replacement(19,24,29). Yet a common issue in local and international health systems is 
restricted access to this elective surgery(50). Relatively short waiting lists for a joint 
replacement have been reported for high income countries, whereas longer waiting times 
of a few years are experienced in lower income countries, such as South Africa(31,32). As a 
consequence of OA being a progressive condition, increases in pain and deterioration in 
functional ability are common as time goes by(75,76). Understandably so, research has shown 
debilitating effects of waiting for surgery without appropriate management in the 
interim(33,34).  
 
To address this issue, particularly in the Western Cape of SA, it was proposed that providing 
evidence-based first-line treatment options for OA could ease the burden for patients 
awaiting an arthroplasty. To the researchers’ knowledge, this is the first RCT to be 
performed in individuals with OA comparing an integrated exercise and education 
intervention to usual care, while on a waiting list in a South African context. Previous 
research has reported on the varying effects of exercise in OA(266-268), education in OA(226,227) 
and self-management in OA(237,249,258), mostly in higher income countries. More recent 
work(271,272,277-279)has shown the positive effects of combining these approaches in one way 
or another in the management of OA. However, the effects of an integrated intervention 
have not been evaluated in the South African population with OA. Therefore this study 
aimed to evaluate the effects of a combined exercise and education intervention in a 
population of individuals affected by OA awaiting a joint replacement. Conclusions are 
drawn below on each specific objective of the present study. 
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To determine, whether participating in a six-week physiotherapist-led exercise and 
education intervention resulted in a significant change in…pain severity and pain 
interference... 
 
The findings of the primary outcome showed that participating in a combined exercise and 
education intervention was able to cause distinct changes in both pain severity and pain 
interference. The most meaningful difference was observed in pain interference at month 
six in participants who received the intervention. Despite commencing the study with 
severe levels of pain, the participants were able to enjoy the intervention and reported 
apparent reductions in pain intensity and less interference with physical and emotional 
functioning after completing the six-week intervention. Remarkably pain severity was 
reduced throughout the follow up period in those who took part in the intervention 
compared to previous pain ratings. Furthermore, at month six the extent to which pain 
interfered in daily life showed the largest difference when compared to the control group 
whose pain interference did not show any significant change.  It is astounding that a short 
six-week intervention can markedly reduce pain severity and interference in individuals 
who have been experiencing chronic pain for many years.  
 
To determine, whether participating in a six-week physiotherapist-led exercise and 
education intervention resulted in a significant change in…function... 
 
The results for the objective functional performance tests demonstrated that partaking in 
this intervention caused sustained improvements in function; specifically walking ability. It 
was observed that many participants showed physical signs of difficultly during walking; 
with the majority making use of a walking aid to assist with this daily function. The main 
difference was again noted at month six whereby the participants who received the 
intervention were able to walk significantly faster when compared to the control group. 
Additionally, those in the experimental group were able to walk significantly further than 
prior to participating in the intervention. Both objective walking scores (15m fastest speed 
walk and six minute walk test) showed evident improvements during the study duration 
without reaching a plateau. Whether time and distance scores could possibly further 
improve would be useful information if participants are followed up for longer durations. 
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This intervention made it possible for participants who have been struggling for years with 
walking and activities requiring the ability to walk, to function at a better level in their daily 
lives.  
 
To determine, whether participating in a six-week physiotherapist-led exercise and 
education intervention resulted in a significant change in…disability... 
 
The findings from the self-reported disability outcome indicated that such an intervention 
appears to have resulted in improvements in disability. The results illustrated that despite 
participants presenting with severe disability after being on a waiting list for a long time, 
those who received the intervention displayed significantly reduced disability compared to 
disability scores prior to the intervention. This reduction in disability was evident directly 
after the six week intervention and was similarly maintained at month six. For these 
individuals awaiting surgery, the burden of OA can cause a loss of independence and in 
many cases a person’s purpose. Remarkably, it seems that an exercise and education 
intervention, led by a physiotherapist can begin to reverse the effects of disability. 
 
To determine, whether participating in a six-week physiotherapist-led exercise and 
education intervention resulted in a significant change in…self-efficacy... 
 
Self-efficacy results for this sample proved interesting, as it was noted that in spite of 
immense pain, functional difficulties and disability, the sample did not display the low 
levels of SE anticipated at the beginning of the study. Furthermore, the results implied that 
the six-week physiotherapist led intervention did not cause any significant effect on SE. 
Since SE was not the primary focus of this study, the results do not discourage the use of 
this intervention for clinical practice or future trials. As discussed in Chapter Five, these 
unexpected results could be due to misunderstanding of the instrument used to measure 




To determine, whether participating in a six-week physiotherapist-led exercise and 
education intervention resulted in a significant change in…health related quality of 
life... 
 
Similarly, the findings of the last outcome used suggested that the exercise and education 
intervention did not produce significant changes in health related quality of life. Again this 
was not the primary outcome of the study and the findings could be due to choice of tool 
used to evaluate HRQoL. However, a more appropriate assessment of HRQoL following an 
intervention in future trials could be achieved if the generic instrument was replaced with a 
tool specific to OA.    
 
To determine whether body mass index…accounted for any significant differences in 
the above outcome measures. 
 
The extremely high values calculated for BMI for the present sample correctly depicts the 
obesity concern experienced in both low and high income countries. Despite small amounts 
of weight loss in a few participants who received the intervention, BMI did not account for 
any differences in the above outcomes as the BMI for either group remained constant 
throughout the study. 
 
To determine whether…OA of the hip or knee or a combination of hip and knee OA… 
accounted for any significant differences in the above outcome measures. 
 
Although the subgroups consisted of small numbers, analysis according to OA of the hip, 
knee or combined hip and knee OA provided substantial information regarding the 
treatment responses of each group. It appears that the subgroups did account for 
differences in the primary and secondary outcome measures. The differences accounted 
for by the group with OA of the knee only were most obvious.  
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Findings showed that those participants with knee OA improved far more than those with 
OA of the hip only or those with a combination of hip and knee OA. This significant 
difference was particularly observed in pain interference and pain severity scores according 
to both the BPI and HAQ pain VAS. These results are particularly important to consider 
when planning further trials in this field. Subgroup findings are also useful when 
implementing this study into clinical practice, as targeting persons with OA of the knee may 
result in better treatment effects, instead of delivering an intervention to a individuals with 
hip OA only who might respond poorly to the management.   
 
Finally, to determine the acceptability of a six-week physiotherapist-led exercise 
and education intervention for patients on the waiting list for joint arthroplasty. 
 
Based on the various positive responses to the open-ended questionnaire by the 
participants involved in the current study, such an intervention is considered to be 
acceptable. 
 
It was surprising that persons from the third priority waiting list would present at baseline 
with such a poor depiction of health as in the current sample. Yet as a result of being on the 
waiting list for such along duration of time, the third priority label given when initially 
assessed for a joint replacement was no longer appropriate; thus the baseline presentation 
is better understood. Despite high levels of pain severity, pain interference and disability 
across the sample, the exercise and education intervention was most effective in 
significantly reducing levels of pain interference as well as significantly improving functional 
ability during walking. Furthermore, it was noted that the intervention favoured those 
participants with knee OA as seen by significant differences in pain interference and pain 
severity on both pain scales when compared to the control group.  
 
Thousands of individuals in the Western Cape are suffering from the burden of OA for far 
too long while awaiting surgery. This study provides an acceptable and effective evidence-
based short term non-pharmacological and non-surgical intervention that can be easily 
delivered by a physiotherapist.  
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The intervention has the ability to reduce this population’s suffering by particularly 
improving long term pain and function. An integrated intervention of exercise and 
education is beneficial and should be urgently implemented for people with OA receiving 
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Appendix A: ESCEO algorithm for 
the management of knee OA 
STEP 2: Advanced pharmacological management in the 
persistent symptomatic patients
If still or severly symptomatic: 
Intermittent or continuous (longer cycles) oral NSAIDs. NORMAL GI RISK - Non selective NSAID 
with PPI-Cox-2 selective NSAID (consider PPI). INCREASED GI RISK* - Cox-2 selecve NSAID with 
PPI-Avoid non-selective NSAIDs *Including use of low dose aspirin. INCREASED CV RISK - Prefer 
naproxen, avoid high-dose diclofenac and ibuprofen (ifonlow-dose aspirin), caution with other 







STEP 1: Background treatment
If symptomatic: 
(Paracetamol on a regular basis) OR 
Chronic SYSADOA: prescription 
glucosamine sulfate and/or chondroitin 
sulfate ± as needed paracetamol
If still symptomatic ADD: 
Topical NSAID (OR) topical 
capsaicin
Referral to physiotherapist for: to control 
malalignment:  Knee braces, insoles.
If symptomatic ADD at any time:
Walking aids, thermal agents, manual 
therapy, patellar taping, Chinese 
acupuncture, TENS
Basic principle and core set
Combination of treatment modalities, including non-
pharmacological and pharmacological therapies is 
strongly recommended
Core set: Information/education, weight loss if 






STEP 4: End-stage disease management and surgery 
If severely symptomatic and poor quality of life: 
Total joint replacement
(Unicompartmental knee replacement)
If surgery contraindicated: 
Opiod analgesics
STEP 3: Last pharmacological attempts 
Short-term weak opioids
Duloxetine
 AppendixA-1 Knee OA treatment algorithm 
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Appendix C: Study information and 
informed consent document 
English version (Initially explained telephonically and then explained in person and given to 
patients at week 0 session) 
 
The effects of a six-week physiotherapist-led exercise and education intervention, 
in patients with osteoarthritis, awaiting an arthroplasty in the Western Cape. 
 
What are we trying to do? 
I am a master’s student doing research from the University of Cape Town and I am 
interested in finding out whether a six week long course for people with arthritis will make 
a difference to your health. The course aims to increase your knowledge about arthritis, as 
well as teaching you various light exercises and relaxation techniques. I want to answer 
questions such as does increasing your knowledge of arthritis affect the way you cope with 
your condition and take part in daily activities?  In order to answer these questions we 
would like to interview people whom we know have arthritis and invite them to commit to 
taking part in a six-week exercise and education course.  
 
Why have we contacted you? 
We have contacted you because you are on the waiting list for a joint replacement at 
Tygerberg hospital and this is the group of people we are looking at. 
 
What will you be asked to do? 
 If you are interested in the study, you will be asked to come into the hospital for 
the first visit. At this initial visit you will be asked a few questions which will check if 




 You will be told about the study and any questions you may have will be answered.  
 You will be assisted to complete four short questionnaires (in your preferred 
language; English, Afrikaans or Xhosa) which ask general questions about you and 
your health.  
 You will be asked to do seven short tasks which test how well you do everyday 
activities. This consists of three short walking tests at different speeds and 
distance, two tests whereby you reach with your arms. One test which looks how 
you stand up and sit down and one which looks at how you put a sock on your foot. 
These will be timed to see how much time you need for each one. This will find out 
more about whether you can cope with your condition, and what things are 
difficult for you to do.  
 This first visit should take about an hour to complete. We know that this is a long 
time but we want to get as much information as possible so that we can better 
understand the problems that you face. 
 
 You will then be placed in one of two groups. The control or the course group. You 
will have an equal chance of being placed in either of these groups. 
 
  If you are placed in the group for the course you will be asked to come back to the 
Tygerberg Physiotherapy department at the hospital the following week for the 
course which will happen once a week for two hours. This course lasts for six 
weeks. You will take part in this course with a group of 12 people who all have 
arthritis either on a Wednesday or a Thursday afternoon between 1pm and 3pm.  
 The course will include discussions on arthritis, diet and other health 
related issues aimed at helping you cope with your condition as well as 
gentle exercises and a time of relaxation. You will be asked to sign an 
agreement to respect the privacy of those attending the group, by not 
sharing group member’s information outside of the group.  
 At the last weekly session you will be asked to fill out the questionnaires 
and do the short tasks again like you did at the first visit.  
 You will be asked to return to do these measurements after another six 
weeks and lastly after six months since beginning the study. This is so that 




  If you are placed in the control group you will continue with your usual care that 
your doctor has prescribed. You will be asked to return to fill out the 
questionnaires and do the tasks again after six weeks and 12 weeks and lastly, after 
six months, so that we can see if anything has changed.  This group is just as 
important as the other group and gives us essential information that we need to 
compare the six week programme with your usual care programme.  
 
Should there be a difference in the two groups and the course shows that it helps 
people with arthritis, if you were in the control group, you will be invited to be a part of 
the six week course and you may join this group for six sessions after the study. We will 
want to stay in contact with you for six (6) months from the beginning to the end of this 
project so that we can see how you are doing over a period of time. To help us keep in 
contact with you we will ask you to give us a telephone number where you can be 
contacted. 
 
Is there any payment for taking part in the study? 
There is no cost to you to take part in this study and there is no payment to you for taking 
part in the study. We will give you R30 to cover transport costs each time you visit the 
hospital for this study.  
 
What are the benefits to you?  
We hope that you will learn more about arthritis by doing this course and that this might 
help you to cope better with your condition. We hope that you will learn the importance of 
exercise and how it may benefit you by making you fitter or stronger and possibly make it 
easier to do certain tasks. We hope that you will learn more about setting goals and 






What are the risks to you? 
We aim to minimise any risks to you which may be caused by exercise having a qualified 
physiotherapist lead all your exercise sessions and by checking beforehand if it is safe for 
you to exercise. Exercise is known to cause some stiffness or mild ache in the muscles the 
day/two afterwards if exercising is new to you , but we will try minimise this by seeing what 
you can do in the beginning and starting off at a slow pace. Each week as you get used to 
exercising, we will see if you can do slightly more exercise. If for some reason, you 
experience any marked increase in pain during the study you will be assessed and if 
necessary you will be advised to do less exercise or stop and will be referred to the 
appropriate doctor at your nearest day hospital to manage this.  
 
What will the results be used for? 
We will make the information which we gather known (but of course not your personal 
details) to the local authorities, to the local institutions that provide assistance to people 
living with arthritis and to provincial and central government. We hope that the 
information we get might lead to changes being made in the treatment of patients with 
arthritis, but we cannot promise this. In the short term we cannot say for definite that 
there will be any direct benefit to you or your family.  
 
Will people know what answers you give to the questions? 
You will be given a code in the beginning of the study and this code will be used instead of 
your name. All the answers will be put together and no-one will know who gave any 
specific answer except the researchers. Your name will not be given to anyone and will not 
be listed anywhere. The results of the project will be made available to organizations 
involved in assisting people living with arthritis, local and government authorities and the 
scientific community but no names will be linked to any results.   
 
Your usual care and appointments will continue as normal if you are in this study. Nothing 
bad will happen to you if you do not want to take part. It is completely voluntary. Even if 
you do take part, you can stop at any time and you can refuse to answer specific questions. 
217 
 
If you wish to stop attending this will have no impact on your normal care. Taking part or 
not taking part in the study will not affect your chances of getting a joint replacement nor 
change your position on the waiting list. If you have any questions during the course of the 
study you are welcome to contact myself or my supervisors or ask during any of the 
sessions.  
If you would like, the researcher will refer people who take part to whatever services they 
need which may be available in the area. Your participation is appreciated.  
Melissa Saw  (physiotherapist)  
Tygerberg Hospital B5 west physiotherapy department 
(021) 938 5152  
 
Romy Parker  (supervisor)  
UCT Dept of Health and Rehabilitation Sciences: Division of Physiotherapy 
(021) 406 6431. 
If you have any questions or concerns about your rights as a research participant, please 
contact:Prof Marc Blockman: 021 406 6492 
 
Please note that UCT does offer a no-fault insurance that will cover all participants in the 
event that something may go wrong.  This insurance will provide prompt payment of 
compensation for any trial-related injury in accordance with the Association of the British 
Pharmaceutical Industry (ABPI) guidelines (1991).  These guidelines recommend that UCT, 
without any legal commitment, should compensate you without you having to prove that 
UCT is at fault.  An injury is considered trial-related if, and to the extent that, it is caused by 
study activities.  You must notify the study investigators immediately of any injuries during 
the trial, whether they are research-related or other related complications.  UCT reserves 
the right not to provide compensation if, and to the extent that, your injury came about 
because you chose not to follow the instructions that you were given while taking part in 
the study.  Your right in law to claim compensation for injury where you prove negligence is 







Please read the attached information sheet for the study titled: The effects of a six-week 
physiotherapist-led exercise and education intervention, in patients with osteoarthritis, awaiting an 
arthroplasty in the Western Cape. 
We hope that this research will help health professionals to better understand whether a six-week 
course (including exercise and education) on arthritis helps people to cope with living with the 
condition.  All questionnaires are anonymous and records will be kept strictly confidential.  
You are welcome to contact the Investigator, Melissa Saw on (021) 9385152, or the supervisor, 
Romy Parker on (021) 4066431 or Professor Blockman on (021) 4066492 for further details about 
the research and your rights. This research is voluntary and refusal to participate or decision to 
withdraw at any time will involve no penalty or loss of benefits to which you, the participant, are 
otherwise entitled. 
I,      have read and understand the above information sheet, 
I have had all my questioned answered. I understand what is required of me and have willingly 
chosen to participate in the study. I know that my usual care continues as normal and I am not 
forced into taking part and that I can withdraw at any time and that I do not have to answer all of 
the questions if I do not want to. I know that there will be no consequences to my usual care if I wish 
to withdraw from the study at any time. I give permission for the researchers to contact me to 
interview me. I agree to attend the course for six (6) weeks if I am placed in the course group, and I 
agree to visit the hospital and take part in the study for a period of six (6) months. 
           
Participant      Date    
    
           
Witness       Date 
           
Researcher      Date   
Department of Health and 
Rehabilitation Sciences. Faculty of 
Health Sciences 
Divisions of Communications Sciences 
and Disorders, Nursing and Midwifery, 
Occupational Therapy, Physiotherapy  
 
F45 Old Main Building, Groote Schuur 
Hospital,  
Observatory 7925 







Appendix D: Telephonic questions and 
the ACSM screening for exercise 
guidelines 
In order for us to use the information we get from you we need to have a group of people who 
are similar to each other in age, language and health. So I need to ask you a few questions first to 
make sure you fit in this group that we want to look at in order to be a part of this study. 
1. How old are you? 
2. Can you understand, read and write either English or Afrikaans or isiXhosa? 
3. Do you have osteoarthritis in your legs? Which joint/s is affected?  
4. Have you had any accidents/previous surgery for problems in your legs before? 
5. Do you have any other joint problems in your legs? 
6. Do you have any condition which affects your ability to understand concepts? 
7.  Have you participated in any self-management programme for arthritis before? 
As a part of this study you will be asked to do exercises. I need to ask you some questions now to 
make sure that it will be safe for you to do these exercises.  
a. Do you have or have you had any of the following? (Category 1 – immediate 
exclusion. Yes to any of these, stop the interview and thank them for their time. 
They are not eligible for the study) 
___ A heart attack  
___ Heart surgery   
___ Cardiac catheterization   
___ Coronary angioplasty (PTCA)   
___ Pacemaker/implantable cardiac defibrillator/rhythm disturbance   
___ Heart valve disease          
___ Heart failure            
___ Heart transplantation    
___ Congenital heart disease 
220 
 
b. Screening question (see specific responses) 
 Do you have diabetes? 
 IF YES, Is it controlled by medication? Yes – OK; No – end interview, thank 
you but not eligible 
 Do you have asthma other lung disease? 
 IF YES, Is it controlled by medication? Yes – OK; No – end interview, thank 
you but not eligible 
YES to 2 or more of these 4 following questions not eligible, end interview, 
thank you for your time 
1. ___ Do you have burning or cramping in your lower legs when walking 
short distances.  
2. ___ Do you experience chest discomfort with exertion.    
3. ___ Do you experience unreasonable breathlessness. 
4. ___ Do you experience dizziness, fainting, blackouts.   









Appendix E: Data collection 
documents and outcome measure 
instruments 











Height: (m)  
 
Calculated BMI (kg/m2) 
 
Underweight = <18.5  
Normal weight = 18.5–24.9  
Overweight = 25–29.9  




































Date put on list:  
dd-mm-yyyy 
____-____-_________ 
Do you use an assistive device? 
Yes 
No 









Do you have any other illnesses? 
                                              Yes      No 
Hypertension/ 



















Do you use any medication for your 
pain/swelling from your arthritis?  









Please note any other medications you may be 













If employed please mark which one: 
Self-employed  
Formal employment 






Level of education: 






















Brief Pain Inventory 
1. Throughout our lives, most of us have had pain from time to time (such as minor headaches, sprains, 







2. On the diagram, shade in the areas where you feel pain. Put an X on the area that hurts the most. 
3. Please rate your pain by circling the one number that best describes your pain at its worst in the last 
week. 
0    1    2    3    4      5    6    7    8    9    10   
No            Pain as bad as 
Pain            you can imagine 
 
4. Please rate your pain by circling the one number that best describes your pain at its least in the last 
week. 
0    1    2    3    4      5    6    7    8    9    10   
No           Pain as bad as 
Pain            you can imagine 
 
5. Please rate your pain by circling the one number that best describes your pain on the average. 
0    1    2    3    4      5    6    7    8    9    10   
No           Pain as bad as 
Pain            you can imagine 
 
6. Please rate your pain by circling the one number that tells how much pain you have right now. 
0    1    2    3    4      5    6    7    8    9    10   
No           Pain as bad as 
Pain            you can imagine 
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7. What treatments or medications are you receiving for your pain? 
________________________________________________________________________________________
________________________________________________________________________________________ 
8. In the last week, how much relief have pain treatments or medications provided? Please circle the 
one percentage that most shows how much relief you have received. 
0%  10%  20%  30%  40%  50%  60%  70%  80%  90%  100% 
No Relief         Complete relief 
 
9. Circle the one number that describes how much, during the past week, pain has interfered with your: 
A. General Activity 
0  1  2  3  4  5  6  7  8  9  10 
Does not interfere       Completely interferes 
B. Mood 
0  1  2  3  4  5  6  7  8  9  10 
Does not interfere       Completely interferes 
C. Walking Ability 
0  1  2  3  4  5  6  7  8  9  10 
Does not interfere       Completely interferes 
D. Normal Work (includes both work outside the home and housework) 
0  1  2  3  4  5  6  7  8  9  10 
Does not interfere       Completely interferes 
E. Relations with other people 
0  1  2  3  4  5  6  7  8  9  10 
Does not interfere       Completely interferes 
F. Sleep 
0  1  2  3  4  5  6  7  8  9  10 
Does not interfere       Completely interferes 
G. Enjoyment of life 
0  1  2  3  4  5  6  7  8  9  10 









In this section we are interested in learning how your illness affects your ability to function in 
daily life. Please feel free to add any comments on the back of this page. 
 






    
 
 
DRESSING & GROOMING 

















- Dress yourself, including tying shoelaces 
and doing buttons? 
_____ _____ _____ _____  
- Wash your hair? _____ _____ _____ _____ DRESSNEW_______ 
      
GETTING UP 
Were you able to: 
     
- Stand up from a chair without armrests? _____ _____ _____ _____  
- Get in and out of bed? _____ _____ _____ _____ RISENEW_________ 
      
EATING 
Were you able to: 
     
- Cut up your meat? _____ _____ _____ _____  
- Lift a full cup or glass to your mouth? _____ _____ _____ _____  
- Open a new milk carton? _____ _____ _____ _____ EATNEW_________ 
      
WALKING 
Were you able to: 
     
- Walk outdoors on flat ground? _____ _____ _____ _____  
- Climb up five steps? _____ _____ _____ _____ WALKNEW________ 
      
Please tick () any of the following AIDS OR EQUIPMENT that you usually use for any 
of the activities mentioned above: 





 _____ Walking frame _____ Specially adapted 
utensils (such as for 
eating and cooking) 
 _____ Crutches _____ Specially adapted 
chair 














Please tick () any of the following categories for which you usually need HELP FROM 
ANOTHER PERSON: 
 _____ Dressing and Grooming _____ Eating 







Sample copy – Do not use without permission 
Sample copy – Do not use without permission 
 
Please tick () the response which best describes your usual abilities 
DURING THE PAST WEEK: 

















- Wash and dry your body? _____ _____ _____ _____  
- Have a bath? _____ _____ _____ _____  
- Get on and off the toilet? 
 
_____ _____ _____ _____ HYGNNEW________ 
REACHING 
Were you able to: 
     
- Reach up for and take down a 
2,5 kg object 
(e.g. a bag of sugar) from just 
above your head? 
_____ _____ _____ _____  
- Bend down to pick up clothing 
from the floor? 
_____ _____ _____ _____ REACHNEW_______ 
      
GRIPPING 
Were you able to: 
     
 
- Open car doors? _____ _____ _____ _____  
- Open jars that have been 
previously opened? 
_____ _____ _____ _____  
- Turn taps on and off? 
 
_____ _____ _____ _____ GRIPNEW_________ 
ACTIVITIES 
Were you able to: 
     
- Go shopping (supermarket, 
post office, bank, etc.)? 
_____ _____ _____ _____  
- Get in and out of a car? _____ _____ _____ _____  
- Do domestic tasks such as 
vacuuming or gardening? 
_____ _____ _____ _____ ACTIVNEW________ 
 
 
Please tick ( ) any of the following AIDS OR EQUIPMENT that you usually 
use for any of the activities mentioned above: 
 _____ Raised toilet seat _____ Bath rail 
 _____ Bath seat _____ Long-handled aids 
for reaching 
things 
 _____ Jar opener (for jars _____ Long-handled aids 
not previously opened)                             bathroom                 













Please tick () any of the following categories for which you usually need 
HELP FROM ANOTHER PERSON: 
 _____ Hygiene  _____ Gripping and 
opening things 
 _____ Reaching _____ Shopping and 
domestic tasks 
We are also interested in learning whether or not you are affected by pain because 
of your illness. 
 
 How much pain have you had because of your illness DURING THE PAST 
WEEK: 
 PLACE A VERTICAL (I) MARK ON THE LINE TO INDICATE THE SEVERITY OF THE PAIN. 
NO         SEVERE                                                                                             
 
















Physical Performance Task Battery 
The original performance battery consisted of a series of nine tasks. Tasks were aimed at testing 
arm and total body movements in seated and standing positions. Since this study’s focus was on 
lower limb OA, tasks testing fine motor skills of the upper limbs were intentionally omitted. 
Distances were converted to metres instead of feet for the use in an SA context. The majority of 
the tasks were timed as usually a decline in performance of a task is seen by decreased reaction 
time or speed of the movement.(361) 
 The tasks are described as follows:  
 
1. 15 metre (m) walk at preferred speed. For this test, participants were timed (sec) as they 
walk 7.5 m turn around, and walk back to the starting position at their preferred walking 
speed. 
2. 15 m walk at fastest speed. Participants were again timed (sec) as they walk 7.5m, turn 
around, and walk back to the start at their fastest walking speed. 
3. Forward reach. For this test, participants stood adjacent to a wall on which a tape 
measure was positioned horizontally at shoulder height. Participants reached forward as 
far as they could and the distance reached was measured in centimetre (cm). 
4. Timed, repeated reach-up. Participants stood facing a wall and reached up as high as they 
could with both hands. A mark was placed on the wall at the reached distance. 
Participants were then times (sec) as they reached up to the mark and returned their 
hands to their sides three times. 
5. Timed, repeated sit-to-stand. Participants sat in a standard chair with arm rests and were 
timed as they stood up and sat back down, twice. The test was repeated after a brief rest 
and the average time (sec) of the two trials was used.  
6. Distance walked in six minutes. Participants walked as far and as fast as they could for six 
minutes. The distance walked is measured in metres at six minutes (Participants were 
allowed to rest if and as necessary during the six minute period). 
7. Sock test. Participants sat in a standard chair. They were timed (sec) as they put on one 
loose-fitting sock on each foot separately.  
 
Participants were instructed to complete each task above and if any worsening of symptoms 
occurred during the tests the participants were allowed to slow down or stop the task and this 
was noted.  If the participant could not complete a task this was documented. 
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Result sheet for Physical Performance Task Battery test and BMI 
measures 
Patient code:  
 
Test: Result week 0: 
 
Week 6: Week 12 Month 6 
 




                               
Sec 
   
 
15 m walk at fastest speed 
 
 
                               
Sec 





                               
cm 








Average:               
Sec 
 





                               
Sec 
   
 
Timed, repeated reach-up 
 
 
                               
Sec 
   
 




                               
m  
   
Assistive device used 
 
 























Self-Efficacy for Managing Chronic Disease 6-Item Scale 
We would like to know how confident you are in doing certain activities. For each of the following 
questions, please choose the number that corresponds to your confidence that you can do the 
tasks regularly at the present time. 
1. How confident are you that you can keep 
the fatigue caused by your disease from 
interfering with the things you want to 
do? 
_____________________________________________ 
Not at all     |     |     |     |     |     |     |     |     |     |   totally 
confident    1     2     3    4    5     6      7     8    9   10  confident 
2. How confident are you that you can keep 
the physical discomfort or pain of your 
disease from interfering with the things 
you want to do? 
_____________________________________________ 
Not at all     |     |     |     |     |     |     |     |     |     |   totally 
confident    1     2    3     4      5    6     7    8      9   10  
confident 
3. How confident are you that you can keep 
the emotional distress caused by your 
disease from interfering with the things 
you want to do? 
_____________________________________________ 
Not at all     |     |     |     |     |     |     |     |     |     |   totally 
confident    1     2    3     4     5    6      7    8      9   10  
confident 
4. How confident are you that you can keep 
any other symptoms or health problems 
you have from interfering with the things 
you want to do? 
_____________________________________________ 
Not at all     |     |     |     |     |     |     |     |     |     |   totally 
confident    1     2     3    4     5     6     7    8      9   10  
confident 
5. How confident are you that you can do 
the different tasks and activities needed 
to manage your health condition so as to 
reduce your need to see a doctor? 
_____________________________________________ 
Not at all     |     |     |     |     |     |     |     |     |     |   totally 
confident    1     2    3     4     5    6      7    8      9   10 
confident 
6. How confident are you that you can do 
things other than just taking medication 
to reduce how much your illness affects 
your everyday life? 
_____________________________________________ 
Not at all     |     |     |     |     |     |     |     |     |     |   totally 






EQ5D Health Questionnaire - South African English version 
By placing a tick in one box in each group below, please indicate which statements best 
describe your own state of health TODAY. 
 
Mobility 
I have no problems in walking about  
I have some problems in walking about  
I am confined to bed  
 
Self-Care 
I have no problems with self-care  
I have some problems washing or dressing myself  
I am unable to wash or dress myself  
 
Usual Activities (e.g. work, study, housework, family or 
leisure activities) 
I have no problems with performing my usual activities  
I have some problems with performing my usual activities  
I am unable to perform my usual activities  
 
Pain/Discomfort 
I have no pain or discomfort  
I have moderate pain or discomfort  
I have extreme pain or discomfort  
 
Anxiety/Depression 
I am not anxious or depressed  
I am moderately anxious or depressed  
I am extremely anxious or depressed  
 
Compared with my general level of health over the past 12 months, my state of health 
today is: 
 
Better  PLEASE TICK 
Much the same  ONE 




To help people say how good or bad their state of 
health is, we have drawn a scale on which the best 
state you can imagine is marked 100 and the worst 
state you can imagine is marked 0. 
 
We would like you to indicate on this scale, in your 
opinion, how good or bad your own health is today. 
Please do this by drawing a line from the box below to 
whichever point on the scale indicates how good or 

































© 1990 EuroQol Group. EQ-5D™ is a trade mark of the EuroQol Group.  
Your own 


















state of health 
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Participant open ended questionnaire 




































Appendix F: “Living with 


















Welcome to the “Living with 
Osteoarthritis” patient workbook. 
 
This is a workbook designed to be used over 6 weeks. We hope that by using the 
workbook people will learn more about osteoarthritis and develop self-management 
skills for living with the condition. Using this workbook is not about sitting and reading or 
listening. In order to get the most out of this course you will be asked to share your 
experiences, you will need to set goals and share those goals with others and you will 
need to take part in activities. This workbook is NOT a substitute for any other medical 
care that has been recommended for the treatment of your condition but an addition to 
see if it helps you in any way. 
 
You will benefit most from this workbook if you commit yourself to completing all the 
sessions within a 6 week period of time. Scientific research tells us that these courses are 
of great benefit to people living with chronic diseases such as diabetes, arthritis and 
HIV/AIDS.  But to benefit from the course, using the workbook regularly over 6 weeks and 
participating in activities is essential. The workbook is divided into six sections: 
 
 Week 1: Osteoarthritis, Self-management and Exercise 
 Week 2: Managing common symptoms 
 Week 3: Stress Management 
 Week 4: Eating Well 
 Week 5: Medication and disease-related problem solving 




Your course leader is . She is a qualified physiotherapist and has been trained in all the 
information you will be going through in the discussions. She is also an expert in safe 




Week 1: Osteoarthritis, Self-
management and Exercise 
What is Osteoarthritis? 
What is osteoarthritis? It is a degenerative joint disease which we often call OA. In simple 
terms, it is the breakdown of previously healthy joint surfaces, causing the two bones 
that make up the joint to rub against each other. This wears away the bone’s surface (the 







OA is different in every person and the way it progresses differs for each person too.  
Usually, as a person ages the condition progresses until in some people there is a lot of 
joint damage with deformities. OA is most common in the hips, knees and hand joints. 
The cause of OA is very seldom due to one factor alone, but rather a combination of 
things acting together usually brings about this condition. Known causes/risk factors for 
OA include but are not limited to:  
- age 
- inherited or genetic predisposition to developing OA, especially in the hands  
- gender – females are seen to have OA more commonly than males  
- obesity and being overweight 
- faulty alignments or having poor posture 
- certain occupations/sports/repeated stresses on the joints  









It is fairly simple for a doctor to make a diagnosis of OA. The doctor makes the diagnosis 
by examining you and by taking a history of the main symptoms. X-rays can help in 
correctly diagnosing OA, but these are not always necessary. Changes which we look for 
on the X-rays include narrowing of the space between the two bones, evidence of wear 
and tear of joint surfaces and extra bone forming at some areas.  
People who have OA mainly complain of:  
- pain in the affected joint or limb 
- stiffness, particularly in the morning for less than two hours 
- muscle weakness 
- difficulties in performing daily tasks like walking or climbing the stairs 
 
Management options: 
Scientific research shows that educating people about their condition in order that they 
may understand it better and manage it better, is the best way to treat it and that this 
works well. People are advised to become more active by exercising and balancing this 
with rest.  
Physiotherapy, which focusses on education and exercise, can also help. 
There are medicines that your doctor will can prescribe for you to treat your 
pain or inflammation. Different surgical methods can also be used to treat this 
condition, the most effective being a joint replacement. Joint replacements 
are big operations though, so they are only done when the OA is very bad. 
Now that you know a bit more about what the condition is, we will go through what we 





What is meant by “self-management”? 
Self-management does not mean that you are expected to look after your health on your 
own with no help. No, someone who is a successful self-manager takes responsibility for 
their health. This means that they choose to work with the health team, with their 
medication and with themselves to live a healthy life (just like a manager in a business – 
they don’t do everything themselves, they work with a team).  
 
There are lots of things you can learn to do which will help you to be a successful self-
manager. First of all it is important to understand osteoarthritis. This is what we have just 
covered. You need to understand what the condition is, why it happens, how it changes 
and how it impacts on your life. You also need to know about the ways to treat it and 
medications which may be used.  
 
The next step in being a self-manager is being able to think about this information in 
terms of how it affects you. The final step in being a self-manager is to think 
about what it is that you want to be able to do, decide how you are going to 
do it and then to learn and practice the skills you need to be able to do it. 
Some of the things you will learn about and practice every day when you do 
this course include exercising, relaxation techniques and healthy eating. 
 
By using this workbook you will learn about exercise and its benefits, in the second 
section you will learn a bit about the common symptoms of osteoarthritis and how to 
manage these. The third section will focus on stress management, the final sections focus 
on eating well and medications. Some people using this workbook may already know a lot 
about these topics, others may not know very much. It is important to share information 
and make sure that everyone has the knowledge they need to become a self-manager, 
even if you think you know a lot about these topics it is still worth your going through the 
workbook to make sure you have not missed out on any information. Scientific research 
tells us that people who are well informed about their health manage better and have a 
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better quality of life. Using this workbook, you will also learn about and discuss the steps 
that are needed to become a good self-manager. Let’s look at these steps here.  
Self-management steps 
Step 1: 
To be good at self-management you need to learn and practice several skills which you 
will practice through using this workbook. The first step is to decide what it is you want 
to be able to do. This can be the hardest step to think about. For example you might be 
feeling very sad and depressed. First you need to think about why you are feeling that 
way. Perhaps one of the reasons you are feeling that way is that you have lost touch with 
your friends. Your first step might be to decide that you need to reconnect with your 
friends or to meet people and make friends. This will help you to feel less sad and 
depressed.  






__            
Step 2: 
But deciding that you are going to meet people and make friends doesn’t mean it will 
happen. You have to make it happen. The second step in being a self-manager is to 
decide how you are going to do it. Sometimes the thought of doing something new can 
seem too much and we don’t even try. If you want to meet people to make friends you 
need to think about all the different options you have to do this. For example you could 
invite your neighbours for tea, or you could decide you would meet people by going to 
church, by joining a support group or an exercise group. Never assume that what you 
want to be able to do is impossible. Always look for every option and look at it from 









Now that you have decided on how you can try to achieve what you want, you need to 
make an action plan. It is important that this plan is realistic otherwise it is likely you will 
not succeed. How do you do this? 
First decide what you are going to do this week 
Now make a specific plan 
 
 Action plans, goal setting 
Saying that this week I’m going to try to meet some people is NOT a specific plan. To be 
specific, the plan must have different parts. It is useful to ask yourself some questions to 
help develop a specific plan. Questions like: 
 What? 
Exactly what are you going to do? For example you could decide that to meet people 
you are going to invite your neighbour for tea. 
 How much?  
Then you must decide how much you are going to do. For example are you going to 
invite one neighbour for tea or are you going to invite lots of neighbours over. Lots of 
people are much more tiring than one person. Or do you want to invite your 
neighbour for lunch? But lunch means a lot more preparation and time and will make 
you more tired. So you have to decide how much you can do. 
 When will you do it? 
Then you must decide on exactly which day you are going to do the activity and at 
what time of the day. Maybe it is better to invite your neighbour for tea in the 
morning because you get tired in the afternoon. Or if you feel sick in the morning 
from your medicines maybe it is better to invite your neighbour for afternoon tea. Or 




 How often? 
This is always the hardest part. We all would like to be able to do more things every 
day. But we are human and this is not always possible. When people want to start 
exercising, we often say we are going to do it every day. But this is often just not 
possible and if we then miss a day we feel that we have failed and we give up. How 
often will you invite your neighbour for tea? Not every day but maybe once a week. 
You know that you won’t become friends immediately and that it will take time.  
 Is it a good plan? 
To test whether you have come up with a good plan you need to ask yourself this 
question: 
“If I give myself a score from 0 -10 for how confident I am that I will achieve my plan 
this week, where 0 is not at all confident, and 10 is totally confident. What score will I 
give to show how confident I am that I can complete this plan?” 
If your answer is 7 or more out of 10 then this is probably a very good plan. If your 
score is less than 7 you need to think about why you are not confident. What are the 
problems or barriers? Can you change the plan or solve the problems to make 
yourself feel more confident? 
 
Step 3: 
Now, you need to write your plan down and put it somewhere you will see it every day. 
There is an action plan form at the end of this section and more in this book. Use them 
every week while you are using this workbook. You can always draw more of them to 







A good action plan is: 
 Something I want to do 
 Something I can expect to do this week 
 Is specific 
 Answers the questions: What? How much? When? How often? 
 I am confident that I can achieve with a score of at least 7 out of 10. 
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Now you need to carry out your action plan. If it is a good plan then doing it is usually 
fairly easy. It helps to tell family or friends what your plan is and to report back to them 
on how you are doing. On this course you are going to make a plan every week and 
record how you get on. It helps to report back on things because you can then have an 
idea on how well you are doing. If you haven’t been able to keep to the plan you can 
discuss the problems you might have had and make plans to cope with them.  
 
Step 4: 
Always check your results and give yourself a reward for having achieved your 
plan. Also think about how achieving your plan is making you feel. In the 
example we talked about, you could congratulate yourself for having invited 
your neighbour for tea, you would also think about how you now feel. Is the 
plan helping you to achieve what you want?  
 
What happens if something doesn’t go according to plan? 
What if your plan doesn’t work? Are you going to give up and decide you had a bad plan? 
There are seven steps to solving problems. These are: 
Deciding what the problem is (you might need friends and family to help here) 
List ideas to solve the problem 
Select one idea to try 
How did it go? 
If it didn’t work, try another idea 
If your ideas don’t work, ask friends, family, counsellors, professionals for ideas 
Finally you might have to accept that you can’t solve the problem now. 
 
At the end of each section and at the back of the workbook there are “Action Plan 
Forms”. Use these forms to plan what you want to do and how you are going to do it. We 
are now going to discuss exercise and we are going to use the “Action Plan Form” at the 





A successful self-manager is someone who: 
 Sets goals 
 Makes a list of ways to achieve those goals 
 Makes action plans to achieve the goals 
 Carries out the action plans 
 Checks on their progress every week 
 Can change the action plan if there are problems  
 Gives themselves a reward for achieving their goals 
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Exercise dos and don’ts 
Exercise is a very important way to keep healthy. Scientific research tells us that exercise 
has a lot of good effects on our bodies like helping our digestive system absorb and 
process food; it trains our hearts so that they are strong and healthy and keeps our lungs 
working well. Exercise makes our muscles and bones strong and our joints 
flexible so that we can keep moving. Exercise also helps to make us feel happy, 
improves concentration and memory, improves sleep and exercise helps to 
decrease the chances of developing chronic illnesses like high blood pressure 
and cancers.  
 
In the past, when people became ill with a chronic illness like high blood pressure or 
diabetes or arthritis, medical care focused on helping them when their symptoms became 
worse. Treatment focused on using medicine and people were often advised to rest or 
decrease their activity. Today we know that if we teach people who develop chronic 
illnesses about their disease and encourage them to do the right exercise we can prevent 
a lot of the problems which used to be treated with medicines. We also know that 
exercise can help to treat a lot of the symptoms which people 
with chronic diseases develop. Symptoms which may be 






Exercise is good for: 
 Improving mood 
 Strength 
 Improving sleep 
 Concentration and memory 
 Heart and lung health 
 Decreasing body fat 
 Digestion 
 Increasing confidence to self-manage chronic illness. 
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You may be wondering if it is safe for you to exercise when you have osteoarthritis. 
Research tells us that exercise has been shown to be beneficial in people with 
osteoarthritis, as well as in those who need a joint replacement. Exercise can help slow 
down the degenerative processes that happen with arthritis when you aren’t exercising. 
Exercise can also help you to lose weight which helps with osteoarthritis of the 
legs as there are less forces through the knee joint. We know that people 
who are physically fit get fewer colds and take fewer days off work because 
of illness. One of the biggest benefits of exercise is that exercising regularly 
makes you feel more in control of your life.  
 
Although exercise is good for you and safe for you to do, sometimes your body will 
give you clues that you need to cancel your exercise for the day. If you have a fever, 
feel dizzy, have vomiting or diarrhoea, if your joints have suddenly become swollen, or if 
you have a pain which is new and you are not sure what is causing it, it is better to miss 
an exercise session until you can speak to a doctor or physiotherapist.  
  
Do not exercise if: 
 You have a fever 
 You are dizzy 
 You have been vomiting 
 You have diarrhoea 
 Your joints have suddenly become swollen 
 You have a new pain which you don’t know the cause of 
Miss one exercise session if you have one of these problems until you can speak to a 
nurse or doctor. This does not mean you should never exercise but you need to make 
sure you are not becoming ill. 
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Types of exercise 
You do not have to join a gym or a club to get exercise. There are lots of ways of 
exercising from formal sports like running, playing football or netball, swimming or 
playing tennis. But, walking is also a very good way to exercise. Any activity which makes 
your heart beat faster and makes you breathe a little harder is exercise. Dancing is 
exercise, walking up the stairs is exercise, gardening is exercise. There are lots of ways 
that we can exercise every day without having to go to a class or join a club. You could 
walk a little further before catching the bus or the taxi or you could play with your 
children or grandchildren!  
 
There are three general kinds of exercise you can do.  
Endurance exercise: like walking, running, dancing or swimming. Endurance 
exercise is sometimes called aerobic exercise which means that you will be 
breathing faster and your heart will be beating faster too. We know that this 
kind of exercise is very important to keep healthy and we need to do 30 minutes 
of this kind of exercise three times a week to keep healthy.  
 
Strengthening exercise: this kind of exercise focuses on making us stronger. 
To make muscles stronger we have to do exercises which make the muscles 
work hard against a resistance, like weight training but you can also do 
strength training by working with heavy bags of shopping!  
 









Types of exercise: 
 Endurance exercise which makes you breathe harder (sometimes called aerobic) 
 Strengthening exercise which makes you stronger 




We know one of the hardest things about exercise is not doing it once, but doing it again 
and again. There are several steps we can follow to make sure that when we start to 
exercise we stick to it. We all make lots of excuses why we can’t exercise. Let’s look at the 
most common excuses. 
 
“I don’t have time” 
It doesn’t take a lot of time to start exercising. Five minutes a day is a good 
start. We make time to take medicine because we know without it we 
would become ill. Exercise is as important as medicine to help us remain 
healthy (remember it can never replace your drugs). If we know that it is 
that important we can make time for it. 
 
“I’m too tired” 
When people become ill they often become less active. As you become less 
active, your body loses fitness and you become weaker, you may feel stiffer 
and you tire more easily. This means that exercising might feel harder and so you exercise 
less. This often results in a downward spiral of activity and people often get to the point 
where even walking down the street to visit the neighbour can feel like too much. Being 
active or doing exercise when you are feeling tired will give you more energy and make 
you feel less tired. 
 
“I’m too sick” 
You may be too sick to undertake very vigorous exercise but you can still aim to 
be more active. You can even break your exercise into one minute sessions 
which you repeat several times through your day. The fitter you get, the better 
you will be able to cope with your illness 
 
“I get enough exercise already” 
You may be getting a lot of exercise already in your job or simply walking around doing 
your daily chores. But for most people if we add this time up, it still isn’t enough exercise 
to keep them fully fit. This kind of exercise also doesn’t include one of the most important 




“Exercise is boring” 
You don’t have to do the exercises that everyone else does if they are boring. Choose 
something that is fun, exercise with a friend or with your favourite music or listen to the 
radio. You can also keep your exercises fun by changing them regularly. 
 
“Exercise is painful” 
Exercise may be uncomfortable but it shouldn’t be painful. If you have pain before you 
start to exercise, it should not get worse while you are exercising. If you do not have pain 
before you start to exercise and you start to feel pain while you exercise you need to stop 
exercising and evaluate your pain using the guidelines in Week 2. If you have muscle or 
joint pain for more than two hours after you exercise then you have probably done too 
much. Next time do a little less, either exercise for less time or less vigorously. 
 
“It’s too dangerous, it’s too hot, it’s too cold” 
There are always reasons like this not to exercise. Remember that exercise can 
be done anywhere and anytime. You can put on music in your home and 
dance, if it’s too hot you could walk around shops which have air-
conditioning. Finding a group of people to exercise with will not only make 
it safer but also more fun! 
 
“I know I won’t stick to it so there is no point in starting” 
First review the steps we discussed on how to be a successful self-manager. If you set 
your exercise goals using these steps you have more chance of sticking to your exercises. 
Remember too, the important step of rewarding yourself for achieving your goals; this 
makes it easier to move on to your next goal. We are now going to have a look at the 























Steps to success with exercise: 
 Set a clear goal using the steps outlined in “How to be a successful self-manager” 
 Choose exercise or activity that you want to do and that is fun 
 Set a specific time and place to do your exercise 
 Decide how long you are going to stick to the plan before you think about changing 
it (6 to 8 weeks is a good time to work on things) 
 Keep an exercise diary to keep track of how you are doing (there is one at the back 
of this booklet for you to use) 
 Keep track of your progress using the exercise diaries in this workbook. 
 Start – don’t wait, start now. Begin gradually and proceed slowly 
 Revise your programme. At the end of the 6 – 8 weeks make a new plan for the next 
6 weeks 
 Reward yourself. It is a reward to feel better and healthier but also give yourself a 
reward for achieving your goal, like eating a favourite meal, or visiting a friend or 




Your exercise programme: 
An exercise programme should include the three different types of 
exercise; remember they were endurance, flexibility and strength 
exercise. Following the steps in the box “Steps to success with exercise”, 
you need to decide on what you want to be able to do and what exercise 
you would like to do. Now that you know what exercise you are going to do, 
you need to decide how much to do. The amount of exercise you are going to 
begin with will depend on a lot of different things. If you have not done any 
exercise for a long time or have been feeling unwell, have had difficulty 
breathing or been short of breath, if you have had stiffness or pain or 
weakness that interferes with your daily activities then you need to start your exercise 
slowly. You can begin slowly by starting with some flexibility and strengthening exercises. 
Do these exercises every other day for 5 minutes. Once you can do that comfortably and 
without feeling stiff or sore the next day, increase it to 10 minutes.  
 
Once you can do 10 minutes comfortably, you can start doing the exercises every day 
(when we say exercise every day, we usually mean exercise for 5 days of the week; it can 
be very hard to keep a routine to exercise on weekends when activities are different). 
Once you can do at least 10 minutes every day then you are ready to begin endurance 
exercises. Choose your exercises from the ones set out in the sections below. Follow the 





















Remember, these exercises are aimed at improving your 
ability to move. There is a long list of exercises that could be 
included here and you might not be able to do them all every 
time you exercise. Try to ensure that you do flexibility 
exercises at least once a week.  
 
Strengthening Exercises: 
You do not need to go to a gym to do strength exercises, the 
exercises described here can be done at home. To make muscles 
stronger you must make the muscles work against a resistance or a 
force – they have to push or pull. You should not do strength 
exercises every day, rather they should be done every second day. 
Your muscles need a day of rest to adapt and get stronger. To make a 
muscle stronger you need to repeat each exercise 5 times to start with. Once you can do 
an exercise 10 times you will not get stronger by doing more exercises. Now you will need 
to add more resistance to the exercise to get stronger.  
Getting the most out of your flexibility and strength exercises: 
 Move slowly and gently. Do not use jerking or bouncing movements as these 
will make your muscles shorter and tighter.  
 Stretch to the point of tension in a muscle and hold for 20 seconds before you 
relax 
 Don’t push until it hurts, stretch to tension not pain 
 Start off with 5 repetitions of each exercise. After one week increase it to 7, 
after another week increase to 10.  
 Always do the same number of exercises on the left side and the right side of 
your body 
 Keep breathing; do not hold your breath when you exercise. Think about 
breathing out as you move to make sure you do not hold your breath. 
 Use the two hour rule. If you have increased symptoms (like pain) for more than 
two hours after you exercise you have probably done too much. Don’t stop 
doing the exercises but decrease how much you do next time. 
 If you find an exercise difficult this does not mean you should not do it at all. 




The most difficult thing for most people is deciding how much exercise 
to start with. The easiest starting point is to ask yourself the question: 
“how much do I think I can do without suffering for it tomorrow?” If 
you feel you can do 5 minutes, then do 5 minutes. Remember that any 
exercise is better than none. You don’t have to do 30 minutes from the 
first day. It is important to start slowly and increase very gradually. It is 
better to start off by doing less than you think you can and increase it 
from there.  
 
There are three things you need to think about when you do endurance exercise. These 
three things are frequency (how often am I going to do this exercise); duration (how long 
am I going to exercise for when I do exercise) and intensity (how hard am I going to work 
when I exercise).  
 
Frequency: 
Try to do endurance exercise 3 or 4 times a week. By doing this you can rest every second 
day and allow your body to recover. All athletes have at least one day a week when they 




How much can I do without suffering for it tomorrow? That is your starting 
point. If you are starting with just a few minutes you can gradually increase it over time 
until you can do 30 minutes at a time. The easiest way to increase the time is to use 
intervals of exercise. For example to walk hard for 3 minutes, then walk slowly for 2 
minutes, then walk hard again for another 3 minutes. Slowly over time cut down the slow 
walking and increase the hard walking. You could also break your exercise into separate 
sessions. You could walk for 10 or 15 minutes in the morning and do it again in the 
evening. This would still count as 30 minutes of exercise.  
 
Intensity: 
How will you know that you are exercising hard enough to be doing some good? How will 
you know if you are exercising too hard? When doing endurance exercise the easiest way 
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to check the intensity is to use the “Talk Test”. When you are doing moderate intensity 
exercise you should be able to talk comfortably, but if you tried to sing it would be a little 
difficult and you would have to stop singing to take bigger breaths. Moderate intensity 
means you should feel that you are breathing a little faster and a little harder but you can 
still talk. It may take you a while to find the right intensity for you for the whole of your 
exercise session. This is normal; take your time to get to know how your body will 
respond.  
 
How will you know you are improving in your exercises? For the flexibility and strength 
exercises it is easy to feel the improvements as you will feel that moving is easier and you 
are stronger and can lift heavier items. For some people it is harder to know if you are 
improving with the endurance exercises. One way to see if you are improving is to do a 
test. One of the easiest tests to do is a timed test. Decide on a route that you can walk 
near your home. Walk this route at a moderate intensity and time how long it takes. After 
several weeks of exercise walk the route again and time it again. You may see that you 
can walk the same route faster within 4 weeks, but it may take 8 to 12 weeks before you 
see that you can do the route in a faster time. The goal is to complete the same route 
faster or in the same time but at a lower intensity (breathing much easier).  
 
Use the exercise diary at the end of each section to record your goals and your progress 









An exercise routine 
This is a 20 – 30 minute exercise routine which is safe for people living with osteoarthritis. 
This routine includes exercises which make you stronger (strength exercises), more 
flexible (stretching exercises) and fitter (endurance exercises). 
 
Start by standing up straight and tall, feel your weight across your feet, 
relax your shoulders and open your chest, hold your head straight. Take 
a deep breath in and breathe out.  
 
March on the spot for 2 minutes. March at a steady pace – that is a pace which you 
can maintain for 2 minutes. Do not start fast and get slower or start slowly and 
get faster. Pace yourself, start and finish at the same speed. You should be 
marching so that you can feel you are breathing a little bit harder than 
normal, you should be able to talk but not be able to sing. 
 
Now stretch your neck – keep your shoulders relaxed and turn to look 
over your right shoulder – hold it for 20 seconds. Bring your head back 
to the middle, then turn to look over your left shoulder – hold it for 20 
seconds and then bring your head back to the middle. Now put your 
left ear on your left shoulder - hold it for 20 seconds and then bring 
your head back to the middle. Repeat to the right. Now put your chin 
on your chest - hold it for 20 seconds and then bring your head back to 
the middle.  
 
Roll shoulders forwards 5 times, then roll your shoulders backwards 5 times. Then stretch 
your arms by stretching your right arm across your body to the left and holding for 20 
seconds and then repeat with the other arm. 
 
March on the spot for another 2 minutes – 30 steps normal, 30 steps lift 
your knees up as high as you can. Keep changing every 30 steps. 
Stretch your quadriceps muscles by bending your right leg backwards and 
holding your foot if possible below your buttock. You will feel the stretch down 
the front of your thigh. Hold it for 20 seconds and then do the same on the left.  
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Stretch your hamstring muscle by putting your right heel on the ground and pulling your 
toes upwards, put your hands above your knee and lean forward to feel the stretch 
behind your knee. Repeat on the left for 20 seconds too. 
 
Sit on a chair – make both your knees straight and then bend again. 
Do this 30 times. This works your front thigh muscles. 
 
Then with your arms folded on your chest, stand up from the chair and 
sit down again. Keep sitting down and standing up for 2 minutes. Do 
this at a steady pace – that is a pace which you can maintain for 2 
minutes.  
 
March on the spot for 2 minutes – 30 steps normal, 30 steps lift your 
feet up as high as you can (try to kick your buttocks). Keep changing every 30 
steps.  
 
Stand on one leg at a time for 30 seconds each: use support by putting your 
hand on a wall or chair if necessary but try balance without holding on. Do this 
twice on each leg 
 
 Step ups: Step onto and off of a low step for 2 minutes. Start with the right leg and then 
step up with the left leg and alternate. This works both your front and back legs muscles 
as well as your hip muscles. 
 
March on the spot for 2 minutes – 30 steps normal, 30 steps lift your knees 
up as high as you can. Keep changing every 30 steps. 
 
 End off the session by stretching your trunk: Slide your hands down the 
front of your thighs to see if you can touch your toes. Bend sideways by 
sliding your hand down the side of your leg. Hold this for 30 seconds and 




Finish by standing up straight and tall, feel your weight across your feet, relax 
your shoulders and open your chest, hold your head straight. Take a deep 
breath in and breathe out.  
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Action Plan Form - Exercise 
Use this form to develop an action plan on exercise. What exercise would you like to do? 
Be sure your action plan includes: 
What you want to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
For example: This week, I will walk (what) around the block (how much) before lunch 
(when) three times (how many). 
This week I will: 
          (what) 
          (how much) 
          (when) 
          (how many?) 
 





Keep a record of how you did: 
 I Plan to….. I did….. 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
 ____________________________ 
Not at all |    |     |     |     |     |     |     |     |     |       Totally 




Week 2: Managing common symptoms 
 
Osteoarthritis is known to greatly affect a person’s quality of life, with pain being the 
most common reason for seeing a doctor or physiotherapist. Other symptoms which are 
often present are: 
- joint stiffness (especially following a period of rest or early morning stiffness for 
less than two hours),  
- swelling and problems moving the joint through the whole range of motion  
- difficulty in performing daily tasks 
- Fatigue 
- Frustration, isolation, depression 
We will look at what each of these are and how you can manage them at home if you 
experience any of the above. 
What is pain? 
It is important for you to understand what pain is and what type of pain you 
may experience with OA in order to manage these symptoms. 
Acute pain is a normal sensation triggered in the nervous system when nerves in the body 
are stimulated and send messages up to the brain to say that there may be damage to 
your body. Acute pain comes on suddenly (e.g. after banging your finger in a door), and 
lasts for a few days or even weeks (usually less than six weeks) while the body heals itself. 
This pain is useful as it protects the part while the body heals. Once the body is healed, 
there is no more pain.  
OA initially presents as acute pain, which means that pain starts suddenly and lasts for a 
short time. This usually happens when the joint is moved or used and then the pain 
subsides. OA doesn’t always remain as acute pain but sometimes changes to what we call 
chronic pain. This can cause pain when you aren’t moving or even at night or during 
movements/activities that don’t usually cause pain. Chronic pain is described as pain that 
is experienced on most days for at least three months. The reason behind why the pain in 
OA starts out as acute and then becomes chronic is not yet known but research is being 






Here is the take-home message about pain: 
 Hurt does not always mean harm. There can be pain without injury or 
something being wrong due to the changes that take place in the nervous 
system.  
 There are physiological reasons why there is pain without injury.  
 Your pain is NOT imaginary or in your head or psychological.  
 Chronic pain is NOT the same as acute pain.  
 Chronic pain is NOT a sign of ongoing damage 
 Chronic pain cannot be “switched off.” 
 Non-pain messengers (e.g. stretching or pressure) may send pain signals rather 
than Stretching or pressure messages to the brain.  
 An increase in your pain (with or without exercise) does not mean a new injury.  
 
Chronic pain is not helpful as acute pain is. It occurs after the body has healed itself and 
this means that there shouldn’t be a reason why we need to protect that area anymore. 
But often we listen to the pain and don’t use that joint or do certain things in case we 
cause damage. In OA the “damage” in the joint is not something new that we can injure 
more by using it or moving it but it is caused by the wear and tear as talked about before. 
 
The reason why chronic pain is different from acute pain is because there are changes 
that take place in your nervous system when you have had chronic pain for some time. 
These changes can explain a lot of why you may experience pain more than someone 
else. When acute pain happens, the normal messages that are sent via your nerves to and 
from the brain are often changed in people who experience chronic pain. The pathways 
often make the messages bigger than they usually are and this can cause a person to be 
more sensitive to normal feelings and feel pain more easily than someone whose 
messages are not sensitive. There is also a “map” in the brain which locates each area of 
the body and in people with chronic pain, the areas which represent the painful area gets 
bigger and smudged so the brain focuses on this and can confuse some normal areas with 
the painful areas. This explains why the pain can feel like it is spreading from just one 





Flare ups of pain 
It is possible to have both pains (acute pain and chronic pain) at the same time; this can 
confuse the picture. Although a person with OA may have chronic pain, pain is not 
necessarily present at all times and you can experience periods of less or worse pain. 
When pain becomes worse this is called a flare up. This means you will have acute pain at 
this time and there are ways to deal with this. It is important to note what causes such a 
flare up so you know what and how those activities can be modified in an attempt to 
reduce the flare up of pain again.  
Common signs of a flare up are:  
- a sudden increase in pain  
- redness  
- a warm or hot joint  
- swelling 
 
What can I do about pain in a flare up? 
A flare up can be managed by taking a short time to 
rest from whatever has caused the flare up to allow it to settle. We don’t want to rest 
TOO much either as then your joints can get stiff.  It is helpful to take painkillers as 
prescribed by your doctor if your pain gets worse but we will talk about medication later 
on too.  Putting ice onto the joint can also help to settle the flare up. Use ice for no more 
than 10 - 20 minutes at a time on the painful area. You can use a small bag of ice 
wrapped in a towel, a gel-filled ice pack or wrap a towel around a bag of frozen 
vegetables. Don’t put ice directly onto bare skin. 
What is stiffness? 
Stiffness is when your joints feel like they aren’t able to move easily or they feel stuck. 
This is common in the morning just after waking up as your joints have not been moving 
much while you sleep. The joints get used to being in the one position and then when you 
try to get up and start moving it feels difficult to move (stiff).  
 
What can I do about stiffness? 
After such a period of rest/sleep or limited movement the joints need to slowly get 
moving in order to get used to moving again. So before getting out of bed in the morning 
move your ankles up and down 20 times. Then bend each knee up and down 20 times 
and open and close your legs 20 times to get the joints warmed up.  
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Warmth also helps the muscles around the joint to relax so a warm water bottle before 
rising or a warm shower in the morning will help get you moving. Make sure you can feel 
the warmth but it should not be directly on your skin or too hot that it will burn you. It’s 
like the parts in a machine that need oil to work well; we need to “oil” our joints first 
before they work without being so stiff. 
What is swelling? 
Swelling is a common symptom of a flare up or may be a regular symptom experienced 
during OA. Swelling is caused by a build-up of fluid in the tissues in and around the joint. 
This causes the area to feel bigger than usual, hard, painful and it’s difficult to move the 
swollen area.  
 









Movement is the best option to deal with swelling as it causes blood (rich in oxygen) to 
flow to the area and flush out the build-up of fluid and waste in the area of swelling. 
Staying in one position is probably the worst thing for swelling so we want you to start 
moving. You can also move your feet up and down and bend your hips and knees while 
sitting/lying down and go for a walk to get your body active.  
It can help to elevate the area when sitting or lying so that gravity can help move the 
fluid back to the body instead of collecting in the leg. You can put your leg up on a small 
chair or two pillows when in a chair or the bed.  
Rubbing/massaging the area from the furthest point towards the body can assist the 
fluid moving back to the body too. Normal body cream or baby oil will make it smooth to 
rub with your hands around the area. Never push the swelling downwards.  
Putting ice on the affected area for no more than 10 - 20 minutes at a time also helps 
with swelling, as explained above.  
 
Difficulties doing certain activities:  
Sometimes you may feel that you are unable to do a specific task at home or outside of 
the house. You may feel too stiff, weak or sore to do a certain activity. You may just need 
to “warm up” in the morning before trying something or you may be having a flare up 
and then you should follow the management tips as given above. It is alright to ask for 
help from a family member if you are struggling with something in the home but be 
careful not to be asking for your family to do everything for you.   
 
What can I do when I am struggling with doing an activity?  
First try and think about WHY you are struggling with a certain activity and then how you 
might be able to deal with this. There are some ways to help yourself when you feel like 
there are certain activities you are struggling with:  
 
Joint protection, assistive devices 
To reduce the weight and stresses through the joint, an assistive device such as a walking 
stick, crutch or walker can be very helpful to protect extra strain on your 
joints. This allows your arms to bear some of the 
weight of your body when stepping on the affected 
leg. Using one stick or crutch gives you a little 
support and allows one of your arms to take the full 
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weight of your body off your leg but also allows your other arm to be free to use during 
activities such as preparing food or carrying items. Two crutches or a walking frame uses 
both arms to push through and gives more support but often take up more space while 
walking and both hands are being used on the device instead of being able to use them 
for daily activities. Try and start with the least supportive if you do feel like you need 
something like this.  
 
Activity modifications: 
There are certain things that can be changed in the way you do activities in order to 
protect the joint.  
- Avoiding certain activities that put a lot of strain on the joint, like kneeling or 
climbing steps can be done.  
- Use a padded pillow under your knee if you insist on 
kneeling for certain reasons 
- Sit on a chair instead of kneeling  
- If you struggle to stand up after sitting for some time then 
try sitting on a harder chair so you are not deep in the 
chair.  
- Using a chair with armrests makes it easier to stand from.  
- Avoid sitting on a low chair as it is more difficult to stand up from a lower chair 
than from a higher one.  
- Walking up a ramp or using the elevator is better than struggling to climb steps if 
this is available.  
 
Wheelchairs are useful to use if you are going to be doing a lot of walking at one time. 
Like going to the shops or taking a day’s outing somewhere. This may just be too much 
walking at one time for your joints. Most big shopping malls have wheelchairs that you 
can borrow for the time you are there. Or another option is hiring a wheelchair or buying 
one from a pharmacy if you have the money. It is important to not rely on the wheelchair 
for everyday activities in the home if it’s not necessary but just to use it for pacing or long 
distances if needed. Remember we want to keep you as able as possible. 
Wheelchair hiring contact details: 
Orthocare Medical Hire and sales (Bellville) 021 946 1717  
Solutions Medical (Goodwood) 021 592 3370  
M-Kem pharmacy (Bellville) 021 948 5706  
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Pacing and activity/resting cycles: 
During exercise and daily life, you need to learn to pace yourself. When you finish an 
activity/exercise you need energy at the end of it for your body to recover easily to 
enable you to carry on for the rest of the day. Exercise should not cripple you for 2 days 
after you do the exercise. When you start an activity you need to pace yourself at a speed 
at which you can maintain throughout the activity without getting faster or slower. At the 
end you should still have energy left over to be able to do more.  
How to pace? 
Pace your activities during the day so that they are spread out with adequate rest periods 
in between so you don’t tire yourself out in one session of too many activities.  
Find a balance between completing a task and resting. You should not do an activity for 
too long that you feel exhausted afterwards and you should also not rest too long so that 
you feel too stiff to get moving again.  
For instance if you have washing and cleaning and ironing to do in a week, instead of 
doing all three on one day, spread them out over three days or if needed, with a day in 
between. Or while exercising or if you have a long day of shopping ahead of you, start 
exercising or walking with the trolley at a pace that you know you can keep the same 
until the end, without stopping or slowing down. If you find you are too tired then you 
must start slower or do less at one time and find the balance. 
 
What is fatigue?  
If too many activities are attempted at one time or in a short time without break 
periods of rest, your body will feel extremely tired and you will experience fatigue. 
It is important to slowly start small activities and short times of exercise to allow 
your body to adjust accordingly. If you do experience fatigue then it is wise to stop 
the activity and rest for a short while (1-2 days) until you have recovered from this 
tiredness. This does not mean you need to lie in bed for this time; you can continue with 
your day but take a break from the exercise and then once you begin again, listen to your 
body and look for signs of doing too much in one go. This could be getting short of breath 
or your muscles feeling weak or shaky, your legs feeling like they want to give way etc. 






• What is frustration/isolation/depression? 
It is common for people living with osteoarthritis to become frustrated and to have 
feelings of isolation/depression. This could be due to not being able to 
do everything as they could before, being reliant on others for normal 
tasks, not being able to participate in activities amongst friends that 
leads to feelings of being alone and often useless/a burden on others.  
Frustration:  
As we said above, try to understand why you struggle with a certain activity and use the 
tips to try and help yourself in these situations before feeling frustrated or useless and 
giving up. It’s important to look at your situation positively and see how you can solve a 
problem instead of feeling frustrated about it.  
Isolation: 
Don’t stop seeing your family or friends in social gatherings because of your condition. As 
we mentioned, there are ways to still be social (like using a walking device or a 
wheelchair when necessary) and having OA should not cause you to be alone or lose your 
friends.  
Depression: 
People with chronic pain can also be depressed due to the large 
effect such a condition can have on daily life. This is often not 
picked up by the nurses and doctors at the clinic. It is important for 
you to tell your nurse or doctor if you think you have depression. 
Depression is an illness; it is not simply being sad, scared, lonely and 
stressed feelings. Depression develops over a few weeks and is a 
general feeling of depressed mood which happens with physical 
symptoms. This is caused by an imbalance of chemicals in the brain. See the 
depression checklist below – if you think you have depression and you have many of 
these symptoms then you probably have some degree of depression. This can be treated 
with medicine and psychological support. It is not something to be ashamed of. Go to the 





Depression Check List: 
 Do you feel down most of the time?  
 Do you lack enjoyment with fun things like music, soccer or chocolate? 
 Do you try to find peace by overeating? 
 Or do you lack appetite and lose weight? 
 Do you sleep badly at night? 
 Do you struggle to get up in the mornings? 
 Do you feel angry and agitated very quickly? 
 Do you feel very passive?  
 Do you lack energy every day? 
 Do you struggle to concentrate? 
 Is it difficult to make decisions about simple matters? 
 Do you feel guilty? 
 Do you feel worthless sometimes? 
 Do you think of death a lot? 
 Do you think of killing yourself? 
If you answer yes to many of these questions, then you may have some degree of depression. 
Speak to the doctor or nurse at the clinic about how you are feeling. 
If you answer yes to one or two of these questions then you may have depressed mood which you 
















• Stop normal activities
• Don’t work
• Don’t socialise
• Don’t exercise, get weak









• Dependant on others
• All alone
• Worried/stressed
Home treatment for Depression:  
There are many things you can do to help manage depression. Make sure that you get 
help straight away if you feel like hurting yourself or someone else. Often talking to a 
person who understand or to a health professional will help you through this mood. Cut 
back on alcohol, although it might make you feel better in the short term. In the long 
term it affects the way your brain works and you will not be able to escape the 
depression. Keep active, make you sure you get up every day, get dressed and get out of 
the house. Even if you don’t feel like doing things, it’s important to keep active, visit 
friends, and join a group. If you start to lose contact with people and withdraw your 
mood will only get worse. Make plans for the future, for tomorrow, for next week, for 
next month. Make sure you do 20 to 30 minutes of exercise every day. As we said in 
Week 1, exercise is very important to keep us healthy and help our moods. Depression 
feeds on depression, when you believe that things will get better, they will start to 
change. Use the suggestions in the section on Week 3: Stress Management to help you 
manage your symptoms. 

































Action Plan Form – Managing common symptoms 
Use this form to develop an action plan on exercise. What exercise would you like to do? 
Be sure your action plan includes: 
What you want to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
For example: This week, I will use an assistive device (what) like 1 crutch (how much) 
when walking outside (when) at least three times (how many). 
This week I will: 
          (what) 
          (how much) 
          (when) 
          (how many?) 
 





Keep a record of how you did: 
 I Plan to….. I did….. 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
 ____________________________ 
Not at all  |    |     |     |     |     |     |     |     |     |       Totally 




Week 3: Stress Management 
• What is stress? 
In our society, we talk about stress a lot. We might say that it is stressful to live in South 
Africa. That it is stressful to worry about our children or our families, it is stressful to 
worry about money or it is stressful worrying about getting a job or coping with my job. 
We use the word stress a lot, but what does it mean? Stress is a feeling; it is a 
combination of feeling tense and worried. When we feel stressed we may be irritable, 
and find it difficult to concentrate or remember things, stress can affect our sleep, our 
appetite and our relationships. 
 
The most common reason why we feel stressed is a lack of control. We tend to feel that 
things are stressful if we don’t have any control over them. We feel stressed if we are 
going to be late for work because the trains are late – this is out of our control. We feel 
stressed about where we live if we don’t feel safe there – those who commit crimes 
against us are also out of our control. In the same way, we may feel stressed when we 
have a chronic illness like arthritis or diabetes or high blood pressure. If you feel that your 
illness is out of your control and there is nothing you can do to affect it, this makes you 
feel stressed.  
 
Stress is not always bad. We know that stress can be useful too. For many people if we 
feel some stress, we might feel under pressure to perform better. You might feel stressed 
because your family is coming to visit, but this stress makes you tidy up your home – a 
good effect of the stress. Students who are studying will only complete their studies if 
there are exams and deadlines for assignments, without the stress of the deadline, the 
students would not complete the work.  
 
Sometimes we wish for a “stress-free” life. But, we know 
that if there was no stress in our lives, if we did not have to 
do anything all day long, this would not be good for us 
either. If I lay in bed all day and did not do anything, my 
muscles would get weak, my joints would get stiff and I 
would become ill. We need some stress in our lives to keep 
us healthy. The important thing is to keep the amount of stress at a level that we feel we 




• Managing stress 
There are many different things we can do in our lives to manage stress. The first step is 
to understand why we are feeling stressed. There are usually three things which affect 
how stressed we feel. 
 
1. The stressful situation:  
Usually the less you expect the situation and the less familiar you are with a situation, the 
more stressful it will be. If you needed to take the train to work but you knew the day 
before that the trains would be late, this would be less stressful than finding out after you 
have got onto the train that it is going to be late. If you think about having pain, if you 
know the cause of the pain is it more or less stressful? If you don’t know what is causing 
your pain and you are worrying that there is something seriously wrong, is this more or 
less stressful? 
 
2. How you see the situation and how you cope with it: 
If the situation you are in is not important to you, you are likely to feel less stressed about 
it. If you are on a train which is going to be late, but you are going shopping on your own, 
then you are likely not to get so stressed about it. If you are on a train which is going to 
be late and you are going to work this might be more stressful, but if you have a cell 
phone with you and you have airtime on the cell phone and you telephone your boss to 
explain why you will be late, then this might be less stressful. Your ability to cope with the 
situation, affects the amount of stress you feel. While it is stressful to live with a chronic 
disease like arthritis, diabetes or high blood pressure, if you thought you could cope with 
it and it would not interfere with your job and your life, would it be more or less 
stressful? Having knowledge about your condition allows you to think about it in a 
different way and will change the way that you cope. 
 
 3. Support from family and friends: 
Friends and family who understand and support you will affect your levels of stress. 
Feeling alone and like you have no support will probably make you feel more stressed. If 
you think about living with osteoarthritis, would it be more or less stressful if there were 
no one to support you? But, we do need to be careful about support from family and 
friends. If they take over doing everything for us (because they care about us and are 
trying to help), we might feel useless and like we don’t have a purpose. Supporting me 
does not mean doing everything for me. 
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Stress is not just the things that happen to us. The amount of stress that we feel depends 
on a lot of different things which can change every day. There are many different things 
we can do to manage stress every day. 
 
Dealing with the cause of the stress 
The first step in dealing with stress is to identify why you are feeling this way. Use the 
self-management steps to help you identify the problem. Once you know why you are 
feeling this way then you need to decide what you can do about it. Sometimes dealing 
with the things that stress us is easy, if you are friends with your neighbours and the 
noise from their television is irritating you, it might be easy to ask them to turn down the 
volume. If you are not friends with your neighbours, or you are very shy, it might be quite 
difficult to ask them to turn down the volume. Sometimes we can identify the things that 
stress us and do something about it. But, often we either cannot deal with it or it is out of 
our control. If you cannot deal with it or it is out of your control, the next step is to 
change the way you are looking at the problem. 
 
Look at the problem in a different way 
Think about how you are feeling. Are your thoughts and feelings about the problem 
inaccurate? Maybe you are very worried about your health, this is stressing you. Are you 
worried that you will be very ill and unable to work soon? Are these thoughts and feelings 
accurate? On what information are you basing these thoughts and feelings? Have you 
spoken to experts about your health or are you basing your thoughts and feelings and 
stress on poor information? 
 
Plan your life 
Do you get stressed by the same things over and over again? Or do you find yourself 
getting stressed because there are times when your life is very busy? If you are doing the 
same things over and over and getting stressed, you might want to look at how you are 
dealing with it and see if you can try a different plan. What about a busy life? This is also 
about planning, being very busy and having no time for ourselves, can be very stressful. 
Plan things over time carefully, make sure you have time to at least do some relaxation or 





Get help from family, friends and support groups 
These are a great way to decrease stress. If we want support from people though, we 
have to tell them clearly what the problem is and what we would like from them. Often 
we do not communicate clearly and this might make the stress worse! If you find your 
family or friends are not very helpful or supportive, it might be worth sitting down with 
them when you are not feeling stressed to talk about these things. It might be that they 
see things differently to you, this does not mean they are right and you are wrong, or that 
you are right and they are wrong. It just means that you see things differently and you 
can discuss how to handle things better. If having a discussion like this is difficult, it might 
be useful to ask a counsellor to help with the conversation. You can ask for assistance at a 




Exercise is a very effective way of managing stress. People who exercise regularly doing at 
least 20 to 30 minutes of exercise, 3 times a week have less risk of suffering from stress 









When we feel relaxed, we feel calm. Sometimes if we are relaxed and we are tired, we 
might feel sleepy. At other times we might feel relaxed and alert and be able to 
concentrate calmly on tasks. Relaxation can help us to concentrate and it can help us to 
unwind and go to sleep. Relaxation is a very useful way to manage stress and some of the 




 Decreases stress 
 Helps us sleep better 
 Decreases pain 




If we are stressed, this can make our muscles tense, our hearts beat faster and we 
breathe faster, if we are also feeling unwell and have pain we will feel worse. Relaxation 
can decrease the tension in muscles and slow down our hearts and breathing and help to 
make us feel better. If we are stressed we often become irritable and moody, relaxation 
helps to calm you and make you feel more in control of your life. When we are stressed 
sometimes it is difficult to fall asleep as we are worrying about things out of our control, 
if you are also unwell, not sleeping will make you feel worse. Relaxation will help you get 
to sleep, this will help manage your stress and improve your health.  
 
Just like learning to play a new sport or doing exercise, relaxation takes practice. The 
specific way that you relax doesn’t matter; we are all different and might relax in 
different ways. The important thing is to practice it regularly. There are two different 
ways of relaxing described at the end of this section. You can do these at home in a quiet 
and comfortable safe place to begin with. But, once you get good at relaxation, you can 
relax in a crowded waiting room, on a train or a taxi. You can do relaxation anywhere! 
  
Good times to practice relaxing are when: 
 You feel you are getting tense or irritable or you are 
worried 
 You feel you are in pain 






 Long relaxation: 
 Find a comfortable position. Lie on your back or sit in a chair with your back supported. 
 Place your hands at your sides, palms up. Close your eyes if you wish. 
 Now begin to become aware of your breathing..... Focus on slowing down the rhythm of your 
 breathing..... Your chest and tummy will expand outward with each breath, like a balloon gently 
 filling with air.... 
 Imagine your ribcage moving out to the sides when you breathe in.... and gently inward as you 
 breathe out.... 
 Slowly take a deep breath in.... Pause for a moment.... and then slowly breathe out. Let the tension 
 melt away as you relax more deeply with each breath... 
 Continue breathing slowly and gently.... 
 Now think about the top of your head. Feel the skin on the top of your head beginning to relax, and 
 spreading slowly downwards.... 
 Even your ears are becoming relaxed and heavy.... Feel your eyebrows resting....  
 Your forehead is becoming relaxed and smooth....all the lines on your face are becoming smooth.. 
 Let your jaw relax by allowing your mouth to be slightly open.... Allow your tongue to relax... 
 Feel your throat relaxing.... relax your cheeks, nose, and eyes.... Feel your eyelids becoming very 
 heavy.... and very relaxed.... more and more relaxed.... 
 Enjoy the feeling of relaxation you are experiencing. 
 Now think about your neck.... allow a feeling of relaxation to begin at the top of your neck, and flow 
 downward... 
 Feel the relaxation as your shoulders become relaxed and loose.... Let your shoulders 
 gently sink downward.... as they become relaxed.... and heavy.... very heavy.... and very relaxed.... 
 deeper and deeper.... relaxed.... 
 Feel your collar bones becoming relaxed as your shoulders move gently back, and your chest widens 
 slightly.... 
 Allow all the muscles in your shoulders to feel smooth... and relaxed.... as the muscles give up their 
 hold completely... 
 Notice your breathing once again... see how regular it has become... continue to take slow.... 
 smooth.... deep breaths... Breathe in the feeling of relaxation... and breathe out any tension... your 
 breathing allows you to become more and more relaxed.... deeply relaxed..... Now turn your 













  Feel the relaxation flowing down from your right shoulder.... allow  your upper arm to relax...     
your elbow.... lower arm... and wrist become loose and relaxed.... 
 Enjoy the feeling of relaxation as the muscles of your right arm give up their hold.... Feel the 
 relaxation flowing into your hand... Let all the tension drain out of each finger tip and flow away.... 
 the relaxation spreads to your thumb... index finger.... middle finger... ring finger... and little finger.... 
 Feel the relaxation flowing down your left arm... Let the muscles of the left upper arm relax.... Relax 
 your elbow.... lower arm.... and wrist....  
 Enjoy the feeling of relaxation you are experiencing. 
 Let the tension melt away.... imagine the tension flowing right out of your finger tips... Allow your left 
 hand to relax completely.... relax your thumb... index finger.... middle finger... ring finger... and little 
 finger.... 
 Both of your arms are now totally relaxed... allow them to be free and limp... pleasantly relaxed... 
 Enjoy the feeling of relaxation you are experiencing...  
 Allow the feeling of relaxation to continue to your chest and stomach....feel the relaxation there... 
 becoming deeper with each breath.... 
 Now turn your attention to your upper back... Feel the relaxation flow down your spine... Let all the 
 muscles give up their hold.... relax your upper back... middle and lower back.... allow your back to 
 relax completely..... Feel the relaxation in your whole upper body .... 
 Relax more deeply with each breath.... more and more relaxed.... deeply relaxed and calm.... 
 Let your hip muscles relax.... Relax all the way from your buttocks (bottom), down the back of your 
 thighs... relax the muscles on the front of your thighs...Feel the relaxation in your upper legs moving 
 down to your knees... your calves and shins.... your ankles.... and your feet.... allow all the muscles to 
 relax and go limp.... 
 Allow any last bits of tension to flow right out of the soles of your feet....Feel the relaxation flowing 
 through your body... From the top of your head... down to the bottoms of your feet.... become more 
 relaxed with each breath.... enjoy the feeling of total relaxation..... 
 You are now as relaxed as you want to be.... Experience the feeling of deep relaxation... enjoy the 
 feeling.... relaxed.... calm..... at peace 
 Focus on the feeling of relaxation throughout your body.... Notice your breathing.... Your relaxed 
 muscles.... Your calm thoughts... Memorize this feeling so you can re-create this relaxed state 
 whenever you wish.... 






















 When you are ready to return to your day, reawaken your body slowly... gently move your muscles... 
 roll your shoulders slowly forward....then slowly backward.... lean your head gently to the left... 
 return to centre.... lean your head gently to the right... turn your head... 




 Deep breathing not only helps to cure anxiety and stress, it also triggers relaxation. Here's how to 
breathe deeply. 
 Breathe in slowly to the count of four (count slowly; to the pace of one-one-thousand, two-one-    
thousand....). Pause to the count of three. 
 Breathe out slowly to the count of five. 
 The breathing process goes like this: 
 Inhale... two, three, four...pause...two, three....exhale...two, three, four five.... 
 Inhale... two, three, four...pause...two, three....exhale...two, three, four five.... 




















People with chronic illnesses often struggle to sleep because they are 
stressed and worried about their condition, they worry about what 
this means for them, for their family, for their future. People also 
often struggle to sleep because of the illness itself, perhaps you have 
pain, you feel sick or you may even be so tired you can’t sleep. Some people find it 
difficult to get to sleep and only fall asleep very late at night, others find that they fall 
asleep but then wake up during the night and can’t get back to sleep. Some people find it 
difficult to sleep at all at night and sleep during the day.  
 
Sleep is very important to keep healthy. We all need different amounts of sleep. Some 
people need 8 hours of sleep a night, some may need 10 hours and some people only 
need 5 hours of sleep. We are all different. We have been learning how to fall asleep and 
sleep well since we were babies. If you do not sleep well, following these steps will help 
you to learn how to fall asleep and sleep well. Remember that like learning anything new, 
this will take time. It might take up to 3 months to learn to sleep well if you have been 
struggling with sleep for a while. 
 
Suggestions for Improving Sleep 
Have a bedtime routine: try to go to bed at around the same time every night and always 
do the same things before getting into bed. A bedtime routine could be to lock the house, 
get undressed, wash your face, clean your teeth, get into bed and do a relaxation 
session.You can’t sleep because of worrying: write down your problems or the things that 
are worrying you, then write down the next step that you think could help sort out the 
problem. If you wake up during the night worrying about the problem, remind yourself 
that you’ve gone over it and you have a plan. If you wake up with a new worry, write 
down that problem to deal with in the morning. Practice your relaxation to take your 
mind off the worry. If you still can’t sleep, it may be better to get up and do something 
relaxing like reading, watching TV, listening to relaxing music or doing relaxation.  
Your bed and bedroom are for sleeping: try not to use your bedroom during the day. Do 
not watch TV in bed. If you are not asleep within 30 minutes of going to bed, get up and 
do something else. Do not lie in bed and worry that you have not fallen asleep. This will 
only make you feel stressed and lessen the chance of falling asleep. 
Have a morning routine: get up at the same time every day, even if you don’t feel like it. 




Avoid drinks containing caffeine for at least 4 hours before going to sleep (drinks like 
coke, tea or coffee). 
Never use alcohol to help you sleep. It might make you feel relaxed at first, but once this 










Communication with your health carer 
Anyone living with a long term health problem, whether it is arthritis or high blood 
pressure or diabetes will have to visit their clinic regularly. Visiting the clinic regularly can 
be stressful because it takes time, you have to plan ahead, you might not be sure how 
long you are going to have to wait, you might be worrying about what the health carers 
are going to tell you. One of the most important ways of managing the stress associated 
with visiting clinics and seeing health carers is to think about and plan how to 
communicate with them.  
 
 When visiting the clinic to see a health care practitioner it is important that you feel 
comfortable asking questions (any questions, even if you feel they are “silly” or “stupid” 
questions) and comfortable expressing how you feel. It is also important that you feel you 
can negotiate your treatment with your health care provider so that both you and the 
carer feel that you are receiving the best care for you. It is important that you not feel 
that your health care provider is ignoring you, “puts you down” or treats you like a child. 
We know that doctors and nurses have a lot of patients to see and they have little time to 
spend with each person. One helpful way to make sure that you get the most out of your 
appointments with the doctor or nurse is for you to take PART – Prepare, Ask, Repeat, 
Take action. 
 
Good sleep habits: 
 Go to sleep at the same time every day 
 Have a bedtime routine 
 Do relaxation before going to sleep 
 Use your bed only for sleeping or relaxing 
 Get up at the same time every day 





Before your appointment at a clinic it is important to prepare. Think about the reason for 
your appointment and whether there are any issues in particular that are worrying you. 
Write down your questions or the things that are worrying you. You need to be realistic 
about the list you write down, there will probably only be time to answer one or two of 
the things on your list. Make sure the most important problems are at the top of the list. 
Take your list with you to your clinic appointment, then when the doctor or nurse asks if 
there is anything you want to ask, you can use your list.  
 
If there are particular symptoms or health issues you want to discuss, prepare for your 
appointment by writing down specific information the doctor or nurse will want to know. 
Things that are helpful are: when did it start, how long do the symptoms last, where are 
they in your body, what makes you feel better or worse, have you had a problem like this 
before and how was it treated; have you changed anything such as your diet, exercise, 
medicines. If you have already received treatment for a problem, be ready to report back 
on how well it has worked, or on whether it has not worked at all.  
 
Be open about how you are feeling and about the things that are worrying you. The more 
open you are, the more the health care provider can help you. Finally, give feedback. If 
you don’t like the way you have been treated you can tell the doctor or nurse. If you do 
not want to tell them directly then you can speak to someone else in the clinic or to 
someone in a support group. Remember too that doctors and nurses and other health 
care providers also appreciate being complimented. If you feel that you have been 




Another important step in having good communication and decreasing stress is to ask 
questions. Having good information is essential to you being successful in self-managing 
your health. Ask questions about your diagnosis such as what is wrong, what has caused 
it, is it contagious and what is going to happen now? Then ask questions if you have had 
tests, what is the test for; what if I don’t have the test and what will the test involve? 
Remember to ask questions about your treatment options, what are the benefits of 
treatment and what are the risks and side effects?  
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Finally ask questions about follow-up, when should you return to the clinic, what should 
you watch out for and what should you do next?If you find you have difficulty 
remembering information it is a good idea to write things down during your visit. Or you 




One of the important things to do to help with remembering things is to repeat it. So if 
the nurse or doctor explains something to you, repeat back to them in your own words 




At the end of your appointment, it is important that you know exactly what you will need 
to do next. It might be that you need to make another appointment, or that you need to 
go home and change something or get new medicine from the pharmacy. Make sure that 




Action Plan Form – Stress management 
Use this form to develop an action plan on exercise. What exercise would you like to do? 
Be sure your action plan includes: 
What you want to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
For example: This week, I will relax (what) using long relaxation (how much) at bedtime 
(when) at least three times (how many). 
This week I will: 
          (what) 
          (how much) 
          (when) 
          (how many?) 
 





Keep a record of how you did: 
 I Plan to….. I did….. 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
 ____________________________ 
Not at all |    |     |     |     |     |     |     |     |     |  Totally 







Week 4: Eating well 
 
You are probably wondering why we talk about nutrition at this course. What has food 
got to do with osteoarthritis or the pain you are having? Well there are many good 
reasons for that, but if you think about it; if managing your pain is all about lifestyle 
changes and making decisions that are good for your health and body, surely wise food 
choices fit in to that as well. This section is not about weight loss – there are many people 
out there who are not overweight, but still suffer from terrible chronic diseases such as 
diabetes, high cholesterol and hypertension, on the other hand there are also overweight 
people, who exercise and eat a well-balanced diet, but don’t suffer from chronic illnesses. 
So it is really about how we are built and how our bodies burn what we decide to feed it. 
What is common for all, is the fact that when we eat a well-balanced diet that is good for 
us, we feel better, we have more energy and we are happier. We will try and explore why 
that is now. 
The Diesel Diet  
Think of the Human Body as a Diesel car. The Human body needs to work and chug along 
at a constant pace throughout the day; it can’t be like a Formula One car that goes very 
fast for a short amount of time and then stops!   
Therefore we must re-fuel our bodies constantly so we are able chug along for the whole 
day without running out of energy. But we also have to be careful about what kind of fuel 
we put into our bodies. It has to be diesel that will last us for a long time. If we give 
ourselves high octane petrol fuel it will give us a quick burst of energy but will run out 
quickly.  
So, to make it easy for everyone, the “diesel” we need to feed our bodies is food that will 
keep us full for long and keep the body’s blood sugar levels steady. It is the high octane 
fuel we need to keep clear of. These are for example sugary and highly processed foods, 
such as cakes, pies, chocolates and any “quick fixes”; the kinds of foods which most 
parents know that if they gave it to small children would give them lots of energy to run 






So how do I run my car on diesel? 
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Two Schools of Thought 
At the moment there is a lot of scientific research about what kind of foods we can 
categorise as healthy. There are generally two schools of thought. One favours a low fat 
and high carbohydrate diet and the other favours high protein and low carbohydrate 
diet. In this booklet there will be a choice of the two. With your doctor or a dietician, you 
can decide which one would suit you better. It is very important to emphasise that 
whichever suits you, neither one should contain high simple carbohydrates, that is foods 
containing a lot of sugar and starch. So in order to understand the options, we need to 
look at the food groups, from which we make our food choices. Let us have a look at what 
these food groups are: 
Carbohydrates 
Carbohydrates are often called starches or carbs. There are two kinds of carbohydrates – 
simple and complex. They both provide the body with energy. But the simple carbs give 
you a quick fix (lots of energy very quickly and a subsequent high rise in blood sugar, 
followed by a rapid drop and you feel tired and hungry again quickly). The complex carbs 
raise your blood sugar more slowly and so you feel more energised for longer. It is safe to 
say, we need more of the complex carbs than the simple ones. Let’s look at the 
difference.  
Examples of complex carbs   Examples of simple carbs 




Why do we need Complex Carbohydrates?  
Carbohydrates are your most important source of energy. 
Where do the Complex Carbohydrates (diesel fuel) come from?  
- Grains 
- Brown Rice 
- Oats 
- Whole Wheat 
- Lentils 
- Vegetables – mainly green and leafy (broccoli, cabbage, lettuce)  
- Whole wheat Pasta 
- Whole Wheat/Brown Bread/rye bread 
- Potatoes 
 






- Sweetened Cereals (e.g. Fruit Loops, Coco Pops) 
- White Rice 
- Wheat based pasta 
- White Bread 
- Chips/Crisps 
- Pies & Pastries 
- Fizzy drinks like Coca Cola 
 
NB! Even on a high carbohydrate diet, you need to keep clear of the simple carbohydrates! 
Simple carbs are very addictive – the more you eat the more your body wants. They are easily 





Why do we need Protein?  
Proteins are important for building and repairing muscle, blood cells, bone, hair, organs, 
other bodily cells and making hormones. They are also an important source of energy. 
 
Where does the Protein come from?  
- Animal Products 




- All other Dairy Products 
- Beans 
- Seeds & Nuts 
- Grains 
- Soy Products       
 
Fibre 
Why do we need Fibre?  
Fibre is important for the smooth running of our stomachs.  
It helps prevent constipation. It helps prevent Stomach Cancer It is especially important 
if you are taking lots of pain killers and anti- inflammatory drugs, which slow the 
stomach down.  
 
Where does the Fibre come from?  
- Vegetables 
- Fruit 
- Whole-Grain Bread, Pasta & cereals 
- Oats, Oat bran 








Why do we need Fat?  
A source of fuel for muscles and brain. Primary source of energy when exercising hard.  
Helps with constipation 
 
Where does the Fat come from?  
Good (unsaturated) Fat 
 Vegetables 
 Fish Oil 
 Olive oil 
 Nuts& Seeds 
 Avocados 
Bad (Saturated) Fat 
 Animal Foods 




 Margarine  




 Fried Foods 







Some helpful Guidelines: 
Bad (saturated) fat and increased fat consumption can increase your chance of having a 
Heart Attack, Stroke and Diabetes.   
Avoid hard fats such as butter, margarine and animal fats. Focus on olive oils, grape seed 
oil and oil from avocados, nuts and seeds. 
Don’t fry or roast food, rather, steam or microwave the food or eat it raw.  
Rather Grill meat than fry it or roast it.  
Use Olive oil rather than butter, Canola Oil or Lard.  
Read the food labels and eat low fat food! The total fat should be less than 10g per 
100g.  




So now that we know all about the food groups, how do we put it all together? Let us 
have a look at the two different kinds of diets described earlier: 




If you burn carbohydrates well, or feel like you need to lose some weight or at least want 
to benefit from better nutrition, a balanced diet of very little saturated fats, complex 
carbohydrates and some protein might do the trick.  
On this kind of diet, it is important to keep the diesel going throughout the day and in 
doing so eating 5-6 smaller meals is the best way. There are more carbohydrates in this 
diet, which will not keep you full for as long as the protein rich diet, so you will need to 
eat more often. It is therefore suggested that your daily meals consist of:    
 Breakfast 
 Mid Morning Snack 
 Lunch 
 Afternoon snack 
 Supper 










you crave more foods like the bad carbs often do. In other words they are not quick fixes. 
Table 2“The Not so Good Carbs” are carbs that you should be aware of not eating too 
many of and finally Table 3“The Bad Carbs” should be avoided as much as possible. Here 
is a recap:  
Table 1: Good Carbs - Eat most of your carbs from this group 
Table 2: Not so Good Carbs - Eat in moderation from this group 
Table 3: Bad Carbs - Avoid eating from this group 
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TABLE 1 GOOD CARBS 
Food Group Examples of foods  
Dairy Low fat/fat free: Milk, Yoghurt, heart foundation margarine spreads, cottage cheese. 
Starches All dried and canned beans, Peas, Lentils\Dahl, Baked beans, Boiled barley wheat, Pasta made from whole wheat or 
durum wheat-semolina, Sweet potato, Mealies/corn, cold samp, brown rice. 
Bread Provita, Seed loaf bread no added sugar, Pimpernickel bread, rye bread, any other bread with lots of whole kernels, 
crushed wheat, and oat bran inside. 
Cereals Bokomo Pronutro Wholewheat, Hi Fibre Bran, Cold Mealie meal, Oat Bran, All-bran flakes, Fine Form muesli no added 
sugar, shredded all bran. 
Vegetables All vegetables not mentioned in table 2 and 3. Stick to leafy and green ones. 
Fruit All deciduous fruit e.g. apricots, cherries, peaches, plums, pears, apples. All citrus fruit e.g. oranges, naartjies, 
grapefruit and lemons. Kiwi and grapes – watch portions there is a lot of sugar in fruit – if in doubt stick to berries. 
Avoid: See fruits in Table 2 and 3  
Snacks Sugar –free jams and sweets, low fat popcorn. 
Drinks WATER! Sugar free cool drinks, no more than 2 glasses of fruit juice per day.  
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TABLE 2 NOT SO GOOD CARBS 
Food Group Examples of foods  
Dairy  
Starches Sweetcorn, potatoes with skin, coarse mealie meal porridge, white rice, couscous.  
Bread Ryvita, brown bread 
Cereals Kellogg’s fruitful bran, Bokomo pronutro flakes, Tastee wheat Kellogg’s corn pops, Kellogg’s frosties, Kellogg’s choc’s, 
Mealie meal –reheated or with added corn 
Vegetables   Beetroot 
Fruit Tropical fruit e.g. banana, mango, sultanas, paw-paw, pineapple and litchis, grapes, melons. Dried fruit: sultana, dates 
and raisins.  
Snacks Bakers Home-wheat digestive biscuits, Low fat biscuits containing oat bran, Low fat bran/fruit muffins/pancakes, Low 
fat oat bran crumpets, Raw honey, Jam Sugar, Fine form canned peaches, Fine Form apricot jam 





TABLE 3 BAD CARBS 
Food Group Examples of foods  
Dairy  
Starches Potatoes: boiled, mashed, baked and fried, Minute noodles, Rice especially sticky rice, Samp, Mealie rice.  
Breads All white bread, all bread rolls and anything made with cake flour, bread flour and nutty wheat flour, Rice Cakes, 
Snackbreads  
Cereals Mealie meal – refined and sugar added, Puffed wheat, Maltabella, Instant Oats, Kellogg’s strawberry pops and frosties 
(any sugary cereal). 
Vegetables Carrots and carrot juice, Pumpkin, Hubbard Squash, Butternut, Parsnips 
Fruit Watermelon, Dried fruit rolls 
Snacks Sweets –boiled and jelly type, Bakers Marie biscuits, Commercial honey, Glucose, Maltose 




How much do I need? 
50-65g per day.  
Some helpful Guidelines! 
Lean meat, poultry or fish (the size of a deck of cards) contain 25 to 35 grams of protein. 
Remember this is a low fat diet and all animal produce contain saturated fats, therefore 
you need to avoid fatty meats and processed meats. 
One cup of cooked beans or lentils contains about 18 grams of protein.  
One cup of low fat cottage cheese contains 28 grams of protein.  
60 grams of solid cheese contains about 16 grams.  
One cup of low fat milk contains 8 grams.  
Two tablespoons of peanut butter contain 8 grams.  
One serving of grain foods (barley, pasta, cereals, whole wheat bread, for example) 
generally contains 3 to 6 grams of protein.  
One serving of vegetables ranges from 1 to 3 grams 
 
FIBRE 
How much do I need? 
You need 25-35g  of fibre per day 
Some helpful Guidelines! 
Choose whole-grain breads and pasta. (Flour from whole wheat contains three times as 
much fibre as refined white flour.)  
Choose brown rice instead of white. (Brown rice has three times as much fibre).  
Eat the whole fruit instead of juice. (One orange contains about six times as much fibre as 
a glass of juice).  
Stir a few tablespoons of wheat germ into yogurt or hot cereal; add a couple of 
tablespoons of bran to pancake or waffle batter.  
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Start your morning with cold or hot cereals that contain at least 4 grams of fibre in a 
serving. Read package labels and compare fibre content. Add fruit to your breakfast 
cereal.  
Pack cold cereal, fruit or cut-up vegetables in your briefcase or handbag for nibbles.  
Buy cut-up raw veggies at a salad bar or vegetable stand if time is short. 
  
FAT 
Remember there are saturated and unsaturated fats. On this diet you need to focus on 
the unsaturated fats which come from non-animal sources such as olive oils and low-fat 
spreads or your avocado, nut and seed oils, as well as fish oils. 
How much do I need?  
For one meal the total fat should amount to the same size as the tip of your thumb or 








There is good scientific research showing that if you suffer from a sluggish metabolism, that is 
your body doesn’t burn food very efficiently, you may benefit from a high protein – low 
carbohydrate diet. People who suffer from this have a hard time losing weight, you gain weight 
easily, get easily bloated when eating bread, rice, pasta and cereal. The researchers think this is 
because some people’s bodies do not metabolise carbohydrates that well – even some of the 
carbohydrates that are more complex, such as pasta and rice. 
On the high protein diet the main focus is on eating good and wholesome protein, such as lean 
meat, chicken, ostrich and fish. The kind of protein that you should keep clear of are processed 
meats like salami, poloni and spreads. They often contain a lot of saturated fats, sugar, flour and 
additives that are not good for us. With this kind of diet you are allowed to eat dairy foods too, 
for example cheese, eggs, full cream milks and yoghurts. Like any other diet it is encouraged that 
you choose nuts and seeds and good oils for fats and use less saturated fats such as cream and 
butter.  
In terms of complex carbohydrates, these are very important but in this diet you get these from 
leafy vegetables. These leafy vegetables include broccoli, cabbage, lettuce, sprouts – basically 
most vegetable are acceptable BUT you need to avoid starchy vegetables such as potatoes, 
pumpkin, sweet potatoes and parsnips. These vegetables have a lot of natural sugars in them and 
if your body doesn’t need them, they are converted into fat and your blood sugar levels rise.  
You can eat some grains – but stick to brown rice, barley wheat, bulgur and quinoa for example. 
Like any diet it is important that you get fibre to maintain your stomach health. Most of your 
fibres you will get from the vegetables. Although it is not recommended to have lots of fruit, 
some is ok, especially berries as they are high in fibre and low in sugar content. Don’t drink fruit 
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The following foods are recommended for this kind of diet: 
 Whole Grain foods  
 (Oats, brown/whole wheat bread, Low GI bread, Oat cereals, Whole wheat 
cereals) 
 Protein – lean fish and chicken, only red meat occasionally 
 Fruit  
 Vegetables 
 Fats – no saturated fats. Stick to olive oils, nuts, avocado, seeds 
 
This kind of diet should contain a balanced variety of the following food groups:   




 Vitamins and minerals 
 
How much carbohydrate? 
25-50% of all food intake 
At one meal the carbohydrates should amount to the size of your first.  
Keep clear of simple (high octane) carbs 
 
Some helpful Guidelines! 
Cut Back on High Octane Foods; avoid fizzy drinks (A single can of fizzy drink has up to 3 
tablespoons of sugar in it!) Try eating as much whole grain and whole wheat as possible 
Eat your carbs with help of The Tables 1, 2, 3 below 
 
How do I choose the right carbs? 
The tables below will help you choose the right kind of carbs. Table 1 we call “The Good 
Carbs”. You should choose most of your carbs from this table. The carbs from Table 1 will 
help you sustain your energy levels – this is food that is good for your brain and muscles. 
These foods help prevent tiredness and give you a nice even flow of energy throughout 






PROTEIN Amount Avoid CARBS Amount Avoid 
Lean meats: Beef, pork, 




Processed meat like 
Salami,pollony, 
sausages 
Green vegetables  A good fist size 
portionwith every 
meal 
Starchy vegetable like 
potatoes, sweet pot. 
Parsnip,  
Diary eggs, cheese or 




Avoid too much 
cream 
Other vegetables i.e. 
tomatoes, cucumber, 
peppers, carrots 
In moderation Pumpkin, butternut 
Nuts and seeds 50g/daily  Grains brown rice, 
barley wheat, bulgur, 
quinoa 
Small portions Bread in general, but 
especially  wheat 
based, white pasta 
and rice 
Legumes and lentils 50g/daily Too many – they 
also high in carbs 
Fruit 
stick to berries 
1-2 pcs per day 
(large)or handful 
of berries 
Sugary fruits like 
grapes and bananas 
FATS Amount Avoid 
 
Omega 6 oils: Olive oil, 
grape seed oil, rape 
seed oil, avo oil 
In moderation 
with all meals 
Margarine spreads. 
Sunflower oils 
butter Only small 
amounts 
(thumb sized)  
Mayonnaise (made 
from sunflower oil) 
Avocado, nuts and seeds ½ avo per day, 
50g of nuts and 




What about drinking habits? 
On all healthy diets we need fluids. Often when we feel hungry, it is the body telling us 
we are in fact thirsty. So we need to drink enough fluids and our main source of good 
fluid is of course water. We have some of the cleanest tap water in the world here in 
South Africa – and it is free! SO go ahead and have a free treat! But in all seriousness, 
why is it important to drink water and avoid some of the other choices of drinks out 
there? Let us explore: 
Water 
Why do we need water?  
 Water makes up 50-55% of your body weight.  
 Water and Oxygen are the most needed elements for life.  
 Carries nutrients to, and waste away from cells 
 Cools the body  
 Necessary for proper body and organ function. 
 
Where does the water come from?  
 The fluid you drink 
 The water in the food you eat 
 Chemical reactions inside your body 
 
How much do I need? 
We usually recommend that adults drink 6 to 8 glasses of water a day but this water 
includes the water in the food we eat so you don’t have to be drinking a whole 8 glasses.  
If it is very hot or you are doing lots of exercise you need to drink more than 8 glasses.  
 
Some helpful Guidelines! 
Drink when you are thirsty. Drink at least one glass of water/juice every morning with 
breakfast. Drink 2 glasses one hour before exercising and another after exercising.  




Often when you take a lot of medication you lose your appetite and you might resort to 
coffee and tea with lots of sugar. Try to avoid this and stick to 1-2 cups per day. Also try 
and substitute normal tea with rooibos teas.  
Alcohol really doesn’t go well with medication. But if you really enjoy it, women shouldn’t 
drink more than 1.5 glasses per occasion and men 2 glasses. You should also know that 
alcohol has been shown to worsen the symptoms of osteoarthritis. 
In general, juices from supermarkets are highly processed and contain a lot of sugar even 
when labels say 100% fruit juice. If you have juice, one glass a day is plenty – and when 





Now that we know about healthy diet options, the question remains: 
Why do I actually need to lose weight? There are several answers to this, 
but first and foremost, not all of us need to lose weight. It is only when 
you are heavily overweight or what doctors call obese, that your weight becomes a big 
problem. Remember when you first came to the hospital to do questionnaires and tests? 
We also measured your BMI (Body Mass Index), which is a measurement of your weight 
according to your height. If you have a BMI of more than 25, you should be concerned. If 
you don’t know whether your weight is a problem, here is a way to calculate your BMI: 
Your weight in kg divided by your height in meters times your height in meters. To give 
you an example: If a person weighs 88kg and she is 1.70m tall, her BMI = 88/1.70x1.70 = 
30. This person would be classified as obese 1 according to the table below. 




Obese 1 31-35 
Obese 2 35-40 
Obese 3 >40 
 
What we know from research is that osteoarthritis is closely linked to obesity and being 
heavily overweight. What this means, is that when you weigh a lot more than you should, 
there are added stresses and strains on your body’s joints. In particular the big joints like 
the hips and knees. This means that when doing daily activities or exercise your 
symptoms of pain increase and the natural reaction is to stop being active. Therefore, if 
you are heavy, losing weight will improve your condition by decreasing the loading on 
your joints and it will feel a lot easier for you to move around,  do exercise and daily 
activities. It is never too late to change your mind set and lose weight – and no matter 
how old, young, tall or short – it will make you feel good about yourself.  
 
Therefore, should you choose to lose weight, you can follow the guidelines for diets, 
which we have already gone through. Remember losing weight is not about starving 
yourself, but making sure that the food we eat, fills us up, gives us energy throughout the 





What about those who’s BMI is normal? Well, as we have already talked about – you can 
be thin or normal and still benefit from a healthy diet. It will still give you the improved 
energy and make you feel less fatigued and most importantly help with your medicine 
uptake (we will talk more about this in a later chapter).  
 
 “I find it hard to eat well!” 
Now that you know what you should be eating let’s talk about why people living with OA 
may be struggling to eat enough. The reasons for not eating enough could be that they do 
not want to eat because they just don’t feel hungry or because they are too tired to eat 
or they are too worried to eat or they feel like they will vomit if they eat, or food just 
doesn’t taste good any more. The next section gives ideas on ways to manage these 
problems.  
 
“I’m not hungry” 
On the days when you do feel like eating, make sure you eat well to make up for days 
when you might not be eating so well. On the days when you do not feel like eating try to 
eat small meals more often, maybe 6 times a day. Eat in a relaxing place, maybe with a 
friend. Keep small snacks (healthy) with you in your bag or next to your bed so that if you 
wake up or suddenly feel hungry you can eat straight away. Make sure these snacks have 
lots of energy in them (are complex carbs). Make sure you have your favourite foods to 
eat, even if it’s just a little bit, it helps.  
 
“I get full too quickly” 
You might be trying to get all your food at one meal. Try to spread it out more by eating 
five or six times a day. When you do eat, make sure it is food with lots of energy and 
protein. Don’t eat foods without energy first and then feel too full for the important 
foods. 
 
“Food doesn’t taste so good” 
Medicines can change the way food tastes. Sometimes you may have a bitter taste or a 
taste of metal in your mouth. Try cleaning your teeth and your tongue before you eat. If 





“My mouth is dry” 
A dry mouth might be a side effect of medications. You can help this by avoiding smoking 
and drinking alcohol as well as sugary drinks as these irritate your mouth and throat and 
make you even more thirsty. Eat softer food, if you mash your food or make soup as this 
will be easier to swallow. Try not to eat food with a lot of spices or drink fizzy drinks. Keep 




Action Plan Form – Nutrition 
Think about your eating habits. Use this form to come up with a plan to improve one 
thing about your nutrition. Be sure your action plan includes: 
What you want to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
For example: This week, I will eat less simple carbs (what) by cutting out one (how much) 
during dinner (when) everyday (how many). 
This week I will: 
          (what) 
          (how much) 
          (when) 
          (how many?) 




Keep a record of how you did: 
 I Plan to….. I did….. 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
  
 ____________________________ 
Not at all     |    |     |     |     |     |     |     |     |     |       Totally 







Week 5: Medication and disease 






Surely you can recognise the above? At this stage, “popping pills” is not an unusual 
occurrence to you. Unfortunately with a chronic condition like osteoarthritis, taking 
medication is a huge part of trying to keep the symptoms at bay. Unfortunately it often 
comes with a lot of physical negatives and unanswered questions. One of the most 
common experiences for OA patients is that after taking the medications for many years 
– they seem to lose their effect. Why is that? Also, many OA patients take many different 
kinds of medication, without always understanding how they work and what they are for 
– what is each medication meant to do? In this section we will look at the different kinds 
of groups of medications and try to understand it all a little better. There are a few things 
that research has found out as well, and that is if a patient understands the medication 
and its purpose, the medication becomes more effective. 
 
Many kinds of drugs are used for osteoarthritis and its symptom management. The 
majority of them fall into one of 4 categories.  
 Analgesic Drugs 
 Anti-Inflammatory Drugs 
 Anti-spasmodic Drugs 







I am so tired of “popping pills” 
and I have no idea what it’s for! I 




The name is derived from the Greek word analgia: an-, "without", and -algia, "pain". In 
other words analgesic drugs are what we commonly refer to as “painkillers.” The 
analgesic drugs act in various ways on the nerves. These are the nerves in our brains (the 
central nervous system) and our bodies (the peripheral nervous system) peripheral and 
central nervous system. There are 3 main types of analgesic drugs, let us have a look at 
them: 
 
Mild Pain Killers 
These painkillers don’t treat the cause of the pain but they work on the nerves in the 
peripheral nervous system which are telling you that you are in pain. They basically tell 
the nerve to stop sending messages. I.e. they tell the nerve to shut up! This is exactly 
what is needed for people with osteoarthritis and associated chronic pain, because the 
painkillers decrease the number of signals in the peripheral nervous system – remember 
when pain has been ongoing for a long time, it often intensifies and “gets louder” even 
though your tissue is not getting more damaged. In other words the nervous system is 
malfunctioning and sending mixed up messages. The mild pain killers have very few side 
effects, which makes them attractive compared to some of the stronger medications. 
These medications are available over the counter. Examples of such drugs are: Panado, 
Paracetemol, Grandpa, Disprin, Asprin, Panadol, Calpol, Panaleve 
 
Strong Pain Killers - Opioid Analgesic Drugs (MORPHINE BASED)  
These drugs are a lot stronger than the normal pain killers. They are similar to a hormone 
that the body produces, called Opiates…which is why we call them Opioid Analgesics. 
These drugs work straight on the nerves by blocking the messages in the brain and spinal 
cord. These medications need to be used carefully as there is a small chance that they can 
produce dependence, addiction and tolerance. Other side effects include drowsiness, 
decreased alertness (take care when driving a car), sedation, elation (sudden joy) or 
dysphoria (unhappiness). Respiratory side effects can include feeling short of breath and 
not coughing as much as you should. People with asthma or chronic obstructive lung 
disease should be careful when using these drugs. Other side effects from these drugs 
can be nausea, dry mouth and vomiting, constipation and difficulty in passing urine and 
itching. If you take opioids for a long time, the effects often fade. Many oral opioids are 
used in the treatment of chronic pain. Combining opioids with other painkillers such as 
paracetamol and NSAIDs involves attacking the pain in the different areas of the nervous 
system. This often decreases your opioid requirements, which then leads to improved 
pain relief and a reduced risk of side effects. These medications require a prescription 
from your doctor. Examples of these drugs are: Morphine, Fentanyl, Methadone, 




Medium Strong Painkillers + Codeine 
These drugs are a combination between the Mild Pain Killers and the Opioid Analgesics. 
The dosage of codeine is much lower than the strong pain killers. They are stronger than 
the Mild Pain killers but weaker than the Opioid Analgesics. Anything with a “co” or a 
“codeine” added to the name will fall into this category. For Example: Panado Co, 
Myprodol and Empacod. These medications are sometimes available over the counter 
and you need to be careful if you are taking these and one of the other mild or strong 




Anti-inflammatory Drugs  
These drugs reduce inflammation. Inflammation is the body’s response to injury. For 
example when you twist your ankle, it will go hot and red and become swollen and 
painful. These are all signs of inflammation. Like pain, inflammation can be acute or 
chronic. Acute inflammation last only for a few days, whereas chronic inflammation lasts 
longer. Anti-inflammatory drugs treat both acute and chronic inflammation. Unlike 
analgesics they treat the cause; Anti-inflammatory drugs help to decrease the heat, 
redness and swelling. There are 2 types of Anti-inflammatory drugs.  
 
Non-Steroidal Anti-inflammatory drugs (NSAIDs).   
This group of drugs is effective against mild to moderate pain and 
inflammation. They are widely used for arthritis and pain 
conditions. “Non-steroidal” means that they are not steroids (i.e. they do not belong to 
the “cortisone” family). Steroids are very effective against inflammation, and the term 
NSAID is used to tell the difference between this group of drugs from the steroid family of 
drugs. 
“Anti-inflammatory” means that they are effective against inflammation. Some are better 
against pain and some better against inflammation. It is also important to know that 
different people react differently, so that one product might work well for one person, 
but may not be as effective in another person. It is important you talk to your doctor 
about these issues. 
Some of these drugs also have negative effects on the stomach and digestive system. 
They can cause constipation, ulceration in the stomach and even bleeding in the stomach. 
It is therefore important to take NSAIDs with or after food. If you have a sensitive 
stomach with these drugs your doctor will prescribe one of the new NSAID drugs which 
do not have the same effect on the stomach. With chronic pain it is important that you 
take these drugs regularly for them to be effective.  Examples of NSAIDS are: Ibuprofen, 
Brufen, Voltarin, Asprin/Disprin, Paracetamol, Pyroxicam, Betacin, Naproxen, 
Ketoprofen  Sometimes doctors will combine anti-inflammatory drugs with Mild Pain 
Killers because they work better together than each on its own. Some pills come with 
them already together in one pill. E.g. (Mypradol). 
 
Steroidal Anti-inflammatory Drugs 
These drugs are made to mimic natural steroids that your body produces. They are very 
strong anti-inflammatories and are often used for arthritic conditions. However there are 
negative effects of short term and long term use. In the long term it can cause high blood 
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pressure, high blood sugar levels, eye problems, fragile skin, osteoporosis and muscle 
wasting. Steroidal injections have fewer side effects than orally taken steroidal anti-




When a person is in pain, their muscles become very tense and can often spasm. These 
drugs are used to relieve the spasm. However they do come with severe side effects if 
taken for longer than recommend – especially if taken together with other chronic 
medication. It is therefore important to understand these when your doctor prescribes 
them. Commonly used antispasmodic medication used for chronic pain is:  Diazepam, 
Baclofen 
 
Anti-depressant & Anti-Epileptic Drugs 
The brain is very sensitive to chemicals therefore, there is something called a Blood-Brain 
Barrier, which filters all the blood going to the brain to make sure there are no chemicals 
in the blood that would harm the brain. Because of this, drugs like mild painkillers cannot 
reach the brain. Antidepressants and Antiepileptic drugs are able to pass through the 
barrier and act on the brain. For this reason they are given to patients with chronic pain. 
You remember all the changes to the nerves that happen in the brain in a person with 
chronic pain. These drugs can help to normalise the pain signals in the brain. They are 
given to chronic pain patients in much smaller doses than they would be given to a 
clinically depressed person or a person who has epilepsy.  
It is important that these drugs are taken regularly and for at least 2 weeks before they 
begin to be effective. Side effects can include: Scratchy eyes, drowsiness, dry mouth, 
constipation and blurred vision. But these side effects usually decrease with time.  
Examples of ANTIDEPRESSANTS are: Amitriptyline, Doxepin, Desipramine, Imipramine. 
Examples of ANTIEPILEPTICS are: Gabapentin, Topiramate, Vigabatin, Phenytoin, 





The Analgesic Ladder  
The analgesic ladder was designed by the World Health Organisation (WHO) to assist the 
doctors when prescribing analgesic drugs by suggesting a logical way for managing pain in 
chronic conditions. 
The ladder takes into consideration the analgesics we have already described earlier. At 
every step of the analgesic ladder non-opioid analgesics form the basis of the pain 
management. Paracetamol and NSAID should therefore always be prescribed with opioid 
analgesia (weak or strong). This is known as multi-modal analgesia and is the concept that 
pain is best managed, not by a single drug or therapy, but by combinations, with 
maximum effect whilst keeping side-effects low. Scientific research has demonstrated 
that when this happens pain relief is better, smaller amounts of pain killers are needed 






























Opiod for moderate 




3. Morphine / Oxycodone / Fentanyl 
2. Codein 
1. Aspirin / Paracetemol / NSAID 




Making informed treatment decisions 
By understanding the medication you are being prescribed, it will help you to understand 
its action as well as why it is to be taken together with other drugs or at specific times. 
For example it makes sense to take NSAIDS with healthy food, as we have learned that 
they can be rather rough on the stomach. If you were to take the NSAIDS with coffee and 
or very acidic foods, you have a high chance of getting an irritated stomach and or heart 
burn. In relation to the stronger pain killers, which might make you drowsy, they can be 
taken at a time where you don’t have to be so alert or have to drive. 
By understanding the medication you are on, research has shown us that the medication 
actually works better. Knowing more about your medicines also helps you understand, 
why you might at times have new and strange symptoms, these being related to some of 
the side effects we have discussed earlier. In this way your conversations with your 
doctor can improve, as you will be in a better position to tell him or her what does or 
does not seem to work for you.  
By understanding the medicinal options for osteoarthritis, it becomes easier for you to be 
part of the decision making process, when deciding on which treatment option to go for. 
You are slowly becoming your own expert. 
 
Appropriate use of medications 
What is really important to understand well, is the analgesic ladder. Here you can see 
how and why the different groups of medications are prescribed at what stage of your 
pain. Therefore you must make sure that whatever level you are on in terms of 
medication, that you don’t go ahead and start “prescribing” your own medication. You 
have to make these decisions together with your doctor by understanding them and 
communicating with him or her. 
 
Link between a healthy lifestyle, good nutrition and exercise 
It is really important to understand that medication is “only” one of the ways in which we 
can try and control your OA. That is also why we are doing this course. By a combination 
of your medication, a healthy lifestyle with good eating and exercise, decreasing the 
stresses in your life and maintaining your social life, you are on a good path to being the 
“manager” of your disease.  
Healthy food helps the uptake of your medication – remember you have more energy, 
which in turns will help you handle the many side effects. Also by eating a fibre rich diet, 
the side effects of NSAIDS will be less.  
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By adding exercise, activities and social engagements to your life, you become happier – 
remember the body’s own production of endorphins (the happy hormone)? The more we 
can produce of these, the better we feel, the more we want to do and the less we think 
about the pain and the downsides to living with OA. Also, by becoming an active 
“manager” of our lives, we can decide which stresses we can do something about, and 
which we cannot do anything about. We make the choices and make sure that when life 
does become a bit too stressful and hectic, to take a step back and say: I need to take a 
break from that, and focus on myself. This ultimately makes us better at communicating 
with our surroundings. 
 
Communicating effectively  
If we understand ourselves better, we can communicate better – it is as simple as that. 
We will be able to explain what is going, we will be able to show we are in charge of our 
own body and mind and thereby condition. We will be able to say, that although we are 
making good lifestyle choices for ourselves, there are days and times when things aren’t 
that great, where the pain is really bad, but we can still communicate and get ourselves 
back on track when the next “good” day comes along.  This makes is easier for our loved 
ones, friends and colleagues to help and support us.  In this way, it becomes easier to say: 
I need a bit of space to cope, so I can get back on track again. Can you help me with this 
today? When they see you are making the positive changes, they are more willing to 





Week 6: Continuing as a successful 
self-manager 
 
Recap of key components of successful self-managing 
Over the last six weeks you have learnt many skills which will help you to live positively 
with your condition. Research tells us that people living with any chronic disease who 
follow these steps have better quality of life, have fewer sick days and have better 
disease control. This is true for people living with high blood pressure, cancer or 
depression. You have learnt how to be a positive self-manager by being able to solve 
problems and set goals for yourself so that you can move forward with your life. You have 
learnt about the importance of exercise. How exercise can make you feel better, what 
exercises you should do and you have been doing those exercises too! You have learnt 
about the common symptoms that trouble people living with arthritis and you have 
learnt how to manage these symptoms. You have learnt about pain, what might be 
causing pain and how to treat and manage any pain you may have. You have learnt about 
food and eating well and how to make sure that your food is safe. With all of these you 
have also had the chance to practice doing things differently and to think about how this 
has made you feel.  
 
• Action planning for the future 
Now it is time to think about the future. People with long term illnesses often worry 
about what will happen if they get very sick, how they will manage their lives; how they 
will they look after themselves or their families. Worrying about these things can also 
make people feel sad, angry or depressed and helpless. These emotions may make 
everything feel even more difficult than they are. By working through this book you have 
already started to deal with these emotions. You have increased your knowledge and this 
is one of the main ways that we manage fear. If we are afraid of something, knowing 
more about it helps us to tackle the fear. If you know more about it, you can make a plan 
around it and making a plan helps us to get a sense of control over the very thing that we 
are afraid of.  
 
Planning for the future means thinking about the things that might happen to you in the 
future and planning for them. You may never ever need to use the plan as the things that 
you worry about may not happen, but, having a plan will help you to worry less about 
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these things and stay in control should they happen. You can use the action planning 
forms you have been using in this workbook to think about the things which worry you 
about the future. You can then start making a plan about what you want to do if these things 
happen. If you are not sure about making a plan, you may want to talk to different people who 
might be able to help you with this. 
 
Step 1: 
To be able to plan for the future, you need to decide what it is that you are worried about 
happening. This can be the hardest step to think about. For example you might be feeling 
very sad and depressed. First you need to think about why you are feeling that way. It 
might be that you are worried about not being able to look after your family if you 
become ill, or you may be worried about making someone else ill, or you may be worried 
about not being able to look after yourself, or you may be worried about dying. Once you 
have identified what it is that worries you and makes you feel sad, depressed, angry or 
afraid then you can start to make a plan to deal with it.  This will help you to 
feel less sad, depressed, angry or afraid.  
Write down here some of the things that might happen in the future that 
you worry about: 
1)          
        
 ______________________________ 
2)            
      ____________________________________ 
3)            











Now that you have identified some of the things which worry you, you can start to think 
about different ways to manage these things. If you were worried about becoming ill and 
not being able to look after yourself, write down a list of things that you would need help 
with. Then write down who you could ask to help you with those things. The people who 
can help might be family, friends, social workers, counsellors, nurses, physiotherapists, 
occupational therapists or doctors. If you are not sure who could help you, you may want 
to talk to someone you trust to help you identify who could help.  
 
Write down here three different things you could do to help plan for 
the things in the future that you worry about: 
1)         
    
2)         
    
3)             
 
There are many organisations and people who you can approach for help in planning for 
the future. These organisations include the Treatment Action Campaign (TAC), the Family 
and Marriage Society of South Africa (FAMSA), your church as well as the health care 
practitioners at your local clinic. The contact details for these organisations are included 
at the end of this section.  
Once you have completed Step 2 and written down three different things you could do to 
help plan for the things in the future that you worry about, choose the one which seems 
to suit you the best (this might be one which is easier or is cheaper or you know has 
worked for someone else). Now use this action plan form to work out what you will do if 
the thing which you worry about happening should happen. You can use this method to 
plan for any of the things which worry you.   
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Action Plan Form for Future Worries  
 
I am worried that in the future I will not be able to: 
            
             
 
My plan to manage this if it happens is to: 
             
            
            
            
            
            
        __________________________ 
(what, who, how, when?) 
 
How confident are you that you can complete this action plan? (Remember you are aiming for 7 






Not at all     |    |     |     |     |     |     |     |     |     |       Totally 




Changes I have made in my life: 
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
           
• Reflection on changes  
Over the last 6 weeks you have learnt many things about how to live with a chronic illness 
like osteoarthritis. You have learnt about the disease and how to be a successful self-
manager. This does not mean that you should be managing your health on your own. 
What it does mean is that you now have the ability to manage your health and your life 
as part of the health team. Remember you are not alone but are part of a team of people 
whose aim is to help you get the most out of life. We encourage you to keep using the 
skills you have learnt in this workbook to live positively. There are extra “Action Plan 
Forms” and “Exercise Diaries” in the back of the workbook for you to use. Tryto keep 
using these forms to help you remain active and give you a sense of purpose and 
accomplishment in your life. Being active and involved, using the skills you have learnt in 
this workbook are important steps in helping you achieve the best quality of life you can. 
In the box write down some of the important changes you have made in your life over the 











Things that are still missing in my life: 
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
           
Now, your final task is to think about changes you still want to make in your life. 
Remember, this is about getting the most out of life, increasing your quality of life. Are 
there still some things missing in your life, things that you would still like to be able to 
do? In the box below, write down some of the things that are still missing. You can use 
















You have now completed this workbook. By working 
through this workbook you made an important 
commitment to yourself. You have chosen to spend time 
looking after yourself and you have taken steps to 
overcome the many challenges that people living with 
osteoarthritis face. Do not put this workbook away; keep it 
somewhere safe where you will be able to review it from 
time to time. We all forget things at times and it is useful 
to be able to look back and remind ourselves of things we 
may have forgotten. We can also look back and see how 
far we have come. We hope that the knowledge and the skills you have learnt by using 






Start off by writing down your goal.  
Write down here what you want to be able to do:     _______ 
Now, what do you want to be able to do this week which will help you to reach your goal? 
Remember from your action plan to include:  
What you want to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
For example: This week, I will walk (what) around the block (how much) before lunch (when) 
three times (how many). 
This week I will: 
          (what) 
          (how much) 
          (when) 
          (how many?) 
 Exercise Planned Exercise I did... How did I feel? Do you need to 
change anything? 
e.g. 20 mins in a.m. after 
breakfast and in p.m. 
after supper 
 Very tired by the second session, I’m 
going to cut it down to morning only 
for this week. 
Monday    
Tuesday    
Wednesday    
Thursday    









Appendix G: Example of exercises and 
visualisation relaxation 
AppendixG-1 Summary of exercise regimen and progression 
Exercise Aim Activities Progression 
Walking  General warm up 
 
Improve cardiovascular  
fitness 
Walking on the spot for 
2 minutes 
Increase speed and  
duration  
Incorporate arm swings 
and boxing  
Lift knees higher 
Quadriceps 
Strength 
Improve  strength Sitting with knees at 90, 
extend the knee.  
Increase speed and 
repetitions 
With back against a wall, 






Single leg stance, 
supported by hand on a 
wall if necessary 
Increase duration 
Stand on soft matt  
Remove wall support 
Sit to stand Strength, control, 
function 
With arms folded, sit to 
stand from chair or 
bench 
Decrease height of chair 
Increase reps 
Step ups Strength, control, 
function 
With one foot on step, 
step on/off step 
Increase height of step 
Increase repetitions 
Stretches Range of motion and 
flexibility 
Stretches of major 
upper and lower limb 
muscles groups: neck, 
shoulder, arms, torso, 













Use smaller ball and 
throw to each other. 
Stand in line and pass 
ball backwards 




Start reading the beach visualization relaxation script here:  
Get comfortable. Sit in a supportive chair or lie on your back. Relax your body by releasing any 
areas of tension. Allow your arms to go limp... then your legs.... 
Feel your arms and legs becoming loose and relaxed... 
Now relax your neck and back by relaxing your spine.... release the hold of your muscles all the 
way from your head, down your neck....along each vertebra to the tip of your spine... 
Breathe deeply into your diaphragm, drawing air fully into your lungs.... and release the air with a 
whooshing sound.... Breathe in again, slowly.... pause for a moment.... and breathe out..... 
Draw a deep breath in.... and out....In..... out..... Become more and more relaxed with each 
breath.... 
Feel your body giving up all the tension.... becoming relaxed.... and calm.... peaceful.... 
Feel a wave of relaxation flow from the soles of your feet, to your ankles, lower legs, hips, pelvic 
area, abdomen, chest, back, hands, lower arms, elbows, upper arms, shoulders, neck, back of 
your head, face, and the top of your head.... 
Allow your entire body to rest heavily on the surface where you sit or lie. Now that your body is 
fully relaxed, allow the visualization relaxation to begin. 
Imagine you are walking toward the ocean.... walking through a beautiful, tropical forest.... 
You can hear the waves up ahead.... you can smell the ocean spray.... the air is moist and warm.... 
feel a pleasant, cool breeze blowing through the trees.... 
You walk along a path....coming closer to the sea....as you come to the edge of the trees, you see 
the brilliant aqua colour of the ocean ahead.... 
You walk out of the forest and onto a long stretch of white sand.... the sand is very soft powder.... 
imagine taking off your shoes, and walking through the hot, white sand toward the water.... 
The beach is wide and long.... Hear the waves crashing to the shore.... Smell the clean salt water 
and beach.... You gaze again toward the water.... it is a bright blue-green.... 
See the waves washing up onto the sand..... and receding back toward the ocean.... washing up.... 
and flowing back down..... enjoy the ever-repeating rhythm of the waves... 
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Imagine yourself walking toward the water.... over the fine, hot sand.... you are feeling very hot.... 
As you approach the water, you can feel the mist from the ocean on your skin. You walk closer to 
the waves, and feel the sand becoming wet and firm.... 
A wave washes over the sand toward you.... and touches your toes before receding... 
As you step forward, more waves wash over your feet... feel the cool water provide relief from 
the heat.... 
Walk further into the clear, clean water.... you can see the white sand under the water.... the 
water is a pleasant, relaxing temperature.... providing relief from the hot sun... cool but not 
cold.... 
You walk further into the water if you wish.... swim if you want to.... enjoy the ocean for a few 
minutes..... allow the visualization relaxation to deepen.... more and more relaxed... enjoy the 
ocean....  
Now you are feeling calm and refreshed... You walk back out of the water and onto the beach... 
Stroll along the beach at the water's edge.... free of worries... no stress... calm..... enjoying this 
holiday.... Up ahead is a comfortable lounge chair and towel, just for you... 
Sit or lie down in the chair, or spread the towel on the sand.... relax on the chair or towel.... 
enjoying the sun.... the breeze.... the waves..... 
You feel peaceful and relaxed.... allow all your stresses to melt away....  
When you are ready to return from your vacation, do so slowly.... 
Bring yourself back to your usual level of alertness and awareness.... 
Keep with you the feeling of calm and relaxation.... feeling ready to return to your day.... 









Appendix H: Socio- demographic 
information 
Attendance records for the six week intervention  



























Waiting time for the experimental group was M = 3.64, SD = 2.66 years and for the control 
group M = 3.58, SD = 2.28 years.  
 
Education 
Only one of the participants completed formal tertiary education (Accounting) and only 
two of the participants completed short informal courses (secretary administration and 






Besides the four main co-morbidities listed in the demographic questionnaire, participants 
were asked to record if they had any other co-morbidity.  
Appendix H-1 Other co-morbidities recorded on demographic information document 
 Participants 
(N = 19) 
Exp 
Group 
(n = 9) 
Cont 
Group 
(n = 10) 
Co- morbidities     
Cholesterol 8 4 4 
Cancer – prostate 1 0 1 
Cancer – breast 1 0 1 
Anxiety/depression 1 1 0 
Sinusitis 2 2 0 
Allergies 1 0 1 
Spinal OA 1 0 1 
Bullous pemphigoid 1 1 0 
Previous stroke 1 0 1 
Previous abdominal surgery/ 
Kidney cancer/ spinal surgery 
1 0 1 
Previous brain surgery/goitre surgery 1 1 0 
















Appendix I: Full pain results 
Pain severity score subgroup analysis: OA hip, OA knee and 
combined hip and knee OA 
 
Appendix I-1 Detailed PSS for OA hip, OA knee and combined hip and knee OA subgroups 
 
Participants 
N = 42 
Experimental Group 
n = 20 
Control Group 
n = 22 
 Mean ±SD Mean ± SD Mean± SD 




5.27 ± 2.89 
6.82 ± 1.77 
7.14 ± 2.15 
6.35 ± 2.84 
6.86 ± 2.13 
8.50 ± 1.27 
4.37 ± 2.86 
6.78 ± 1.48 
5.79 ± 2.04 




4.59 ± 2.80 
5.34 ± 1.83 
5.19 ± 3.12 
5.00 ± 3.41 
4.61 ± 1.93 
3.67 ± 3.27* 
4.25 ± 2.47 
6.00 ± 1.53 
6.71 ± 2.26 




4.86 ± 3.22 
5.80 ± 2.83 
4.44 ± 3.39 
4.55 ± 3.52 
4.56 ± 3.50 
4.38 ± 3.72* 
5.13 ± 3.27 
6.93 ± 1.48 
4.50 ± 3.39 




5.30 ± 2.98 
5.61 ± 3.01 
4.90 ± 2.94 
5.45 ± 3.13 
3.19 ± 2.65** 
5.33 ± 3.20 
5.17 ± 3.14 
7.78 ± 0.88** 
4.46 ± 2.89 
*Indicates a significant improvement in PSS of OA both hip and knee subgroup in the experimental group 





























Indicates a significant improvement in PSS of OA both hip and knee subgroup at week 6 (p = 0.02) 
Indicates a significant improvement in PSS of OA knee subgroup at month 6 (p = 0.03) 
Appendix I -1 Change in PSS of OA hip, knee and both hip and knee subgroups in 



























Appendix I-2 Change in PSS of OA hip, knee, both hip and knee subgroups in control 

































 Indicates a significant improvement in PSS in OA of both hip and knee subgroup within the experimental group at week 
6 (p < 0.01) and 12 (p = 0.03) 




































BPI Worst, least, average and current pain scores  
 
Appendix I-2 Detailed BPI scores showing worst, least, average and current pain (N = 42) 
 
Participants 
N = 42 
Experimental 
Group 
n = 20 
Control Group 
n = 22 
 Mean  ±SD Mean ± SD Mean ± SD 





8.17 ± 2.24 
5.63 ±2.95 


























5.14 ±3.23  















5.62 ± 3.12 
5.64 ±  3.32 


























































Indicates a significant improvement in the least PSS in the experimental group at week 6, 12 and month 6 (p < 0.01) 


































































































Indicates a significant improvement in the current PSS in the experimental group at week 6 and 12 (p < 0.01) and 
month 6 (p = 0.02) 
Appendix I-8 Change in current PSS (N= 42)  
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Pain interference score: subgroup analysis of OA hip, knee, both hip 
and knee 
 
Appendix I-3Detailed PIS for OA hip, knee, both hip and knee subgroups (N = 42) 
 
Participants 
N = 42 
Experimental Group 
n = 20 
Control Group 
n = 22 
 Mean ±SD Mean ± SD Mean± SD 





5.50 ± 2.71 
6.68 ± 2.29 
7.82 ± 1.49 
6.71 ± 3.03 
5.46 ± 2.14 
8.72 ± 1.20 
4.50 ± 2.17 
7.78 ± 1.91 
6.93 ± 1.24 




4.05 ± 2.15 
4.82 ± 2.50 
4.65 ± 2.78 
4.36 ± 1.86 
3.27 ± 2.38 
2.80 ± 2.50* 
3.78 ± 2.48 
6.21 ± 1.72 
6.50 ± 1.58 




5.14 ± 1.94 
5.43 ± 3.21 
5.38 ± 2.96 
5.14 ± 1.41 
4.21 ± 3.60 
5.14 ± 3.45* 
5.14 ± 2.45 
6.54 ± 2.49 
5.62 ± 2.68 




4.60 ± 2.58 
4.70 ± 3.23 
5.32 ± 2.48 
4.40 ± 2.08 
2.02 ± 2.24** 
4.95 ± 2.72* 
4.76 ± 3.13 
7.11 ± 1.64** 
5.69 ± 2.41 
** Indicates a significant improvement in PSS of OA knee subgroup between groups  




























Indicates a significant improvement in PIS of OA knee subgroup (p = 0.04) 
Indicates a significant improvement in PIS of OA both hip and knee subgroup (p < 0.01)  
Appendix I -9 Change in PIS of OA hip, OA knee and combined hip and knee OA subgroups 






























Appendix I-10 Change in PIS of OA hip, OA knee and combined hip and knee OA 

































Indicates a significant improvement in PIS of OA both hip and knee subgroup in the experimental group at week 6 (p < 
0.01), week 12 and month 6 (p = 0.02) 










































Percentage pain relief from medication and medication usage  
 
Appendix I-4 Percentage pain relief from medication (N = 42) 
 Participants 
N = 42 
Experimental Group 
 n = 20 
Control Group 
 n = 22 
 Mean ± SD Mean ± SD Mean ± SD 
Percentage pain relief from medication 
Baseline  
Week 6  
Week 12  
Month 6 
45.50 ± 27.64 
62.43 ± 22.41 
54.86 ± 22.93 
61.17 ± 20.89 
38.42 ± 25.88 
60.59 ± 24.87 
56.67 ± 23.20 
58.07 ± 24.68 
51.90 ± 28.22 
64.00 ± 20.62 
53.50 ± 23.23 
63.50 ± 17.85 
    
 
 

















































It is noted that considerably more participants from the control group use analgesia and 
anti-inflammatories than the experimental group, however there is no significant 
difference between groups; although at week six the difference approached significance (p 
= 0.06).  
  
Appendix I-5 Medication usage for the relief of OA symptoms (N = 42) 
 Participants 
N = 42 
Exp Group 
n = 20 
ContGroup 
n = 22 
 Number Number Number 




































































N = 42 
Exp Group 
n = 20 
Cont Group 
n = 22 
 Number Number Number 


























Appendix J: Full function results 
Physical performance task battery walk tests – 15m fastest and 
normal speed 
 
Appendix J-1 Detailed 15m fastest and normal speed walk scores (N = 42) 
 Participants 
N = 42 
Experimental Group 
n = 20 
Control Group 
n = 22 
 Mean ± SD Mean ± SD Mean± SD 
15 m fastest walk (sec)    
Baseline  18.04 ± 5.91 18.65 ± 6.27 17.51 ± 5.67 
Week 6  18.12 ± 725 16.56 ± 6.27 19.53 ± 7.92 
Week  12 16.91 ± 6.12 15.52 ± 6.33* 18.17 ± 5.77 
Month 6 17.71 ± 7.93 15.09 ± 6.04** 20.10 ± 8.79** 
15 m normal walk (sec)    
Baseline 23.20 ± 7.58 24.82 ± 8.43 21.81 ± 6.64 
Week 6  22.97 ± 6.99 21.76 ± 6.46 24.07 ± 7.41 
Week  12 20.79 ± 6.64 19.42 ± 5.99* 22.03 ± 7.09 
Month 6 21.20 ± 7.39 18.60 ± 5.45* 23.57 ± 8.21 
**Indicates a significant improvement in the time taken to walk 15m at fastest speed between groups 





Physical performance task battery walk tests – fastest speed: 
 
Appendix J-2 Detailed time taken to walk 15m at fastest speed in OA hip, knee, both hip 
and knee subgroups 
 
Participants 
N = 42 
Experimental Group 
n = 20 
Control Group 
n = 22 
 Mean ±SD Mean ± SD Mean± SD 
Baseline 15m fastest 




17.44 ± 5.30 
19.58 ± 7.42 
16.09 ± 2.32 
20.11 ± 6.78 
19.93 ± 7.73 
15.75 ± 1.93 
15.66 ± 3.67 
19.26 ± 7.54 
16.44 ± 2.81 




19.61 ± 7.70 
19.20 ± 8.47 
15.03 ± 3.19 
22.23 ± 9.81 
15.80 ± 3.65 
13.00 ± 1.67 
17.43 ± 5.40 
22.27 ±10.47 
17.07 ± 3.11 




18.98 ± 7.33 
17.21 ± 6.38 
14.53± 3.66 
21.10 ± 9.78 
14.75 ± 3.99* 
12.02 ± 1.87* 
17.22 ± 4.77 
19.42 ± 7.48 
17.04 ± 3.29 




18.48 ± 7.21 
18.64 ± 10.00 
15.54 ± 4.05 
20.46 ± 10.03 
13.40 ± 2.78* 
13.13 ± 2.70 
16.82 ± 4.03 
23.35 ± 11.89 
17.96 ±3.85 
* Indicates a significant improvement in time taken to walk 15m at fastest speed in experimental OA 































Indicates a significant improvement in the OA knee subgroup at week 12 (p = 0.01) and month 6 (p < 0.01) 
Appendix J-1 Change in OA hip, knee, both hip and knee subgroups in the experimental 






























Appendix J-2 Change in OA hip, knee, both hip and knee subgroups in the control group 





































Indicates a significant improvement in time taken in OA both hip and knee in experimental group at week 12 (p = 0.04) 
Appendix J-4 Change in time taken for 15m fastest speed walk of OA both hip and knee 


































































Physical performance task battery walk tests – normal speed: 
 
Appendix J-3 Detailed time taken to walk 15m at normal speed for OA hip, knee and both 
hip and knee subgroups 
 
Participants 
N = 42 
Experimental 
Group 
n = 20 
Control Group 
n = 22 
 Mean ±SD Mean ± SD Mean± SD 
Baseline 15m normal 




21.59 ± 5.86 
23.72 ± 9.49 
23.72 ± 5.52 
25.95 ± 6.78 
26.80 ± 11.22 
21.09 ± 1.37 
18.68 ± 2.97 
20.95 ± 7.08 
26.36 ± 6.96 




25.13 ± 7.04 
23.53 ± 7.85 
20.08 ± 4.65 
28.24 ± 7.74 
21.07 ± 4.93 
17.38 ± 2.41 
22.53 ± 5.78 
25.75 ± 9.50 
22.79 ± 4.91 




21.74 ± 6.61 
21.70± 7.22 
18.48 ± 5.60 
24.09 ± 8.43 
19.82 ± 4.41* 
14.94 ± 1.57 
19.78 ± 4.53 
23.38 ± 8.97  
22.03 ± 6.02 




21.60 ± 6.38 
22.23 ± 8.76 
19.21 ± 5.88 
22.78 ± 9.09 
18.22 ± 2.92* 
15.69 ± 2.23 
20.61 ± 3.58 
25.84 ± 10.74 
22.73 ± 6.42 
* Indicates a significant improvement in time taken to walk 15m at fastest speed in experimental OA 































Indicates a significant improvement in the time taken to walk 15m at normal speed of OA knee subgroup at week 12 (p 
= 0.03) and month 6 (p < 0.01) 
Appendix J-6 Change in OA hip, knee, both hip and knee subgroups in the experimental 
































Appendix J-7 Change in OA hip, knee, both hip and knee subgroups in the control group 












































































































Physical performance task battery six minute walk test  
 
Appendix J-4 Six minute walk test (N = 42) 
 Participants 
N = 42 
Experimental Group 
n = 20 
Control Group 
n = 22 
 Mean± SD Mean ± SD Mean ± SD 
Six minute walk test (m)   
Baseline  280.21 ± 109.55 267.80 ± 123.90 291.5 ± 96.24 
Week 6  308.48 ± 105.67 315.65 ± 124.81 301.95 ± 87.26 
Week  12 312.43 ± 125.58 340.85 ± 145.19* 286.59 ± 101.23 
Month 6 317.86 ± 122.85 347.85 ± 123.55* 290.59 ± 118.41 
*Indicates a significant improvement in six minute walk test for the experimental group 
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N = 42 
Experimental Group 
n = 20 
Control Group 
n = 22 
 Mean ±SD Mean ± SD Mean± SD 
Baseline 6MWT 




266.73 ± 142.09 
274.32 ±101.66 
301.92 ± 93.32 
250.60 ± 186.81 
253.00 ± 113.10 
304.33 ±87.47 
280.17 ± 109.46 
293.50 ± 91.85 
299.50 ± 107.20 




284.45 ± 119.35 
288.58 ± 96.60 
362.00 ± 94.93 
271.60 ± 146.85 
271.78 ± 108.51 
418.17 ±71.31* 
295.17 ±104.57 
303.70 ± 87.54 
305.83 ± 84.67 




285.45 ± 135.87 
285.21 ± 114.28 
380.25 ± 116.63 
256.80 ± 142.54 
309.00 ± 131.54 
458.67 ±103.84* 
309.33 ± 138.42 
263.80 ± 98.76 
301.83 ± 66.21 




305.09 ± 142.59 
286.95 ± 112.79 
378.50 ± 105.49 
273.80 ± 155.47 
322.78 ±  91.54* 
447.17 ±82.50* 
331.67 ± 139.77 
254.70 ± 124.72 
309.83 ± 79.74 
* Indicates a significant improvement in distance walked in experimental OA knee and both hip and 

































Indicates a significant improvement in the distance walked in 6 minutes for OA hip subgroup at week 6 (p = 0.01), 12 
and month 6 (p < 0.01) 
Appendix J-11 Change in OA hip, knee, both hip and knee subgroups in the experimental 
























Appendix J-12 Change in OA hip, knee, both hip and knee subgroups in the control group 
































































Indicates a significant improvement in the experimental OA knee subgroup at month 6 (p = 0.01) 



























Indicates a significant improvement in experimental OA both hip and knee subgroup at week 6 (p = 0.02), 12 and month 6 (p < 0.01) 
Appendix J-15 Change in OA both hip and knee subgroup (n = 12)   
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Physical performance task battery repeated sit to stand test  
 
Appendix J-6 Repeated sit to stand test (N = 42) 
 Participants 
N = 42 
Experimental 
Group 
n = 20 
Control Group  
n = 22 
 Mean± SD Mean  ± SD Mean  ± SD 
Repeated sit stand (sec)    
Baseline  9.82 ± 3.96 10.05 ± 4.77 9.61 ± 3.15 
Week 6  7.80 ± 2.82 6.45 ± 2.18* 9.04 ± 2.80 
Week  12 6.89 ± 2.23 6.13 ± 1.85* 7.57 ± 2.37* 
Month 6 6.45 ± 2.34 5.66 ± 1.63*  7.17 ± 2.67* 
*Indicated a significant improvement in repeated sit to stand for the experimental and control groups 
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Appendix J-7 Detailed time taken for repeated sit-stand for OA hip, knee and both hip 
and knee subgroups 
 
Participants 
N = 42 
Experimental 
Group 
n = 20 
Control 
Group 
n = 22 
 Mean ±SD Mean ± SD Mean± SD 
Baseline repeated sitstand 




10.03 ± 3.03 
9.21 ± 4.53 
6.05 ± 3.00 
11.31 ± 2.91 
8.85 ± 5.38 
10.80 ± 5.32 
8.96 ± 2.94 
9.54 ± 3.89 
10.36 ± 2.19 




7.77 ± 2.28 
7.35 ± 2.52 
8.56 ± 3.67 
7.01 ± 1.46* 
5.95 ± 1.24 
6.72 ± 3.61 
8.39 ± 2.78 
8.61 ± 2.76 
10.40 ± 2.91 




7.34 ± 2.32 
6.63± 1.58 
6.88 ± 3.05 
6.86 ± 1.68* 
6.21 ± 2.00 
5.41 ± 1.80 
7.74 ± 2.85 
7.01 ± 1.05  
8.34 ± 3.47 




6.68 ± 2.06 
6.50 ± 2.11 
6.05 ± 3.00 
7.05 ± 1.49* 
5.80 ± 1.45 
4.31 ± 0.90 
6.62 ± 2.57 
7.13 ± 2.46 
7.80 ± 3.41 
* Indicates a significant improvement in time taken for repeated sit- stand in experimental OA hip 































Appendix J-16 Change in OA hip, knee, both hip and knee subgroups in the experimental 































Appendix J-17 Change in OA hip, knee, both hip and knee subgroups in the control group 



























































































Indicates a significant improvement in experimental OA hip subgroup at week 6, 12 and month 6 (p < 0.01) 





Physical performance task battery reach tests – forwards and 
upwards 
 
Appendix J-8 Forward and upward reach test (N = 42) 
 Participants 
N = 42 
Experimental 
Group 
n = 20 
Control Group 
n = 22 
 Mean  ± SD Mean  ± SD Mean  ± SD 
Forward reach (cm)    
Baseline  83.69 ± 16.51 81.53 ± 21.74 85.66 ± 9.79 
Week 6  85.27 ± 16.46 84.58 ± 21.78 85.91 ± 9.95 
Week  12 86.01 ± 16.61 86.03 ± 22.08 86.00 ± 9.87 
Month 6 87.27 ± 17.45 87.18 ± 23.14 87.36 ± 10.5  
Upward reach (sec)    
Baseline 8.93 ± 3.53 8.73 ± 3.72 9.09 ± 3.46 
Week 6 8.72 ± 3.57 7.48 ± 3.06 9.90 ± 3.71 
Week  12 7.78 ± 2.74 7.35 ± 3.03 8.15 ± 2.47 
Month 6 7.37 ± 2.42 6.78 ± 2.04 7.88 ± 2.64 





Physical performance task battery sock test  
 
Appendix J-9 Ability to don a sock (N =42) 
 Participants 
N = 42 
Exp Group 
n = 20 
Cont Group 










Sock test     













































Appendix J-10 Time taken to don a sock on right and left foot (N = 42) 
 Participants 
N = 42 
Experimental 
Group 
n = 20  
Control 
Group 
n = 22 
 
 
Mean ± SD Mean ± SD Mean ± SD 
Significance 
test 
Able: Time right  
sock (sec)    
F(3, 84) = 1.13, 





16.73 ± 20.41 
14.48 ±17.22 
11.08 ± 8.94 
8.59 ± 5.66 
12.52 ± 17.49  
10.00 ± 8.09 
10.20 ± 10.97 
7.06 ± 5.61 
20.44 ± 2.55 
18.96 ±22.41 
11.92 ± 6.69 
10.22 ± 5.40 
 
Able: Time left  
sock (sec) 
   
F(3, 78) = 3.60,  





14.64 ± 11.14 
13.11 ± 901  
11.76 ± 9.18 
8.48 ± 5.19 
14.71 ±12.61 
9.43 ± 5.74* 
10.35 ± 9.16 
6.27 ± 3.54* 
14.56 ±9.90 
17.03 ± 0.32 
13.18 ± 9.25 
10.58 ± 5.70 
 
p = 0.04 
 
p < 0.01 




Appendix K: Full disability results 
HAQ and HAQ pain VAS scores  
 
Appendix K-1 HAQ disability and pain VAS scores (N = 42) 
 Participants 
N = 42 
Experimental Group 
n = 20 
Control Group 
n = 22 
 Mean ±SD Mean ±SD Mean ±SD 
HAQ score    
Baseline  1.56 ± 0.55 1.61 ± 0.59  1.51 ± 0.52 
Week 6  1.17 ± 0.60  0.92 ± 0.53* 1.39 ± 0.59 
Week  12 1.21 ± 0.65 1.07 ± 0.63 * 1.33 ± 0.65 
Month 6 1.23 ± 0.73   1.01 ± 0.66* 1.43 ± 0.75 
HAQ VAS    
Baseline  69.02 ± 23.40 73.35 ±25.45 65.09 ±21.18 
Week 6  56.67 ± 32.32 44.30 ± 33.70* 67.91 ± 27.10 
Week  12 58.36 ± 32.41 53.35 ± 34.58* 62.91 ± 30.38 
Month 6 59.90 ± 31.09 48.30 ± 33.95* 70.45 ± 24.47 





Correlation between the two pain severity scores  
 














































Correlation between the two pain severity scores for OA of the knee  
 




































Appendix K-2 Detailed HAQ for OA hip, knee, both hip and knee subgroups (N = 42) 
 
Participants 
N = 42 
Experimental Group 
n = 20 
Control Group 
n = 22 
 Mean ±SD Mean ± SD Mean± SD 
Baseline HAQ 




1.54 ± 0.57 
1.36 ± 0.53 
1.89 ± 0.42 
1.85 ± 0.38 
1.31 ± 0.65 
1.86 ± 0.47 
1.27 ± 0.60 
1.41 ± 0.42 
1.92 ± 0.40 




1.21 ± 0.60 
0.97 ± 0.56 
1.45 ± 0.59 
1.20 ± 0.60* 
0.64 ± 0.42* 
1.11 ± 0.48* 
1.21 ± 0.65 
1.26 ± 0.52 
1.80 ± 0.51 




1.24 ± 0.61 
1.14 ± 0.77 
1.29 ± 0.49 
1.28 ± 0.51 
0.78 ± 0.73* 
1.34 ± 0.42 
1.21 ± 0.72 
1.46 ± 0.68 
1.23 ± 0.58* 




1.23 ± 0.62 
1.07 ± 0.82 
1.50 ± 0.65 
1.30 ± 0.51 
0.63 ± 0.62* 
1.35 ± 0.57 
1.17 ± 0.75 
1.46 ± 0.79 
1.65 ± 0.74 
* Indicates a significant improvement in HAQ OA knee, hip and both hip and knee subgroups in 

































Indicates a significant improvement in HAQ of OA knee subgroup at week 6 (p < 0.01), week 12 (p = 0.02) and month 6 
(p < 0.01) 
Indicates a significant improvement in HAQ of OA both hip and knee subgroup at week 6 (p < 0.01) 
Indicates a significant improvement in HAQ of OA hip subgroup at week 6 (p = 0.048) 
Appendix K-3 Change in HAQ of OA knee, hip and both hip and knee subgroups in 



































Indicates a significant improvement in HAQ of OA both hip and knee subgroup at week 12 (p = 0.03) 
Appendix K-4 Change in HAQ of OA knee, hip and both hip and knee subgroups in control 




































Indicates a significant improvement in HAQ of OA knee subgroup at week 6 (p < 0.01), week 12 (p = 0.03) and month 6 
(p < 0.01) 




































Indicates a significant improvement in OA both hip and knee in experimental group at week 6 (p < 0.01) 
Indicates a significant improvement in OA both hip and knee in control group at week 12 (p < 0.01) 












































Appendix K-3 Detailed HAQ pain VAS of OA hip, knee, both hip and knee subgroups 
 
Participants 
N = 42 
Experimental 
Group 
n = 20 
Control Group 
n = 22 
 Mean ±SD Mean ± SD Mean± SD 
Baseline HAQ pain VAS 




62.36 ± 34.89 
69.89 ± 15.61 
73.75 ± 21.57 
68.00 ± 39.11 
70.22 ± 19.26 
82.50 ± 22.32 
57.67 ± 33.96 
69.60 ± 12.54 
65.00 ± 18.49 




57.45 ± 39.37 
57.74 ± 28.13 
54.25 ± 34.38 
50.40 ± 45.64 
38.67 ± 24.62** 
47.67 ± 39.65 
63.33 ± 36.65 
74.90 ± 18.77** 
60.83 ± 30.39 




57.64 ± 34.46 
61.11 ± 30.48 
54.67 ± 35.87 
58.60 ± 38.76 
48.00 ± 33.73 
57.00 ± 37.92 
56.83 ± 34.23 
72.90 ± 22.93 
52.33 ± 37.14 




66.64 ± 29.73 
54.37 ± 34.30 
62.50 ± 27.71  
66.00 ± 33.53 
26.78 ± 27.19** 
65.83 ± 27.97 
67.17 ± 29.44 
79.20 ± 15.78** 
59.17 ± 29.67  





























Indicates a significant improvement in HAQ VAS of OA knee subgroup at month 6 (p < 0.01) 
Appendix K-8 Change in HAQ VAS of OA hip, knee, both hip and knee subgroups in the 

























Appendix K-9 Change in HAQ VAS of OA hip, knee, both hip and knee subgroups in the 




























































Appendix L: Full Self-efficacy 
results 
 
Appendix L-1 Self-efficacy scores (N = 42) 
 Participants 
N = 42 
Experimental 
Group 
n = 20 
Control Group 
n = 22 
 Mean ±SD Mean ±SD Mean ±SD 
Self-efficacy score    
Baseline  6.30 ± 2.38 5.75 ± 2.71  6.80 ± 1.98 
Week 6  6.52 ± 2.21  7.15 ± 2.32 5.95 ± 1.99  
Week  12 6.11 ± 2.27 6.68 ± 2.33  5.59 ± 2.14  
Month 6 6.92 ± 2.02   7.33 ± 2.13 6.56 ± 1.88 













































Appendix L-1 Change in self-efficacy scores (N = 42) 
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Appendix M: Full Health related 
quality of life results 
EQ-5D Health index and current state of health  
 
Appendix M-1 Health index and current state of health (N = 42) 
 Participants 
N = 42 
Experimental 
Group 
 n = 20 
Control Group 
n = 22 
 Mean  ± SD Mean  ± SD Mean  ± SD 
Health index    
Baseline  0.33 ±  0.33 0.31 ± 0.34 0.35 ± 0.32 
Week 6 0.56 ± 0.31 0.58 ± 0.36 0.55 ±0.26 
Week  12 0.46 ± 0.36 0.53 ± 0.36 0.4 ±0.36 
Month 6 0.47 ± 0.36 0.51 ± 0.38 0.43 ± 0.35 
Current state of health    
Baseline  58.26 ±20.46 57.45 ± 23.74 59.00 ± 17.5 
Week 6 59.67 ± 20.07 58.25 ± 24.13 60.95 ± 16.01 
Week  12 63.12 ± 24.07 63.3 ± 24.51 62.95 ± 24.23 
Month 6 66.19 ± 22.49 65.75 ± 23.13 66.59 ± 22.43 









































































EQ-5D category domains 
 
Appendix M-2 Mobility, self-care, activity, pain/discomfort, anxiety/depression (N = 42) 
 Participants 
N = 42 
Exp Group 
n = 20 
Cont Group 
n = 22 
 
 
Number Number Number 
Significance 
test 
Mobility  – Baseline   n = 22  
I have no problems 
walking  
I have some problems 
walking  













χ2 =0.2.94;  
p = 0.23 
Mobility  – Week 6     
I have no problems 
walking  
I have some problems 
walking  













χ2 =0.31;  
p = 0.58 
Mobility  – Week  12     
I have no problems 
walking  
I have some problems 
walking  













χ2 = 1.55;  
p = 0.46 
Mobility  – Month 6     
I have no problems 
walking  
I have some problems 
walking  













χ2 = 2.44;  
p =  0.12 





N = 42 
Exp 
Group  
n = 20 
Cont 
Group 
n = 22 
 
 
Number Number Number 
Significance 
test 
Self-care - Baseline      
I have no problems with  
self-care 
I have some problems  
self-care 
















χ2 = 3.53;  
p = 0.32 
Self-care Week 6      
I have no problems with  
self-care 
I have some problems  
self-care 
















χ2 = 3.41;  
p = 0.18 
Self-care – Week 12     
I have no problems with  
self-care 
I have some problems  
with self-care 
















χ2 = 0.96;  
p = 0.62 
Self-care – Month 6     
I have no problems with  
self-care 
I have some problems  
with self-care 
















χ2 = 0.11;  
p = 0.75 






N = 42 
Exp 
Group  
n = 20 
Cont 
Group 
n = 22 
 
 Number Number Number Test 
Activity - Baseline     
I have no problems with usual 
activities 
I have some problems with usual 
activities 





















χ2 = 1.42;  
p = 0.70 
Activity – Week 6     
I have no problems with usual 
activities 
I have some problems with usual 
activities 

















χ2 = 5.05;  
p = 0.08 
Activity – Week 12     
I have no problems with usual 
activities 
I have some problems with usual 
activities 

















χ2 = 2.44; 
 p = 0.29 
Activity – Month 6     
I have no problems with usual 
activities 
I have some problems with usual 
activities 

















χ2 = 4.05;  
p = 0.13 
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Pain/discomfort – Baseline     
I have no pain/discomfort 
I have moderate pain/discomfort 










χ2 = 0.36;  
p = 0.84 
Pain/discomfort – Week 6     
I have no pain/discomfort 
I have moderate pain/discomfort 










χ2 = 3.56;  
p = 0.17 
Pain/discomfort – Week 12     
I have no pain/discomfort 
I have moderate pain/discomfort 










χ2 = 0.74;  
p = 0.69 
Pain/discomfort – Month 6     
I have no pain/discomfort 
I have moderate pain/discomfort 










χ2 = 0.44;  
p = 0.80 






N = 42 
Exp Group  
n = 20 
Cont 
Group 
n = 22 
 
 Number Number Number Test 
Anxiety/depression – Baseline     
I have no 
anxiety/depression 
I have moderate 
anxiety/depression 

















χ2 = 0.35; 
 p = 0.84 
Anxiety/depression – Week 6     
I have no 
anxiety/depression 
I have moderate 
anxiety/depression 

















χ2 = 3.88;  
p = 0.14 
Anxiety/depression – Week 12     
I have no 
anxiety/depression 
I have moderate 
anxiety/depression 

















χ2 = 3.56;  
p = 0.17 
Anxiety/depression – Month 6     
I have no 
anxiety/depression 
I have moderate 
anxiety/depression 

















χ2 = 2.60;  
p = 0.27 




Appendix N: Full Body mass index 
results 
 
Appendix N-1 Change in BMI (kg/m2) (N = 42) 
 Participants 
N = 42 
Experimental 
Group 
n = 20 
Control 
Group 
n = 22 
 
 Mean  ± SD Mean  ± SD Mean  ± SD Significance 
test 
BMI (kg/m2)    P = 0.56 
Baseline  35.78 ± 8.81 33.69 ± 9.21  37.68 ± 8.17  
Week  12 35.54 ± 9.00 33.48 ± 9.22  37.41 ± 8.58   
Month 6 35.76 ± 8.92   33.55 ± 8.92 37.77± 8.63  







Appendix P: Full assistive device 
usage 
 
Appendix P-1 RA recorded assistive device usage (N = 42) 
 Participants 
N = 42 
Experimental Group 
n = 20 
Control Group 
n = 22 
Assistive device used Number Number Number 










































































































    
 
There was a significant change noted (χ2= 19.14, p < 0.01) in usage of AD between baseline 
and week sixand week 12 (N = 42): fiveparticipants using an AD at baseline were not using 
an AD at week six.Two participants not using an AD at baseline were using an AD at week 
six. 35 participants usage were unchanged. 
 
There was a significant change noted (χ2= 24.37, p < 0.01) in usage of AD between baseline 
and month six (N = 42): threeparticipants using an AD at week 0 were still not using an AD 
at month six.Two participants not using an AD at baseline were now using an AD at month 











Appendix Q: Themes and full 
responses to open ended 
questionnaire 
 
Appendix Q-1 Themes emerged from participant's responses to open ended questions 
   
 Examples of the experimental group’s answers to open ended 
questions  
 
Theme:  Question 1: Did you find the 6 week course helpful to you in 
any way?  

























Participant B: “Yes.” 
Participant K: “Yes the information about healthy eating and 
that I don’t have to drink pills all the time.” 
Participant DD: “Learnt more exercises, especially with 
equipment.” 
Participant CC: “How to live healthier… “ 
Participant NN: “To eat healthy and how to lose weight.” 
Participant WW: ”…learnt about how to control pain, eat 
healthier…” 
Participant YY: “Very helpful. Helped me physically, taught me 
exercise and better eating habits.” 
 
Participant A: “Yes, I began with two crutches, now I walk most 
of the time with just one crutch and short distance with none.” 
Participant P: “This course helping me very much because I 
moving myself every day.” 
Participant R: “It was very helpful, especially the exercising…”  
Participant S: “It was helpful; I can go to the shops now when I 
wake up. When I feel pain I don’t need to take pain pills 
anymore, instead to rather exercise or walk.” 
Participant NN: “Yes, much more mobile which decreases pain. 
Exercises.” 



















Participant A: “Much better with pain and sometimes without 
pain.” 
Participant N: “Yes, pain relief.” 
Participant R: ”…and now I don’t have to rely on pain pills 
anymore.” 
Participant V: “All the pain was gone.” 
Participant AA: “It gave my motivation again because my life 
was all about pain before. Now I use my workbook and it helps 
a lot.” 
Participant CC: “…and it decreased my pain.” 
Participant XX: “…and to decrease pain.” 
 
Participant L: “It gave me the opportunity to get out and meet 
people with the same sort of problem” 
Participant UU: “Made me very positive.” 
Participant WW: “It made me very positive… very motivating to 
exercise in a group instead of alone.” 
 
 



















Participant A: “I learnt a lot.” 
Participant B: “The people and Melissa who helped me a lot.” 
Participant P: “I like this course because I learn a lot and I’m so 
happy” 
Participant R: “Learnt a lot about stress management and diet.” 
Participant NN: “Everything that Melissa taught us…”  
Participant UU: “Everything that we learnt.” 
 
Participant C: “everything, I can walk better and I feel better.” 
Participant K: “I enjoyed it a lot. The exercise was very nice, at 
the hospital and at home.” 
Participant V: “…exercise.” 
 
Participant S: “I learnt how to put ice on my knee to relieve the 
pain.” 









Participant A: “Fun. Built my self-confidence” 
Participant L: “Exercise with people, it was fun.” 
Participant V: “The people who came together to help.” 
Participant N: “Fun of it all.” 
Participant AA: “A lot. I am now part of an exercise group. I have 
more friends and am not alone with pain anymore.” 
Participant NN: “…every week's meeting and to exercise in a 
group as we motivate each other.” 
Participant WW: “Learnt how to be more sociable.” 
Participant XX: “The group exercises were better than exercising 
alone.” 

























Participant K: “Diet, healthy eating for myself.” 
Participant L: “Helpful for myself and others at home and 
around me.” 
Participant N: “Everything.” 
Participant P: “I’m just teaching others from the book.” 
Participant S: “Learnt about a lot of things I didn’t know 
before.” 
Participant V: “The nutrition section.” 
Participant AA: “Yes.” 
Participant CC: “That we had to write our illnesses down.” 
Participant NN: “All the knowledge that I gained.” 
Participant UU: “Everything.” 
Participant WW: “it was very interesting. Learnt a lot of 
knowledge from the experience.” 
Participant XX: “All the knowledge that I gained. It was 
fantastic.” 
Participant YY: “it was clear and understandable.” 
 
Participant A: “Exercises.” 
 
Participant R: “…also the section about pain management and 
not having to rely on pills” 
Participant B: “Everything I learnt, especially about self-
confidence.” 
Participant R: “It was helpful when it spoke about 
communication with others and getting support.” 
 






Appendix R: CONSORT table 
Table R-1 CONSORT guidelines and indication of chapter where items were addressed 
Section/Topic Item 
No 
Checklist item Reported in 
Title and abstract 1b Identification as a randomised trial in the title 







Scientific background and explanation of rationale 
Specific objectives or hypotheses 




Trial design 3a 
3b 
Description of trial design (such as parallel, factorial) including allocation ratio 





Eligibility criteria for participants 
Settings and locations where the data were collected 
Chapter 3.2 
Chapter 3.2 and 
3.5 
Interventions 5 The interventions for each group with sufficient details to allow replication, including how and when 
they were actually administered 
Chapter 3.5 and 





Completely defined pre-specified primary and secondary outcome measures, including how and when 
they were assessed 
Any changes to trial outcomes after the trial commenced, with reasons 
Chapter 3.4 and 
Appendix E 
Chapter 3.4, 3.6  
and Appendix E 
(pg. 219) 
Sample size 7a 
7b 
How sample size was determined 
When applicable, explanation of any interim analyses and stopping guidelines 
Chapter 3.3 





Method used to generate the random allocation sequence 





9 Mechanism used to implement the random allocation sequence (such as sequentially numbered 
containers), describing any steps taken to conceal the sequence until interventions were assigned 
Chapter 3.6 and 
3.7 





Checklist item Reported in 
Implementation 10 Who generated the random allocation sequence, who enrolled participants, and who assigned 





If done, who was blinded after assignment to interventions (for example, participants, care providers, 
those assessing outcomes) and how 
If relevant, description of the similarity of interventions 
Chapter 3.6 
Statistical methods 12a 
12b 
Statistical methods used to compare groups for primary and secondary outcomes 
Methods for additional analyses, such as subgroup analyses and adjusted analyses 
Chapter 3.8 
Results 
Participant flow (a 





For each group, the numbers of participants who were randomly assigned, received intended 
treatment, and were analysed for the primary outcome 






Dates defining the periods of recruitment and follow-up 
Why the trial ended or was stopped 
Chapter 4.3 and 
Appendix C 
Baseline data 15 A table showing baseline demographic and clinical characteristics for each group Error! Reference 
source not 
found. – 4.3 
Numbers analysed 16 For each group, number of participants (denominator) included in each analysis and whether the 
analysis was by original assigned groups 







For each primary and secondary outcome, results for each group, and the estimated effect size and 
its precision (such as 95% confidence interval) 
For binary outcomes, presentation of both absolute and relative effect sizes is recommended 
Chapter 4.3 – 4.8 
and 4.10 and 
Appendix I - Q 
Ancillary analyses 18 Results of any other analyses performed, including subgroup analyses and adjusted analyses, 
distinguishing pre-specified from exploratory 
Chapter 4.3 – 4.8 
and 4.10 and 
Appendix I - Q 
Harms 19 All important harms or unintended effects in each group  
Discussion 
Limitations 20 Trial limitations, addressing sources of potential bias, imprecision, and, if relevant, multiplicity of 
analyses 
Chapter 5.8.2 
Generalizability 21 Generalizability (external validity, applicability) of the trial findings Chapter 5.8.1 
and 5.9 
Interpretation 22 Interpretation consistent with results, balancing benefits and harms, and considering other relevant 
evidence 
Chapter 5.9 and 
6 
Other information  





Checklist item Reported in 






Protocol 24 Where the full trial protocol can be accessed, if available N/A 
Funding 25 Sources of funding and other support (such as supply of drugs), role of funders Acknowledgeme
nts 
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